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Neurobehavioural problems (i.e. cognitive impairment/behaviour problems) are common in 
childhood epilepsy. There are very limited data in children with early-onset epilepsy (CWEOE; 
onset ≤4 years). This study: (1) estimated the incidence of early-onset epilepsy, (2) described 
the spectrum and prevalence of neurobehavioural problems in CWEOE, and their risk factors, 
and (3) explored eye-gaze behaviour as a marker of neurobehavioural problems. 
This two year, prospective, population-based, case-controlled study identified newly 
diagnosed CWEOE in South East Scotland using active multi-source capture-recapture 
surveillance. CWEOE and controls completed detailed age-appropriate neuropsychological 
assessment - including Bayley III/WPPSI III, NEPSY II and social-emotional behaviour 
questionnaires. Children completed five eye-tracking tasks which assessed memory, attention, 
and social cognition.  
59 CWEOE were identified (36M:23F); ascertainment-adjusted incidence 62/100,000 ≤4yrs/yr 
(95%CI 40-88). Asian and White-European children were at increased risk of epilepsy. 46 
CWEOE (95%CI 62-84, 27M:19F) and 37 sex-age matched controls (18M:19F) underwent 
neuropsychological assessment. CWEOE had poorer general cognitive ability (p<.001, 𝜂2=.24), 
and increased parent reports of abnormal behaviour – significantly so in adaptive behaviour, 
ASD behaviours, hyperactivity/inattention, and atypical social behaviour. Overall 63% of 
CWEOE met criteria for neurobehavioural problems across multiple domains, vs 27% of 
controls (p<.001). Risk factors varied by domain. Prematurity and symptomatic/cryptogenic 
aetiology were common risk factors but other seizure-related variables were not. CWEOE with 
social problems exhibited abnormal eye-gaze behaviour toward social stimuli. Subtle 
atypicalities in sustained attention were noted in CWEOE, and an unexpected absence of 
antisaccade production was seen in all children.  
This is the first population-based study to describe the neurobehavioural profile, and explore 
eye-gaze behaviour, in CWEOE. Neurobehavioural problems are present, detectable, and 
highly prevalent in CWEOE, with implications for medical, psychosocial and educational 
resource provision, and provides an argument for early intervention. Eye-tracking may be a 
viable marker of neurobehavioural problems, and this study provides impetus for future eye-
tracking investigations in CWEOE. Lastly, certain ethnic groups may be at increased risk of 




Thinking and behaviour problems have been reported in up to 80% of school aged children 
with epilepsy. Much less is known about the extent and types of problems in children with 
early-onset epilepsy (CWEOE; epilepsy which starts in children under five years of age). This 
study aimed to describe the kinds of problems CWEOE might have, how often they occur, and 
to also explore what might increase the risk of these problems occurring. It is helpful to identify 
new ways that problems could be detected early in life, when children could be helped more 
quickly. This study used a technology that tracked children’s eye movements, to see if using 
this method would help identify problems in CWEOE at a very early age. 
To meet the aims above, this study attempted to find all children, who had recently been 
diagnosed with epilepsy, in an area of South-East Scotland. These CWEOE, along with healthy 
control children of the same age, completed some assessments that measured their thinking 
and reasoning, while parents answered questionnaires that evaluated the children’s behaviour. 
The children’s eye movements were tracked while watching some specially designed pictures 
and animations.  
The number of new cases of CWEOE in South-East Scotland was determined, and meant that 
every year there are approximately 62 new diagnoses of epilepsy, for every 100,000 children 
under the age of five. Children from mainland Europe and of Asian origin were at increased 
risk of developing epilepsy compared to white British children. CWEOE had more problems 
with thinking and behaviour compared to control children. A broad spectrum of problems were 
identified in CWEOE, with 63% having a problem with thinking and/or behaviour, compared to 
27% of controls. Those CWEOE who had epilepsy as the result of a structural brain abnormality, 
who were born premature, or who had a family member with a thinking or behaviour problem, 
were more likely to have a thinking or behaviour problem themselves. CWEOE looked less at 
pictures of children during eye-tracking compared to healthy control children, which may 
indicate a difficulty in social reasoning in CWEOE.  
Given that problems are evident and detectable during infancy, toddlerhood, and preschool, 
there are implications for the care and management of CWEOE in Scotland. Thus, the findings 
may be of interest to researchers, and medical, social, and educational policy makers. It also 
provides argument for early intervention in CWEOE. Eye tracking has shown potential as a tool 
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Chapter I.  Introduction and Study Background 
 
*** 
Chapter I offers an introduction to this thesis, and argues the rationale and importance of 
gathering data on neurobehavioural problems in children with early-onset epilepsy (i.e. 
CWEOE; onset ≤4 years). A systematic literature review on the subject revealed a major gap in 
detailed information on the prevalence and spectrum of neurobehavioural problems in 
CWEOE, providing justification for the current study. The chapter then describes the structure 






1.1 Neurobehavioural Comorbidities in Epilepsy: A call to Action 
The importance of knowledge and understanding of epilepsy and comorbid neurobehavioural 
problems (i.e. cognitive impairments and behavioural problems) is of paramount importance. 
The International League Against Epilepsy (ILAE1) has recognised the presence and importance 
of neurobehavioural problems by incorporating this into the very definition of epilepsy itself, 
conceptually defining it as “a disorder of the brain characterised by an enduring predisposition 
to generate epileptic seizures and by the neurobiologic, cognitive, psychological, and social 
consequences of this condition” (Fisher et al., 2005). Epilepsy has a substantial economic 
burden (Hunter et al., 2015; Strzelczyk et al., 2008), and is an important detriment to quality of 
life - more so than other health conditions (Moreira et al., 2013). Neurobehavioural problems 
add to the financial and health burden imposed by seizures, and further impair quality of life 
beyond that of seizures themselves (Ferro et al., 2013).  
The significance of impairing comorbid conditions has been recognised by the scientific 
community, who have called for increased funding and research into neurobehavioural 
problems in childhood epilepsy (Baulac et al., 2015; England et al., 2012). In 2010 the Institute 
of Medicine (England et al., 2012) set out a number of recommendations to promote and 
improve research into epilepsy and its comorbidities, with a view to improving understanding 
and public health; citing the financial, social, and health-care challenges associated with 
epilepsy, as well as the personal consequences of the condition toward education, 
employment, stigma and quality of life.  The World Health Organisation’s Resolution on the 
Global Burden of Epilepsy (WHO, 2015) recognised the need to transform and implement 
policy change surrounding all aspects of care for people with epilepsy by ‘urging’ member 
states, including the UK, to: 
Strengthen effective leadership and governance, for policies on general health, mental health 
and noncommunicable diseases that include consideration of the specific needs of people with 
epilepsy, and to make the financial, human and other resources available that have been 
identified, as necessary, to implement evidence-based plans and actions (p. 3) 
                                              
1 See appendix J for a full list of common abbreviations used in this thesis. 
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Furthermore, in 2013 the European Forum on Epilepsy Research recommended a number of 
research priorities, which have been summarised by the ILAE and International Bureau for 
Epilepsy’s (IBE) joint task force (Baulac et al., 2015). The task force has recommended particular 
focus into childhood epilepsy populations, endorsing research that promotes understanding 
of comorbidities, and factors that lead to neurobehavioural problems, in the developing brain. 
Such research has been recommended with the aim of increasing public awareness of epilepsy 
and its comorbidities, and to craft local and European policy and legislation in order to improve 
community integration and access to health-care services. 
The need to address neurobehavioural comorbidities in the first five years of life are of 
particular concern given the increased epileptogenic nature of the developing brain, and its 
vulnerability to abnormal and maladaptive development (Dennis et al., 2013). The National 
Scientific Council on the Developing Child (NSC, 2007) has advocated the need for early 
childhood policies and practices across the first five years of life, for all children, which support 
healthy development, and which are preventative, or intervening, in factors or processes that 
contribute toward maladaptive development. Therefore, data on comorbidities in children with 
early-onset epilepsy (CWEOE, onset ≤4 years) is of critical importance in order to meet the 
requirements of understanding epilepsy within the developing brain, and to understand the 
burden of epilepsy on the child, family and wider community.  
Early childhood would be the most advantageous time to identify those with, or at risk of, 
neurobehavioural problems, in order to put interventional or preventative strategies into place. 
Despite a lack of clinical focus and neuropsychological assessment in very early childhood 
(Baron and Anderson, 2012), evidence suggests behavioural problems are common and 
detectable during the early-onset period (Bagner et al., 2012; Poulou, 2015), and are often 
stable, persisting into adolescence and adulthood (Asendorpf et al., 2008; Bayer et al., 2011; 
Bosquet and Egeland, 2006). Taken together with evidence that childhood epilepsy is 
associated with adverse psychosocial consequences in adulthood, even in cases with seizure 
remission (Camfield and Camfield, 2009; Camfield and Camfield, 2010; Chin et al., 2011; Jalava 
et al., 1997; Sillanpaa et al., 1998; Wakamoto et al., 2000; Wirrell et al., 1997) (c.f. Camfield and 
Camfield, 2014), it is imperative to intervene early to improve both current circumstances, and 
future psychosocial outcomes. Early interventions have been shown to be effective. In a 
systematic review of randomised control trials in children 0-8 years old, Bayer and colleagues 
(2009) concluded that early interventions have been successful in reducing internalising and 
externalising problems. Furthermore, early interventions can have lasting implications into 
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adulthood (Hawkins et al., 1999), and may be more advantageous than school-age 
interventions (Ramey and Ramey, 1998), and more cost effective (Chowdry and Oppenheim, 
2015).  
Taken together, the identification of, and knowledge surrounding, neurobehavioural 
comorbidities in CWEOE is extremely valuable toward the formulation of health, social, and 
educational policy, as well as vital toward targeted, early medical and psychosocial 
intervention. 
1.2 Early-Onset Epilepsy: An Important but Understudied Risk Factor 
Here, the argument is put forward for an increased risk of abnormal neurobehavioural 
development in CWEOE compared to later childhood onset epilepsies. First, the theoretical 
ground for an increased biological risk is stated, then some of the current evidence from the 
scientific literature is reported to support that assertion. It is acknowledged that this answer 
remains uncertain and incomplete, and that further evidence is required.    
Neurogenesis is lifelong. However, at no point is it faster than during the prenatal period and 
early years of life. By four or five years of age the brain weighs approximately 89% of that of 
an adult brain (Dekaban and Sadowsky, 1978), and cerebral volume has reached 95% of its 
adult peak by age six (Lenroot and Giedd, 2007). The first years of life include rapid overgrowth 
of neurons and differentiation, neuronal maturation and elaboration, and axonal myelination 
(Anderson et al., 2001). Neural overgrowth and pruning occur at different locations at different 
times, meaning that structural and functional development in those regions may be particularly 
sensitive during those periods (Thompson and Nelson, 2001). Magnetic resonance imaging 
(MRI) studies show age-related changes in cortical area size, cortical thickness, and in 
functional development during infancy and the preschool years (Brown and Jernigan, 2012) - 
with the development of psychological skills presumably mirroring those anatomical and 
functional changes within the brain. To date, there is limited direct imaging evidence to 
corroborate this in the preschool age group (Brown and Jernigan, 2012). Nevertheless, skill 
development does coincide with neuroanatomical growth and differentiation (Herschkowitz et 
al., 1997; Paterson et al., 2006).   
The brain’s rapidly changing landscape during maturation makes it particularly prone to 
adverse events (Dennis et al., 2013), with evidence suggesting that plasticity in the developing 
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brain is not as advantageous as once believed (Dennis et al., 2013). Indeed, there is a higher 
prevalence of developmental (i.e. congenital malformations, neuronal migration abnormalities) 
and structural (e.g. hypoxic-ischemic, post-infection, trauma) antecedents to epilepsy during 
the early years than later childhood (Annegers, 2004). And as will be discussed in section 1.4, 
these structural aetiologies are strongly associated with cognitive impairment. This is of 
particular importance to CWEOE, as the developing brain is more prone to seizures than the 
mature brain. Indeed, febrile and neonatal seizures are common in the first year of life, and the 
incidence of epilepsy (Hauser et al., 1996) and single unprovoked seizures (Olafsson et al., 
2005) are disproportionately higher than at any other time in childhood or adulthood.  
While it is difficult to establish a cause and effect relationship between recurrent epileptic 
seizures and adverse cognition in the childhood brain, epilepsy and repeated seizures may 
have a more prominent effect in the very early brain. Rhythmic and synchronous bursts of 
electrical activity (i.e. seizures) in the brain can be a normal adaptive function (Avanzini et al., 
2014), but activity-dependent age-related structural and functional change coupled with 
immature GABA-ergic excitatory/inhibitory mechanisms, and immature synaptic architecture 
contributes to an increased risk of non-adaptive seizures, and the likelihood of maladaptive 
functional and structural changes in response (Ben-Ari and Holmes, 2006; Nardou et al., 2013; 
Sutula, 2004).  
Taken together, the immature brain is a high-risk ground for abnormal development. Indeed, 
early age of epilepsy onset is associated with poor developmental and cognitive outcomes 
(Battaglia et al., 1999b; Chevrie and Aicardi, 1978; Rantanen et al., 2011; Vendrame et al., 2009), 
and is the period that includes most of the epileptic encephalopathies (Neville, 1997).  An 
increased risk of cognitive impairment is also seen in those children with refractory seizures 
undergoing epilepsy surgery who have earlier onsets (Cormack et al., 2007; Freitag and 
Tuxhorn, 2005; Lespinet et al., 2002; Vasconcellos et al., 2001). Several studies have 
demonstrated that early-onset epilepsy is associated with poorer cognitive outcomes than 
onset after five years of age (Berg et al., 2008; Dikmen et al., 1977; O'Leary et al., 1981; O'Leary 
et al., 1983; Reilly et al., 2014a), even when structural aetiology and encephalopathy are 
controlled for (Battaglia et al., 1999b; Berg et al., 2008).   
Although the theoretical and scientific evidence suggests a strong relationship between 
CWEOE and cognitive impairment, most of the studies mentioned above are based on children 
assessed during the school-age or beyond, and the findings might simply reflect a longer 
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duration of epilepsy when compared to children whose onset began in later childhood. An 
effect of early age of onset does remain in some studies after controlling for epilepsy duration 
(Dikmen et al., 1977; Hermann et al., 2002), but not in all (Park et al., 2013). There is also 
emerging evidence to suggest that poorer cognition may be due to the duration of epilepsy 
as a function of poor seizure control, rather than because of age-of-onset, or length of epilepsy, 
per se (Berg et al., 2012; Park et al., 2013).  
The above data suggest the relationship between early-onset epilepsy and neurobehavioural 
problems is unclear. Primarily, data on the prevalence and spectrum of neurobehavioural 
problems during the early-onset period itself, rather than during later childhood or adulthood, 
is required in order to understand if problems exist during the early stages, or if they are more 
likely to develop in later childhood. To address this lack of knowledge a systematic review on 
the topic was undertaken. 
1.3 Prevalence and Spectrum of Neurobehavioural Problems in CWEOE: A Systematic Review  
1.3.1 Systematic Review: Methods 
Studies of early childhood often report observations from parent interview and clinic 
observation. While this is useful, in order to increase the empirical validity of findings, this 
review focused on studies reporting standardised psychometric data. The main goal of the 
literature review was to identify studies with psychometric data reported from standardised 
cognitive and behavioural assessment tools on five or more CWEOE during the first five years 
of life. This review follows the guidance set out in the Preferred Items for Systematic Reviews 
and Meta-Analyses (PRISMA) report (Moher et al., 2009). 
The electronic databases Medline (Ovid), Embase (Ovid), PsycINFO (Ovid), Web of science Core 
Collection (Thomson Reuters), and CINAHL were systematically searched for period 1970 to 
July 1 2015. Searches were performed August 8 2015 using MeSH terms, database specific 
subject headings, or equivalent, for terms; “children”, “epilepsy”, “cognition”, and “behavior”. 
Indexed searches were supplemented with free-text searches, including non-indexed searches 
for Medline and Embase. Database specific search protocols are documented in appendix A. In 
addition, articles were searched for additional references, and study authors were approached 
for unpublished data when appropriate. 
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Inclusion criteria were: (1) children with physician confirmed, or validated diagnosis of epilepsy 
(≥2 unprovoked seizures), with or without a comorbid condition (e.g. Autism Spectrum 
Disorder, ASD) as the main cohort, (2) age of children were five years or less at the time of 
assessment, (3) cognitive or behavioural assessment using standardised tools or diagnosis of 
behaviour disorder based on Diagnostic and Statistical Manual of Mental Disorders (DSM) or 
International Classification of Diseases (ICD) classifications, (4) English-language based journal 
articles from high and low/middle income countries (World Bank, 2016),  and (5) population-
based, community-based, hospital-based, cohort studies, case-control studies, and case series, 
with the exception of studies with less than five participants meeting criteria, were included.  
Exclusion criteria were: (1) children ≥6 years at time of neuropsychological assessment, (2) 
articles focused exclusively on non-epileptic seizure disorders, neonatal or febrile seizures, or 
exclusively status epilepticus, (3) <5 children with available data , and (4) data based on 
informal parent or clinic observation, or from unvalidated/unstandardised assessment tools. 
Extracted data included assessment scores or qualitative categorisations, based on 
validated/standardised assessment tools. Where possible, individual and group level 
psychometric data were extracted, and means and standard deviations calculated. Study and 
participant demographics, study design, assessment tool, and presence of control group were 
recorded.  
Study selection was carried out by consensus agreement of two reviewers (Candidate & Dr 
Michael Yoong). Titles and abstracts were screened for relevant articles. Full-text papers were 
acquired when title/abstracts did not contain enough information, or when inclusion criteria 
were met. Full-text reviews were carried out applying the above inclusion/exclusion criteria.  
Dr Michael Yoong contributed to the written production of the systematic review, by writing 
an initial draft of the infantile spasms and surgical cohorts sections of the results. The 
remainder of the review was written by the candidate.  
1.3.2 Systematic Review: Results 
(i) Overview 
13,954 articles were screened (figure 1). Fifty-two articles reported psychometric data on 
CWEOE, and met criteria for review. Findings were reviewed according to category: six studies 
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were in CWEOE of all types, 14 were in children with infantile spasms, 18 were in other epilepsy 
syndromes, and 14 were in epilepsy surgery cohorts. As study methods, assessment measures 
and populations were heterogeneous, formal meta-analysis was inappropriate.   
Neuropsychological tools varied but primarily described cognitive or general development in 
terms of developmental quotient (DQ), general quotient (GQ), Intelligence Quotient (IQ), or 
adaptive behaviour. Each of these constructs are standardised to a mean of 100 with a standard 
deviation of 15. Cognitive or developmental impairment is widely classified as an IQ/DQ/GQ 
score <70 (i.e. ≥2 standard deviations, SD, below the mean), with scores in the 71-80 range 
considered borderline, and scores >80 normal. Behaviour scores and problems were reported 
less frequently, with problems typically defined according to DSM criteria. 




(ii) CWEOE Cohorts 
Six articles reported psychometric data on CWEOE of all types (table 1.1). Four reported on 
cognitive or general development - one of which also reported on ASD features (Fisher et al., 
2012b). Three of the four articles were based on single centre studies (Czochanska et al., 1994; 
Fisher et al., 2012a; Vendrame et al., 2009), and the fourth was a population-based study 
(Martinos et al., 2013, additional data obtained from author). The remaining two papers 
focused on adaptive behaviour from the community-based population of the Connecticut 
Study of Epilepsy (Berg et al., 2004; Berg et al., 2013). 
Population-based studies are a preferred source of reporting, with reduced sampling bias and 
greater generalisability of disease characteristics within a culture. The population-based study 
here, however, was limited to a small sample of children (n=18) with epilepsy and an 
accompanying history of convulsive status epilepticus (Martinos et al., 2013, additional data 
obtained from author) – a seizure condition whose effect on cognitive functioning is uncertain 
but possibly detrimental (Novorol et al., 2007). It was, therefore, not possible to build an 
accurate and representative neurobehavioural profile of CWEOE. Nevertheless, it was clear that 
cognitive and general development in CWEOE was unfavourable in significant proportions of 
children represented by the studies, particularly those from at risk populations, including those 
with symptomatic/structural aetiologies.  
Martinos et al. (2013) cohort had a mean cognitive development score, as assessed by the 
Bayley III, in the borderline range (Mean, M, =78.8, SD=17.64). After breaking the cohort down 
by aetiology, those with idiopathic epilepsy were relatively spared (M=90.60) but scores 
decreased markedly in those with cryptogenic (M=79.29), and symptomatic (M=68.33) 
aetiologies. Eight of 18 children (44%) were cognitively impaired – four children with 
cryptogenic aetiology, and four with symptomatic aetiology. Impaired development (DQ<70) 
ranged between 33-91% of children in the remaining three studies. In the first of these, one 
third of children with epilepsy in the first year of life, and over two thirds of children with 
infantile spasms had impaired development (Czochanska et al., 1994). The second found 
developmental impairment in all but three of 33 children (91%), and with an overall extremely 
low mean DQ of 37 (Vendrame et al 2009). However, the children involved in that study were 
either surgical candidates or had been referred for developmental evaluation – two high risk 












N       
(age, m) 
Outcome   
(tool) 
Mean (SD) Other Results Commentary 










78.8 (17.64),  
vs controls 
107.35 (16.87) 
Mean score by aetiology: idiopathic 
90.6, cryptogenic 79.29, and 
symptomatic 68.33. Eight (44%) 
impaired (cognitive score <70). 












63 (69%) children with infantile 
spasms, and 14 (33.3%) with other 
epilepsies were developmentally 
impaired (DQ<70). 
At 3-7 years follow-up, no overall 
change in DQ; poor seizure control 






Epilepsy 33 (<34) 
DQ  
(BSID III) 
37 (29) 30 (91%) had DQ <70 
Lower DQ associated with earlier 
onset, epilepsy duration, and spasms. 
But not seizure type, frequency, or 
brain pathology. No control group. 










47 (72%) had abnormal development. 
32 (49%) had positive screening for 
ASD  
Abnormal development was 
associated with positive ASD 
screening. No control group. 









92 at baseline, 
81.5 at three 
year follow-up 
(trend p<.001) 
Poor adaptive behaviour and decline 
at follow-up in symptomatic 
aetiology or encephalopathy only. 
Cryptogenic/ idiopathic epilepsy 
preserved VABS at 98.1.  
Age of onset not associated with 
VABS, except daily living composite. 
No control group. 












103 (SD 17.1)* 
Adaptive behaviour score predicts 
later achievement at school. 55% of 
cohort had school problems. 
*Derived from supplementary 
material. No control group. 
ASQ – Ages and Stages Questionnaire  
BSID – Bayley Scales of Infant and Toddler 
development 
CG – Control Group 
CSE – Convulsive Status 
Epilepticus 
MCHAT – Modified Checklist for Autism in 
Toddlers 
SCQ – Social Communication Questionnaire 
VABS – Vineland Adaptive 




centre, found abnormal development in 72% of children, based on the Ages and Stages 
Questionnaire; half of whom screened positive for ASD (Fisher et al 2012). Similar to the 
previous study, this cohort may not have been representative of the general epilepsy 
population, as there was an increased risk of referral centre bias (Sackett, 1979). 
Berg and colleagues (2004; 2013), in their community-based cohort, focused on adaptive 
behaviour, as assessed by the Vineland Adaptive Behaviour Scales (VABS). Adaptive behaviours 
are a set of conceptual, social and practical skills, reflective of the child’s ability to develop and 
function in everyday life circumstances. Adaptive behaviour assessment is a necessary 
component in the formulation of an intellectual disability diagnosis. Berg et al found preserved 
adaptive functioning in children with no neurological abnormality and normal IQ (Berg et al., 
2004; Berg et al., 2013). However, adaptive behaviour was significantly poorer in refractory 
epilepsy, symptomatic aetiology, and epileptic encephalopathy (Berg et al., 2004). Interestingly, 
adaptive behaviour scores for those in the former category remained stable across time, but 
declined for those in the latter over the three years of follow-up. Age of onset was not a 
significant predictor of adaptive behaviour, except for the daily-living domain, which was 
higher in the first year of life. 
(ii) Infantile Spasms 
14 papers were found describing a total of 468 patients, all of whom had met clinical criteria 
for a diagnosis of infantile spasms or West Syndrome, herein referred to as infantile spasms, 
(table 1.2). Case definitions were characterised by the electro-clinical triad of: 1) spasms 2) 
hypsarrhythmia on electroencephalogram (EEG) and 3) developmental regression at seizure 
onset. The majority of studies were small cohort studies of consecutive patients with infantile 
spasms from single tertiary centres (Prats et al., 1991; Koo et al., 1993; Guzzetta et al., 1993; 
Ouss et al., 2014)  or groups of centres (Rando et al., 2005; Guzzetta et al., 2008), with two 
larger multi-centre randomised controlled trials also contributing cognitive data on their 
cohorts – the United Kingdom Infantile Spasms Study (UKISS; Lux et al., 2005; O'Callaghan et 
al., 2011), and a Canadian group (Bitton et al., 2012; Bitton et al., 2015). Three small studies 
looked specifically at subgroups: children with prominent visual impairment and infantile 
spasms (Jambaque et al., 1993), children with cryptogenic infantile spasms and good response 
to initial treatment (Gaily et al., 1999) and children with tuberous sclerosis (Humphrey et al., 
2014). Four studies looking at the impact of epilepsy surgery on cognitive outcomes in children 







Table 1.2 Infantile spasms studies 
Author (year) N Outcome (tool) 
Age 
(m) 
Mean DQ (SD) or equivalent  Other results Commentary 
Takahashi et al. 
(1990) 
33 
DQ (Enjoji test 
of development)  
3-32 
89 (14) in children without 
structural brain abnormality (n=8)  
58 (32) in children with structural 
brain abnormality (n=25) 
Follow-up 4m-19y. DQ declined 
in structural brain  abnormality 
group, but not normal brain 
group 
Method of patient selection 
unknown 







12 (28%) had normal intellect, 4 
(9%)  mild impairment, 26 (62%) 
severe impairment 
 
Jambaque et al. 
(1993) 
8 DQ (Gesell) 24-36 49.3 (19.1) 
5 (63%) with severe impairment 
(DQ <60) 
Method of patient selection 
unclear. All patients had moderate-
severe visual loss 




Overall: 55.1 (26.4) 
Cryptogenic 71.2 (24.2) 
Symptomatic 48.3 (24.5) 
41  (73%) impaired (DS <70) 
Cognitive outcome better with 
early AED treatment. No significant 
difference between ACTH or 
nitrazepam treatment groups. 





28-60 39.9 (SD not given)  
22 (71%) had moderate-severe 
delay (DQ < 60) at diagnosis, 
16/29 (55%) at follow-up 
2 patients died during study period 





48-71 96.0 (23.2) 
8 children showed specific 
impairments of attention and/or 
memory 
All children had cryptogenic 
aetiology, and were selected from a 
larger cohort of 46 children with 
infantile spasms 
Rando et al. 
(2005) 
25 DQ (Griffiths) 4-16 
60.3 (31.8) at onset 
56.2 (29.4) at 2 months after onset 
19 (76%) had impairment (DQ < 
70)at onset, 18 (72%) at follow-
up 
3 of 4 children with cryptogenic WS 









Table 1.2 continued 






Overall: 78.0 (14.9)  
Cryptogenic: 83.8 (16.5) 
Symptomatic: 73.3 (11.4) 
 
Higher VABS scores after steroid 
treatment, compared to vigabatrin, 
in cryptogenic infantile spasms. 
Guzzetta et 
al. (2008) 
21 DQ (Griffiths) 24 53.6 (39.9) 
14 (66%) had impairment (DQ < 
70)  
Follow-up study from Rando et al. 
O’Callaghan 





76.2 (28.4) at shortest treatment 
delay (<8 days), to 55.5 (24.3) at 
longest delay (>2m). 
Younger age of onset and longer 
treatments delays associated 
with poorer VABS scores 
Steroid treatment had a positive 
effect on VABS in those with 
unknown aetiology 






7 & 24 
DQ: 38.0 (33.2) at onset, 51.8 
(33.7) at 24 months 
VABS: 90.1 (12.7) at onset, 65.4 
(16.6) at 24 months 
DQ: 29 (64%) had impairment 
(<70) at follow-up 
No significant impact of flunarizine 




IQ (Mullen Scales of 
Early Learning) 
<10-70 
92.4 (23.2) (prior to onset) 
65.9 (11.9) (after seizure onset) 
IQ drop in the 6 children with 
TSC+IS, but none in 5 children 
with TSC+ other seizure types 
Development of spasms in children 
with TSC associated with IQ decline 




ASD (ADI-R, CHAT 
& CARS) 
DQ : 24 
ASD: 48 
59.5 (27.6) 
7 (28%) had ASD, and 2 (8%) had 
PDD-NOS 
CHAT scores were highly predictive 
of eventual autism status. 








ADOS:     
30 & 60 
22/39 (56%) patients assessed 
had DQ <70 
10/44* (22.7%) patients were 
diagnosed with ASD on ADOS 
*25 patients were not assessable 
due to severe delay or death 
ACTH - Adrenocorticotropic Hormone 
ADI-R - Autism Diagnostic Interview - Revised 
ADOS - Autism Diagnostic Observation Schedule 
ASD - Autism Spectrum Disorder 
BSID - Bayley Scales of Infant and Toddler Development  
CARS - Children’s Autism Rating Scale 
CHAT - Checklist for Autism in Toddlers 
NEPSY – Developmental Neuropsychological Assessment 
TSC – Tuberous sclerosis complex 
VABS - Vineland Adaptive Behaviour Scale   
WISC-R – Wechsler Intelligence Scales for Children 
Revised  





A number of different neuropsychological tools were used, predominantly measuring DQ. Two 
studies reported on measures of autism, and the two larger multi-centre studies used the VABS 
to measure adaptive behaviour. Despite the varying methodology, all studies of an unselected 
cohort of children with infantile spasms found them to be highly impaired, with 60-70% of 
children having moderate-severe impairment, and mean reported DQ between 40 and 60, with 
the exception of a small group of children with normal brain imaging who had a mean DQ of 
89 (Takahashi et al., 1990). Standard deviations were high, suggesting considerable 
heterogeneity of outcome. Children without a diagnosed aetiology for infantile spasms (i.e. 
cryptogenic) performed better; with significantly higher DQ (Koo et al., 1993) and lower rates 
of moderate-severe impairment (Rando et al., 2005). Gaily et al (1999) found that 15 patients 
with cryptogenic infantile spasms who became seizure-free on medication had IQs within the 
normal range, although over half of them showed measurable deficits of attention and/or 
memory suggesting the persistence of subtle deficits.  
The timing of assessment was important, as two studies with longitudinal measurements 
reported that cognitive scores are lowest at seizure onset and improved at 1-2 year follow-up, 
albeit remaining in the moderate-severely impaired range (Guzzetta et al., 1993, Bitton et al., 
2012). The one study that found scores to remain static (Rando et al., 2005), re-tested children 
2 months after seizure onset, which may be too early to see meaningful clinical recovery and 
cognitive improvement. 
Changes in medical practice do not appear to have made significant impacts on cognitive 
outcomes, with similar rates of impairment in more recent studies (Ouss et al., 2014, Bitton et 
al., 2015) as earlier ones (Prats et al., 1991, Koo et al., 1993), despite different treatment 
regimes. An interesting study by Humphrey et al (2014) that monitored 11 children with 
tuberous sclerosis before and after the onset of seizures and showed that, at least for this 
group of patients, DQ fell from the normal range prior to seizure onset, deteriorating markedly 
after the of spasms, but not other forms of epilepsy.  
The two more recent clinical trials (Lux et al., 2005; Bitton et al., 2012) showed that children 
with infantile spasms also perform below population norms on measures of adaptive 
behaviour.  Bitton et al. (2012) were also able to show an impact on cognition at baseline and 
at 2 years, consistent with the DQ scores reported in previous studies. Neither showed an effect 




spasms showed significant improvements in adaptive behaviour with hormonal treatment (Lux 
et al., 2005; O’Callaghan et al., 2011), or flunarizine (Bitton et al., 2012). Interestingly, age of 
seizure onset and time delay from first seizure to treatment, were independently and negatively 
correlated with VABS scores by four years of age (O’Callaghan et al., 2011).   
Performance on autism-specific screening tools (PreAut, CHAT) was found to be strongly 
related to lower DQ (Ouss et al., 2014; Bitton et al., 2015).  However, the general risk of Autism 
was much higher than the general population, regardless of DQ. 
In summary, there is now good quality data from prospective multicentre infantile spasms 
cohorts recruited as part of randomised controlled trials that confirm the findings from earlier 
case series. That being, approximately 60% of children with infantile spasms have moderate-
severe impairment in cognition, adaptive behaviour and/or autism. The risk of this is highest 
in symptomatic IS, and lower in children with cryptogenic IS. Children with cryptogenic infantile 
spasms may benefit from rapid treatment, but the evidence for symptomatic causes is weaker.  
(iii) Other Early-Onset-Related Syndromes 
Eighteen single- and multi-centre studies, describing nine early-onset syndromes, excluding 
infantile spasms/west syndrome, were included for review. Study details can be found in table 
1.3 (several studies compared younger age groups with older onset groups. These have been 
referenced in the table for comparison). Dravet Syndrome, was described in seven of those 
studies (39%), with the eight remaining syndromes represented by only one (Benign Epilepsy 
with Centrotemporal spikes, PCDH19-related epilepsy, Symptomatic Focal Epilepsy, and 
Sturge-Weber Syndrome) or two studies (Benign Myoclonic Epilepsy of Infancy, Childhood 
Absence Epilepsy, and Panayiotopoulos Syndrome). Sample sizes varied between 5 and 110 
children across studies, with 12 (67%) having ≤15 children. No study had a control group. 16 
of 18 studies described cognitive development via DQ, IQ, or GQ. Nine studies reported 
behavioural data. Behaviour disorders, including ASD and ADHD, were identified using the 
DSM in four, whilst three studies reported behaviour outcomes using the CBCL or SDQ 
questionnaires. 
Despite receiving limited and uneven attention, several broad conclusions can be proposed. 







Table 1.3 Studies of other early-onset-related syndromes  
Author (year) Location 
Type 
(N) 
Age Outcome (tool) Results Commentary 




DS (62) 24-60m Total Stress  (SDQ) 
2 & 3y old children scored in borderline range 
(16, SD 6). 4 & 5y old children scored in high risk 
range (18, SD 5). 
Similar scores noted in children >5 years. 
Behaviour most important predictor of 
quality of life. 








Mean DQ 79.5 (SD 12.0) in children <2 years, 
and 73.7 (SD 15.0) in children <3 years of age. 
Long term follow-up showed decrease in 
DQ/IQ after age 3. 13/15 children with 
DQ <60. No difference in DQ/IQ between 
SCN1A+ or -. Abnormal learning and 
hyperactivity and attention deficit noted, 
at 2-5y. Figures not stated by age.  








GQ (Griffiths) & 
Various cognitive 
tests 
GQ in normal range for 5 patients <3 years of 
age. Nine children had subnormal cognition by 
age 5.  Visuomotor and perceptive skills 
particularly affected, even in those with normal 
GQ. Those with borderline DS did not have 
motor disorders. 
After long term follow-up (≤10y), 
cognitive decline was found to occur 
between 3-5 years before stabilising.  












Mean GQ/DQ 100.5 (SD 9.5) at 6-12m. Cognitive 
decline in four children at final follow-up (30-
51m); mean 94 (SD 16.5). One had IQ <70.  
Four patients had visual dysfunction by fourth 
year of age. Three had behaviour issues. 
Behaviour was normal in two cases. Two also 
had emotional problems. 
Visual impairment precedes cognitive 
decline in the early stages of DS. 
BECTS – Benign Epilepsy with Centrotemporal 
Spikes 
BMEI – Benign Myoclonic Epilepsy of Infancy 
BVMGT – Bender Visual Motor Gestalt Test 
CAE – Childhood Absence Epilepsy  
CBCL – Childhood Behaviour Checklist 
CRS – Conners Rating Scale 
DS – Dravet syndrome 
PS – Panayiotopoulos Syndrome 
SDQ – Strength and Difficulties 
Questionnaire 
SFE – Symptomatic Focal Epilepsy 
SWS – Sturge Weber Syndrome 
TSC – Tuberous Sclerosis Complex 






Table 1.3 continued 
Author (yr) Location Type (N) Age Outcome (tool) Results Commentary 








Mean GQ 88.46 (SD 14.56) at 12m, and 56.15 (SD 
22.09) at 60m. All but two children aged 4-26m 
had normal GQ. At 60m 19 had GQ <70. 
Absence of myoclonus and absences 
early in disease course may be associated 
with a reduction in severity of cognitive 
decline. SCN1A variations were not 
predictive of cognitive outcome. 




DS (5) 2y & 4y 
GQ (Griffiths) 
Various visual tests 
Mean GQ 88.2 (SD 16.24) at 2 years, and 
75.2 (SD 14.70) by 4 years of age.  
Evidence of broad visuomotor/cognitive 
and executive difficulties. 
Mean GQ/IQ 59 (SD 9.54) by age 6-8 years.  




DS (8) ≤65m DQ (Brunet-Lezine) Mean DQ 50.88 
Age-related DQ decline noted, stabilising at 
age 4 years. Behavioural abnormalities noted, 













Mean DQ/IQ 64.87 (SD 26.18). Six 
children (75%) had DQ/IQ <70. Six 
children had behaviour problems: most 
notably hyperkinesia in four. 
Children aged 6-16y mean DQ/IQ 58.53 (SD 
32.15). 67% had DQ <70. Abnormal behaviour 
in 67%, including 6 with ASD. Cognitive 











Eleven children (73.3%) were intellectually 
impaired (IQ<69), seven of those severely. 
Cortical dysplasia associated with poorer 
cognitive outcome. Six children >5y at test, all 
with moderate-severe impairment.  
BECTS – Benign Epilepsy with Centrotemporal 
Spikes 
BMEI – Benign Myoclonic Epilepsy of Infancy 
BVMGT – Bender Visual Motor Gestalt Test 
CAE – Childhood Absence Epilepsy  
CBCL – Childhood Behaviour Checklist 
CRS – Conners Rating Scale 
DS – Dravet syndrome 
PS – Panayiotopoulos Syndrome 
SDQ – Strength and Difficulties 
Questionnaire 
SFE – Symptomatic Focal Epilepsy 
SWS – Sturge Weber Syndrome 
TSC – Tuberous Sclerosis Complex 






 Table 1.3 continued 
Author (yr) Location Type (N) Age Outcome (tool) Results Commentary 
Verrotti et al. 
(2011) 
Italy CAE (9) 47-71m IQ (WPPSI-R) 
Eight (89%) had normal intellectual 
development. One had mild cognitive 
impairment (IQ 69).  
Further 31 children 5-15y at test. Overall, 83% 
had normal IQ. Poor IQ associated with poor 
seizure control.  
Masur et al. 
(2013) 
USA CAE (110) 30-60m 
IQ/Attention/ 
Executive Function  
(including WPPSI-III 
and K-CPT) 
Mean IQ 97.6 (SD 16.2). Normal 
vocabulary, verbal memory, and 
visuomotor ability. 17% had attention 
difficulties at baseline.   
Children tested prior to AED treatment. Similar 
results found in 336 children >5 years. 
Attention problems, mainly inattentive, 
persisted at follow-up. Attention deficits 
related to AED type.  
Auvin et al. 
(2006) 
France BMEI (8) 38-67m 
IQ (WPPSI-R) and/or 
Adaptive Behaviour 
(VABS) 
Mean IQ 79.5 (SD 10.34). Mean adaptive 
behaviour 85.2 (SD 16.16). 
Similar results found in 12 patients 6-26y; 
VABS mean 83.42 (SD 20.9). 
Mangano et 
al. (2005) 









Mean DQ 91.71 (SD 15.09), and IQ 78.57 
(SD 14.36) at follow-up. 2 children had 
language impairment and 2 had 
visuomotor deficits. 
Final follow-up 5-10y, Mean IQ 74.0 (SD 
18.43). Behaviour issues reported but 








1y & 5y 
GQ (Griffiths) 
Behaviour (DSM-IV) 
Mean GQ 81.2 (SD 22.19) at 1y, and 78.6 
(SD 24.28) at follow-up (3-5y). All had 
language delay. One had ASD and three 
had attention difficulties.  
Including 6 others (n=11), long-term follow-
up 3-37y: Mean GQ/IQ/AQ= 61.6 (SD 27.4). 5 
had ASD, 1 had mood disorder, and 5 had an 
attention deficit  
BECTS – Benign Epilepsy with Centrotemporal 
Spikes 
BMEI – Benign Myoclonic Epilepsy of Infancy 
BVMGT – Bender Visual Motor Gestalt Test 
CAE – Childhood Absence Epilepsy  
CBCL – Childhood Behaviour Checklist 
CRS – Conners Rating Scale 
DS – Dravet syndrome 
PS – Panayiotopoulos Syndrome 
SDQ – Strength and Difficulties 
Questionnaire 
SFE – Symptomatic Focal Epilepsy 
SWS – Sturge Weber Syndrome 
TSC – Tuberous Sclerosis Complex 






Table 1.3 continued 
Author (yr) Location Type (N) Age Outcome (tool) Results Commentary 






36-54m IQ (WPPSI-III) 
Mean IQ 101.60 (SD 20.16) 
Control data not reported 
10 children aged 6-12y. Mean IQ 63.2 (SD 
15.36). IQ associated with white matter 
abnormalities. 










7 (66%) had neurobehavioural disorders. 
Two had borderline to mild retardation 
(i.e. 80-50 IQ), 1 had ADHD, 1 ASD, and 1 
learning disability. 
No difference in IQ between atypical or 
typical PS (n=45, 18-91m). However, 
incidence of neurobehavioural disorders 
higher in atypical PS. 










IQ (Modified Binet/ 
WPPSI) 
Behaviour (DSM-IV) 
BECTS had significantly more 
development and behaviour disorders 
(Asperger’s, LD, ADHD) than PS (21% vs 
8%).  BECTS had significantly more 











Adaptive behaviour score 90.56 (SD 
12.86). Auditory and visuomotor skills 
were impaired. 
No difference in adaptive behaviour vs a late 
onset epilepsy group (n=8, 6-8y). Different 
pattern of impairment between ages 
suggests epilepsy onset at different periods 
interferes with different developing 
functions.  
BECTS – Benign Epilepsy with Centrotemporal 
Spikes 
BMEI – Benign Myoclonic Epilepsy of Infancy 
BVMGT – Bender Visual Motor Gestalt Test 
CAE – Childhood Absence Epilepsy  
CBCL – Childhood Behaviour Checklist 
CRS – Conners Rating Scale 
DS – Dravet syndrome 
PS – Panayiotopoulos Syndrome 
SDQ – Strength and Difficulties 
Questionnaire 
SFE – Symptomatic Focal Epilepsy 
SWS – Sturge Weber Syndrome 
TSC – Tuberous Sclerosis Complex 




of studies reported mean IQ/DQ/GQ scores in the borderline, or impaired ranges, or they 
reported moderate-high percentages of children with developmental impairment. Secondly, 
developmental profiles differed between syndromes in severity and extent, suggesting some 
syndromes are more at risk than others. Finally, behaviour problems and other developmental 
or cognitive skills (e.g. attention or visuomotor skills) were apparent, when investigated. Of the 
studies applying DSM criteria, behaviour problems were identified in 8-80% depending on 
syndrome studied (Cappelletti et al., 2015; Hirano et al., 2009; Jambaque et al., 1991; Ohtsu et 
al., 2008). Although no control groups were available for comparison, these figures are 
considerably higher than the estimated prevalence of 6-7% in the general preschool-age 
population (Niemczyk et al., 2015; Wichstrom et al., 2012). These were found to be present 
despite preserved IQ or adaptive functioning (e.g. Masur et al., 2013; Gonzalez et al., 2014), 
suggesting that difficulties in early-onset syndromes are multi-dimensional. The main 
outcomes of the early-onset-related syndromes are summarised below. 
Dravet Syndrome is a well-documented epileptic syndrome associated with severe long-term 
developmental regression and intellectual impairment. Studies reviewed here showed a clear 
pattern of age-related developmental decline over the first five years of life, typically after age 
two or three years. Four of seven studies were conducted by Chieffo and colleagues (Chieffo 
et al., 2011b; Chieffo et al., 2011c; Ragona et al., 2011; Ricci et al., 2015), using overlapping 
cohorts. They showed that Dravet Syndrome presents with normal intellectual development 
during the first two years of life followed by progressive cognitive decline. Although this may 
be debatably regarded as developmental stagnation rather thean decline. Borderline cases of 
Dravet Syndrome (i.e. children with severe myoclonic epilepsy in infancy without myoclonic 
seizures or atypical absence seizures) often present with an absence of gross motor 
dysfunction and later cognitive stagnation compared to non-borderline cases (Chieffo et al., 
2011a). Visuo-motor dysfunction may be a universal feature of the syndrome, even during late 
development of the syndrome (Ricci et al., 2015). The pattern of age-related cognitive 
stagnation was supported in two other single-centre studies (Nabbout et al., 2013; Wolff et al., 
2006b). Age-related increases in behavioural difficulties, as measured by the SDQ, were also 
reported (Brunklaus et al., 2011), although it is unclear what the precise nature of those 
difficulties entailed. Hyperactivity and attention deficit was noted between ages 2 and 5 in one 




Childhood Absence Epilepsy (CAE) peaks between the ages of 5-7 years, and is associated with 
normal intellectual development, although subtle neuropsychological and behavioural 
difficulties have been reported (Caplan et al., 2008). Two multi-centre studies with data 
gathered on 119 children with early-onset CAE (onset <3 years) were included for review here 
(Masur et al., 2013; Verrotti et al., 2011).  Verrotti et al. (2011) reported normal IQ in eight of 
nine children. Similarly, Masur et al. (2013) found normal IQ (M=97.6, SD=16.2) in a larger 
sample of 110 children. However, Masur et al. also noted that 17% of children ≤5 years had 
attentional difficulties, as assessed by the KIDDIE Continuous Performance Test. Interestingly, 
poor attention was evident at study entry, prior to antiepileptic drug (AED) treatment. 
Tuberous sclerosis complex (TSC) is an autosomal disorder often accompanied by epilepsy. 
Approximately 45% of children with TSC have intellectual impairment, which is strongly 
associated with the presence of epilepsy (Joinson et al., 2003). Two papers reviewed here, 
describing 23 children with TSC and early-onset epilepsy, support that assertion (Jambaque et 
al., 1991; Kotulska et al., 2014). Three quarters of the samples were found to be intellectually 
impaired, often severely so. 
Benign Myoclonic Epilepsy of Infancy (BMEI) is a rare idiopathic generalised form of epilepsy 
occurring before age three. The two studies reviewed here both reported mean IQ in the 
borderline range, between three and five years of age (Auvin et al., 2006; Mangano et al., 
2005a). There was a notable decline between DQ (1-3 years of age) and IQ at 3-5 years, in a 
longitudinal follow-up assessment (Mangano et al., 2005b), suggesting developmental 
stagnation. Additionally, two children displayed language impairment and two had visuomotor 
deficits in that study.   
The remaining five studies had modest sample sizes and described six different syndromes 
with variable outcome measures. One study included both Panayiotopoulos Syndrome and 
Benign Epilepsy with Centrotemporal Spikes (BECTS) (Ohtsu et al., 2008). It is impossible to 
draw firm conclusions for each syndrome based on a very limited pool of studies. However, 
from the available data, it was evident that developmental and behavioural profiles differed 
across syndromes, and in many cases adversely so. Specifically, IQ was in the normal range in 
those with epilepsy and Sturge-Weber syndrome (Alkonyi et al., 2011), while GQ was in the 
borderline range in PCDH19-related epilepsy (Cappelletti et al., 2015). All those with PCDH19-
related epilepsy (n=5) also had language delay, and ASD or attention difficulties. 8% of children 




Syndrome (Hirano et al., 2009), and 21% with early-onset BECTS (Ohtsu et al., 2008) had 
developmental or behavioural problems. Lastly, adaptive behaviour was in the normal range 
in children with symptomatic generalised epilepsy, but as a group, children had 
visuoperceptive and auditory deficits (Gonzalez et al., 2014). 
(iv) Surgical Cohorts 
Fourteen papers meeting inclusion criteria were identified that described series of patients 
undergoing epilepsy surgery (table 1.4). All represent case series from single centres, with the 
largest cohort being 55 patients by Jonas et al. (2005). The majority of papers described a 
mixed case load of children with any symptomatic epilepsy occurring in the first years of life 
who received resective surgical treatment for epilepsy. Four papers described cohorts of 
children with symptomatic infantile spasms, and there were single papers describing series of 
children with focal cortical dysplasia (Tanaka et al., 2004), and hemimegalencephaly (Battaglia 
et al., 1999a). No studies included a control group for comparison.  
A number of tools were used for neuropsychological assessment. The most common was the 
Bayley series (five studies), but several studies calculated a DQ for each patient and used this 
to combine results from multiple different types of assessment. Many papers tried to assess 
improvement in cognition following surgery but varying follow-up times and general low 
methodological quality of the studies make comparison and drawing definitive conclusions 
difficult. Nevertheless, some broad conclusions can be drawn.  
Children receiving neurosurgical treatment for epilepsy within the first five years of life are 
highly likely to be impaired. Mean cognitive scores lie over three standard deviations below 
population norms regardless of assessment tool, although isolated patients are reported with 
relatively preserved cognition. There is little evidence of improvement in DQ following surgery, 
regardless of seizure outcome; although several papers highlight that children subjectively 
improve and start learning new skills, with improvement in their raw scores; in each case this 
parallels their increasing chronological age.  
This group of children is comprised of severe, medically refractory epilepsy, and may have 
considerable intellectual morbidity from ongoing seizure activity and aetiological antecedents. 






Table 1.4 Studies of Surgical Cohorts 








age, m, Mean (SD) 












Social interaction  
M=0.03 (SD 0.05) 
 
Language age  
M=6.25m (SD 8.8) 
Social interaction  
M=0.12 (SD 0.02) 
 
Language age  
M=8.53m (SD 10.16) 
Significant increase in post-
surgery communication scores but 
as expected for increasing age 










1 child in normal range 
(>85), 3 borderline (68-85), 
and 20 with moderate-
severe impairment (<67) 
Significant improvement two 
years post-surgery 












All children had below 
normal non-verbal 
communication 
Social interaction improved 
(p<.001) but remained 
below normal. No 
improvement in joint 
attention. 
Post-surgical improvement in 
social interaction was restricted to 
right-sided resection. 
Iwatani et al. 
(2012) 
6 IS 





Mean DQ=35.6 (SD 
9.1) 
Mean DQ=33.4 (SD 8.9) 4/5 patients diagnosed with ASD 
Lee et al. 
(2014) 
13 IS 






Mean difference in DQ=  
-3 (SD 6.0; p=.055), and 
SQ= 15.0 (SD 9.1; p<.05) 
Social developmental improved 
post-surgery but DQ unchanged 
BSID Bayley Scales of Infant Development 
DQ - Developmental Quotient 
ESCS: Early Social Communication Scales 
FCD – Focal Cortical Dysplasia 
HME – Hemimegalencephaly 
KSPD - Kyoto Scale of Psychological development 
REEL – Receptive Emergent Language Scale 
SIE – Symptomatic Infantile Epilepsy 
SQ - Social Quotient 
TIDS - Tsumori-Inage Developmental Scale  
VABS - Vineland Adaptive Behaviour Scale  







 Table 1.4 continued 
Author (year) N Type 
Outcome 
(tool) 





age, m, Mean (SD) 






42.1 (44.8) 36 (4.8) 
Composite= 39.2 
(23) 
Composite: 41.2 (19). 53% 
of children had increase in 
scores. 
Better VABS scores associated 
with earlier surgery, shorter 
epilepsy duration, and treated 
hypsarrhythmia in IS cases 
Loddenkemper 








Median 37 (0-92) Median 49 (2-92) 
Modest post-surgical 
improvement. Improvements 
associated with younger age at 
surgery and epileptic spasms 





26.1 (19.8) 109 (40) 
Mean DQ= 41.8 
(SD 18.2)  
Mean DQ= 39.7 (SD 17.8) 
2 patients showed significant (>10 
points) improvement in DQ at 
follow-up 
Roulet-Perez 
et al. (2010) 
11 SIE DQ (BSID-II) 34.5 (19.4) 2-6y 
Mean DQ= 42.8 
(SD 21.4) 
Mean DQ= 50 (SD 13.8) 
4 children showed increase of >10 
DQ points, little further gains after 
2 years follow-up 
van 
Schooneveld 




17.8 (11.8) >2 years 
Mean DQ= 38.4 
(SD 18.7) 
Mean DQ= 37.0 (SD 26.7) 
DQ extrapolated from 
developmental delay figures. 
Resumption of development post-
op but no catch-up 
BSID Bayley Scales of Infant Development 
DQ - Developmental Quotient 
ESCS: Early Social Communication Scales 
FCD – Focal Cortical Dysplasia 
HME – Hemimegalencephaly 
KSPD - Kyoto Scale of Psychological development 
REEL – Receptive Emergent Language Scale 
SIE – Symptomatic Infantile Epilepsy 
SQ - Social Quotient 
TIDS - Tsumori-Inage Developmental Scale  
VABS - Vineland Adaptive Behaviour Scale  






Table 1.4 continued 








age, m, Mean (SD) 














in 2, and 16 
severely impaired 
(<55) 
2 children improved, 5 
declined (15 point decrease) 
 
Normal DQ in 1, mild-
moderate impairment (55-
75) in 3, and 19 severely 
impaired (<55) 
No correlation between seizure 




30 SIE Various 20 (5-33.6)  
Normal (IQ ≥70): 7 
Moderate (IQ 50-69): 3 
Severe (IQ <50): 18 
 
Long-term follow-up (1-9y 
post-surgery):  
Normal (IQ ≥70): 3 
Moderate (IQ 50-69): 3 
Severe (IQ <50): 22 






27 (5-60) 45.8 (13.3) 
Mean DQ/IQ= 41.84 
(SD=17.74). 18/19 had 
DQ/IQ <70 
 
At long-term follow-up (8.9 
(3-15) years), mean DQ/IQ 
was 39.79 (SD=17.32).    





37.1 (15.3) 93.1 (29.5) Mean DQ= 50.0 (26.3) Mean DQ= 50.8 (28.8) 
No mean change in post-
surgical DQ 
BSID Bayley Scales of Infant Development 
DQ - Developmental Quotient 
ESCS: Early Social Communication Scales 
FCD – Focal Cortical Dysplasia 
HME – Hemimegalencephaly 
KSPD - Kyoto Scale of Psychological development 
REEL – Receptive Emergent Language Scale 
SIE – Symptomatic Infantile Epilepsy 
SQ - Social Quotient 
TIDS - Tsumori-Inage Developmental Scale  
VABS - Vineland Adaptive Behaviour Scale  





of impairment in these cohorts compared to other groups of children with early onset epilepsy 
provides weak evidence that outcomes of symptomatic epilepsies themselves are worse  
1.3.3 Systematic Review: Discussion 
The aim of this review was to extract and synthesise psychometric data on the 
neurobehavioural characteristics of CWEOE during the first years of life. Of the 52 studies 
meeting criteria for review, only six described a general CWEOE cohort. The majority of the 
articles reviewed (32) focused on specific early-onset syndromes - most notably, infantile 
spasms and Dravet Syndrome. The remaining fourteen described surgical candidates. These 
three populations represent a minority of the early-onset epilepsy population. Infantile spasms 
accounts for 6-11% of cases in children ≤5 years (Dura-Trave et al., 2007; Wirrell et al., 2011), 
whilst Dravet Syndrome and epilepsy surgery occur in an even smaller number of patients 
(Neligan et al., 2013; Wu et al., 2015). Therefore, it was impossible to build a complete 
neurobehavioural profile of CWEOE, the benefits for which have been argued earlier. 
In terms of the prevalence of cognitive impairment in general CWEOE cohorts, a wide range of 
33-91% of children was reported. This data came from a limited number of studies with several 
stemming from potentially biased population sources; namely children <1 year of age, and 
children referred to tertiary centre settings. Thus, the true prevalence across the early-onset 
period may present a different picture. A relevant series of studies by Rantanen and colleagues 
(Rantanen et al., 2009; Rantanen et al., 2010b; Rantanen et al., 2011) is of notable mention. 
Rantanen et al. described cognitive and social-behavioural aspects in a population-based 
sample of children aged 3-6 years in Tampere, Finland. The authors found impaired intellectual 
development in 50% of children with established epilepsy, and an increased indication of 
subtle social-behaviour difficulties, particularly in children with ‘complicated’ epilepsy (i.e. 
symptomatic aetiology and/or neurological abnormality). Although well within the range 
reported in the current review, this study included children with established epilepsy, and as 
such, other factors such as chronic seizure and chronic AED use may have played a role.  
The age at which data is collected is an important factor when considering the true prevalence 
of impairment. In population-based studies, cognitive impairment is estimated in 21-41% of 
children 0-16 years, and 31-43% in children ≥5 years (Hoie et al., 2005; Reilly et al., 2014a; 
Sillanpaa, 1992; Waaler et al., 2000). It is possible these figures have been diluted by children 




When age of onset is considered, the prevalence of impairment may be more age biased. In 
their community-based study of persons aged ≤29 years, Berg et al. (2008) found subnormal 
cognition in 33.4% of persons whose onset began 0-5 years, and 11.2% in those with onset 5-
16 years. Taken together with the data presented above, the evidence potentially suggests a 
higher prevalence of cognitive impairment in CWEOE compared to later onset epilepsy. 
Nevertheless, a baseline estimation of cognitive impairment in approximately 1/3rd of CWEOE 
is not unreasonable. Further data from CWEOE cohorts are required. As yet, there is no 
population-based study, or otherwise, that has reported the prevalence of cognitive 
impairment or behaviour problems during the early-onset age period, and at the beginning of 
the disease. It is important to mention that the relationship between age of onset and cognitive 
impairment may vary within the early-onset period (Reilly et al., 2014a), and further studies are 
needed to establish age-specific risk in CWEOE.  
Our findings in children with Dravet Syndrome echo that of earlier reviews (Ceulemans et al., 
2004; Incorpora, 2009). That is, normal development before the age of two with stagnation 
from age three. Two of the longitudinal studies reviewed also noted stable and low DQ/IQs 
after the age of five (Nabbout et al., 2013; Wolff et al., 2006a), consistent with other reports. In 
children with CAE, earlier-onset CAE (<3 years) has been associated with less favourable 
cognitive and behavioural outcomes, albeit in a small sample of children, many of whom had 
poor seizure control (Chaix et al., 2003). Evidence from two studies of earlier-onset CAE 
reviewed here did not support that conclusion (Verrotti et al., 2011; Masur et al., 2013), with 
one consisting of a large cohort of 110 children with CAE, although a high prevalence of 
attention problems were noted indicating the presence of subtle deficits (Masur et al., 2013). 
There was little difference in performance between children below or above six years of age in 
the latter study, suggesting earlier-onset CAE may provide no further risk to cognitive status 
than typical onset. 
Studies describing developmental outcome in infantile spasms are often estimated from 
clinical observation and/or medical review. The results from studies using standardised tools 
in this review were comparable. For example, a population-based study by Lúthvígsson (1994) 
reported the number of infantile spasms children developmentally impaired, based on medical 
record review, at 54%. This was similar to the figure of 40-60% found in the current review. 
Similarities in estimation are presumably due to the severity of psychomotor impairment 
apparent upon clinical presentation. A much lower figure of developmental/cognitive 




by adulthood (Riikonen, 2001b). In that study, 31% of patients died over the course of follow-
up, with the vast majority of those who died having previous intellectual impairment. This 
suggests that the difference in prevalence observed in that study may be a result of death 
rather than intellectual improvement in children with infantile spasms. Thus, there appears to 
be relative stability in impaired cognitive functioning with age. Follow-up data from the studies 
in this systematic review suggest that children with cryptogenic/unknown aetiologies have 
more favourable outcomes. A similar finding is echoed in long-term follow-up studies 
(Luthvigsson et al., 1994; Karvelas et al., 2009; Kivity et al., 2004; Montenegro et al., 2008; Oh et 
al., 2010). 
It is evident from the articles reviewed here that impaired development is detectable in CWEOE, 
and is not uncommon. However, the spectrum and prevalence of neurobehavioural problems 
remains unclear, particularly in the general CWEOE population. There was a clear dearth of 
information on behavioural problems with most studies limited to cognition or adaptive 
behaviour, commonly used as an indicator of general development. Whilst behaviour problems 
are commonly recognised in school-age children with epilepsy (see Besag, 2004; Caplan and 
Austin, 2000; Dunn and Austin, 2004; Ekinci et al., 2009; Hamiwka et al., 2011; Otero, 2009; 
Plioplys et al., 2007; Rantanen et al., 2012; Reilly et al., 2013; Reilly et al., 2011; Rodenburg et 
al., 2005; Verrotti et al., 2014, for reviews), much less is understood about the spectrum and 
prevalence of behaviour in CWEOE. This is despite the fact that behavioural problems are 
detectable and common during the preschool period (Poulou, 2015).  
The studies reviewed provided little information on the risk factors for neurobehavioural 
problems in CWEOE. From the available evidence, the occurrence of comorbid 
neurobehavioural problems seem to be related to aetiology, or epileptic syndrome. Dravet 
Syndrome and infantile spams were two syndromes particularly at risk, whilst those with 
structural causes for their epilepsy, including infantile spasms and surgical candidates, had a 
higher prevalence of problems than those with unknown causes. Development in idiopathic 
epilepsies was more favourable, although neurobehavioural problems could still present. 
Sociodemographic and epilepsy-related risk factors were rarely addressed in the studies 
reviewed. There were insufficient data on the effect of socioeconomic status, gender or 
geographical differences, whilst epilepsy-related variables received occasional mention. Of the 
six studies on general CWEOE cohorts, only two included information on epilepsy-related 




for neurobehavioural problems in children with epilepsy across all age groups (section 1.4), 
these have not been robustly examined as risk factors in CWEOE.   
This review highlights the need for high-quality population-based studies investigating the 
neurobehavioural profile of CWEOE. That is, the need to identify the prevalence and spectrum 
of neurobehavioural problems, particularly including behavioural data. There is also a need to 
identify risk factors for neurobehavioural problems. To determine which risk factors need to 
be evaluated in CWEOE, the following section will briefly review the possibilities. 
1.4 Neurobehavioural Problem Risk Factors in Children with Epilepsy of All Ages 
Brain abnormality is a clear risk factor of neurobehavioural problems. Cognitive impairment 
and behaviour problems are strongly and consistently associated with neurological disorders 
(Camfield and Camfield, 2007; Davies et al., 2003; Ellenberg et al., 1986; Rutter et al., 1970; 
Steffenburg et al., 1995), complicated epilepsy (i.e. IQ<70 or 80, and a structural brain lesion 
or neurological problem; (Berg et al., 2008; Berg et al., 2011a; Rantanen et al., 2011; Rutter et 
al., 1970), and structural/symptomatic epilepsy (for an explanation of aetiological 
classifications see section 2.4.2), with more favourable outcome in children with 
idiopathic/unknown aetiology (Berg et al., 2008; Hoie et al., 2005; Park et al., 2013). In other 
words, impaired cognition and behaviour problems are associated with brain abnormalities as 
identified via clinical examination or clinical brain imaging. Research based MRI studies have 
found abnormalities at the macro and micro structural level, where neurobehavioural problems 
have been associated with brain volumes, white matter integrity, and functional differences, 
across epilepsy syndromes (see Addis et al., 2013; Hermann et al., 2009; Braakman et al., 2012; 
Yoong, 2015). Brain abnormalities are also evident in non-lesional localisation-related 
epilepsies (Widjaja et al., 2013), and idiopathic generalised epilepsies (Betting et al., 2006; Chan 
et al., 2006; Pulsipher et al., 2011), which have been associated with cognitive deficits (Lin et 
al., 2013; Pulsipher et al., 2009; Tosun et al., 2011) – indicating that cognitive deficits can be 
apparent in otherwise clinically normal brains, and non-structural-related epilepsies.  
Epilepsy-related variables are inconsistently linked to neurobehavioural problems. The most 
robustly linked factors are having a diagnosis of an epileptic encephalopathy and seizure 
intractability (Smith et al., 2002), with up to 70% of surgical candidates evidencing cognitive 
impairment (Van Schooneveld and Braun, 2013). Epileptic encephalopathies are epileptic 




impairment above that caused by the underlying pathology alone (Berg et al., 2010). Infantile 
spasms, Dravet Syndrome, and Lennox-Gastaut Syndrome, for example, are all associated with 
poor and often severe developmental outcomes (Khan and Al Baradie, 2012; Neville, 1997; 
Shields, 2000). Epileptic encephalopathies are characterised by gross EEG abnormalities, 
reflective of underlying aberrant neuronal activity. In non-encephalopathic epilepsies, and in 
children without epilepsy, abnormal epileptiform and non-epileptiform (i.e. slow wave) EEG 
recordings have been associated with both temporary and long-term adverse cognitive and 
behavioural outcomes (Aldenkamp and Arends, 2004; Clarke et al., 2001; Massa et al., 2001; 
Mulligan and Trauner, 2014). This suggests that abnormal EEG is a potential risk factor for 
neurobehavioural problems.  
It is unclear if seizures themselves, chronicity of seizures, or high frequency of seizures 
represent increased risk for cognitive impairment or behavioural problems. One would expect 
cognitive decline in children with chronic epilepsy if seizure activity had a cumulative and 
damaging effect on the brain. However, reviews of longitudinal studies in childhood epilepsy 
provide mixed findings (Dodrill, 2004; Seidenberg et al., 2007). Vingerhoets (2006) reviewed 
longitudinal and cross-sectional studies, finding that while IQ remained relatively stable across 
time in longitudinal studies, it was only subsets of children (11-24%) who had evidence of 
cognitive decline. The frequency of seizures was inconsistently associated with decline. Indeed, 
seizure frequency may play a less significant role once other factors such as aetiology are 
considered (Park et al., 2013). The case for single or repeated prolonged seizures (>30 minutes) 
may be stronger. Martinos et al. (2012; 2013) reported cognitive deficits in children with at least 
one episode of convulsive status epilepticus, but also in children with a single prolonged febrile 
seizure without epilepsy.  
AEDs have been associated with adverse cognitive and behavioural effects, although only 
limited studies exist on newer generation AEDs, and studies are often fraught with 
methodological limitations making findings inconclusive or tentative (Caplan, 2012; Eddy et 
al., 2012; Ekinci et al., 2009; Lagae, 2006; Loring and Meador, 2004). There is a general 
consensus however, that multiple AED use, termed polytherapy, is more detrimental to 
cognitive functioning than monotherapy (Aldenkamp and Bodde, 2005; Hermann et al., 2010; 
Mula and Trimble, 2009).  
Non-epilepsy related variables including gender, socioeconomic status (SES), and familial 




cognitive performance and behaviour are uncommon but have been reported (see Menlove 
and Reilly, 2015; Ekinci et al., 2009; Otero, 2009; Reilly et al., 2011). In the general population, 
behaviour and cognition are robustly associated with SES (Bradley and Corwyn, 2002), 
including those with intellectual disability or chronic health conditions (Emerson and Hatton, 
2007; Gortmaker et al., 1990). In childhood epilepsy however, SES has not been robustly linked 
to behaviour problems (Ekinci et al., 2009; Plioplys et al., 2007) (c.f. Carson et al., 2015), or 
cognitive functioning (Hoie et al., 2005; Hoie et al., 2006).  Adverse familial and child factors, 
however, are more consistently associated with neurobehavioural problems, particularly 
depression. These include maladaptive parenting styles and parent-child relationships 
(Carlton-Ford et al., 1997; Hoare and Kerley, 1991; Austin et al., 1992; Mitchell et al., 1994; 
Rodenburg et al., 2006), negative perceptions and sense of control over epilepsy and behaviour 
problems (Austin and Huberty, 1993; Austin et al., 2004; Dunn et al., 1999; Plioplys, 2003), family 
stress (Adewuya and Ola, 2005; Dunn et al., 1999; Oostrom et al., 2001; Pianta and Lothman, 
1994), and the effect of stigma (Adewuya and Ola, 2005; Dunn et al., 1999; MacLeod and Austin, 
2003). Psychopathology in the parent is associated with behaviour problems in the child (Hoare 
and Kerley, 1991; Lothman and Pianta, 1993; Shore et al., 2002; Shore et al., 2004), but this is 
not always supported (Baki et al., 2004).  
In summary, a number of epilepsy and non-epilepsy related variables have been associated 
with neurobehavioural problems in children with epilepsy of all ages, with some variables more 
strongly associated than others. The relationship between these variables and 
neurobehavioural problems specifically in CWEOE remains unknown and requires direct 
investigation. 
1.5 Biological/Cognitive Markers of Neurobehavioural Problems  
In the previous section it was shown that neurobehavioural problems were variably associated 
with epilepsy- and non-epilepsy-related risk factors. Whilst these relationships can provide 
insight into neurobehavioural problems, there is a need for more robust markers of 
neurobehavioural problems in children with epilepsy. Recently, the ILAE-IBE joint task force 
(Baulac et al., 2015) have advocated the development of biomarkers that could allow the early-
identification of those at risk of severe cognitive impairment. It would also be advantageous 





As reported previously, brain imaging studies have linked MRI abnormalities with cognitive 
impairments, suggesting that MRI might provide a readily available biomarker. Additionally, 
studies have reported cognitive and behavioural problems at, or before, the onset of epilepsy 
(Austin et al., 2001; Dunn et al., 2002; Hesdorffer et al., 2004; Hermann et al., 2006; Hermann et 
al., 2007b; Oostrom et al., 2003; Oostrom et al., 2005; Jones et al., 2007), with associated 
neuroanatomical differences (Pulsipher et al., 2011; Lin et al., 2012b; Tosun et al., 2011) - 
suggesting that these neuroanatomical abnormalities might underlie both epilepsy and 
neurobehavioural problems. To date, there are no brain imaging studies focused on 
neurobehavioural problems on CWEOE (Yoong, 2015), and requires attention.  
MRI does, however, have its limitations in its application to the general epilepsy population, 
not all of whom will receive brain imaging in the course of regular care. MRI requires expensive 
machinery, and technical speciality in its application, maintenance, and interpretation. 
Alternative technologies are therefore advantageous.  Eye-tracking is one possible alternative, 
which has the potential to provide fast and cost-effective assessment. Eye-tracking technology 
assesses eye-gaze behaviour through the use of visual attention paradigms. Eye-gaze 
behaviour itself reflects underlying neuropsychological processes, and neurological correlates 
of cognition. It has been widely used to aid the understanding of visual attention and 
neurodevelopment (Boraston and Blakemore, 2007; Duchowski, 2007; Karatekin, 2007). Eye-
gaze behaviour can be indicative of cognitive impairment (Rose et al., 2005), or behaviour 
problems (e.g. ADHD; Tseng et al., 2013) in children, and has been extensively used in children 
with ASD (Ames and Fletcher-Watson, 2010; Falck-Ytter et al., 2013; Karatekin, 2007), 
highlighting its application in clinical populations. 
A major advantage of using eye-tracking in the investigation of neurobehavioural 
comorbidities in CWEOE is that paradigms can be developed which are not reliant on verbal 
instruction. This makes the technology accessible to non-verbal populations such as infants, 
toddlers, and preschool children, where it has widely been employed. It may also be 
advantageous to children with common disorders associated with epilepsy, such as 
communication disorders, and developmental disabilities. As young children and 
developmentally delayed children may otherwise be unable to complete standardised 
neuropsychological assessments, it provides a promising means of identifying those with, or 
at risk of, neurobehavioural problems. Therefore, it may be valuable to explore eye-tracking as 




1.6 Summary, Scope, and Aims of the Study 
It was argued in this introduction that early-onset epilepsy is a risk factor for neurobehavioural 
problems, particularly cognitive impairment, and that the risk for neurobehavioural problems 
may be potentially greater than that of later onset epilepsies. However, the evidence presented 
in the systematic review of CWEOE identified a clear lack of representative data on the 
prevalence, spectrum, and risk factors of neurobehavioral problems. It was reasoned that 
information on neurobehavioural problems in CWEOE are of crucial importance for several 
reasons. Firstly, neurobehavioural problems are impairing, even beyond the impact of seizures 
themselves, which has prompted calls from the scientific community for further research into 
these epilepsy related comorbidities. Second, the immature brain is particularly vulnerable to 
adverse events, and the early years are a period of rapid neural and psychological development 
where new skills are being learned and foundations are laid for future skill acquisition. It is 
imperative to understand the potential impact to cognitive and behavioural functioning after 
disruption by epilepsy during this critical time of development. Third, should neurobehavioural 
problems be present and detectable, then there is the need to identify risk factors for those 
problems, particularly if the prevalence is high. Data on risk factors of children with epilepsy of 
all ages has received more attention, yet it is unknown if risk factors for problems are different 
in CWEOE. Fourth, accurate data is needed to better inform policy makers on the planning of 
early interventions, and toward the delivery of targeted health, social, and educational 
resources. Lastly, there is also a need to identify biological or cognitive markers which could 
allow rapid and early detection of neurobehavioural problems in children with epilepsy.  
Thus, the research reported in this thesis was primarily concerned with determining the 
neurobehavioural profile of CWEOE - defined here as the quantitative representation of 
neurobehavioural characteristics, including distributions of assessment scores and prevalence 
of problems, as determined by psychometric tests. To meet this aim, the study recruited a 
population-based sample of CWEOE. An incidence based cohort was preferred, as this allowed 
a closer appraisal of the true burden of epilepsy than a prevalent sample (further explanation 
is described in section 2.2). Thus, a secondary main aim of the study arose, which involved the 
estimation of the incidence of early-onset epilepsy.  The third main aim of the study was to 
explore eye-tracking, using selected eye-tracking tasks, as a potential cognitive marker of 
neurobehavioural problems. To summarise, this thesis addressed three main aims: (1) to 




of CWEOE, and (3) to explore eye-gaze behaviour (via eye-tracking) as a marker of 
neurobehavioural problems in CWEOE. 
The central hypothesis of this study was that CWEOE would have an abnormal 
neurobehavioural profile compared to the general population. That is, poorer cognitive 
functioning and more problematic social-emotional behaviour compared to controls, as well 
as having a greater prevalence of neurobehavioural problems. It was expected that the 
epilepsy- and non-epilepsy-related risk factors would have a similar relationship to that of 
older children as reported in the scientific literature. It was also expected that children with 
neurobehavioural problems would be identified by the selected eye-tracking tasks. 
There were limitations on the scope of this study, which meant several factors alluded to in the 
introduction could not be directly addressed, and which deserve mention here. First, it was 
suggested that CWEOE may be at greater risk of neurobehavioural problems than later 
childhood onset epilepsy. This question requires direct focus using younger and older 
childhood onset epilepsies, and as the thesis was focused on determining the 
neurobehavioural profile of CWEOE, this could not be directly assessed. Second, brain imaging 
was identified as a potential biological marker of neurobehavioral problems in children with 
epilepsy. However, quantitative MRI was not explored by the candidate due to the additional 
time and expertise required. Quantitative MRI markers, including T1 and T2 weighted images, 
and diffusion tensor imaging, were undertaken by Dr Michael Yoong in a sibling project 
entitled “Biomarkers in early-onset epilepsy” using the same cohort of children as the current 
study. Instead, qualitative MRI classifications were included as a risk factor variable in the 
present study. Lastly, this study focused on quantitative epilepsy-related and 
sociodemographic variables in the study of risk factors. Familial risk factors, which have a 
robust association with behavioural problems were not studied. This particular variable 
requires focused attention, including assessment of parent and family relationships.   
1.7 Thesis Overview 
As outlined above, this study is characterised by three main aims, and this thesis is structured 
according to those aims. Chapter II describes the identification and recruitment of CWEOE onto 
the study, including descriptive statistics of the cohort, and an estimation of the incidence of 
early-onset epilepsy. Chapter III details the methods of neurobehavioural assessment, and 




and controls, as well as determining the risk factors for neurobehavioural problems in CWEOE. 
Chapter IV introduces eye-tracking and its application in the exploration of neurobehavioural 
problems. It details the results of selected eye-tracking tasks in exploring eye-gaze behaviour 
in CWEOE compared to controls, and toward identifying neurobehavioural problems in 
CWEOE. Chapter V concludes this thesis by summarising the findings of this study, and offering 
suggestions for future research. Prior to these chapters, the remainder of chapter I describes 
study methods common to all chapters. 
1.8 Unique Contributions of the Study 
This study provides a number of unique contributions to the scientific literature including; 
(1) The first population-based study of the incidence, sociodemographic, and clinical features 
of early-onset epilepsy (onset ≤4 years of age) in the UK.   
(2) The first population-based, case-control study of the prevalence, spectrum and risk factors 
for neurobehavioural problems in CWEOE. 
(3) The first case-control study to examine eye-gaze behaviour as a marker for 




2. General Methods 
2.1 Overview 
NEUROPROFILES is a prospective, population-based, case-controlled, observational study, 
primarily aimed at estimating the incidence of early-onset epilepsy, determining the 
neurobehavioural profile of recently diagnosed CWEOE (to remind the reader, onset ≤4 years 
of age), and the exploration of eye-gaze behaviour as a marker of neurobehaviour. The 
following subsection lists the primary aims and associated research questions for each chapter. 
The remainder of the general methods section describes methods relevant to all chapters of 
this thesis.  
2.2 Chapter Aims and Primary Research Questions 
Chapter II. Incidence of Early-Onset Epilepsy in Fife and Lothian 
Main aims: To estimate the incidence of early-onset epilepsy, describe the clinical and 
sociodemographic characteristics, and in doing so, obtain a population-based CWEOE 
cohort.  
Primary research Question: What is the incidence of, and risk factors for, early-onset 
epilepsy in Fife and Lothian? 
Chapter III. The Neurobehavioural Profile of Children with Early-Onset Epilepsy 
Main aims: To understand the neurobehavioural burden of epilepsy by determining the 
neurobehavioural profile (i.e. distribution of cognitive and behavioural scores, and the 
prevalence and spectrum of cognitive impairment and behaviour problems) of the 
population-based sample of CWEOE, in contrast to a control sample, and to identify 
the risk factors for neurobehavioural problems identified.  
Primary Research Questions: What is the neurobehavioural profile of CWEOE compared 





Chapter IV. Eye-gaze Behaviour in Children with Early-Onset Epilepsy 
Main aims: To explore differences in eye-gaze behaviour between CWEOE and controls, 
and to assess eye-gaze behaviour as a means of predicting neurobehavioural problems 
in CWEOE. The inclusion criteria for this aim was broadened to also include children 
outwith the defined population-based region. This aim did not require a population-
based sample, as it explored the identification of neurobehavioural problems, not the 
distribution of problems within a population.  
Primary Research Questions: Is eye-gaze behaviour different in CWEOE compared to 
controls; and, amongst CWEOE, does eye-gaze behaviour differentiate between those 
with and without neurobehavioural problems? 
2.3 Project Development 
2.3.1 Methodology: Development of the Study Methods 
The systematic review in the introduction revealed that most studies investigating cognition 
and behaviour in CWEOE used hospital-based cohorts and/or specific early-onset syndromes, 
and thus may provide biased information. To obtain data on the general population, a 
population-based approach was preferred since these have greater external validity while 
reducing selection bias (Szklo, 1998). Applying a case-controlled element to the study allowed 
the findings to be contrasted against a healthy peer group, and increase the validity of those 
findings.   
An incidence cohort was chosen for study, as opposed to, or in addition to, a prevalence cohort, 
based on the following theoretical and practical reasons: (1) data gathered from an incidence 
cohort offers a more accurate reflection of the burden of epilepsy, compared to a prevalence 
cohort, as the data are not influenced by epilepsy remission or death rates; (2) combined with 
a prospective approach, an incidence cohort allowed the assessment of the burden of epilepsy 
at the beginning of the disease, and which may have reduced the influence of confounding 
epilepsy related factors, such as the influence of chronic seizures or AEDs; (3) the resources 
required for both an incidence and prevalence cohort would have been potentially 
unmanageable based on the available resources. To explain, based on a prevalence of 0.18% 




UK (Kurtz et al., 1998; MacDonald et al., 2000; Martinez et al., 2009), it was estimated that 
between 136-162 cases would be identified over the study period. With approximately 6 hours 
assessment time, scoring, and written feedback, per child, the time demands may have been 
untenable given the limitations on the use of shared assessment equipment, shared 
assessment space, and the time available for the candidate to carry out those research activities 
during the recruitment and assessment phase; and (4) an incidence study allowed the creation 
of a cohort that could be followed up in future investigations. This is advantageous as the 
natural history of CWEOE is unknown. 
2.3.2 Study Branding 
In an effort to aid recognisability, communication, and 
awareness of the study to participants, colleagues, and 
the scientific community, a study name and logo was 
created by the candidate. Study branding has well-
known influences on consumer behaviour (Girard et al., 
2013). The acronym, NEUROPROFILES - 
Neurodevelopment in Preschool children Of Fife and 
Lothian Epilepsy Study – was created. A name brand and logo distinguishes this study from 
others in a simple and recognisable way by using a meaningful identifier, and increases 
memory retention for that brand (Kanungo, 1969). The title served to represent the purpose of 
the study, and the acronym served to make reference to the overall aim of the study, namely, 
neurodevelopmental ‘profiling’.  
The logo created is illustrated in figure 2.1. It was designed with children in mind and reflects 
a simple, child-like drawing of a person. The figure is of neutral-gender to encompass both 
male and female children, and using the entire body in the picture is meant to be 
representative of a holistic profile (i.e. the cognitive, social and emotional aspects of 
development), rather than a narrow perspective.   
2.3.3 Research Team 
The core research team consisted of: (1) Matthew Hunter, PhD Candidate at The University of 
Edinburgh, and Honorary Assistant Psychologist with NHS Lothian; (2) Dr Richard F Chin, Senior 
Clinical Lecturer in paediatric neurosciences, University of Edinburgh, and Consultant 





Paediatric Neurologist, Royal Hospital for Sick Children, Edinburgh (RHSC). Dr Chin was the 
main PhD supervisor and Principal Investigator on the project; (3) Dr Kirsten Verity, Paediatric 
Neuropsychologist, RHSC, and (4) Dr Ruth Sumpter, Consultant Clinical Psychologist in 
neuropsychology, formerly of RHSC and now Head of Neuropsychology at the Institute of 
Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, were also PhD 
supervisors. They supervised clinical assessment training, and advised on neuropsychological 
testing, assessment analysis, and aided in the interpretation of test results; (5) Dr Michael 
Yoong, clinical lecturer at Edinburgh University, was responsible for the analysis of quantitative 
magnetic resonance and diffusion tensor imaging of the CWEOE and controls.  
Additionally, chief collaborators at the relevant NHS boards included: (6) Dr Ailsa McLellan, 
Paediatric Neurologist, RHSC, and lead clinician for the South East Scotland Epilepsy Network, 
was key project collaborator for NHS Lothian; and (7) Dr Christopher Steer, Paediatric 
Neurologist (Ret.), Victoria Hospital Kirkcaldy, Fife, was the key project collaborator for NHS 
Fife, prior to Dr Jamie Cruden’s appointment as Consultant Paediatric Neurologist. 
2.3.4 Ethical Approval 
Ethics, reference number 13/SS/0031, was granted by the South East Scotland Research Ethics 
Committee 01 on 18th March 2013, with amendments on 21st May 2013, and 4th December 
2013. The first amendment added a consent request for access to routinely stored health and 
social care data for participants, with a view for longer term follow-up data beyond the current 
study. A second amendment was added to the original study in order to include Diffusion 
Tensor Imaging to the protocol, a recently added standard clinical imaging procedure at RHSC, 
and to recruit children from outside the predefined geographical area, in order to increase the 
number of participants for eye-tracking. Local Research and Development ethical approval was 
granted by Research Governance of NHS Lothian (reference number 2013/0013) and NHS Fife 
(reference number 13-018 NRS13/P61 13/SS/0031). Participant information sheet and consent 
form can be found in appendices B and D, respectively).   
2.4 Definitions 
2.4.1 Epilepsy Definition 
Epilepsy is conceptually defined as “a disorder characterized by an enduring predisposition to 




consequences of this condition. The definition requires the occurrence of at least one epileptic 
seizure” (Fisher et al., 2005). 
The diagnosis of children in this study was based on the ILAE 2005 (Fisher et al.), and 2014 
(Fisher et al.), definitions and criteria of epilepsy. That is, the occurrence of two or more seizures 
more than 24 hours apart, unprovoked by acute or transient causes, or one unprovoked 
epileptic seizure with a ≥60% risk or recurrence, or diagnosis of an epilepsy syndrome. All 
diagnoses were established from clinical history, clinical examinations and investigation 
findings by a paediatrician/paediatric neurologist with expertise in epilepsy from RHSC, St. 
John’s Hospital, or Victoria Hospital Kirkcaldy, and thus met criteria for “definite” epilepsy 
(Thurman et al., 2011). This is differentiated from “probable” epilepsy, which does not have 
both documented source evidence of epileptic seizures and a diagnosis from a specialised 
clinician, or “suspected” cases, which are persons with suspected epilepsy but without the 
evidence of either of the previously mentioned criteria (e.g. a single ICD code for unspecified 
seizure). These indicate a lesser degree of reliable evidence supporting the diagnosis of 
epilepsy (Thurman et al., 2011). Febrile seizures, neonatal seizures, acute symptomatic seizures, 
or single episodes of status epilepticus were not considered as epileptic seizures.  
2.4.2 Epilepsy Classification 
Epilepsy type, seizure, and aetiological classification was determined by members of the core 
research team according to the ILAE Commission on Classification and Terminology 2005-2009 
(Berg et al., 2010), as well as the Commission on Classification and Terminology of the 
International League Against Epilepsy (ILAE, 1989).  Classification was made independently by 
clinicians within the research team and differences in opinion resolved by consensus opinion. 
At recruitment, children were classified according to the data available, with subsequent review 
of medical data at the end of recruitment into the study. The final classifications presented in 
this thesis reflect all available data at the end of the recruitment period, although some children 
may not have been “classifiable” based on the available data.  
CWEOE were classified according to epilepsy type (i.e. syndrome/constellation/type), seizure 
type (i.e. mode of onset; focal or general), and aetiology. The most recent aetiological 
classification system was proposed in 2010 by ILAE (Berg et al., 2010), with the previous 
classification system published in 1989 (ILAE, 1989) (table 2.1). The two aetiological 




received criticism (Panayiotopoulos, 2011; Shorvon, 2011). The change in classification is likely 
to impact the current utility of aetiology as a prognostic factor for cognitive and behavioural 
problems.  For example, children with cryptogenic aetiologies are at risk of lower intelligence 
(Park et al., 2013), yet these same children could now be classified as ‘unknown’ or ‘genetic’, 
which are associated with more favourable cognitive outcomes (Berg et al., 2008; Hoie et al., 
2005; Park et al., 2013). Additionally, some syndromes formerly classified as symptomatic could 
now be classified as genetic, such as Dravet Syndrome, which is associated with unfavourable 
cognitive outcomes (Ceulemans et al., 2004; Incorpora, 2009). Therefore, for the purposes of 
this study, patients were classified according to both aetiological classification systems in order 
to evaluate the predictive value of one system against the other.   
Table 2.1 Aetiological Classification Systems 
ILAE 1989 ILAE 2010 
Idiopathic – No underlying structural or 
neurological cause identified. Presumably 
genetic in nature 
Genetic – The epilepsy is the direct result of a 
known or presumed genetic cause in which 
seizures are the core symptom of the disorder 
 
Symptomatic – Epilepsy is the result of a 
structural lesion in the brain 
 
Structural/Metabolic – The epilepsy is the result 
of a distinct structural or metabolic condition. 
These conditions may be of acquired or of 
genetic origin  
Cryptogenic/Probably Symptomatic – Believed 
to be the result of a brain lesion, but which has 
not been identified 
 
Unknown –The underlying cause is as yet 
unknown or not presumed genetic 
ILAE – International League Against Epilepsy  
 
2.4.3 Socioeconomic Status (SES) 
SES is the social and economic standing of an individual, group of individuals, or geographic 
location based on a combination of predefined contributors, such as monetary income, 
education level, or occupation. A higher SES is considered to be more advantageous. Power 
and resources available, such as money, health services, and amenities, are all potential 
contributors to the promotion of health, or may “buffer individuals from detrimental effects of 
adverse situations and events” (American Psychological Association Task Force on 
Socioeconomic Status, 2007, p.9). Therefore, SES is an important consideration for assessing 




 Social deprivation is a term used to describe the relative inequality of resource provision and 
access to resources within a population, and can be considered a proxy for well-being. The 
Scottish Index of Multiple Deprivation (SIMD) is a quantitative tool for assessing the variability 
in wealth, resources, and environment across geographic locations in Scotland. SIMD provides 
a relative measure of deprivation across Scotland by ranking predefined geographic areas, 
called datazones, from least to most deprived. Ranking is based on the weighted sum of seven 
domains of interest, namely income, employment, health, education, geographic access to 
services, housing and crime. SIMD allows the comparison of one area in Scotland to another 
based on their deprivation rank. Ranks range from one to five, where quintile one is the most 
deprived, and quintile five is the least deprived. SIMD provides a relative measure of 
deprivation, not an absolute one.  SIMD is a Scottish Government initiative with the latest data 
published in 2012 (http://www.gov.scot/Topics/Statistics/SIMD). Quintile rank for each 
participant was obtained using resident postal code at time of diagnosis, or study entry if 
control (http://www.gov.scot/Topics/Statistics/SIMD/SIMDPostcodeLookup).  
For the purposes of this study, SES was 
classified as ‘high’, reflecting SIMD 
quintiles 4 and 5, or ‘low’, reflecting 
quintiles 1, 2 and 3. Two categories were 
selected due to modest sample sizes. In 
the reference population of our defined 
geography, 37.4% reside in high SES 
areas, and 62.6% reside in low SES areas.   
2.5 Participants and Demographics 
2.5.1 Population and Geography 
Scotland has a population of 5,295,403 
people (2011 Scottish Census, http:// 
www.scotlandscensus.Gov.uk/), and land 
area of 77, 925 km2. Fife and Lothian are 
two densely populated geographic areas 
of Scotland. Fife is a distinct council region while Lothian is made up of the distinct council 
regions of City of Edinburgh (herein, referred to as Edinburgh), Midlothian, East Lothian, and 





West Lothian (figure 2.2). The regions of Lothian and Fife cover 1,724km2 and 1,325 km2, 
respectively, and are comprised of 22.7% of the total Scottish population. They have a similar 
proportion of children aged 0-4 years (5.9%) as the national structure (5.3%).   
Edinburgh, West Lothian, and Fife were selected as the geographic location of our population-
based samples. East Lothian and Midlothian were omitted due to logistical reasons. Specifically, 
a child presenting with seizures in either of these regions may be admitted or managed during 
the course of diagnosis, at various hospital sites including those outside of the Fife and Lothian 
region. The method of patient identification, described in the following sub-section, used 
district hospitals as a primary gateway. Accordingly, we could not be sure of capturing every 
child in the desired remit. Additionally, these councils have relatively lower population 
densities, and the addition of hospitals to the existing network, which would include another 







During the preparation stages of the study, the research team became aware that some CWEOE 
from Fife may be managed by hospitals and health services outside the Fife council district. 
We could not be certain of accurately identifying all these cases through our identification 
networks, which may have resulted in an underestimation of the true incidence. Fife was 
therefore restricted to children residing in postal codes KY1, KY2, KY5, KY6, and KY7. Children 
from these areas were guaranteed to be routed to, and managed by, the main district hospital 
as part of the diagnostic and/or management process for epilepsy, thereby increasing the 
likelihood of capture. For the purposes of this Thesis, the term Fife herein refers to these 
specific postal codes. These three well defined regions of Edinburgh, West Lothian, and Fife 
represent 14.6% of the Scottish population (table 2.2), and can still be considered 




White (British/Irish) 83.57% 





Other non-white 3.18% 
Table 2.2 Council population size 
Region Population 
% of total 
population Scotland 5,295,403 
 - Edinburgh 476,626 9.0 
 - West Lothian 175,118 3.3 
 - Fife 122,799 2.3 




representative of the population as a whole. Edinburgh, West Lothian, and Fife are 
predominantly white but ethnically diverse regions (table 2.3). 
2.5.2 Participants  
NEUROPROFILES prospectively recruited children with early-onset epilepsy, and neurologically 
healthy controls, over a 26 month period, between the dates of May 1st 2013 and June 30th 
2015. 
Inclusion Criteria 
CWEOE and control children were male or female Scottish residents (i.e. resided at a permanent 
address in Scotland), and were of any cultural or ethnic background. CWEOE and controls were 
included in the population-based components of the study if they resided in the City of 
Edinburgh, West Lothian, or Fife council districts at the time of diagnosis (CWEOE), or 
recruitment (controls), even if they later migrated during the study period. All children within 
and outwith the defined population region were included in the eye-tracking component of 
the NEUROPROFILES study as previously explained.  
All children were aged ≤4 years at time of epilepsy diagnosis (CWEOE), or at the time of initial 
contact or identification (controls). CWEOE were included in neuropsychological assessment if 
they were five years old at the time of assessment, but had a diagnosis of epilepsy made before 
their fifth birthday.  Likewise, controls were given neuropsychological assessment if they were 
five years of age at the time of assessment but were identified and recruited prior to their fifth 
birthday.  
Exclusion Criteria 
Children were excluded if they were not resident in Scotland. For population-based 
components, children were excluded if they resided outside the predefined geographical 
boundary, at the time of diagnosis (CWEOE), or recruitment (controls). CWEOE were excluded 
if they did not meet the criteria for epilepsy indicated in section 2.4.1, or were five years or 
older at the time of epilepsy diagnosis. CWEOE were withdrawn after recruitment if an initial 




seizure disorder upon review of medical records.  Controls were excluded if they had a known 
neurodevelopmental disability or neurological abnormality. 
2.6 Procedures 
2.6.1 Participant Identification 
Children with Early-Onset Epilepsy 
A multi-source, multi-site active surveillance capture-recapture system utilising the usual 
clinical care pathway of managing children with a suspected new diagnosis of epilepsy was 
used to identify CWEOE.    
Incidence calculations assume that all possible persons with a disease are identified and 
included in analysis. In practice, capturing all new cases is unlikely. Cases may be missed 
depending on the accuracy of the strategies and sources used for case identification. One 
method of estimating and adjusting for missing cases is capture-recapture. The premise of 
capture-recapture is that persons with a disease are captured by one source, then recaptured 
by a second [or third] independent source. The discrepancies between source estimates are 
used to estimate the number of potential missing cases, and subsequently ascertainment-
adjusted incidence rates can be calculated (Brittain and Böhning, 2008; Stephen, 1996). As the 
identification system used in the current study used multiple sources within the natural clinical 
care pathway, it is first necessary to understand that pathway.  
A child who is suspected of having seizures would normally seek medical advice at a General 
Practitioner (GP), or Hospital accident & emergency unit. After initial assessment by either 
route, if the child is believed to have had a seizure it is recommended that they be referred to 
a paediatrician with a specialism in epilepsy for further assessment and investigation (SIGN 81, 
2005, Section 2.2, http://www.sign.ac.uk/pdf/sign81.pdf). Therefore, paediatricians/paediatric 
neurologists with expertise in epilepsy would be a primary point of identification for newly 
diagnosed CWEOE.  However, a recent national UK wide audit examining the provision of 
epilepsy services to children and young people from 2010 to 2011 (RCPCH, 2012), recognised 
that a small number of patients in Scotland were being managed by community paediatricians 
without any input from experts in epilepsy, signifying that further sources of identification were 
needed. As part of the diagnostic procedure for epilepsy, whether by GP, neurologist, or other 




tests. This means that the EEG department can act as a point of convergence for children 
undergoing diagnosis (irrespective of whether they were being managed by a paediatrician 
with expertise in epilepsy or not), and serve as another point of identification.  Indeed this was 
the single source of identification of epilepsy subjects for the Epilepsy 12 Audit.  
Once a diagnosis has been reached, a child should have access to specialist epilepsy services, 
including an epilepsy specialist nurse (SIGN 81, 2005). Epilepsy specialist nurses play an integral 
part in the management of CWEOE, acting as a point of contact for the child and family, and 
liaison between school and multidisciplinary services (SIGN 81, 2005).  Thus, they were a third 
potential source of identification. Any single CWEOE on their clinical care pathway should be 
identified by any of those individual sources, or via a combination of those sources, thus 
increasing the likelihood of capture.   
Therefore, three sources of case identification were used in the present study: (1) paediatricians 
with expertise in epilepsy, (2) epilepsy specialist nurses and, (3) EEG departments. Figure 2.3 
shows a simplified pathway of natural clinical care with case identification points.  






Capture-recapture assumes that all cases have an equal chance of being captured by each 
independent source. Lack of source independence leads to an underestimation bias (Stephen, 
1996). In NHS Lothian and NHS Fife, epilepsy patients are referred to epilepsy specialist nurses 
directly by paediatricians. Therefore, sources 1 and 2 lacked independence, and were collapsed 
into a single data source – labelled here as ‘neurology department’. The EEG department 
receives referrals investigating seizures from all hospital departments, and community 
physicians, and thus, has low positive dependency. 
Three hospital sites acted as the primary gateway sites for case identification: RHSC, St. John’s 
Hospital, West Lothian, and Victoria Hospital, Kirkcaldy, Fife. These are the main paediatric 
hospitals for Fife and Lothian. All CWEOE in the defined geographical study area are routed 
through these hospitals. At each of these Hospitals there was one or more consultant 
paediatric neurologists who collaborated on the project and acted as contact points. Two 
epilepsy specialist nurses, based at RHSC, covered the areas of Edinburgh and West Lothian, 
while a single epilepsy specialist nurse was responsible for Fife. Children from West Lothian 
and Edinburgh are referred to the neurophysiology department at RHSC, while children from 
Fife attend the neurophysiology department at Victoria Hospital. These three hospitals also 
manage and admit patients resident outside the study area from other areas of Scotland - due 
to physical location, or due to specialist paediatric services. Thus, with multiple identification 
sources, and by checking home postal codes, most if not all CWEOE from the study area could 
be confidently identified, and additional CWEOE from outwith the study region could be 
identified in order to address the eye-tracking component.   
In order to identify new diagnoses of epilepsy at the earliest possible time, active surveillance 
of data sources was carried out. To do so, a network of paediatricians and epilepsy specialist 
nurses at the aforementioned Hospital sites was established. This network was contacted 
through regular emails, telephone calls, and face-to-face contact, where new cases could be 
referred directly to the candidate. Awareness of the study was further increased through 
candidate presence at weekly neurology meetings. The EEG departments were audited by 
clinical neurophysiologists on a fortnightly to monthly basis for cases displaying an abnormal 
EEG consistent with epileptiform activity. As epileptiform activity is also high in patients with 
neurological or medical disorders without epilepsy (Panayiotopolous, 1999, 
http://www.ncbi.nlm.nih.gov/books/NBK2601/), EEG testing is not a definitive diagnostic tool 
but an instrument used to aid diagnosis. Therefore, the referring paediatrician of the patient 




was to allow the diagnostic process to unfold. If no diagnostic conclusion had been drawn, the 
referring paediatrician would then be contacted again at regular intervals by the research team. 
If the child was subsequently diagnosed with epilepsy but was not identified through the 
neurology department source, the GP or paediatrician would be invited by the research team 
to refer the child to a paediatric epilepsy specialist through the normal care pathway (figure 
2.3).  
Control Children 
Controls were identified through public advertisement. Recruitment posters were located at 
the main hospital sites, and flyers were placed at nursery schools and parent & toddler groups. 
A digital recruitment poster was posted online at http://www.mumsnet.com/ using the 
mumsnet “Local Talk” services for Edinburgh, Falkirk & West Lothian and Fife. A study 
advertisement email was drafted to all NHS Lothian staff using a global email system. 
In addition to public advertisement, non-epileptic patients attending the MRI department at 
RHSC, for the investigation of headaches, and who had no abnormalities on their subsequent 
brain scan, were invited to take part as controls on the previously mentioned sibling project, 
entitled “Biomarkers in early-onset epilepsy”, led by Dr Michael Yoong. This project 
investigated MRI brain markers in early-onset epilepsy using the same cohort of CWEOE 
recruited for the current study. Thus, control children identified for that study were invited to 
participate in the NEUROPROFILES study during the active recruitment phase. Control children 
recruited via this pathway underwent the same neuropsychological assessment and eye-
tracking protocol as all other controls. 
2.6.2 Participant Recruitment 
Families of CWEOE were informed of the study by their paediatrician or epilepsy specialist 
nurse, during routine clinic, or as a Hospital inpatient. They gave eligible patients study 
information sheets, if available, and asked for permission to pass on the family’s contact details 
to the research team. Once assent had been granted, the candidate contacted the family at 
least 24 hours after information sheets had been provided, to allow time to read the material. 
For those that did not receive information sheets, these were emailed or posted to the family 
after telephone contact. Contact was then made again by the candidate no less than five days 
after posting information sheets. If the family agreed to take part in the study, arrangements 




the recruitment process is illustrated in figure 2.4. The target time from diagnosis to 
assessment was three months. Families who assented to be a part of the study but who failed 
to attend the appointment, were given repeated attempts to do so. Those who failed to attend 
on three occasions without notice were considered not to have consented for study 
participation. If assent was not granted at initial contact or through repeated non-attendance, 
anonymised data on demographic and epilepsy characteristics (appendix D) were obtained by 
the research team through a paediatrician within the child’s care team, for population-based 
children only. This data was held under a unique non-patient identifiable study identification 
number, and used for incidence cohort characteristics.     
Families of control children responded to public advertisement by contacting the candidate 
directly via email or telephone. Inclusion and exclusion criteria, including the neurological 
health of the child, were checked with the family, and information sheets were then emailed 
or posted if criteria were met. The same recontact latency period given to families of CWEOE 
was followed.  If the family agreed to take part, arrangements for assessment were then made. 
Controls identified through the MRI department for the sibling study were approached 
immediately post-scan, by Dr Michael Yoong, and informed of the study. The same recruitment 
procedure for controls was then applied.   





2.6.3 Consent Procedure 
Written consent was gained from the parent/legal guardian, when families attended for 
neuropsychological assessment. Consent was gathered for entry onto the study, to access 
medical records including EEG and MRI, to access routinely stored data on NHS and 
educational databases, and to retain contact information for further follow-up studies. Like 
those participants who did not assent to be contacted by the research team, anonymised data 
was gathered for those CWEOE from the population-based region who did not did not consent 
to the study, (see section 2.6.2, and appendix D).  
Parents or legal guardians are required by law to give consent for children under the age of 16 
for medical treatment (The Children (Scotland) Act 1995). This can be extrapolated to research 
other than clinical trials of medical products (Medical Research Council, http://www.hra-
decisiontools.org.uk/consent/principles-children-Scotland.html). Although the Children 
(Scotland) Act considers age 12 years as sufficient for the child to give consent, personal 
research observations by Rosie Flewitt (2005) suggest that preschool children can often have 
sufficient understanding of what is being asked of them. As such, ’assent’ was gained from the 
children, when appropriate, and on an ongoing basis. A children’s information sheet was 
provided that the parent could read to their child prior to study assessment. It consisted of 
short direct statements with child friendly pictures. It directly asked the child if they would like 
to take part. On the day of assessment, verbal consent from the child was gathered prior to 
assessment, where appropriate. Mood and behaviour was monitored throughout each 
assessment, and verbal assent was reiterated periodically. 
2.6.4 Study Assessment Procedure 
All potential CWEOE and controls identified for the study were invited to take part in 
neuropsychological assessment and eye-tracking. Specific details on neuropsychological and 
eye-tracking test measures, and procedures are detailed in sections 8 and 12, respectively. 
Elements common to both are reported here. 
Each family/child who agreed to participate completed a comprehensive assessment, involving 
age-appropriate standardised face-to-face assessment of cognitive functioning, eye-tracking, 
and parent-rated questionnaires of various aspects of behaviour. Assessments were planned 
to be conducted within three months of diagnosis. However, this varied depending on the 




Face-to-face neuropsychological assessment and eye-tracking took place at The Child 
Development Lab, Moray House of Education, School of Education, University of Edinburgh. In 
September 2014 (16 months into data collection) the venue for the Lab was changed, due to 
administrative reasons, to Kennedy Tower, Department of Psychiatry, University of Edinburgh. 
Home visits were arranged for families who could not, or did not want to, travel to appointment 
locations. Families of children who assented to take part were given details of what to expect 
on the day of neuropsychological assessment, and directions to the place of testing. 
Participants who had home visits did not undergo eye-tracking, unless they had attended and 
completed eye-tracking on a previous occasion. Study participation included a single or 
multiple visits to the Lab, depending on the child’s attention and fatigue levels. Each 
assessment session lasted between 1-3 hours in total, including breaks. Participants were 
reimbursed for travel expenses but no other financial incentives were offered. 
Study questionnaires were sent to parents upon receiving verbal assent to participate in the 
study. Questionnaires were completed prior to arrival for face-to-face assessment, but were 
not collected until written consent was obtained. If parents did not bring questionnaires to the 
assessment appointment, they were asked to post questionnaires directly to the research team. 
If parents were unsure of questions or questionnaires, for whatever reason, they were then 
completed at the end of assessment with support from the candidate. Families who did not 
have a parent literate in English were not asked to complete questionnaires. 
Parents also completed a short standardised proforma via direct interview (appendix E), which 
gathered clinical and background information on the child and family. The interview collected 
information that was not routinely collected in clinic or recorded in medical notes (e.g. family 
history of psychiatric or developmental disorder), and gathered up-to-date clinical information 
at the time of assessment (e.g. current seizure frequency). Epilepsy-related information 
gathered here was used to supplement missing or dated information in medical records. 
Medical records were reviewed, supplemented by the proforma introduced above, by the 
research team after the date of neuropsychological assessment.  
Face-to-face assessments and parent interview were carried out by the candidate, and all 
standardised assessments, including questionnaires, were scored by the candidate. 
Administration of eye-tracking was also carried out by the candidate. Face-to-face assessment, 
eye-tracking, parent interview, and collection of the questionnaires completed the child’s 




2.7 Data and Analysis 
Chapter specific analyses for the three main aims of the study are detailed and described in 
chapters II-IV. Data and analyses common to all chapters are described here. 
2.7.1 Epilepsy- and Non-Epilepsy-Related Variables 
The following variables were collected from medical records and/or parent interview, in order 
to establish clinical and sociodemographic characteristics of the cohort; or to use during 
analysis of risk factors.  
Non-Epilepsy-Related Variables 
(a) Age (at neuropsychological assessment), (b) Gender (male/female), (c) Birth weight (normal 
≥2500g/low birth weight <2500g), (d) Prematurity (full-term ≥37 weeks/pre-term <37 weeks), 
(e) Ethnicity (White UK/White European/Asian/Black), and (f) SES (high/low). 
Epilepsy-Related Variables 
(a) Epilepsy classification (Berg et al., 2010), (b) Mode of seizure onset (focal/general/both), (c) 
Seizure type(s), (d) Seizure frequency at time of neuropsychological evaluation (low <one 
seizure per day/high ≥one seizure per day), (e) Aetiology (1989 and 2010 ILAE Classifications), 
(f) Number of AEDs at time of neuropsychological evaluation (0-1/≥2 polytherapy), (g) MRI 
status (normal/abnormal-minor/abnormal-major), (h) EEG status  (normal/abnormal 
epileptiform/abnormal slow-wave), (i) Family history of epilepsy, (j) Family history of psychiatric 
or developmental disorder, (k) Age (at first unprovoked seizure), (l) Age (at diagnosis), and (m) 
Time delay from diagnosis to assessment. 
2.7.2 MRI and EEG Ratings 
MRI images were rated by consensus agreement of two neuroradiologists who were blinded 
to the child’s clinical history. Ratings were classified as normal, minor structural abnormality, 
or major structural abnormality.  
As children may have multiple EEG recordings, the child’s EEG closest to the date of 
neuropsychological assessment was chosen. EEG recordings were rated by one of four 




were then reviewed by one consultant paediatric neurologist (KKT). KKT used other EEG 
recordings for guidance if more information was required. EEGs were rated as normal or 
abnormal. For the purposes of this study, abnormal EEGs were characterised as having 
epileptiform, non-epileptiform (i.e. slow-wave) features, or both. 
2.7.3 Statistical Analysis 
Statistical analysis techniques relevant to the specific chapters are detailed in the respective 
methods sections. Elements of statistical analysis common to all chapters are outlined here. 
Statistical analyses were performed using IBM SPSS Statistics for Windows, Version 21.0.0 
(Armonk, NY: IBM Corp., Released 2012), with the exception of the systematic review on the 
incidence of early-onset epilepsy (section 3) where Stata-MP v13.1 (2013, Statacorp LP, College 
Station, TX) was used.  
Normality of all variables was assessed according to Shapiro-Wilk test and upon visual 
inspection of histograms and QQ-plots. Data transformation was attempted for variables with 
a non-normal distribution. Parametric tests were applied preferentially, with non-parametric 
analyses applied for non-normal data that could not be transformed. Fisher’s exact test (FET) 
was applied for all 2x2 or 2x3 contingency tables comparing associations of nominal variables. 
Estimates of effect size, or equivalent, were reported throughout. Mean difference between 
group scores (MD) with 95% confidence intervals were reported for t-tests. Pearson’s r was 
reported for nonparametric Mann-Whitney U or Wilcoxon signed rank tests. Eta squared (𝜂2) 
was reported for analysis of variance tests (ANOVAs), and partial-eta squared (𝜂𝑝
2) for analysis 
of covariance tests (ANCOVAs). Group differences of p<.05 were considered significant. The 
relative strength of effect sizes were qualitatively assessed using guidance from Cohen (1988; 
table 2.4). Odds Ratios (OR) and 95% confidence intervals were reported for all 2x2 contingency 
tables as an estimation of effect size.   
Table 2.4 Qualitative guidance on strength of effect size (from Cohen, 1988) 
 small medium large 
r .1 .3 .5 









Chapter II.  Incidence of Early-Onset Epilepsy 
 
*** 
This chapter describes and reviews the literature on early-onset epilepsy incidence, with 
additional focus on infantile spasms/West Syndrome. It describes the specific methods for this 
part of the NEUROPROFILES study, the process of establishing an early-onset epilepsy cohort, 
and presents the study’s findings. The annual incidence of early-onset epilepsy, applying an 
ascertainment-corrected adjustment, was 61.71 (95% CI 40.22 – 88.14) per 100,000 children ≤4 
years. Risk factors were explored, with ethnicity identified as a potential risk factor for early-
onset epilepsy but not socioeconomic status. The cumulative incidence of West Syndrome was 
estimated at 4.01 per 10,000 live births, 95% CI (1.47-8.72). The relationship of the findings are 







3. Incidence of Early-Onset Epilepsy: Introduction 
3.1 Introduction 
The aim of this chapter was to ascertain the incidence of early-onset epilepsy (i.e. onset ≤4 
years of age) in the existing literature base, and in a new, unique, population-based prospective 
cohort of CWEOE, whilst providing a rationale for doing so. A systematic review of the literature 
was conducted in order to estimate the incidence of early-onset epilepsy in the knowledge 
base, and to identify any gaps that could be addressed through the NEUROPROFILES study. 
The approach toward estimating the incidence of early-onset epilepsy in the present study is 
then described, followed by results and discussion.  
3.2 Systematic Review and Meta-Analysis of the Incidence of Early-Onset Epilepsy 
As mentioned above, to meet the aim of estimating the incidence of CWEOE in the existing 
literature base, a systematic review and meta-analysis of incidence studies in CWEOE was 
completed. Particular attention was placed on data from the United Kingdom (UK), due to its 
relevance to the current study. 
3.2.1 Systematic Review: Introduction and Background  
The incidence of epilepsy across the lifespan is 50.4/100,000/year (interquartile range, IQR, 
33.6-75.6) (Ngugi et al., 2011). It is not evenly distributed but follows a U-shaped curve, with 
peak incidence in infancy and old age (Annegers, 2004; Christensen et al., 2007; Hauser et al., 
1993) - a pattern also replicated in the UK population (MacDonald et al., 2000). The reason for 
such a pattern is due to age-related risk factors in the determinants of epilepsy. Knowledge on 
age-specific incidence data, and corresponding aetiological information, is therefore necessary 
in order to better understand epilepsy, to identify age-relevant risk factors, and determine 
prognostic implications. Such data will then aid resource provision, and targeted intervention 
strategies. 
The Rochester Epidemiology Project has contributed to the understanding of the causes of 
epilepsy across the lifespan (Annegers et al., 1996; Annegers, 2004; Hauser et al., 1993), with 
the causes of structural related epilepsies much better understood. Data from the Rochester 




Brain trauma and tumours are common to all ages, but are the leading precipitant of epilepsy 
in young people and adults. Cerebrovascular and degenerative diseases are leading causes in 
the elderly, while congenital and developmental causes are the main antecedents in childhood 
epilepsy. Identified genetic causes of epilepsy are more often syndrome specific (Berkovic et 
al., 1998), with most syndromes having onset in infancy and childhood. While the aetiological 
profile differs broadly between childhood, adulthood, and old age, it is also important to note 
that it varies markedly within childhood. This relates to different aetiological risk factors 
associated with different stages of development, and the occurrence of age-dependent 
epilepsy syndromes (Appleton and Camfield, 2011). For instance, structural related epilepsies 
are common in the neonatal period and infancy, often caused by developmental abnormalities 
such as congenital malformations or hypoxic-ischemic encephalopathy, whilst syndromes such 
as CAE, Dravet Syndrome, or BECTS occur in childhood, and Juvenile Myoclonic Epilepsy, or 
Temporal Lobe Epilepsy more often occur in adolescence (Appleton and Camfield, 2011; Berg 
et al., 2010). Ascertaining incidence estimates and clinical characteristics across childhood is 
therefore necessary.    
Numerous epidemiological studies have addressed childhood-onset epilepsy, and have been 
summarised in three reviews (Cowan, 2002; Forsgren et al., 2005; Kotsopoulos et al., 2002) - 
although none have specifically addressed the early-onset period. From these reviews, the 
annual incidence of epilepsy in children ≤15 years, was estimated between 25 and 82, per 
100,000 children, per year. The incidence of childhood epilepsy in the UK specifically, has been 
reported in eight studies (Cockerell et al., 1995; Eltze et al., 2013; Heaney et al., 2002; Kurtz et 
al., 1998; Martinez et al., 2009; MacDonald et al., 2000; Meeraus et al., 2013; Wallace et al., 1998). 
The incidence of epilepsy across childhood in the UK is presented in table 3.1, and estimates 
range between 41.4 and 114.8, per 100,000 children. As with other epidemiological studies of 
epilepsy, there is considerable heterogeneity in age stratifications reported, making it unclear 
how the incidence of early-onset epilepsy relates to general childhood estimates.  
As argued in chapter I, the first five years of life are an extremely important period in neural 
and functional development (National Scientific Council on the Developing Child, NSC, 2007). 
The early-onset period is the time at which epilepsy is most common, the most severe forms 
occur, and where epilepsy may be likely to result in increased risk of neurobehavioural 
problems (see section 1 for further details). Age-specific point estimates of epilepsy are likely 




and Camfield 2011; Berg et al., 2010). As such, it is pertinent to detail the incidence of epilepsy 
during the first five years of life so that age-appropriate interventions can be better directed.   
Table 3.1 Incidence of Childhood Epilepsy in the UK (per 100,000) 
Author (year) Cohort Age (y) 
Incidence Rate 
(95 % CI) 
Cockerell et al (1995) 1983 GP cohort 0-20 60.9 (33.0 – 103.3) 
Kurtz et al (1998)  1958 Birth Cohort 0-15 41.0 (33.3 – 49.8) 
Wallace et al (1998) GPRD cohort 1995 5-14 58.7 (49.7 – 68.8) 
MacDonald et al (2000) Unselected GP cohort 1995-1996 0-14 75.3 
Heaney et al (2002) Unselected GP cohort 1995-1997 0-14 114.8 (88.6 – 146.3) 
Martinez et al (2009) GPRD cohort 2005  0-9 48.0 (39.1 – 58.2) 
Eltze et al (2013) GP survey 2005-2006 0-2 70.1 (56.3 – 88.5) 
Meeraus et al (2013) THIN 1994-2008 birth cohort 0-7 
70.6 (65.6 – 75.9) to  
116 (100 – 123)† 
GP – General practitioner 
GPRD – General Practice Research Database; 5.5% of UK population 
THIN – The Health Improvement Network Database; 5% of UK population 
† Least to most sensitive criteria for epilepsy 
 
As incidence estimates vary markedly between studies, it is additionally important to 
understand the factors that contribute to that variance. Methodological factors are important 
(Ngugi et al., 2011), whilst SES and ethnicity are two factors that also require consideration. 
Differences in SES within an area or culture may reflect health inequalities via the availability 
of health and social resources, knowledge and attitudes to care, and health and lifestyle 
choices. Low SES is associated with increased risk for abnormal development, adverse health, 
and incidence of neurological disorders in children (Bradley and Corwyn, 2002; Kumar et al., 
2013). There is strong evidence that lower SES increases risk of epilepsy (Hesdorffer et al., 2005; 
Pickrell et al., 2015), although this relationship appears less robust in children, including within 
the UK (Hesdorffer et al., 2005; Reading et al., 2006). Contrary to this, Heaney et al. (2002) 
reported higher incidence of epilepsy in areas of lower socioeconomic status in children 0-14 
years in the UK, raising the possibility of regional, temporal, or circumstantial variations in risk. 
Data on differences in incidence across ethnicities are scarce (Banerjee et al., 2009). Of those 




American ethnicities in North America (Annegers et al., 1999; Benn et al., 2008). In the UK, no 
significant difference was found in the incidence of recurrent nonfebrile seizures between 
South Asian and non-South-Asian children in Bradford (Hamdy et al., 2007), although Eltze et 
al. (2013) found a higher incidence of epilepsy among Asian infants in London, raising the 
possibility of ethnicity-specific regional variations. How the incidence of Asian and other ethnic 
groups of children compare in Scotland is unknown. Such data may be particularly important 
given that epileptic syndromes may differ based on ethnicity (Friedman et al., 2013), which may 
signify different risk or causal factors. Such knowledge may be useful for resource planning.  
The main aim of the systematic review was to identify studies with incidence data reported on 
children with epilepsy under the age of five years, and to explore heterogeneity in estimates 
between studies. This is the first review specifically targeting the incidence of early-onset 
epilepsy. 
3.2.2 Systematic Review: Search Strategy 
This review follows guidance set out in the PRISMA report (Moher et al., 2009). Early searches 
and screening revealed a significant number of incidence studies on Infantile Spasms/West 
syndrome (herein referred to as infantile spasms), an early-onset epilepsy syndrome. Infantile 
spasms is a prevalent syndrome, typically manifesting in the first year of life. Therefore, infantile 
spasms specific studies were extracted and reviewed separately to those based on general 
cohorts of mixed early-onset epilepsies.  
The electronic databases Medline (Ovid), Web of Science (Thomson Reuters), and EMBASE 
Classic + EMABSE (Ovid) were searched for original research articles between years 1946-2015 
(appendix G). Searches were conducted on 8th May 2015, and search terms included MeSH 
terms (Ovid databases) ‘epilepsy’, AND ‘preschool/child/infant/toddler/infancy’ [or] ‘minors’, 
AND ‘incidence’ [or] ‘epidemiology’. Indexed searches were supplemented with free-text 
searches of titles and abstracts using truncation of search terms. Web of Science search used 
topic searches of target terms, including truncated searches, of (1) epilepsy: ‘epilepsy’, 
‘p[a]ediatric epilepsy’, ‘childhood epilepsy’, ‘epileptic encephalopathy’; (2) children: ‘preschool’, 
‘infant’, ‘children’, ‘childhood’, ‘toddler’; and (3) incidence: ‘incidence’, ‘epidemiology’. 





3.2.3 Inclusion and Exclusion Criteria 
Articles included were: (1) English language, (2) original research articles, (3) published on or 
after 1946 as identified from electronic database search, (4) population-based or community-
based study design, (5) children with epilepsy diagnosed ≤4 years of age, (6) reported annual 
incidence figures, or cumulative incidence data from which annual figures could be calculated, 
for general epilepsy populations, and (7) cumulative incidence for studies of infantile spasms. 
Research studies often publish data on children with ≥1 unprovoked seizures. The operational 
definition of epilepsy in epidemiological studies is defined as two or more unprovoked seizures 
(Thurman et al., 2011; ILAE, 1993). Therefore, incidence data was only gathered when reported 
from cohorts of children where the study defined epilepsy as ≥2 unprovoked seizures, when 
the study classified epilepsy as ‘recurrent’ seizures, or when based on diagnostic codes for 
epilepsy.  
Study articles were excluded if: (1) data were not reported for any age stratification below five 
years of age (e.g. <1 year, <2 years, 0-4 years), (2) were cross-sectional, single or multi-centre 
studies, (3) were review articles including systematic reviews, letters, abstracts, single-case 
studies, or other non-original research articles, or (4) if the study described incidence of 
epilepsy syndromes other than infantile spasms, epilepsy within special populations (e.g. ASD), 
or of solely seizure types. 
3.2.4 Data Extraction and Synthesis  
Early-onset epilepsy, restated here, is epilepsy onset ≤4 years of age. Pilot searches revealed 
that data was typically reported for ages <1, 1-4, and 0-4 years. Therefore, these were the main 
target ages for data extraction, and focus for review. Less often, studies reported on children 
<2 years. These were included here for the purposes of completeness. Several studies reported 
data for more than one age stratification, and as such, extracted age-stratification specific 
datasets were labelled as ‘observations’, so that there may be more than one incidence age 
observation per study. For age groups of interest, the total number of incident cases, and total-
person-years were extracted from reviewed articles. To achieve standardisation across studies, 
incidence rates, standard errors, and 95% confidence intervals were independently calculated 
from available data for all studies, and presented in the data tables to follow. Where insufficient 




available data on incidence rates and confidence intervals were extracted from the published 
results, and transferred directly to tables, but those studies were not included in meta-analysis. 
Meta-analysis was used to provide pooled estimates, and meta-regression to explore the 
heterogeneity in incidence estimates. Incidence rates for epilepsy were reported per 100,000 
children per year, and per 10,000 live births for studies of infantile spasms.  
Extracted data included study authors, year of publication, study location, years of data 
collection, age group, incidence rate, 95% confidence intervals, total-person-years, study 
design (i.e. retrospective or prospective design), population type (i.e. cohort, 
population/community-based), case identification strategy (i.e. surveillance methods or 
medical registries, with case validation if completed), and case identification source (i.e. single-
source or multi-source). Case identification is often a heterogeneous process, involving a 
combination of strategies from single or multiple data sources. For simplicity, strategies and 
sources of identification were considered separately. Independent resources of case 
identification included general practitioners, paediatricians, EEG departments, hospital or clinic 
departments, or medical registries (e.g. general practitioner database or medical records), for 
example. Multiple sources were defined as the use of more than one independent resource.   
3.2.5 Individual Study Assessment of Risk of Bias  
Risk of bias is a phenomenon in any research study where the findings may be unduly 
influenced by methodological factors. The Cochrane Collaboration (2009) recommends that an 
appraisal of quality be conducted in systematic reviews and meta-analyses. The use of a scoring 
system for assessing risk of bias is debated, but recommended by at least one group for 
observational studies (Stroup et al., 2000). A risk of bias assessment proforma was constructed 
by the candidate based on one produced for a previous systematic review of incidence studies 
(Kotsopoulos 2002). It was developed further, for the specific purposes of this review, and 
included factors that could potentially influence incidence estimates. There were six factors in 
total, and was made up of epilepsy definition, case identification methods, availability of 
confidence intervals or underlying population denominators, and length of time each 
population was observed for.  Each factor was scored between 0 and 3 points depending on 
the risk for potential bias, and each study received a total score which was treated as a 




3.2.6 Meta-Analysis with Meta-Regression 
Analyses were performed using Stata-MP v13.1 (2013, Statacorp LP, College Station, TX). The 
Metaprop command (Nyaga et al., 2014) for Stata applies random-effects modelling for 
proportional data based on the binomial distribution, and was used to calculate pooled 
incidence rates and 95% confidence intervals. Heterogeneity explained by sampling variability 
is represented by the I2 statistic. In addition to meta-analysis, this study explored the 
heterogeneity in incidence estimates using the meta-regression command Metareg (Harbord 
and Higgins, 2008). The random-effects regression model relates the contribution of study-
level covariates to the heterogeneity of studies, applying both within- and between-study 
variance. The standard error was used as the coefficient for within-study variance; calculated 
using the formula: 𝑠𝑞𝑟𝑡[𝑝 ∗
1−𝑝
𝑛
], where p is the proportion (i.e. incidence). The standard error 
is a marker of the relative accuracy of the incidence estimate based on the dispersion of values 
around the sampling distribution. Larger standard errors indicate more variability in the 
estimate. Between-study variance explained by the covariate(s) is represented by the adjusted 
R2 statistic (R2adj), and residual between-study variation due to heterogeneity is measured with 
the I2res statistic. The remaining variation not explained by I2res is attributable to within-study 
sampling variability (Harbord and Higgins 2008). 
Heterogeneity was explored firstly through univariate analyses using study-level covariates 
that may influence incidence estimates: gross national income status (World Bank 2016), study 
design, cohort age stratification, case identification strategy, and case identification source. 
Covariates were included in multivariable meta-regression analysis if significant at the .05 level 
on univariate analyses. In addition, infantile spasms is typically classified according to broad 
aetiological category; i.e. symptomatic or cryptogenic/idiopathic – the risk factors for which 
may vary temporally or culturally. Therefore, aetiology was included as a study-level covariate 
for regression in studies of infantile spasms. For comparison of incidence estimates within 
study-level covariates, incidence rate ratios were calculated (i.e. incidence rate of one level of 
the covariate level divided by the incidence rate of the opposing level). 95% confidence 
intervals were calculated using the following formula, where a is the number of observations 
with one level of the covariate, and b is the number of observations of the opposing level:  







Figure 3.1 Systematic review exclusion flow chart Figure 3.2 Age-specific data observations 
extracted from all studies 
 
 
3.2.7 Systematic Review: Results 
See figure 3.1 for PRISMA flow chart of inclusion/exclusion process. 2693 articles were 
screened, and two additional studies were included from screening references (Riikonen, 
2001a; Sillanpaa, 1973). One article was missing from the original search after being indexed 
as a review but contained original data (Riikonen 2001a). The other was missed from database 
searches due to a combination of non-indexing, and because the specific synonym used in the 
article title, ‘epidemiological’, was not covered by free-text title searches where the term 
‘epidemiology’ was used. 39 articles were accepted for final review: 29 studies described the 
annual incidence of epilepsy ≤4 years, and 10 reported the incidence of infantile spasms. 
Studies were published between 1973 and 2013 (figure 3.3), reporting on incident samples 
observed from 1935 to 2008. 26% (n=10) were published on or prior to 1993, the year of the 
publication of the ILAE guidelines for epidemiological studies on epilepsy (ILAE, 1993). Only 
three studies were from low or middle income countries across different age stratifications 








Of the 29 studies of annual incidence rates in early-onset epilepsy populations, figure 3.2 lists 
how many unique observations were available for data synthesis, and how many were available 
in each target age for meta-analysis. One study provided a vague incidence estimate for 
children <1 year of “up to 200 new cases” (Christensen et al., 2007, p62), and was not 
synthesised further. This, and three further studies, were not included in meta-analysis. Two 
studies published incidence rates without underlying population data (Doose and Sitepu, 1983; 
MacDonald et al., 2000), and the populations reported in Hauser et al. (1975) were reported 
and extended in (Hauser et al., 1993), which was preferred instead. Consequently, 41 unique 
age-specific observations from 25 studies were included in the meta-analysis and regression. 
There was a total of 2137 incident cases from 2,129,516 total-person-years for all included 
studies on children with epilepsy of onset 0-4 years.  Study characteristics for age-specific 
observations (i.e. 0-4 years, <1, <2 years, and 1-4 years) are listed in tables 3.2, 3.3, 3.4, and 
3.5, respectively. Corresponding forest plots were produced (figures 3.4, 3.5, 3.6, and 3.7). 
The pooled incidence estimate for observations of children 0-4 years only (n=13 studies) was 



























Table 3.2 Study characteristics and annual incidence rates of epilepsy per 100,000 children 0-4 years 
Author (year) Location Incidence years Design 
Case Identification: Incidence Rate /100,000 
(95% Confidence Interval) Strategy Source 
Blom et al. (1978) 
Västerbotten, 
Sweden 
1973-1974 Prospective Surveillance Multiple 130.86 (84.73 – 202.05) 
Hauser et al. (1993) Rochester, USA 1935-1984 Retrospective Medical registry Single 67.13 (56.55 – 79.70) 
Olafsson et al. (1996) Iceland 1993 Retrospective Medical registry Multiple 112.30 (59.10 – 213.31) 
Kurtz et al. (1998) UK 1958  Prospective Questionnaire Single 58.15 (43.46 – 77.79) 
Annegers et al. (1999) Texas, USA 1988-1994 Retrospective Medical registry Single 67.0 (48.82 – 91.94) 
Beilmann et al. (1999) Estonia 1995-1997 Prospective Surveillance Multiple 76.08 (60.52 – 95.64) 
MacDonald et al. (2000) London, UK 1995-1996 Prospective 
Medical registry & 
surveillance 
Multiple 86* 
Freitag et al. (2001) 
Heidelberg/ 
Mannheim, Germany 
1999-2000 Prospective Surveillance Multiple 76.80 (46.55 – 126.68) 
Saha et al. (2008) West Bengal, India 1992-1998 Prospective Questionnaire Single 129.45 (70.33 – 238.14) 
Martinez et al. (2009) UK 2005 Retrospective Medical registry Single 56.97 (43.78 – 74.14) 
Banerjee et al. (2010) Kolkata, India 2003-2008 Retrospective Questionnaire  Single 63.35 (34.42 – 116.59) 
Casetta et al. (2012) Ferrara, Italy 1996-2005 Prospective 
Medical registry & 
surveillance 
Multiple 68.76 (54.78 – 86.31) 
Cesnik et al. (2013) Ferrara, Italy 2007-2008 Prospective 
Medical registry & 
surveillance 
Multiple 63.69 (30.85 – 131.42) 
Meeraus et al. (2013) UK 2001-2008 Retrospective Medical registry Single 130.06 (122.45 – 138.13) 







Table 3.3 Study characteristics and annual incidence rates of epilepsy per 100,000 children <1 year 
Author (year) Location Incidence years Design 
Case Identification: Incidence Rate /100,000 
(95% Confidence Interval) Strategy Source 
Sillanpää (1973) SW Finland 1961-1964 Retrospective Medical registry Single 92.0 (72.58 – 116.60) 
Blom et al. (1978) Västerbotten, Sweden 1973-1974 Prospective Surveillance Multiple 95.72 (32.56 – 281.08) 
Doose and Sitepu 
(1983) 
Kiel, Germany 1957-1966 Retrospective Medical registry Single 201.6* 
Granieri et al. (1983) Ferrara, Italy 1964-1978 Retrospective Surveillance Multiple 212.02 (137.30– 327.28) 
Benna et al. (1984) Alba-bra, Italy 1974-1978 Retrospective 
Medical registry & 
surveillance 
Multiple 211.14 (133.60 – 333.53) 
Joensen (1986) Faroe Islands 1970-1980 Retrospective Medical registry Multiple 202.87 (124.91 – 329.30) 
Tsuboi (1988) Fuchu, Tokyo 1974-1980 Retrospective Surveillance Single 193.62 (137.90 – 271.78) 
Hauser et al. (1993) Rochester, USA 1935-1984 Retrospective Medical registry Single 86.30 (62.34 – 119.44) 
Camfield et al. (1996) Nova Scotia, Canada 1977-1985 Retrospective Medical registry Single 118.14 (98.20–142.12) 
Olafsson et al. (1996) Iceland 1993 Retrospective Medical registry Multiple 256.41 (99.76 – 657.45) 
Kurtz et al. (1998) UK 1958 Prospective Questionnaire  Single 90.35 (53.83 – 151.60) 
Freitag et al. (2001) 
Heidelberg/Mannheim, 
Germany 
1999-2000 Prospective Surveillance Multiple 145.86 (62.32 – 341.01) 
Dura-Trave et al. 
(2008) 






Table 3.3 continued       
Martinez et al. (2009) UK 2005 Retrospective Medical registry Single 84.25 (56.63 – 125.34) 
Wirrell et al. (2011) Rochester, USA 1980-2004 Retrospective Medical registry Single 102.40 (77.69 – 134.96) 
Cassetta et al. (2012) Ferrara, Italy 1996-2005 Prospective 
Medical registry & 
surveillance 
Multiple 109.42 (72.93 – 164.14) 
Eltze et al. (2013) London, UK 2005-2006 Prospective Surveillance Single 82.10 (63.24 – 106.59) 
Meeraus et al. (2013) UK 2001-2008 Retrospective Medical registry Single 220.19 (201.56 – 240.54) 
*excluded from meta-analysis (no population statistics) 
 
Table 3.4 Study characteristics and annual incidence rates of epilepsy per 100,000 children 1-4 years 
Author (year) Location Incidence years Design 
Case Identification: Incidence Rate /100,000  
(95% Confidence Interval) Strategy Source 
Blom et al. (1978) Västerbotten, Sweden 1973-1974 Prospective Surveillance Multiple 139.92 (87.38 – 223.97) 
Granieri et al. (1983) Ferrara, Italy 1964-1978 Retrospective Surveillance Multiple 100.40 (72.20 – 139.59) 
Hauser et al. (1993) Rochester, USA 1935-1984 Retrospective Medical registry Single 61.87 (50.57 – 75.70) 
Olafsson et al. (1996) Iceland 1993 Retrospective Medical registry Multiple 77.47 (33.10 – 181.24) 
Freitag et al. (2001) 
Heidelberg/Mannheim, 
Germany 
1999-2000 Prospective Surveillance Multiple 62.10 (33.73 – 114.28) 
Wirrell et al. (2011) Rochester, USA 1980-2004 Prospective Medical registry Single 65.30 (54.70 – 77.96) 
Cassetta et al. (2012) Ferrara, Italy 1996-2005 Prospective 
Medical registry & 
surveillance 




Table 3.5 Study characteristics and annual incidence of epilepsy per 100,000 children <2 years 




Case Identification: Incidence Rate  





1990-1992 Prospective  Surveillance Multiple 
70  
(41.70 – 117.47) 
Rantala and 
Ingalsuo (1999) 





(103.42 – 163.92) 
Eltze et al. 
(2013) 
London, UK 2005-2006 Prospective Surveillance Single 
70.58  
(56.31 - 88.45) 




2007-2008 Prospective Surveillance Single 
172.02  
(58.52 – 504.54) 
 
Figure 3.4 Forest plot: Annual incidence rate per 100,000 children  0-4 years 
 
Vertical line represents 0-4 years pooled estimate 
 
Figure 3.5 Forest plot: Annual incidence per 100,000 children <2 years 
 





Figure 3.6 Forest plot: Annual incidence rates per 100,000 children <1 years 
 
Vertical line represents 0-4 years pooled estimate 
 
Figure 3.7 Forest plot: Annual incidence 1-4 years (per 100,000) 
 
Vertical line represents 0-4 years pooled estimate 
 
of children <1 years only (n=17 studies), the estimated pooled incidence was 126.73 (95% CI 
97.22 – 159.97), and was 70.21 (95% CI 57.18 – 84.51) in observations of children aged 1-4 
years only (n=7 studies). There was greater heterogeneity in <1 age group (I2=90.21%), 
compared to 1-4 years (I2=56.49%).  Age was directly compared by inputting observations of 
ages <1 and 1-4 into a regression model (24 observations from n=17 studies). Age explained 




Univariate analysis of heterogeneity using study-level covariates revealed that heterogeneity 
was not significantly explained by study design, case identification strategy, case identification 
source, or risk of bias, in any of the age stratifications. 
Incidence rate ratios were examined by including data from all unique observations from ages 
<1, <2, 1-4, and the remaining unique studies for ages 0-4 years - done in order to avoid 
duplication of underlying populations between observations (32 observations from n=25 
studies). Incidence rates of covariate levels were similar, whilst all had considerable variance, 
and are displayed in table 3.6. Additionally, risk of bias did not significantly explain 
heterogeneity in incidence estimates (ß=1.51 (95% CI -4.54, 7.56), p=.6). No single covariate 
could significantly explain variance in incidence estimates.  
Table 3.6 Rate Ratios for study covariates 
Covariate Rate Ratio (95% CI) 
Study design: retrospective vs prospective  1.31 (-1.15, 2.62) 
Case identification strategy: medical registry vs surveillance 1.05 (-1.90, 2.14) 
Case identification source: multiple vs single  1.03 (-1.80, 1.97) 
Income: Low/Middle vs High 0.94 (-3.40, 3.06) 
 
Only four studies looked directly at socioeconomic aspects of incidence rates (Banerjee et al., 
2010; El-Tallaway et al., 2008; Meeraus et al., 2013; Granieri et al., 1983). No difference in 
incidence rates were found between urban and rural communities in Egypt or Italy (El-Tallaway 
et al., 2008; Granieri et al., 1983), slums and nonslum communities in India (Banerjee et al., 
2010), between areas of increasing social deprivation in the UK (Meeraus et al., 2013), or 
between populations in Italy when based on occupation status (Granieri et al., 1983), although 
this latter finding was based on both children and adults. Similar to data on socioeconomic 
status, there was extremely limited data on ethnicity, with only two studies reporting incidence 
based comparisons. In the United States, Annegers et al. (1999) found increased incidence of 
epilepsy in African-American and Hispanic children <5 years, compared to non-Hispanic white 
children. In the UK, Eltze et al. (2013) reported a higher incidence of epilepsy in Asian children 





Data on age-gender-specific incidence rates were limited.  There were 17 age-gender-specific 
observations from 13 studies (table 3.7). Population denominators were available in only four 
studies (n=8 observations) (Banerjee et al., 2010; Beilmann et al., 1999; Cassetta et al., 2012; 
Olafsson et al., 1996), which were inputted into a meta-analysis. In observations of children 0-
4 years, estimates ranged between 51.9 and 145.1 in males, and between 68.17 and 82.9 in  
Table 3.7 Age-gender-specific epilepsy incidence rates per 100,000 children per year   
Author, year Age 
Males  
Incidence (95% CIs) 
Females 
Incidence (95% CIs) 
Olafsson et al, 1996† 0-4 145.14 (53.26-315.90) 77.34 (15.95-226.02) 
Annegers et al, 1999 0-4 51.8 82.9 
Beilmann et al, 1999† 0-4 74.96 (52.78-103.33) 77.27 (54.12-106.98) 
Banerjee et al, 2010† 0-4 59.17 (1.50-329.68) 68.17 (1.73-379.80) 
Cassetta et al, 2012† 0-4 66.00 (46.47-90.98) 70.80 (49.85-97.59) 
Pooled 0-4 71.09 (45.66-96.52) 73.76 (46.99-100.52) 
Sillanpaa 1973 <1 110 75 
Doose et al, 1983 <1 230.5 170.6 
Granieri et al, 1983 <1 353.2 81.3 
Benna et al, 1994 <1 214.4 207.2 
Olafsson et al, 1996† <1 375.47 (77.43-1097.28) 131.41 (3.33-732.15) 
Freitag et al, 2001 <1 158 109 
Cassetta et al, 2012† <1 79.77 (36.48-151.43) 134.13 (73.33-225.04) 
Eltze et al, 2013* <1 85 (70-103) 79 (60-95) 
Pooled <1 149.65 (-1446.52, 1745.83 133.94 (-305.15, 573.04) 
Granieri et al, 1983 1-4 81.4 118.8 
Olafsson et al, 1996† 1-4 89.96 (18.55-262.89) 64.14 (7.77231.71) 
Freitag et al, 2001 1-4 72 51 
Cassetta et al, 2012† 1-4 62.53 (41.55-90.38) 55.00 (34.87-82.53) 
Pooled 1-4 63.88 (-82.44, 210.20) 55.55 (-85.63, 196.72) 
† Data inputted into meta-analysis 





females. Pooled estimates (n=4 observations) were roughly equivalent in males 71.09 (95% CI 
45.66-96.52), and females 73.76 (95% CI 46.99-100.52).  Gender-specific estimates for children 
<1 years were higher in males in all but one study, ranging from 79.8 to 375.5, and 75 to 207.2 
in females. Pooled estimates (n=2), however, were similar. 149.65 (95% CI -1446.52, 1745.83) 
in males, and 133.94 (95% CI -305.15, 573.04) in females. In observations of children 1-4 years, 
estimates were narrower. Pooled estimates in males were 63.88 (95% CI -82.44, 210.20), and 
55.55 (95% CI -85.63, 196.72) in females. 
Infantile Spasms Studies 
There were 10 studies reporting the cumulative incidence of infantile spasms based on 553 
cases over 1,551,977 live births. Study characteristics are presented in table 3.8. Infantile 
spasms was defined in most studies by the presence of spasms, and hypsarrhythmia on EEG, 
although definitions were not always stated. The majority of studies were published in a narrow 
time period, with eight of the ten studies published between 1994 and 2002, with the 
remaining two studies published in 1979 and 2009. Despite this, population birth cohorts were 
monitored between 2 and 21 years within studies, and in a notable 31 consecutive years in 
Uusimaa County, Finland (Riikonen and Donner, 1979; Riikonen, 2001a). All studies were 
retrospective design, with three studies unclear about case identification methods (Hino-
Fukuyo, Haginoya, Iinuma, Uematsu, and Tsuchiya 2009; Riikonen 2001a; Riikonen & Donner 
1979).  
The range of cumulative incidence estimates for infantile spasms was relatively narrow, ranging 
between 2.06 and 4.55 per 10,000 live births (forest plot figure 3.8). Pooled incidence was 
estimated at 3.53 (95% CI 2.95 – 4.15) per 10,000 live births, with significant heterogeneity in 
between-study incidence estimates (I2 73.24%). There was insufficient sub-group sample sizes 
for study-level covariates to perform meaningful meta-regression. Aetiological data was 
reported in 9 studies. Symptomatic causes were reported in 50-83% (median 75%) of cases, 
and cryptogenic or idiopathic aetiologies in 17-50% (median 25%). Aetiology was univariately 
assessed using the proportion of cases with symptomatic aetiology as a continuous variable. 
Aetiology explained 50.30% (R2adj) of between-study variance, although this, marginally, did 
not reach statistical significance (p=.053). With each one percent increase in the number of 






Table 3.8 Incidence of Infantile Spasms per 10,000 live births  
Author (year) Location Incidence years Study Design 




Riikonen & Donner (1979) Uusimaa, Finland 1960-1976 Retrospective Unclear Unclear 4.10 (3.40 – 4.96) 
Lúthvígsson et al. (1994) Iceland 1981-1990 Retrospective  
Medical Registry 
& Surveillance 
Multiple 3.02 (1.76 – 5.16) 
Sidenvall and Eeg-
Olofsson (1995) 
Central Sweden 1987-1991 Retrospective  Medical Registry Multiple 4.55 (3.51 – 5.89) 
Trevathan et al. (1999) Atlanta, USA 1975-1977 Retrospective  Surveillance Multiple 2.89 (1.87 – 4.46) 
Rantala and Putkonen 
(1999) 
Oulu, Finland 1976-1986 Retrospective  Medical Registry Multiple 4.14 (3.01 – 5.71) 
Riikonen (2001a) Uusimaa, Finland 1977-1991 Retrospective  Unclear Unclear 4.42 (3.65 – 5.35) 
Brna et al. (2001) 
Nova Scotia/ Prince 
Edward Island, Canada 
1979-1998 Retrospective  Medical Registry Multiple 3.07 (2.45 – 3.85) 
Matsuo et al. (2001) Nagasaki, Japan 1989-1998 Retrospective  Surveillance Single 3.15 (2.37 – 4.19) 
Primec et al. (2002) Slovenia 1985-1995 Retrospective  
Medical Registry 
& Surveillance 
Multiple 2.06 (1.55 – 2.74) 




There was insufficient information to statistically analyse gender differences. Eight of 10 studies 
stated the absolute number of males and females with infantile spasms but gender-specific 
population denominators were not reported (Brna et al., 2001; Hino-Fukuyo et al., 2009; Matsuo 
et al., 2001; Primec et al., 2002; Rantala and Putkonen, 1999; Luthvigsson et al., 1994; Riikonen, 
2001a; Sidenvall and Eeg-Olofsson, 1995). Gender-specific incidence was reported in only one 
study, with a male predominance (4.5 vs 1.4 per 10,000 live births; Luthvigsson et al., 1994). In 
total, across studies, there were 239 males with infantile spasms, and 189 females reported. 
Figure 3.8 Forest plot: Cumulative incidence of infantile spasms per 10,000 live births 
 
 Vertical bar represents pooled estimate 
  
3.2.8 Systematic Review: Discussion 
Children with Early-Onset Epilepsy 
The incidence of early-onset epilepsy was estimated at 79.79 (95% CI 60.19 – 102.06) per 
100,000 children ≤4 years. As expected, annual incidence rates in CWEOE were highest in the 
first year of life compared to years 1-4. In the few studies which reported incidence data for 
each year, peak incidence was in the first year of life as expected (Beilmann et al., 1999; Kurtz 
et al., 1998; Meeraus et al., 2013). There was no definitive pattern across individual years 1 
through 4, with both a gradual decline (Meeraus et al., 2013), and variable age point estimates 
(Beilmann et al., 1999; Kurtz et al., 1998) reported. In those latter two studies, a second peak at 
age three years was noted.  
Gender differences in children with epilepsy were inconclusive. Inconsistent findings were 




well as considerable variability in incidence or absolute values between-studies and resulting 
wide confidence intervals. Although there is a slight male bias observed across the lifespan 
(Christensen et al., 2007; Forsgren et al., 2005; Kotsopoulos 2002), pooled estimates between 
genders in children ≤4 years were similar.  
There was limited data on the incidence of early-onset epilepsy in the UK, with four studies 
reporting incidence estimates for the selected age stratifications. For observations of age 0-4 
years, two studies reported annual incidence rates of 57 and 58 (Kurtz et al., 1998; Martinez et 
al., 2013), with one further study recording a notably larger estimate of 130 (Meeraus et al., 
2013). There was no data for children 1-4 years, but the incidence for <1 years was estimated 
at 82-90 in three studies (Eltze et al., 2013; Kurtz et al., 1998; Martinez et al., 2013), and 220 in 
Meeraus et al. (2013). The large discrepancy between these data reported by Meeraus et al. 
and three alternative studies may be partially explained by first stage case identification 
methods, resulting in possible underestimation (Eltze et al., 2013; Kurtz et al., 1998), or 
overestimation (Meeraus et al., 2013). To explain, Meeraus et al. used three indicators for 
epilepsy classification with differing levels of sensitivity. The data above was formulated on 
their most liberal indicator (i.e. a prescription for an AED, epilepsy diagnosis code, or code for 
two or more non-febrile seizures). Although they found lower incidence rates based on more 
restrictive criteria in 0-7 year old children, that information was not available for children ≤4 
years only. Interestingly, Kurtz et al. (1998) also noted higher estimations when similar selection 
criteria was applied in their prospective birth cohort (table 1, p316), but their final estimations 
were based on validation of individual cases through extensive interview and review of medical 
records. Meeraus et al. did perform a validation on 10% of their sample by examining medical 
records for further evidence of epilepsy - or for the absence of other diagnoses that could 
explain AED prescription. The authors found corroboratory evidence in 82-100% of children. 
This suggests that a combination of case identification and validation methods may play a role 
in these discrepancies. Kurtz et al. (1998) suggested that their data may be an underestimation 
due to uncertainty surrounding cases who died, particularly those in the early-onset period, 
where no medical information was obtained other than that stated on the death certificate. In 
the remaining UK studies, Eltze et al. (2013) used multi-tiered capture-recapture methods for 
first stage case identification, statistically compensating for potentially missing cases. Under-
ascertainment was estimated at 24%, and additional studies are needed to corroborate 
estimations.  Whilst all studies mentioned here, contributed extremely important and useful 




methods with individual case validation for all cases in a prospective population-based cohort 
is required, in order to provide further clarification. 
As well as providing pooled incidence estimates, this systematic review explored the variance 
in estimates using study-level covariates. Whilst age explained some of the variance between 
studies, most of the heterogeneity remained unexplained. An attempt was made in this review 
to partition study-level variables based on broad methodological variables that could 
theoretically influence estimates. In practice, studies varied in their approach often using 
combinations of these methodological factors, with individual differences often within the 
same methodological covariate. Above, it was suggested that the variance in incidence 
estimates between studies in the UK could be partially explained by close scrutiny of 
methodological differences. This suggests that any single methodological factor may not be 
enough in and of itself to explain variability in estimates, although further exploration of 
covariates in larger sample sizes is required. Modest study and observation sample sizes 
restricted the ability to investigate interaction effects between these variables in meta-analysis. 
It should also be noted that the risk or bias assessment used in this study attempted to take 
into consideration methodological biases. However, this had two potential limitations. The first 
is that, the risk of bias gave an assessment of methodological bias but did not indicate the 
direction of bias. That is, it was not determined if the specific study bias could lead to 
overestimation, or to underestimation. Second, the methodological factors were scored 
equally, and it may be the case that certain factors have greater or lesser influence on 
heterogeneity. Therefore, further development of such a system is needed to weight the 
variables appropriately. Although, heterogeneity could not be adequately explained in this 
study, it is important to note that incidence estimates are likely to vary temporally and across 
geographical locations (Sillanpaa et al., 2011). As such, it is important to ascertain incidence 
estimates in different locations in order to plan targeted resource provision.   
Several of the study-level covariates necessitate further mention. First, in a meta-analytic 
review of epilepsy incidence in adults and children, Ngugi et al. (2011) found higher estimates 
in prospective studies compared to retrospective. The current review found no significant 
difference. The reason for this is unknown, although differences in methodologies and 
inclusion/exclusion criteria may offer potential explanation. Ngugi et al. included hospital-
based studies and research database studies, and their review was based on studies of adults 
and children of all ages, where the present review included only children ≤4 years. It is unclear 




countries have higher incidence estimates than low/middle income countries (Kotsopoulos, 
2002; Ngugi et al., 2011). There were limited studies from lower/middle income countries in 
the present study with which to make a robust comparison. Based on the very limited data 
available, income status of the country did not explain variance in incidence estimates.  
Similarly, few studies directly investigated SES or ethnicity as a risk factor for epilepsy incidence 
in children with early-onset epilepsy. In those that did, no effect of SES was apparent. This 
finding was based on only four studies using different indicators of SES (i.e. rural vs urban 
dwellers, slum vs nonslum, and social deprivation), meaning that the relationship still remains 
unclear. Only two studies reported data on ethnicity, making this a particularly neglected area 
of study in early-onset epilepsy.  It is interesting to note that while adult studies have found 
no difference in incidence estimates between ethnicities, the two studies of early-onset 
epilepsy reported here did so (Annegers et al., 1999; Eltze et al., 2013). This raises the possibility 
that different ethnicities present different risk factors for early-onset epilepsy, and studies 
reporting incidence estimates of various childhood and adult populations should take this into 
consideration. Direct evidence for this came from Annegers et al. (1999), who found higher 
incidence rates in African-American and Hispanic children <5 years, but similar rates in other 
childhood and adult age stratifications.    
Infantile Spams/West Syndrome 
The incidence of infantile spasms appears relatively stable across studies, ranging between 
2.06 and 4.55 per 10,000 live births. Primec et al. (2002) reported the lowest incidence figure. 
The authors assumed that all cases from community hospitals would be redirected to their 
centre, but it was unclear if attempts were made to verify this, raising the possibility of missing 
cases lost to sampling bias. Nevertheless, all estimates lay in a relatively narrow band. Three 
commonly cited studies, which were not included in this review -because of estimates drawn 
from single or multiple centres with limited population coverage - provided lower estimates 
of 0.6 (Chen et al., 2004) and 1.68 (Hwang and Korean Child Neurology, 2001), with the third 
providing a population adjusted estimate of 3.1 (Lee and Ong, 2001), similar to the estimates 
from studies reviewed in this article.  
A relationship across time could not be directly addressed in the analysis due to a narrow 
period of study publication. Three studies did find a high degree of stability across time within 




Olofsson 1995), with two of those showing stability across a 32 year observation period from 
1960-1991 in one region of Finland (Riikonen & Donner 1979; Riikonen 2001a). In contrast, 
Brna et al. (2001) found a notable decrease in overall trend after 1993 – suggesting the 
possibility that incidence is in decline. However, the authors also found a high degree of yearly 
variability, and noted that this variability may distort any true overall trend. One study in this 
review was conducted solely after 1993, reported an incidence estimate at the higher end of 
the scale; 4.27 (Hino-Fukuyo et al., 2009), providing contradicting evidence. Should a relative 
overall stability in incidence remain, it would suggest that improvements in pre- and perinatal 
care have had little impact in decreasing the risk of infantile spasms over time.  
Gender differences in infantile spasms could not be reliably assessed due to an absence of 
gender-specific population denominators. However, there were more male cases in absolute 
terms, cautiously suggesting that males may be at more at risk of developing infantile spasms 
than females. It is recommended that future studies include gender statistics for a robust 
evaluation.  
Between-study heterogeneity remained unexplained. The small number of studies reviewed 
here had considerable homogeneity in methods, meaning that only aetiology could by 
factored into meta-regression. A trend toward aetiology was found, with higher proportions 
of symptomatic cases positively correlated with cumulative incidence. There was evidence of 
regional variation in incidence estimates (Hwang and Korean Child Neurology, 2001; Sidenvall 
and Eeg-Olofsson, 1995), as well as annual variations in incidence rates (Brna et al., 2001), and 
are two further factors that have the potential to explain some of the additional heterogeneity.  
Limitations 
The main limitation of the findings presented here, was that the exploration of heterogeneity 
was limited by the number of studies that could be modelled in meta-regression. Each study 
used various methodological approaches, and multivariate linear regression would have been 
preferred in order to explore combinations of methodological approaches. An attempt was 
made to assess risk of bias, which may have partly taken this into consideration. However, this 
did not significantly explain heterogeneity. One alternative possibility to explain between study 
heterogeneity could be argued, and which rests with differences in case identification sources. 
In this review, we considered single vs multiple identification sources, and surveillance vs 




same covariate. Medical coding procedures for instance may be defined differently according 
to country or site, or response rates from human informers during active surveillance may be 
variable between studies. Such variability would not have been identified in the current review. 
Nevertheless, the non-significant differences between study level covariates suggests that 
significant variation between study estimates remains, and which could be explained by other 
factors, such as regional and temporal variations in epilepsy incidence.  
A methodological limitation of this review itself was that the study search was conducted by, 
and inclusion/exclusion criteria applied by, a single reviewer. Consequently, it is possible that 
some articles may have been missed. Additionally, infantile spasms specific articles were not 
the original intention of this review at conception, which increases the possibility that studies 
focused on infantile spasms were missed. However, epidemiological studies are well defined, 
and easily identifiable in literature searches, which would have reduced the risk of missing data. 
As one study was missed despite a comprehensive systematic approach, it highlights the 
benefits of using a systematic review search strategy than relying only on electronic searches 
only. To reduce this risk further, the systematic search was supplemented by screening papers 
for additional references.   
Conclusion  
In conclusion, this review was aimed at describing the pooled incidence estimates of CWEOE, 
and factors influencing heterogeneity in estimates between studies. It did so in general 
populations of epilepsy, and in those with infantile spasms, a common and well-studied early-
onset syndrome. As expected, incidence estimates were higher in the first year of life compared 
to years 1-4. Whilst age explained some of the variance in epilepsy, most remained 
unexplained. In infantile spasms studies, methods were relatively narrow, and the 
heterogeneity of incidence in studies of infantile spasms was unexplained, although aetiology 
was a likely contributor. It is recommended that future incidence studies using early-onset 
epilepsy populations take into account age-gender-specific estimates, whilst reporting 
underlying population characteristics. It is also recommended that data on ethnic groups, and 
SES be examined in order to better understand the relative risk. 




In addition to synthesising data from a review of studies, the systematic review identified 
several issues in the current literature on the incidence on early-onset epilepsy in the UK. First, 
there was limited up-to-date data on early-onset epilepsy in the UK. Most of the incidence 
data from the UK were gathered in the 1990s, and with evidence suggesting the incidence of 
childhood epilepsy is decreasing over time in children (Cowan, 2002; Kotsopolous, 2002), 
including in the UK (Meeraus et al., 2013), new data are required to monitor trends as well as 
to help identify time-relevant risk factors. Second, there is a need for population-based studies, 
with prospective case identification, and with well-defined and validated epilepsy. The four UK 
studies identified in the review used different methods of first stage case identification (i.e. 
pre-validation stage), and epilepsy verification. Eltze et al. (2013) and Kurtz et al. (1998) 
surveyed data sources at first stage, which can have varying levels of response rates. The two 
remaining studies retrospectively accessed medical registry coding (Martinez et al., 2009; 
Meeraus et al., 2013), which are reliant on the accuracy of diagnostic coding, potentially 
increasing risk of miscoding, and under- or over-diagnosis. In addition, Meeraus et al. (2013) 
demonstrated that incidence varies depending on the selection criteria used when using 
coding systems. All studies validated or partially validated the diagnosis of cases, providing 
improved accuracy of validated epilepsy post-case identification. That said, there is a need for 
complementary, prospective, population-based data that includes both a comprehensive 
approach to case identification, and full validation of epilepsy diagnoses. Third, prospective 
studies on the incidence of infantile spasms are required to supplement the existing 
retrospective data, and to provide up-to-date information. Fourth, there is very limited data 
on SES and ethnic risk factors for epilepsy in the UK. Lastly, data on the incidence of epilepsy 
and infantile spasms has not been gathered in Scotland, and such data will allow comparison 
of geographical data to past and future studies in the UK.  
In addition to a basic knowledge requirement, incidence studies can provide detailed 
descriptive information on the age-related profiles of children with epilepsy. They provide a 
platform from which to identify age-related risk factors of epilepsy, and region or economic-
specific data from which to guide policy making and advise on resource provision. Incidence 
data at different time points allows the assessment of change, and provides valuable 
information on the development of risk factors, and to determine the successes or failures of 
health policy changes and preventative measures. The establishment of a population-based 
cohort in the present study provided the platform on which to investigate the cognitive and 
behavioural development of a representative sample of CWEOE. The remainder of this chapter 




4. Incidence of Early-Onset Epilepsy: Methods 
The systematic review on the incidence of early-onset epilepsy (section 3) revealed that 
updated data was required in the UK, and, for the first time, Scotland. From the UK studies 
identified in that review, it was concluded that complementary incidence estimates based on 
prospective population-based data with comprehensive case ascertainment methods and 
individually validated diagnoses were needed. Furthermore, socioeconomic data, and age- and 
gender-specific data using population denominators was required. This section describes the 
methods for the ascertainment of the incidence sample and estimates in the present 
NEUROPROFILES study. 
4.1 Aims 
As outlined in the previous chapter, the objective of Chapter II was to establish a population-
based cohort of CWEOE with the primary research aim of determining the incidence of newly 
diagnosed early-onset epilepsy. Secondary research aims were as follows:  
i) To describe the clinical and sociodemographic characteristics of the CWEOE cohort 
ii) To provide gender and age-specific epilepsy incidence rates 
iii) To provide ascertainment-adjusted epilepsy incidence rates, in order to account for 
potential missing cases, thereby providing the most accurate and comprehensive estimate 
iv)  To investigate SES and ethnicity as risk factors for epilepsy  
v) To determine the cumulative incidence of infantile spasms  
4.2 Participants  
CWEOE were identified and recruited from the pre-defined population-based region. The 
description of which, and methods for case identification, can be found in Chapter I, section 2. 
The reference population for analysis was comprised of all resident children aged ≤4 years 




ethnicity (table 4.3), were obtained from the 2011 Scottish Consensus 
(http://www.scotlandscensus.gov.uk/ods-web/standard-outputs.html). Statistics by age and 
gender can be found in table 4.2. 
Table 4.1 Area population for children 
≤4 years 
 
Table 4.2 Total population by age and 
gender 
 Age (m) Total Male Female 
Area Total Male Female  <12 9, 527 4, 856 4,671 
Edinburgh 26,163 13, 234 12, 929  12-23 9, 348 4, 775 4,573 
West 
Lothian 
11,565 5, 952 5, 613  24-35 9, 174 4, 605 4, 569 
Fife 7,516 3, 886 3, 630  36-47 8, 917 4, 604 4, 313 
Total 45,244 23, 072 22, 172  48-59 8, 278 4, 232 4, 046 
 
Population data on SES were based on Scottish Index of Multiple Deprivation 2012 data (SIMD; 
http://www.gov.scot/Topics/Statistics/SIMD; for more details on SIMD, see section 2.4). SIMD 
quintiles 1-3 were classified as low SES, and quintiles 4-5 as high SES. In the pre-defined 
general population, 63% of people reside in areas of low SES, and 37% in high SES areas.  
The cumulative incidence of infantile spasms is typically reported according to the number of 
live births within the reference population. Statistics on live births was accessed from the 
Information Services Division Scotland (http://www.isdscotland.org/Health-Topics/Maternity-
and-Births/Publications/data-tables.asp), with geography specific data supplied by the 
Information Services Division upon request from the candidate. Data was available for 
Edinburgh and West Lothian only. No gender-specific data was available. There were 13,825 
live births from 1st April 2013 to 31st March 2015. Because the present study collected data 
over a 26 month period (May 2013 – June 2015), the total live births in Edinburgh and West 






4.2.3 Statistical Analyses 
(i) Cumulative Incidence and Annual Incidence Rates 
Cumulative incidence, and annual incidence rates were calculated, applying the formulae 
described below, using the general population of 0-4 year old children from the defined 
geographical region. Age- and gender-specific values were calculated for age bands 1-
11months, 12-23months, 24-35 months, 36-47 months, and 48-59 months using age and 
gender specific population statistics detailed in tables 4.2 and 4.3; and further summarised for 
ages 1-4 year and 0-4 years for comparison with studies identified from the systematic review 
(section 3). 
Cumulative incidence was defined as the proportion of new cases of epilepsy over the period 
of data collection (1st May 2013 – 30th June 2015) from amongst the general population in 






Incidence rate was defined as the frequency of new cases from amongst the general population 







95% Confidence intervals (CI) for rates were calculated in excel using Byar’s approximation for 
Poisson distributions as described by the Association of Public Health Observatories (Eayres, 
2008) (resource available from http://www.apho.org.uk/).  
Cumulative incidence for infantile spasms was reported per 10,000 live births using the 
estimated number of live births in the general population. As identified in the systematic review 
in section 3, studies reporting the incidence of infantile spasms did not always provide a 




terms reflect age-related onset of infantile spasms (usually in the first year of life) but with the 
definition of West syndrome including documented hypsarrhythmia on 
electroencephalograph (EEG) (Wong and Trevathan, 2001). In the present study, cumulative 
incidence calculation was based on those fulfilling criteria for West Syndrome only.  
(ii) Ascertainment-adjusted Incidence Rate 
Using the capture-recapture methods set out in chapter I section 2, the frequency of children 
identified from source 1, the neurology department, and from source 2, EEG departments, were 
used to estimate the number of possible missing cases. An adjustment to incidence rates 
accounting for missing cases was then made using Chao’s lower bound estimator (figure 4, 
adapted from Brittain & Böhning, 2008). This is less sensitive to dependency of sources in a 
two-source model (Brittain & Böhning, 2008). Both unadjusted and adjusted incidence rates 
were reported for overall, and age- and gender-specific data. 
Figure 4 Chao’s estimator 




 EEG Depts. 
 
Identified Not identified  
 Identified 
 
ƒ11 ƒ01  
 Not identified 
 
ƒ10 ƒ00 ⱡ Nc 
 ⱡestimated number of cases missing from both sources 
Nc Chao’s estimated population size 
  




 Nc = f11 + f01 + f10 + ⁡f00⁡ 





(iii) SES and Ethnicity as Risk Factors for Epilepsy 
The relative risk of developing epilepsy in the general population was determined for (i) SES, 
and (ii) ethnicity. Risk ratios were calculated for the likelihood of developing epilepsy for 
children residing from low SES areas compared to children residing from high SES areas. Risk 




African/Caribbean and Asian) compared to children from white ethnicity (i.e. white-UK and 
white-European). In addition, risk ratios were calculated for individual ethnic sub-groups (i.e. 
African/Caribbean, Asian, and white-European), using white-UK as the comparator. Population 
statistics on SES and ethnicity were obtained from the Scottish 2011 Consensus (see section 
4.2). 
Risk ratios and 95% confidence intervals were calculated using the following formulae; 
 Epilepsy Non-epilepsy Total 
Subgroup 1 𝑥1 𝑦1 𝑥1 + 𝑦1 



















5. Incidence of Early-Onset Epilepsy: Results 
5.1 Population Descriptives 
59 (36 Male, 23 Female) children from the general population were identified in the 26 months 
of data collection. 46 were recruited into the study and anonymised data were collected on 
the remaining 13. As explained in Chapter I, section 2, anonymised data on demographic and 
epilepsy characteristics (appendix D) were passed to the research team by a paediatrician 
within the child’s care team. Children were predominantly white (n=51, 86%) vs non-white 
(n=8, 14%). 61% (n=36) of children were from a lower SES, and 39% (n=23) from a higher SES. 
Median age at epilepsy diagnosis was 28.52 (IQR 9.43 – 47.74), 1-59, months. Median age at 
first unprovoked seizure was 18.0 (IQR 6.0 – 36.0), <1-55, months. Epilepsy was most frequent 
at <1 years of age, with further spikes at ages three and four (figure 5.1). The median interval 
from age of onset (i.e. age at first unprovoked seizure, Thurman et al., 2011) to diagnosis was 
4.4 (IQR 1.03 – 10.47), months.  
Figure 5.1 Age at epilepsy diagnosis 
 
 
Clinical characteristics are presented in table 5.1, and aetiological information is visually 
depicted in figure 5.2. Known structural causes were more common in the first two years of 
life, regardless of classification system. Examining the ILAE 1989 classification, 
symptomatic/cryptogenic and idiopathic aetiologies displayed a clear trend of increasing 




















































Unclassifiable 1 (1.7) 0 (0) 1 (12.5) 0 (0) 0 (0) 0 (0) 
Idiopathic 33 (55.9) 6 (31.6) 5 (62.5) 2 (50.0) 9 (60.0) 11 (84.6) 
Cryptogenic 13 (22.0) 6 (31.6) 0 (0) 2 (50.0) 3 (20.0) 2 (15.4) 




Genetic 22 (37.3) 5 (26.3) 3 (37.5) 2 (50.0) 7 (46.7) 5 (38.5) 
Structural/Metabolic 11 (18.6) 7 (36.8) 2 (25.0) 0 (0) 2 (13.3) 0 (0) 
Unknown 26 (44.1) 7 (36.8) 3 (37.5) 2 (50.0) 6 (40.0) 8 (61.5) 
Mode of Seizure 
Onset 
Focal 20 (33.9) 7 (36.8) 3 (37.5) 1 (25.0) 6 (40.0) 3 (23.1) 
Generalized 34 (57.6) 10 (52.6) 5 (62.5) 3 (75.0) 8 (53.3) 8 (61.5) 
Both 5 (8.5) 2 (10.5) 0 (0) 0 (0) 1 (6.7) 2 (15.4) 




Table 5.2 Epilepsy syndrome classification table (developed according to ILAE, Berg et al., 2010)  





Otahara Syndrome 1 (1.7%)  
Infancy 
Infantile Spasms/West Syndrome 10 (16.9%) 
5x Structural 
     - 2x HIE 
     - 3x CM 
5x Unknown  
Benign Infantile Epilepsy 3 (5.1%)  
Benign Myoclonic Epilepsy of 
Infancy 
1 (1.7%)  
Childhood 
Panayiotopoulos Syndrome 1 (1.7%)  
Childhood Absence Epilepsy 5 (8.5%)  
Generalised Epilepsy with Febrile 
Seizures + 
1 (1.7%)  
Benign Epilepsy with 
Centrotemporal Spikes 
1 (1.7%)  
Distinctive Constellations MTLE with HS 1 (1.7%)  
Genetic Generalised Epilepsy 10 (16.9%)  
Genetic Focal Epilepsy 4 (6.8%) 
Presumed 
Genetic 
Other Structural-Metabolic Causes 




Epilepsies of Unknown Cause Mixed Focal & Generalised Epilepsy 
of Unknown Origin 
2 (3.4%)  
Generalised Epilepsy of Unknown 
Origin 
8 (13.6%)  
Focal Epilepsy of Unknown Origin 6 (10.2%)  
CM – Cerebral Malformation 
HIE – Hypoxic-ischaemic encephalopathy 
MTLE with HS – Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis 





occurring in over half of children. In the 2010 classification 
system, the frequency of unknown and genetic causes were 
similar across ages. 
Epilepsy classifications and seizure characteristics are 
described in table 5.2 and 5.3, respectively. Of the 59 
children identified, 23 (39%) had two seizure types, and 4 
(7%) had three seizure types. 
5.2 Incidence 
59 children (36M:23F) were diagnosed with early-onset epilepsy between 01.05.2013 and 
30.06.2015 inclusive, providing a crude incidence rate of 60.19/100,000 children ≤4 years/year. 
Case ascertainment was high, with under-ascertainment estimated at 2.46%. Capture-
recapture ascertainment-adjusted incidence was estimated at 61.71 (95% CI 40.22 – 88.14) 
(figure 5.3).  
Figure 5.3 Capture recapture ascertainment adjusted estimate  
 Neurology Departments  
Identified, n Not identified, n  
EEG 
Departments 
Identified, n 43 6 
Nc=61.71 
Not identified, n 10 1.49ⱡ 
ⱡ estimated number of missing cases 
Nc Chao’s estimated population size 
Under-ascertainment percentage = ⱡ/Nc*100 = 2.46% (M=1.02%, F=4.21%) 
 
Age-specific cumulative incidence, unadjusted incidence rate, and ascertainment-adjusted 
incidence rates are listed in table 5.4. Incidence rate peaked in the first year of life, and was 
lower for years 1-4; 51.61 (95% CI 35.62 – 67.60) unadjusted, and 54.04 (95% CI 37.67 – 70.40) 
after ascertainment-adjustment. Incidence was lowest at age two years. 
 
Table 5.3 Seizure Type 
Seizure Type n % 
Focal 22 37.3 
GTCS 20 33.9 
Absences 17 28.8 
Spasms 14 23.7 
Myoclonic 5 8.5 
Atonic 3 5.1 
Unclassified 3 5.1 




Table 5.4 Age-specific incidence  
Age (year) n Population 
Cumulative 
(100/26m) 
Incidence rates per 100,000/y (95% CI) 
Unadjusted  Ascertainment-adjusted 
0 19 9527 .20 92.05 (39.70–172.42) 92.34 (39.70 – 172.42) 
1 8 9348 .09 39.50 (9.04–101.75) 44.44 (11.66 – 109.56) 
2 4 9174 .04 20.12 (1.18–69.94) 20.12 (1.18 – 69.94) 
3 14 8917 .16 72.46 (24.69-146.46) 73.55 (28.09 – 154.13) 
4 14 8278 .17 78.06 (26.60-157.76) 87.81 (34.00 – 174.23) 
0-4 59 45244 .13 60.19 (39.33-86.83) 61.71 (40.22 – 88.14) 
 
Variations in age-specific incidence reflected differences in age-related seizure types. The 
prevalence of GTCS and focal seizures was relatively stable across ages, while spasms and 
absence seizures had an age-related disposition. Peak incidence in the first year of life was 
attributed to spasms. 92% of children with spasms had onset <1 years of age. Likewise, the 
higher incidence at ages three and four years were attributed to the onset of absence seizures; 
50% of children with absences had onset at age three, and 50% at age four.  
Point incidence estimates were higher for males (table 5.5) than females (table 5.6), particularly 
at ages <1 and 4 years (figure 5.4). Confidence intervals of estimates between males and 
females overlapped at all ages, indicating uncertainty between true gender differences. 
Unadjusted incidence rate for age range 1-4 years in males was 60.72 (95% CI 36.43 – 85.00), 
and 42.13 (95% CI 21.49 – 62.77) for females. Ascertainment-adjusted incidence rate for ages 
1-4 years was 62.54 (95% CI 37.89 – 87.18) in males, and 45.71 (95% CI 24.21 – 67.21) in females.  
Table 5.5 Age-specific incidence estimates: Males  
Age (year) n Population 
Cumulative 
(100/26m) 
Annual incidence per 100,000/yr (95% CI) 
Unadjusted Ascertainment-adjusted 
0 12 4856 .25 114.05 (39.29 – 254.69) 115.0 (39.29 – 254.69) 
1 4 4775 .08 38.66 (2.26 – 134.37) 39.44 (2.26 – 134.37) 
2 2 4605 .04 20.05 (0.01 – 101.50) 20.05 (0.01 – 101.50) 
3 8 4604 .17 80.20 (18.35 – 206.59) 80.60 (18.35 – 206.59) 
4 10 4232 .24 109.06 (31.90 – 258.98) 122.69 (38.36 – 275.72) 





Table 5.6 Age-specific incidence estimates: Females 
Age (year) n Population 
Cumulative 
(100/26m) 
Annual incidence per 100,000/yr (95% CI) 
Unadjusted Ascertainment-adjusted 
0 7 4671 .15 69.17 (13.24 – 187.70) 69.17 (13.24 – 187.70) 
1 4 4573 .09 40.37 (2.36 – 140.31) 63.08 (9.09 – 175.08) 
2 2 4569 .04 20.20 (0.01 – 102.30) 20.20 (0.01 – 102.30) 
3 6 4313 .14 64.21 (9.64 – 185.63) 66.88 (9.64 – 185.63) 
4 4 4046 .10 45.63 (2.67 – 158.58) 51.33 (5.99 – 178.56) 
0-4 23 22172 .10 47.88 (23.19 – 85.86) 49.48 (23.19 – 85.86) 
 
Figure 5.4 Ascertainment-adjusted Incidence by age and gender 
 
 
There were 10 (7M:3F) children with infantile spasms. Six (3M:3F) had hypsarrhythmia on clinical 
EEG, and thus met criteria for West Syndrome. The cumulative incidence of West Syndrome 
was 4.01/10,000 live births, 95% CI (1.47-8.72). Mean age at diagnosis of West Syndrome was 
5.10 months (SD=2.13, range 3-9 months). Three children had an unknown cause of West 
Syndrome, and three had a structural/metabolic cause viz:  hypoxic-ischaemic encephalopathy, 


































5.3 Socioeconomic and ethnicity as risk factors for epilepsy 
36 CWEOE resided in an areas of lower SES, with 23 from a higher SES. Risk ratio for lower SES 
compared to higher SES was 1.42 (95% CI 0.84, 2.39), p=.19, indicating that low SES was not 
associated with an increased risk of epilepsy. 
Of the 59 children who developed epilepsy, 51 were white (43 white-UK, and 8 white-European) 
and 8 were non-white (1 African/Caribbean, and 7 Asian). The risk of developing epilepsy was 
not statistically different for non-white children compared to white children; risk ratio for non-
white ethnicities was 1.40 (95% CI 0.66, 2.94), p=.38, compared to white children. However, 
there was increased risk of epilepsy identified during sub-group analysis. Whilst 
African/Caribbean ethnic origin was not associated with higher risk of developing epilepsy 
compared to white-UK origin (risk ratio = 1.11 [95% CI 0.15, 8.04], p=.92), increased risk was 
found for children from white-European origin (risk ratio= 2.46 [95% CI 1.16, 5.24], p=.02), and 




6. Incidence of early-onset epilepsy: Discussion 
The aim of this chapter was to estimate the incidence of early-onset epilepsy in the existing 
literature base, and in a newly-diagnosed unique population-based sample of children in the 
South-East of Scotland. The systematic review in section 3 identified a number of studies 
providing incidence data on CWEOE. One of the main gaps in the literature was a lack of up-
to-date data on incidence within the UK. The review also emphasised the need for data that 
provided a prospective, population-based approach with comprehensive case identification 
and full validation of epilepsy diagnoses. The review also highlighted the need for data on 
sociodemographic risk factors for epilepsy in CWEOE. The NEUROPROFILES study provided a 
means to address those gaps.  
The ascertainment-adjusted annual incidence estimate of newly diagnosed early-onset 
epilepsy was 61.7 (95% CI 40.2 – 88.1) per 100,000 children ≤4 years per year. This was similar 
to that reported by Kurtz et al. (1998) and Martinez et al. (2013) in the UK, and toward the lower 
end of that found in the systematic review for this age range, i.e. 60.2 – 102.1. Age explained 
some of the variance between incidence estimates in the systematic review but most remained 
unexplained, suggesting that temporal and regional variations may be likely influences, 
although methodological factors may also play a role (see systematic review discussion; section 
3.2.8). The robust methodological parameters used in the current study add confidence to the 
current estimate. All epilepsy cases were prospectively made, confirmed diagnoses, and 
comprehensive active surveillance methods were used, resulting in an extremely low under-
ascertainment estimation.  
In the current study, incidence rate was highest in the first year of life compared to years 1-4, 
echoing the pattern found in the systematic review; whilst incidence estimates were within the 
confidence intervals of the pooled estimates of the systematic review.  The pattern of age-
specific point estimates over the first five years of life - which peaked at age <1  year, followed 
by decline and further peaks at ages 3 and 4 years - was similar to that observed in two other 
studies that provided year-by-year estimates (Beilmann et al., 1999; Kurtz et al., 1998). 
However, this pattern was not observed in Meeraus et al. (2013), where a decreasing linear 
trend was observed. It is unknown why this difference in pattern was observed, although it 
could potentially be attributed to natural variance in time and age-specific point estimates. 
Alternatively, the case inclusion criteria leading to a masking effect could be another potential 




criteria for epilepsy (i.e. AED prescription, or codes for epilepsy, or ≥2 non-febrile seizures). 
Misdiagnosis is common in childhood epilepsy, including those prescribed AED medication 
(RCPCH, 2013; Hindley et al., 2006; Uldall et al., 2006), and overestimation particularly in 
younger children may have been possible. However, the candidate is not aware of data on age-
specific AED prescribing rates during the data collection period, and this possibility is purely 
speculative. 
Consistent with the systematic review, a gender difference in epilepsy incidence rates was 
uncertain, with overlapping confidence intervals, despite a male predominance in the first year 
of life and at age four. Inconsistent gender estimates are also found in general childhood 
epilepsy populations (Wallace et al., 1998). The majority of children with absence seizures in 
this study were male, including all five diagnosed with Childhood Absence Epilepsy (CAE). The 
prevalence of absence seizures is slightly higher in females compared to males, although 
significance values or confidence intervals are not always stated, or the differences are not 
statistically significant (Christensen et al., 2005; Lennox, 1960; Loiseau, 1985; Waaler et al., 
2000). Asadi-Pooya et al. (2012) found no significant gender difference in early-onset CAE, 
whilst there may be a higher male presence in children with absence seizures and myoclonus 
(Tassinari and Bureau, 1985). However, only one child in the current cohort had myoclonus. 
Therefore, the increased presence of male CAE is unclear but may be a chance occurrence. 
The development of epilepsy was not associated with SES, supporting previous findings in 
childhood epilepsy (Hesdorffer et al., 2005; Reading et al., 2006). The role of ethnicity as a risk 
factor in childhood epilepsy is unclear. In the current study, an increased risk of epilepsy was 
found in children from white-European, and Asian descent. This is now the second study in the 
UK to observe a higher incidence of CWEOE in those with Asian descent (Eltze et al., 2013), and 
the third to report ethnic-related differences in CWEOE (Annegers et al., 1999; Eltze et al., 2013). 
It is not known why higher incidence rates are reported in these studies, although genetic 
factors are a potential explanation. Environmental factors, such as cultural differences in child 
rearing, diet, attitudes to care and medicine, may be another. To the candidate’s knowledge 
the higher risk of epilepsy seen in white children from European families has not previously 
been reported. This may be an erroneous result, although cultural or genetic differences cannot 
be ruled out. 
In addition to the incidence of CWEOE in general, the cumulative incidence of West Syndrome 




first UK study to do so.  The cumulative incidence was 4.01 per 10,000 live births, and was 
similar to estimations found in the systematic review; 3.53 (95% CI 2.06-4.55). As expected, all 
children were diagnosed in the first year of life (3-9 months). An equal number of male and 
female children were diagnosed with West Syndrome. No gender-specific birth statistics were 
available in order to calculate gender-specific incidence. Nevertheless, population statistics of 
resident children in the South-East Scotland over this time period were roughly equivalent for 
genders, suggesting that West Syndrome, in the UK, is likely to hold a similar risk for both 
genders. Given the relative rarity of West Syndrome, the total number of cases identified in 
this study was small. Nevertheless, the syndrome was well-defined, and the estimate is similar 
to that reported elsewhere, providing further credibility of the estimate. The findings also offer 
further evidence of global and temporal stability in the occurrence of West Syndrome.    
In conclusion, this study was the first Scottish prospective population-based study, with high 
ascertainment, and has provided up-to-date data on the incidence of newly diagnosed early-
onset epilepsy, and is the first in the UK to provide incidence data on children with West 
Syndrome. The sample size with which to assess sociodemographic risk factors was arguably 
modest, meaning an in-depth analysis of SES using individual stratifications of social 
deprivation quintiles was not possible. Nevertheless, ethnicity was identified as a significant 
risk factor despite a modest sample size, and requires further investigation in future studies.  
This study has focused on children 0-4 years of age providing detailed and comprehensive 
information on demographic, aetiological, and syndromic characteristics in this highly 
vulnerable infant, toddler, and preschool group. Incidence rates, including, age- and gender- 
specific incidence rates, are rarely reported for each individual year of life, and may be useful 
when formulating targeted intervention/prevention strategies. A major strength of this study 
was the use of a comprehensive prospective case identification strategy, with ascertainment 
adjusted corrections, and confirmation of epilepsy diagnoses. The findings presented here, can 
therefore be considered more robust to measurement error related to misclassification of cases 








Chapter III. Neurobehavioural Profile of Children With Early-Onset Epilepsy 
*** 
Chapter III details the construction and implementation of the comprehensive age-appropriate 
neurobehavioural assessment battery in the NEUROPROFILES study. Results are reported, and 
showed that CWEOE had an abnormal neurobehavioural profile compared to control children. 
That is, CWEOE had poorer cognitive functioning, and less age-appropriate social 
behaviour/more parent-reported behaviour problems compared to controls. The spectrum of 
neurobehavioural problems in CWEOE was broad, with a prevalence of 63% in CWEOE versus 
27% in controls. The degree of comorbidity was varied. Risk factors varied but predominantly 
included aetiology, prematurity, and family history of developmental or psychiatric issue. These 





7. Neurobehavioural Profile of CWEOE: Introduction 
It is now widely recognised that neurobehavioural problems are overrepresented in childhood, 
adult, and elderly epilepsy populations (Duchowny and Bourgeois, 2003; Hermann et al., 2008; 
Lin et al., 2012a; Pellock, 2004). In children of all ages, the spectrum of problems are broad, 
and are wide reaching across the spectrum of epilepsies (Berl et al., 2015; Fastenau et al., 2009; 
Hoie et al., 2006; Jackson et al., 2013; Menlove and Reilly, 2015). These problems include 
cognitive impairment (Camfield and Camfield, 2007; Sidenvall et al., 1996; Sillanpaa, 1992), 
specific neuropsychological impairments - including memory, attention, executive functioning, 
and language (Elger et al., 2004; Lassonde et al., 2000)-, and behaviour problems, including 
ADHD, ASD, conduct disorders, and affective disorders (Berg et al., 2011b; Cohen et al., 2013; 
Davies et al., 2003; Suren et al., 2012; Reilly et al., 2015a; Russ et al., 2012). The prevalence of 
problems are greater than that found in the general population, in sibling controls, or in 
children with other chronic health conditions (Caplan and Austin, 2000; Dunn and Austin, 2004; 
Ekinci et al., 2009; Hamiwka et al., 2011; Maulik et al., 2011; Otero, 2009; Plioplys et al., 2007; 
Rantanen et al., 2012; Reilly et al., 2011; Reilly et al., 2013; Rodenburg et al., 2005; Verrotti et 
al., 2014). Thus, epilepsy is a serious neurological condition, with serious adverse cognitive and 
behavioural consequences.  
As evidenced from the systematic review in chapter I, section 1.3, the data above has largely 
come from studies of children of all ages, or older childhood epilepsy populations. The review 
identified a major need for detailed knowledge surrounding the neurobehavioural profile of 
CWEOE, especially during the first five years of life. The systematic review specifically 
acknowledged the need for a population-based, prospective, case-control study, with the aim 
of determining the spectrum and prevalence of, and risk factors for, neurobehavioural 
problems in CWEOE in the UK. In chapter I it was argued that early-onset epilepsy could be an 
important independent risk factor for neurobehavioural problems (section 1.2), and combined 
with recent calls for research into childhood epilepsy (section 1.1), the case for pursuing this 
knowledge was strongly established.   
Thus, the NEUROPROFILES study was designed with the aim of understanding the burden of 
early-onset epilepsy by determining the neurobehavioural profile of a cohort of CWEOE as 
identified in chapter II. Restated here, the neurobehavioural profile is defined as the 




assessment scores and prevalence of neurobehavioral problems, as determined by 
psychometric assessment.  
Additionally, the neurobehavioural profile of children is multi-dimensional, yet few studies 
provide detailed information on the degree to which cognitive and behavioural problems co-
occur within a given population. This data is useful considering the rate of comorbidity can be 
high, and knowledge of comorbidities should inform patient and disease management. In the 
Children with Epilepsy in Sussex Schools study, in the UK, Reilly et al. (2014a) reported that 
40% of children had cognitive impairment and 60% met criteria for a behavioural problem. 
When considered together, 80% of children had a cognitive and/or behavioural problem. 
Children had up to four coexisting disorders, highlighting the need for better understanding 
and improved reporting of multi-dimensional difficulties. Gathering such data could aid in the 
development of targeted strategies toward the provision of comprehensive healthcare, 
psychosocial, and educational resources.  
The remainder of the current chapter will now detail the methods of determining the 
neurobehavioural profile of CWEOE in the NEUROPROFILES cohort, followed by results of the 





8. Neurobehavioural Profile of CWEOE: Methods 
8.1 Aims and Objectives 
The primary objective of this chapter was to describe the neurobehavioural profile of CWEOE 
by comparing performance on cognitive and behavioural psychometric assessment tools to 
that of control children; and to describe the spectrum and prevalence of neurobehavioural 
problems. Neurobehavioural problems were defined here as cognitive impairment or 
behaviour problems, as determined by empirically defined, and literature evidenced, cut-off 
points on those assessment tools. Operational definitions and cut-off points are described in 
detail in section 8.7.2.  
The secondary objective was to identify potential risk factors associated with poor performance 
on the psychometric tools, or with neurobehavioural problems, in CWEOE.  Research questions 
were as follows; 
I. Does the distribution of neurobehavioural assessment scores differ between CWEOE 
and controls? 
II. What are the types, and prevalence, of neurobehavioural problems in CWEOE and 
controls? 
III. What are the sociodemographic and epilepsy-related variables associated with 
neurobehavioural problems in CWEOE?  
8.2 Participants 
CWEOE and controls were prospectively identified and recruited from the pre-defined 
population-based region. Methods for which are described in Chapter I, section 2.6. Whilst 
data was gathered for all children who were identified as having epilepsy in the analysis of 
early-onset epilepsy incidence, only data for those who consented for neurobehavioural 
assessment were included here. Inclusion and exclusion criteria are detailed in section 2.5.2. In 
addition, the face-to-face assessment tools were English language based, and children were 
excluded from face-to-face assessment if the child was exclusively foreign-language taught. 




language was considered sufficient for inclusion. Study questionnaires were also English 
language based, and were not issued if no parent or main caregiver (herein referred to as 
parent) was literate in English. No child who consented for study entry was excluded based on 
this criteria, and all families had at least one parent who was literate in English. 
8.3 Neurobehavioural Assessment Battery: Rationale and Materials  
The neurobehavioural profile of the children was assessed through an age-appropriate battery 
of validated face-to-face assessment tools and parent-rated social-emotional behaviour 
questionnaires. A mixed approach of questionnaires and face-to-face assessment has been 
used successfully in school-aged children with epilepsy (Reilly et al., 2014a) and in a large 
longitudinal childhood epilepsy cohort (The Connecticut Study of Epilepsy, 
http://medicine.yale.edu/lab/ctepilepsy/publications/). The battery was divided broadly into 
cognitive functioning and behavioural functioning. The former included domains of general 
cognitive ability, and more specific neuropsychological domains of memory, social perception, 
and attention & executive functioning. Behavioural functioning included domains of adaptive 
behaviour, internalising behaviour, externalising behaviour, executive functioning, social 
functioning, and ASD associated behaviours (table 8.1).  
The neurobehavioural assessment battery was designed with the intention of generating 
psychometric scores across as much of the early-onset age as possible in each of the domains 
described above. Only age-appropriate validated tools with strong psychometric properties 
were selected. A lack of research and development of standardised psychometric tools for 
preschool-aged children (Baron and Anderson, 2012), and gross developmental differences 
throughout the early years, meant that standardised instruments were not available across the 
age span within each of the domains. Instead, different age-appropriate tools were used, and 
paired within domains. The domains of interest themselves were included based on their 
particular relevance to childhood epilepsy populations, and which are typically investigated in 
epilepsy research. The rationale for domain selection, and psychometric properties of the tools 
used to assess each domain, are described below;  
8.3.1 Cognitive Functioning 
General Cognitive Ability (GCA) is a term used within this study to describe general intellectual, 








Table 8.1 Neurobehavioural assessment battery tools and main outcome variable; by domain and age 
Domain 
Age (months)  
1-11 12-23 24-35 36-47 ≥48 Age 
General Cognitive Ability Bayley III Cognition WPPSI III FSIQ ≥1m 
Neuropsychological Skills   
NEPSY II  Memory, Social Perception, and Attention 
& Executive Functioning 
≥36m 
Adaptive Behaviour ABAS II General Adaptive Composite ≥1m 
Executive Functioning  BRIEF-P General Executive Composite ≥24m 




Externalising Behaviour  ITSEA Externalising 
CEC Inattention/ Hyperactivity 
CEC Defiance/Aggression 
≥12m 




SDQ Peer Relationship Problems 
SDQ Prosocial Behaviour 
ASD Behaviours  M-CHAT SRS-2 Total ≥16m 
Completion  Time  1.0hr 1.5hrs 1.5hrs 1.5 – 2hrs 2 – 3hrs  
Bayley III – Bayley Scales 3rd ed. 
WPPSI III – Wechsler Preschool and Primary Scales of Attention 3rd ed. 
NEPSY II – The Dev. Neuropsych. Assessment 2nd ed. 
ABAS II – Adaptive Behaviour Assessment System 2nd ed. 
ITSEA – Infant and toddler Social Emotional Assessment 
CEC – Conners Early Childhood 
BRIEF-P – Behaviour Rating Inventory of Executive Function - Preschool 
SEGC – Greenspan Social-Emotional Growth Chart 
M-CHAT – Modified Checklist for Autism in Toddlers 
SDQ – Strengths and Difficulties Questionnaire 




used to describe this concept in children and adults.  However, IQ tools are not available across 
the infant/toddler ranges, where developmental abilities are more appropriately ascribed to 
indicate cognitive function. GCA was assessed using the Bayley Scales of Infant and Toddler 
Development, 3rd Edition (Bayley III; Bayley, 2006a), for children aged 1-29 months (m), and the 
Wechsler Preschool and Primary Scales of Intelligence, 3rd UK Edition UK (WPPSI III; Wechsler, 
2002), for children aged ≥30m. Memory, social perception, and attention & executive 
functioning were assessed using The Developmental Neuropsychological Assessment-2nd 
Edition (NEPSY II; Korkman and Kemp, 2007), for children ≥36m. These were all face-to-face 
assessment tools.  
(i) General Cognitive Ability 
The Bayley III consists of three scales; Cognition, Language (Receptive and Expressive 
subscales), and Motor (Fine and Gross motor subscales). The Bayley III is standardised on 1700 
U.S. children and normed to ages 1-42m (Bayley, 2006b). It is validated in a UK & Ireland sample 
of 221 children aged 1-27m (Bayley, 2010). The Bayley III generates scaled scores of 1-19 with 
a mean of 10 and standard deviation (SD) of 3, and composite scores with a mean of 100 and 
SD of 15.  
The WPPSI III measures the intellectual ability of children between the ages of 2:6 years and 
7:3 years. There are two age-based versions; 2:6-3:11 years, and 4:0-7:3 years. The former 
consists of four main subtests and generates scaled scores for each, as well as a composite 
Verbal IQ (VIQ), Performance IQ (PIQ), and Full Scale IQ (FSIQ). The latter version consists of 8 
main subtests with corresponding scaled scores, and composite VIQ, PIQ, and FSIQ scores. This 
version also includes a processing speed quotient (PSQ). Normative data is based on 805 UK 
children and the UK version has been anglicised. Scaled scores have a mean of 10 and SD of 3, 
and IQ index scores have a mean of 100 and SD of 15. 
The term GCA reflects the fact that both the Bayley III Cognition scale and WPPSI III FSIQ aim 
to measure general/global intellectual or cognitive functioning. The Bayley III Cognition scale 
is founded on the development of cognitive features of play – including symbolism, 
relationships, information processing, memory, problem-solving and concept development. 
Despite its basis in sensorimotor play, the Bayley III Cognition scale has a strong correlation 
with the WPPSI III FSIQ (.79, Bayley, 2006b). The language domain of the Bayley III also offers 




measurements of development and IQ respectively, and have been extensively used in both 
clinical and research settings. 
(ii) Memory, Social Perception, and Attention & Executive Functioning (NEPSY II) 
The NEPSY II consists of 32 age-specific subtests that can be tailored for individual assessment 
or administered according to any of eight preset combinations of subtest batteries designed 
for specific referral types (e.g. language delay, attention, or school readiness) (Korkman et al., 
2007). The subtests are categorised into six domains: Attention & Executive functioning, 
Language, Memory & Learning, Sensorimotor, Social Perception, and Visuospatial Processing. 
Unlike the NEPSY I, composite scores are not generated based on the clinical sensitivity of 
subtest scores alone (Korkman et al., 2007). The NEPSY II was standardised on 1200 U.S. 
children aged 3-16 years. It generates scaled scores of 1-19 with a mean of 10 and SD of 3. 
Internal consistency (.62-.89) and test-retest reliability (.62-.82) for subtests are satisfactory 
(Korkman et al., 2007).   
The Memory & Learning, Social Perception, and Attention & Executive Functioning domains of 
the NEPSY II were selected for the current study due to their applicability to an epilepsy 
population, and in order to directly complement the specific goals of the assessment battery 
by assessing aspects of cognitive functioning, social cognition/behaviour, and 
attention/executive functioning, respectively. Of the NEPSY II domains, all age-relevant 
subtests were selected.  Popular face-to-face standardised alternatives for memory assessment 
(e.g. Children’s Memory Scales) and attention (e.g. Test of Everyday Attention for Children, TEA-
Ch) are not available for children under five years, meaning the NEPSY II was one of the few 
face-to-face tools standardised to preschool-aged children that assess specific 
neuropsychological skills.  
The Memory & Learning domain consisted of three memory subtests: Memory for Designs, 
Narrative Memory, and Sentence Repetition. Memory for Designs measures immediate 
visuospatial recall and learning; Narrative Memory assesses immediate cued verbal recall and 
recognition memory; and Sentence Repetition assesses immediate verbal recall of short 
sentences. The Social Perception domain includes Theory of Mind, and Affect Recognition 
subtests. These assess the ability to understand the beliefs and perspectives of others, and the 
ability to discriminate emotional faces, respectively. Theory of mind and emotional facial 




with ASD (Baron-Cohen, 2000; Uljarevic and Hamilton, 2013). The subtests complemented the 
social behaviour aspects of the assessment battery. The Attention & Executive Functioning 
domain consisted of only the Statue subtest. The Statue subtest assesses the ability of the child 
to maintain a defined statue position over a 75 second period whilst inhibiting the impulse to 
move or speak in the face of distractions, thereby relying on executive functions such as 
inhibition, and on the ability to attend to internal and external cues. The BRIEF-P and CEC 
Inattention/Hyperactivity (described in 8.3.2 below) complemented the Statue subtest by 
offering a behaviour based assessment of executive functioning and attention, respectively. 
Performance based and questionnaire based measures of executive functioning may tap into 
different mechanisms (Mahone and Hoffman, 2007), and was further justification for 
considering these tools separately.  
8.3.2 Behavioural Functioning 
Behavioural functioning was assessed via parent-rated social-emotional behaviour 
questionnaires. Parent-rated questionnaires offer quick and cost-effective means of surveying 
a broad spectrum of behaviours, whilst maintaining predictive diagnostic validity (e.g. Reilly et 
al., 2014c; Charman et al., 2007). Questionnaires used aimed to assess social-emotional 
behaviour issues pertinent to children with epilepsy. The battery assessed the domains: 
adaptive behaviour, internalising behaviour, externalising behaviour, executive functioning, 
social functioning, and ASD behaviours. Study specific questionnaires are described according 
to domain, below. 
(i) Adaptive behaviour 
Adaptive behaviour is commonly assessed in the clinical setting and is used in conjunction with 
an IQ assessment to diagnose intellectual disability (Alves et al., 2000). It is commonly 
measured in young children, and has previously been used in preschool-aged children with 
epilepsy (Berg et al., 2004; Berg et al., 2013). It provides a measure of everyday age-appropriate 
functional abilities that should be reached in order to achieve independent functioning. The 
Adaptive Behaviour Assessment System-2nd Edition (ABAS II) (0-5 years; Harrison and Oakland, 
2003a) was used here. The ABAS II is a questionnaire consisting of 7 (<1 year age), or 10 (1-5 
years), adaptive skills areas. Skill areas generate composite scores for: Practical Adaptive 
Behaviour, Social Adaptive Behaviour, Conceptual Adaptive Behaviour, and an overall General 




reports. Scaled scores have a mean of 10 and SD of 3, and composite scores have a mean of 
100 and SD of 15. The ABAS-II has good internal consistency (α) for composite domains (.91 - 
.97), test-retest reliability (.86 - .88), and inter-rater reliability between different parents (.72 - 
.86) (Harrison and Oakland, 2003b). 
(ii) Executive Functioning 
The Behavioural Rating Inventory of Executive Function - Preschool (BRIEF-P; Gioia et al., 
2003b) is a 63 item questionnaire consisting of clinical scales measuring five aspects of 
executive functioning in children aged 2-5 years. The subscales (Inhibit, Shift, Emotional 
Control, Working Memory, and Plan/Organize) form three index scales (Inhibitory Self-Control 
Index, Flexibility Index, and Emergent Metacognition Index) and a global composite score 
(General Executive Composite). All scales and indices generate T-scores with a mean of 50 and 
SD of 10. Internal consistency (.80 - .95), and test-retest stability (.78 - .90) for indices and scales 
is high (Gioia et al., 2003a). The BRIEF-P has shown discriminant validity in children with a 
clinical diagnosis of ADHD, who have higher scores than typically developing children (Gioa et 
al., 2003a; (Mahone and Hoffman, 2007; Skogan et al., 2015). Children with anxiety disorders 
also score higher, as do children with ASD, although scoring profiles differ (Gioia et al 2003a; 
Skogan et al., 2015). The normative sample was standardised on 460 parents of U.S. children. 
Although executive functioning can be considered a cognitive skill, the questionnaire assesses 
the behavioural impact of executive functioning. The BRIEF-P is the only executive functioning 
rating scale for preschool children, and has only a modest correlation with the other executive 
functioning measure in the battery, the NEPSY II Statues subtest (r=0.35, Mahone, 2005). 
(iii) Internalising Behaviour, Externalising Behaviour, and Social Functioning 
The internalising, externalising, and social functioning domains were constructed by selecting 
relevant infant/toddler or preschool-aged questionnaires, or questionnaire scales, and 
merging them into the relevant domain of interest in order to maximise age coverage (table 
8.1). Scales from two questionnaires, the Infant and Toddler Social Emotional Assessment 
(ITSEA) for ages 12-23m, and Conners Early Childhood-Behaviour Scales (CEC), for ages ≥24m, 
were allocated into all three domains. The social functioning domain included two additional 
questionnaires which are described in the relevant section below. Note that scores for each 
domain were not pooled. The internalising, externalising, and social functioning domains are 





The internalising domain consisted of the ITSEA Internalising scale (12-23m; table 8.2), and 
CEC Anxiety and CEC Mood/Affect scales (≥24m).  
Externalising Domain 
The externalising domain consisted of the ITSEA Externalising scale (12-23m; table 8.2) and the 
CEC Inattention/Hyperactivity and CEC Defiant/Aggressive scales (≥24m).   
Social Functioning Domain 
The social functioning domain consisted of the Greenspan Social-Emotional Growth Chart 
(SEGC; Greenspan, 2004)) (≤12m), the ITSEA Competence scale (12-23m; table 8.2), and the 
CEC Social Functioning/Atypical Behaviour scale (≥24m).  
The terms internalising and externalising were first conceptualised by (Achenbach, 1966). 
Internalising behaviours consist of emotional or introverted behaviours, such as anxiety or 
depression, whilst externalising behaviours are more extroverted and socially apparent, such 
as disruptive behaviour, ADHD, or conduct disorder. Social competence is a term used to 
describe age- and culturally-appropriate social interactive behaviour. Inadequate childhood 
social competence can adversely affect social relationships, workplace relations and success, 
and mental health in later life (Jones et al., 2015). However, social competence is not well 
defined conceptually or operationally (Cavell, 1990; Rantanen et al., 2012). To avoid 
problematic conceptualisation, and to make a clear distinction from other social-behaviour 
domains and concepts, in the current study a ‘social functioning’ domain was created and 
defined here as reflecting the behaviour scales associated with social skill development, social 
interaction and social relationships. Individual questionnaires and scales in these domains are 
now described. 
The ITSEA (Carter and Briggs-Gowan, 2005), was constructed in order to identify social and 
emotional problems in children from ages 12-35 months. It was standardised on 600 U.S. 
children, and consists of four scales: Internalising, Externalising, Competence, and 
Dysregulation. Each scale is made up of several subscales (table 8.2), and each generates a T-




(.85 - .89), inter-rater agreement (parent-pairs; .72 - .79), and test-retest reliability (.76 - .91) of 
scales are good (Carter and Briggs-Gowan, 2006). The ITSEA offers discriminant validity for 
children with mental health problems, and development delay (Carter and Briggs-Gowan, 
2006), and for those at high-risk of social-emotional difficulties as early as 12m of age (Sanner 
et al., 2016).  
Table 8.2 ITSEA selected scales, and subscales 
Scale Internalising Externalising Competence 
Subscales - Depression/Withdrawal 
- General Anxiety 
- Separation Distress 
- Inhibition to Novelty 
- Activity/Impulsivity 
- Aggression/Defiance 
- Peer Aggression 
- Compliance  
- Attention 
- Mastery Motivation 
- Imitation/Play 
- Empathy 
- Prosocial Peer Relations 
 
The CEC (Conners, 2009) is a 110 item questionnaire designed to assess a range of social and 
emotional behavioural concerns in children aged 2-6 years. The CEC generates an overall total 
score, three global index scores, and six behaviour scale scores (Inattention/Hyperactivity, 
Defiant/Aggressive behaviours, Social Functioning/Atypical Behaviour, Anxiety, Mood/Affect, 
and Physical Symptoms). The Defiance/Aggressive behaviours and Social Functioning/Atypical 
behaviour scales are subdivided further into subscales. Individual scales provide discriminant 
validity for corresponding clinical groups of ADHD, behaviour problems, adaptive problems, 
and social-emotional problems, providing positive predictive power between 69-98% 
(Conners, 2009). Scales have good internal consistency (.64 - .94), test-retest reliability (.73 - 
.92), and inter-rater reliability (parent-pairs; .62 - .85) (Conners, 2009) – and were thus used for 
domain analysis in this study. Each CEC scale generates T-scores, with a mean of 50 and SD of 
10. 
The SEGC measures social-interactive and emotional milestones – which are important 
indicators of social functional development – in children aged 0-42 months. It is an 
accompaniment to the Bayley III and validated on the Bayley III standardisation sample. It has 
high internal consistency (.90), and was standardised on 456 children aged 15 days to 42 
months (Bayley, 2006b). It returns a standard score with a mean of 100 and SD of 15. The SEGC 




To provide a complementary and focused examination of social relationships in CWEOE and 
controls, the Peer Problems and Prosocial Behaviour scales of the Strength and Difficulties 
Questionnaire (SDQ; Goodman, 1999) was used. The SDQ is widely used in clinical practice and 
in research, with parent report forms available for children aged 3-4 years, or 4-16 years. The 
SDQ provides raw scores and qualitative descriptors (i.e. low score, average, high, very high). 
Both age versions of the questionnaire were used, which have minor differences in comparative 
scores. Thus, qualitative descriptors were preferred. Internal consistency for Peer Problems and 
Prosocial Behaviour is 0.57 and 0.65, respectively, while test-retest correlations are 0.61 in both 
scales (Goodman, 2001). The parent versions of the SDQ were used for children ≥36m in this 
study.  
(iv) ASD behaviours 
Two ASD assessment tools were included in this study: The Modified Checklist for Autism in 
Toddlers (M-CHAT; Robins et al., 1999; Robins et al., 2009), and The Social Responsiveness 
Scale - Second Edition (SRS-2; Constantino and Gruber, 2012). ASD screening tools, such as 
the M-CHAT and SRS-2, offer quick, validated, standardised evaluations of abnormal social 
behaviour used to identify children for further clinical evaluation from general, or ‘at risk’, 
populations.  
The M-CHAT is a 23 item questionnaire designed to screen for ASD behaviours in toddlers 
aged 16-30 months. The M-CHAT has been validated on a sample of children with Pervasive 
Developmental Disorders (Robins et al., 2001; Snow and Lecavalier, 2008) and is an extension 
of the original Checklist for Autism in Toddlers (CHAT; Baron-Cohen et al., 1992). The M-CHAT 
generates a binary outcome of “risk” or “low risk” for ASD. It has good internal consistency 
(.85), and variable sensitivity (.70-.82), specificity (.38-.54), and positive predictive value (.36-
.79) (Charman et al., 2016; Chlebowski et al., 2013; Kleinman et al., 2008; Snow and Lecavalier, 
2008). The M-CHAT is widely used, freely accessible (via http://www.M-CHAT.org/), and has 
similar outcome properties to the few screening tools available for toddlers (Dudova et al., 
2014; Smith et al., 2013). 
The SRS-2 is a 65 item questionnaire which measures typical features of ASD and associated 
social reciprocal behaviours. It includes a preschool version (30-54 months) and a school-aged 
version (4-18 years). The SRS-2 generates T-scores for five subscales (Social Awareness, Social 




Behaviour), a composite Social Communication Index, and a Total score. Constantino and 
Gruber (2012) suggest that T-scores above 60 indicate levels of social communication and 
reciprocal social behaviour deficiencies; 60-65 indicate mild to moderate deficiencies, 66-75 
suggests behaviours typical for children with moderate ASD, and >75 is strongly associated 
with a clinical diagnosis of ASD. Normative data was standardised using 247 U.S. preschool 
children (30-54 months) and 1014 U.S. school-aged children (4-19 years). The SRS-2 is a recent 
derivative from the SRS questionnaire published in 2012, and therefore, has only limited, but 
promising, validation from clinical populations in children aged 2-5 years (Constantino, 2011; 
Turner-Brown et al., 2013). The school-aged version has shown good predictive value (Bruni, 
2014), and has been validated in a UK sample of children (Wigham et al., 2012). Internal 
consistency is high (.94), and inter-rater reliability (.77) is good (Constantino and Gruber, 2012).  
The M-CHAT and SRS-2 complemented one another by spanning ages 16-63m in the current 
cohort. These screening tools were preferred to the popular performance-based measure of 
ASD evaluation, the Autism Diagnostic Observation schedule (ADOS), due to their acceptable 
psychometric properties, applicability as broad first stage screening tools in ‘at risk’ 
populations, and their timely use in an already large assessment battery. The ADOS is a semi-
structured face-to-face instrument requiring clinical expertise, with its administration time a 
considerable disadvantage (Akshoomoff et al., 2006).  
8.4 Procedure 
General procedures for study identification, entry, consent, and involvement are detailed in 
chapter I, section 2.6. To remind the reader, after identification of CWEOE and controls, families 
were invited to take part in the study, and those who consented were sent age- and domain-
appropriate parent-rated questionnaires (table 8.1) to the family’s home. These were 
completed prior to face-to-face assessment, or in situ if parents requested further clarification 
of questionnaire items from the candidate.  Face-to-face assessments were completed at the 
child development lab or in the family home if they were unable/unwilling to attend the lab. 
Eye-tracking was also completed at the lab (see section 12). Further details specific to 
procedures surrounding neurobehavioural assessment are described below. 
Face-to-face neurobehavioural assessment was carried out by the candidate. The candidate 
received training and supervision from RS, Consultant Clinical Psychologist, and KV, Paediatric 




and attended a two-day training course from Pearson UK.  Parents were briefed on what 
assessment tool would be used and what to expect during the assessment, and were given the 
opportunity to ask questions before face-to-face assessment. The candidate was sensitive to 
the needs of the families during assessments and would introduce breaks as necessary or when 
requested.  
Children <30 months of age completed the Bayley III assessment. Children ≥30 months of age 
completed the WPPSI-III, and children ≥36m also completed the NEPSY II. In children ≥36m, 
FSIQ was seen as the relatively more fundamental aspect of the study, compared to the specific 
neuropsychological functions measured by the NEPSY II. Therefore, the WPPSI III was 
completed first to reduce any potential attrition from fatigue or failure to return to 
appointments. For those that attended the child development lab, the eye-tracking battery was 
completed, typically after cognitive assessment. Occasionally, eye-tracking was performed first 
if the child was nervous or uncooperative, or during break time if the child was uncooperative 
or fatigued from cognitive assessment. After face-to-face assessment and eye-tracking was 
completed, parents were interviewed with the medical questionnaire (appendix E) to obtain 
information on the child’s epilepsy-related characteristics and family history of epilepsy or 
developmental/psychiatric issues (see section 2.6 for further details). At the end of face-to-face 
assessment, families were given the opportunity to ask questions about the study and their 
child’s participation. This may have been about the study purpose or progress, or about the 
child’s performance, for example. Families were reminded that this was not a clinical evaluation 
and that a feedback report would be generated. 
Figure 8 Reward stickers 
 
 
8.5 Assessment Engagement 
The anticipated length of each assessment session was expected to vary according to age, 




assessment duration was also expected to vary according to the child’s temperament, cognitive 
abilities (including attention), familiarity with an assessment environment, and personal 
preferences for these types of tasks. One of the challenges during assessment was to promote 
attention and engagement. To manage this, stickers were created (figure 8) as a motivational 
tool and issued for task completion.  
8.6 Assessment Feedback 
Guidance on informing patients on assessment results was taken from Lefaivre et al. (2007). All 
families who participated received written feedback of their child’s assessment. The language 
was accessible for the lay person, and sensitive in nature, particularly when relaying 
information on subnormal findings. Each feedback report was reviewed by a member of the 
research team, KV, Paediatric Neuropsychologist, who has years of experience of paediatric 
assessment and parent liaison. Assessment reports were not treated as clinical interpretations, 
as this was not the nature of the assessment. Each report summarised the findings of the 
assessment across each neuropsychological domain tested, and indicated if the child was 
“below average”, within the “normal ranges”, “above average” or within the “elevated ranges”, 
depending on the tool reported. Individual test scores were not given, as they should not be 
interpreted by someone not trained in their use and limitations.  
Every child’s GP and paediatrician, if the child had one, was informed of their patient entering 
the study, and was given a copy of the feedback report with adjoining cover letter, summarising 
the findings of the assessment - unless the child’s family did not provide written consent for 
this to happen. Although it was made clear that the report was not a clinical evaluation, parents 
of children taking part were recommended to contact the child’s GP, paediatrician, or Health 
Visitor, if they had any developmental concerns about the child. GPs and paediatricians were 
invited to refer the child to the appropriate clinical services using existing referral systems if 
they had concerns. Feedback reports were offered upon completion of the study, although 
reports were compiled and sent when time permitted; typically between 3-6 months of the 
individual completing face-to-face assessments. 
8.7 Analysis 
Analyses were aimed at: (1) examining intergroup differences (CWEOE vs controls) in 




in CWEOE and controls, and (3) examining the association between study variables and 
assessment scores/neurobehavioural problems. 
Descriptive data on seizure and epilepsy-related characteristics were reported according to the 
ILAE Commission on Classification and Terminology 2005-2009 (Berg et al., 2010), as well as 
the Commission on Classification and Terminology of the International League Against 
Epilepsy 1989 (ILAE, 1989) (see section 2.4 for rationale), and were presented first.  
The order of intergroup analyses [of assessment scores, and prevalences of neurobehavioural 
problems] followed the domain structure laid out in table 8.1. Analyses were conducted for 
each questionnaire or scale within each domain of interest using the overall composite score 
of the tool, if applicable, or individual scale score (see table 8.1 for primary outcome variable). 
The relationship between scores/prevalences and study variables were examined throughout. 
Secondary analysis using subsidiary composite scores or subscales, where applicable, were 
conducted if group differences were found on the main outcome variable.  
Study variables were selected, a priori, based on the published literature, and included: gender, 
SES, prematurity, family history of epilepsy, seizure frequency, number of AEDs, mode of 
seizure onset, aetiology (ILAE 1989 & 2010 classifications), MRI status, EEG status, assessment 
age, and age at first seizure. There was insufficient subgroup sample sizes for analysis of family 
history of psychiatric issue or developmental disability by disorder type (e.g. anxiety, 
depression, ASD, etc), and this variable was reserved for global analysis of presence/absence 
of any neurobehaviour problem. Study variable categories are described in section 2.7.1. 
Bivariate analyses tables were presented throughout, in order to appraise the strength of, and 
trends in, relationships with study variables, due to small subgroup sample sizes, and absence 
of corrections for multiple comparisons.  
Multiple comparisons are not recommended by some statisticians (Rothman, 1990; Saville 
1990), and potentially increase type II errors by reducing type I errors. This study examined a 
relatively understudied age group, and thus serves as a platform for further and focused 
analysis. Thus, an increased risk of false positives was considered acceptable, and p-values 
and/or confidence intervals/effect sizes were presented throughout. Given a p-value of .05, 5% 





8.7.1 Assessment Scores Analysis 
T-tests were used to assess group differences in neurobehavioural assessment scores when 
data was normally distributed. Between-group differences were followed by analysis of 
covariance (ANCOVA) to control for differences in SES or age, when appropriate. Additionally, 
mixed ANOVAs were used to assess between- and within-group differences in WPPSI III IQ 
scales, and ABAS II composite scales. For group comparisons following non-normal 
distributions, data transformation was attempted. When unsuccessful, Mann-Whitney U tests 
were applied, as well as rank-based ANCOVAs (Quade, 1967) when adjusting for SES and/or 
age.  
Relationships between assessment scores and sociodemographic and clinical study variables 
were assessed via Pearson or Spearman’s Rank correlations for continuous variables, and T-
tests or Mann-Whitney U tests for categorical variables. FET was applied for all 2x2 or 2x3 
contingency tables comparing sub-group associations of nominal variables. In CWEOE, 
multiple linear regression was used to assess the contribution of variables identified at the 
p<.01 level from bivariate analysis toward the neurobehavioural assessment outcome score, 
when sample sizes were sufficiently powered. If variables were highly correlated, the 
main variable of clinical interest was included in the model and explained in the relevant 
model. 
The Bayley III Cognition scale (for children aged 1-29m) and WPPSI III scales (≥30m) were 
analysed individually for group differences in cognition and IQ scales, respectively.  Index 
scores were then converted to z-scores and pooled for comparison (Jackson et al., 2013; Reilly 
et al., 2015b), under the concept of GCA. This was done in order to increase power for bivariate 
analysis and multiple linear regression with study variables, and to examine the effects of age 
and tool type across the early-onset age range. Conversion to z-scores allows the comparison 
of scores from different tools by standardising the scores to a mean of zero and SD of one. 
Positive scores indicate performance above the mean, and negative scores indicate 
performance below mean. Increasing scores indicate better performance, and vice versa.  
The Bayley III is used in the clinical assessment of infants with suspected developmental delay, 
meaning that all children <30m could be reliably assessed with this tool. The WPPSI III relies 
on understanding verbal task instructions, and having sufficient psychomotor ability to carry 




could be alternatively assessed using the Bayley III, should WPPSI III administration have been 
unsuccessful. Children who were >42m could not be entered into analysis of assessment 
scores, but could be included in the analysis of GCA impairment if sufficient evidence of 
impairment was present from medical history (e.g. history of global developmental delay). 
Sensitivity analyses of group comparisons on the Bayley III/GCA were performed by re-running 
analyses without outlying children (i.e. cases ≥3SDs below the mean) in order to address 
potential uncertainty in the group estimates caused by participants with floor scores due to 
severe developmental delay.   
Most behaviour questionnaires in the battery produced T-scores for scales and subscales. T-
scores are standardised scores with a mean of 50 and SD of 10, where increasing scores 
represent increases in problem behaviours, or absences of age-expected behaviours. For 
consistency, the ABAS II and SEGC, which produced standard scores with a mean of 100 and 
SD of 15, were converted to T-scores and inverted for comparison with other scales. The ITSEA 
Competence scale was also inverted for comparison with other scales. Conversion and 
introversion does not alter the meaning of scores, but only the scale and direction. Note that 
the M-CHAT provides only a categorical classification and was not included in analysis of ASD 
behaviour scores.  
Some previous studies on childhood epilepsy have conducted subgroup analysis using 
complicated and uncomplicated epilepsy groups (e.g. Berg et al., 2008; Rantanen et al., 2011; 
Rutter et al., 1970). Definitions often vary but uncomplicated epilepsy typically consists of 
idiopathic or cryptogenic epilepsies, whilst complicated epilepsy consists of structural or 
symptomatic epilepsies, or those with epilepsy and additional neurological disorders. This is a 
useful distinction but has some drawbacks. Children with cryptogenic aetiologies can have 
poor cognitive outcome, and those with structural/symptomatic aetiologies may have typical 
outcomes. As brain imaging techniques advance it is also likely that lesions will be identified 
more often on clinical imaging, and the suggested changes to aetiological classification (Berg 
et al., 2010) means the definition must evolve.  As the sample size in the present study was 
modest, and to provide a comprehensive picture of CWEOE, the cohort was analysed as a 
whole. For closer comparison with previous studies, a supplementary analysis of assessment 
scores was made. As unknown and genetic aetiologies (Berg et al., 2010) may now include 
cases previously classified as symptomatic/cryptogenic, supplementary analysis with children 
with idiopathic aetiology was preferred. None had neurological disorders, making this group 




8.7.2 Neurobehavioural Problem Analysis 
In order to determine the spectrum and prevalence of neurobehavioural problems (i.e. GCA 
impairment or behaviour problem), cut-off points on psychometric tools were assigned and 
children were categorised as having, or not having, a neurobehavioural problem in each of the 
relevant scales. Cut-off points were based on tool author recommendations and the published 
literature, rather than a blanket approach.  
Table 8.3 Neurobehavioural problems cut-off points: Cognitive Impairments 
Tool Scale specific 
SD below 
mean 
Percentile  Note on cut-off point 
Bayley III 
WPPSI III 
z-score ≤ -2 2 ≤2.5 
Widely used, including in epilepsy research (e.g. 
Berg et al., 2008; Rantanen et al., 2011; Reilly et 
al., 2014; Sidenvall et al., 1996)  
NEPSY II scaled score ≤5 1.5 <10 
Cut-off point used in Barron-Linnankoski et al. 
(2015); Bender et al. (2007); Rasmussen et al. 
(2013) and Lind et al. (2011) 
 
Information on cut-off points for cognitive impairments are listed in table 8.3. Table 8.4 details 
scale cut-offs for behaviour problems. Scale cut-offs captured at least the ≥90th percentile of 
children. Two behaviour scales used a higher cut-off of ≥2 SD above mean (T-score ≥70), based 
on tool author comparison with clinical groups. A lower threshold with greater sensitivity in 
the SEGC has been suggested for use in screening for ASD (Casenhiser et al., 2007), but as this 
was not the specific purpose of use in this study, original cut-off was retained. The remainder 
used a cut off at approximately the 90th percentile (≥1.5 SD above mean). Whilst a stricter 
criterion for behaviour problems of ≥2 SD above mean may reduce false positives, it may be 
too stringent to identify all those who will go on to develop psychopathological problems 
(Edelbrock and Costello, 1988; Petty et al., 2008; Shekim et al., 1986). Edelbrock and Costello 
(1988), for example, found a surprising 63% of children with a T-score of 66-70 (1.5-2 SD) in 
their sample went on to receive a conduct disorder diagnosis. Cut-off points at or below 1.5SD 
are common in the analysis of behaviour problems (e.g. Briggs-Gowan and Carter, 2007; 
Mazefsky et al., 2011; Rantanen et al., 2009). To assess low/high risk for ASD, the M-CHAT and 
SRS-2 were pooled. The M-CHAT categorises children into low or high risk of ASD, whilst 





   




Percentile Note on cut-off point 
ABAS II ≥70 2 ≥98 
Used for clinical validity analysis (Harrison & Oakland, 2003), 
and recommended cut-off in assessment of intellectual 
disability (Joyce et al., 2015) 
SEGC ≥70 2 ≥98 Used for analysis of clinical groups (Bayley, 2006b) 
BRIEF-P ≥65 1.5 ≥90 
Author recommended threshold for abnormally elevated 
score that is of ‘potential clinical significance’ 
M-CHAT - - - 
Author recommended: three total failed items or ≥2 critical 
items failed, equates to a risk of ASD 
SRS-2 ≥65 1.5 - 
Author recommended threshold for ‘clinically significant 
deficiencies in social behaviour that interference with 
everyday social interactions, and are typical for children with 
moderate severity’ 
CEC ≥65 1.5 ≥93 
Author recommended threshold that indicates significant 
concerns  
ITSEA ≥65 1.5 ≥90 
Author recommended threshold that identifies children at 
risk for delayed, deficient, or deviant behaviour 
SDQ - - ≥90 
Scores associated with a substantial increase in psychiatric 
risk (Goodman, 2001) 
Note: T-scores are standard scores but corresponding percentiles may differ depending on scale. Figures here 
are those reported by scale author(s). ABAS II and SEGC have been converted to T-scores and inverted. ITSEA 
Competence scale has been inverted to match direction of other scales. 
 
FET was applied to between-group (CWEOE vs controls) differences in the prevalence of 
neurobehavioural problems at the scale and domain levels, and to subgroup analysis of 
associations with study variables in CWEOE (i.e. number of children with problem vs no 
problem). Associations with age-related variables applied Mann-Whitney U tests. Study 
variables significant at the p<.01 level in bivariate analyses were entered into multivariable 
logistic regression analysis.  
Lastly, the extent of comorbidity of neurobehavioural problems was ascertained by calculating 





8.8 Epilepsy and ESSENCE – Screening for coexisting disorders  
As identified in section 7, neurobehavioural problems in epilepsy are often multi-factorial, and 
there is a need for the identification of coexisting neurobehavioural problems, in order to 
provide comprehensive targeted care. The term ESSENCE, which is an acronym for Early 
Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations, was coined by 
Gillberg (2010), in order to aid in the recognition and management of children who have an 
ESSENCE disorder. ESSENCE syndromes describe a group of neurodevelopmental disorders, 
such as ASD, ADHD, learning disability, Tourette Syndrome, and rare epilepsy syndromes, 
mainly in children under 5 years of age, in which there is high likelihood of the coexistence of 
those disorders. By identifying disorders subsumed under ESSENCE, a child with an ESSENCE 
disorder could then be screened for other coexisting disorders under the ESSENCE umbrella 
(Neville, 2013). An ESSENCE questionnaire was devised by Gillberg 
(http://gillbergcentre.gu.se/english) with the primary motive to help in the process of 
identifying children with coexisting symptoms that require further investigation or follow-up 
with specialist services, and thus promote a multi-faceted approach to the child’s care.  
Epilepsy is a neurodevelopmental disorder, and whilst it was beyond the scope of this study to 
identify ESSENCE disorders in CWEOE, the ESSENCE questionnaire was used to identify children 
that may potentially have an ESSENCE disorder or other co-existing disorders aside from 
epilepsy itself, and relate that to the outcome of the neurobehavioural assessment battery. In 
such a way, the viability of the ESSENCE questionnaire as a pre-screening instrument in CWEOE 
could be explored. 
The first version of the ESSENCE questionnaire (ESSENCE-Q, appendix I; now replaced by a 
revised edition, Gillberg, 2012, http://gillbergcentre.gu.se/english /research/essence--early-
symptomatic-syndromes-eliciting-neurodevelopmental-clinical-examinations-), is an 11 item 
questionnaire that asks the parent if they have been “concerned” about their child’s 
development in any one or more of 11 categories (e.g. general development, communication, 
and behaviour). It is scored on a “yes”, “no”, or “maybe” format. The ESSENCE-Q has recently 
been validated in a Japanese sample of 130 children ≤6 years of age (Hatakenaka et al., 2016), 
offering sensitivity of .87 and specificity of .77 using a cut off score of at least two yeses or 
three maybes. Reaching this criteria prompts a recommendation for further assessment and 




In the current study, the number of children meeting essence criteria was recorded, and the 
findings were then compared to the presence of neurobehavioural problems identified from 
the assessment battery. Subgroup analysis between those who did and did not meet ESSENCE 
criteria and study variables was assessed using FET for associations with nominal variables, and 




9. Neurobehavioural Profile of CWEOE: Results 
9.1 Participants 
46 of the population-based sample of 59 CWEOE (78% [95% CI 65.9, 86.6]) and 37 controls 
consented for the study, and received neurobehavioural assessment, the details of which are 
provided in section 8. However, in brief, the assessment was comprised of a battery of validated 
parent-rated questionnaires, and face-to-face assessments. There were no significant 
differences in sociodemographic or clinical variables between those CWEOE who had 
neurobehavioural assessment, and those who did not (table9.1A and B). Therefore, the CWEOE 
cohort who received assessment were representative of the entire population-based cohort.   
Table 9.1 CWEOE who received (n=46), or did not receive (n=13), neurobehavioural 
assessment: Comparison of sociodemographic and clinical characteristics 
 
A. Gender, SES, and aetiology 
Variable Levels 
  Assessed, n (%) 










































B. Age (months) 




25.54 (9.18, 47.93) 
36.01 (8.25, 46.44) 
.72 (.05) 
At first seizure 
Yes 
No 
17.5 (6.0, 36.0) 





The 46 CWEOE who were enrolled onto the study, did not significantly differ in gender, age, 
family history of developmental disability or psychiatric problems, or the proportion of children 
born prematurely (table 9.2), compared to controls. A higher proportion of controls were 
resident in areas of higher SES compared to controls.  As such, SES was included across the 
analyses as a confounder.   
Table 9.2 Sociodemographic comparisons between CWEOE and control children 
Variable 
Group, n (%) Group Comparison 
















<.001 (0.18 [0.07, 0.47]) 
Family history of 
developmental 



















.38 (3.43 [0.37, 32.08]) 




31.21 (3-63) 31.47 (3-59) †p=.65, r= .05 
†Mann-Whitney U test 
Emboldened p<.05 
 
CWEOE were diagnosed at a median 
age of 31.21 (3-63) months (m), and 
received neurobehavioural 
assessment a median of 2.97 (IQR 1.51 
– 4.95)m after diagnosis. CWEOE were 
characterised according to ILAE’s 1989 
and 2010 aetiological classifications 
(table 9.3), and by epileptic syndrome 
classification (Berg et al 2010) (table 
9.4). Focal seizures were the most predominant seizure type, occurring in 37% of cases, 
followed by Generalised Tonic Clonic Seizures (24%), and spasms (20%). The remainder was 
Table 9.3 Aetiological Classification ILAE 1989 and 2010 
ILAE Classification Aetiology n (%) 















made up of absences (13%), atonic (2%), myoclonic (2%), and clonic (2%) seizures. 8.7% percent 
of CWEOE had one seizure type, 34.8% had two, and 6.5% of children had three seizure types.   
Table 9.4 Epilepsy syndromes and classifications (N=46) 
Epilepsy Classification Syndrome n (%) 
Electroclinical 
Syndromes 
Neonatal Period Otahara Syndrome 1 (2.2%) 
Infancy 
West Syndrome 7 (15.2%) 
Benign Infantile Epilepsy 3 (6.5%) 
Childhood 
Panayiotopoulos 1 (2.2%) 
CAE 4 (8.7%) 




MTLE with HS 1 (2.2%) 
Genetic Generalised Epilepsy 7 (15.2%) 
Genetic Focal Epilepsy 4 (8.7%) 
Other Structural-Metabolic Causes Focal Epilepsy 5 (10.9%) 
Epilepsies of Unknown Cause 
Mixed Focal & Generalised Epilepsy 
of Unknown Origin 
1 (2.2%) 
Generalised Epilepsy of Unknown 
Origin 
5 (10.9%) 







9.2 Cognitive Functioning 
In this section, analysis of group differences in cognitive functioning are reported.  Data on the 
Bayley III Cognition scale (0-29m) and WPPSI III IQ scales (≥30m) are reported individually, and 
then pooled to provide analysis of General Cognitive Ability (GCA). The effects of age, tool 
type, and sociodemographic variables across the early-onset period on GCA are examined. 
Data on NEPSY II: Memory, Social Perception, and Attention & Executive Functioning, in 
children (age ≥36m) are then presented. For all tools, the distribution of scores for CWEOE and 
controls are presented first, followed by the prevalence of cognitive functioning impairments. 
41 of the 46 population-based CWEOE completed face-to-face cognitive assessment using the 
Bayley III or WPPSI III. Demographic details and comparisons of the 41 CWEOE and 37 controls 
who completed a Bayley III or WPPSI III are listed in table 9.5.  
Five children could not be assessed with the WPPSI III, despite attempted administration. Four 
of the five could not be reliably assessed due to learning, language, and/or psychomotor 
difficulties. All had previously diagnosed global developmental delay according to medical 
records, and were over the upper age limit of the Bayley III; and an assessment score could not 
be generated. These children were consequently classified as GCA impaired. Additionally, all 
four could not be assessed on the NEPSY II for the same reasons. The fifth child, who was 31m 
of age and was eligible for alternative assessment on the Bayley III, did not return for 
assessment. This child was unsuccessfully assessed in a community care setting by an associate 
psychologist using a similar developmental assessment tool, and was therefore classified as 
GCA impaired. Similar methods of qualitatively classifying children have been used elsewhere 
(e.g. Cormack et al., 2007; Rantanen et al., 2011).  





N (M:F) Age, m (SD) N (M:F) Age, m (SD) Age Gender 
Bayley III 22 (12:10) 13.05 (7.48) 19 (9:10) 19.10 (8.14) .02 .76 
WPPSI III 19 (14:5) 49.63 (8.85) 18 (9:9) 47.58 (9.97) .51 .18 





9.2.1 Bayley-III Cognition Scale 
Mean Bayley III cognition score for CWEOE was significantly poorer than that of controls (Group 
Mean difference (MD)= -22.00 (95% CI -12.13, -31.86), p<.001). A one-way analysis of 
covariance (ANCOVA) found a significant main effect of group on Bayley III cognition, after 
adjusting for age and SES (F(1,37)=15.01, p<.001, 𝜂𝑝
2=.29), with lower estimated marginal 
means (EMM) in CWEOE compared to controls. Unadjusted and adjusted means are displayed 
in table 9.6. 
Seven CWEOE and zero controls scored ≥3 SD below the normative mean, and were excluded 
as part of a sensitivity analysis (see section 8.7.1 for discussion and rationale). The ANCOVA 
was reran, and a group (𝜂𝑝
2=.34) and SES (𝜂𝑝
2=.29) main effect remained. Therefore, poor 
performance in CWEOE could not be explained by children with severe developmental delay 
disproportionately decreasing the group mean. 
Table 9.6 Bayley III Cognition scores 
Group Analysis CWEOE (n=22) Controls (n=19) 
Group Comparison 
MD (95% CI) 
or effect size 
Unadjusted Mean (SD)† 79.32 (20.43) 101.32 (9.11) -22.00 (-12.13, -31.86) 
SES and Age Adjustment 
EMM (95% CI) 
78.75 (71.15, 86.36) 101.97 (93.69, 110.26) 𝜂𝒑
𝟐=.29 
Sensitivity Analysis 
EMM (95% CI) 
88.18 (82.55, 93.82)ǂ 103.28 (98.34, 108.21) 𝜂𝒑
𝟐=.34 
† unequal variances t-test 




9.2.2 WPPSI III IQ Scales  
CWEOE (n=19) had poorer FSIQ compared to controls (n=18) (p=.001), although FSIQ lay close 
to the normative mean in CWEOE (table 9.7). Group difference in FSIQ remained after 
controlling for SES (ANCOVA; F(1,34)=9.9, p=.003, 𝜂𝒑
𝟐=.23) (table 9.7). There was no main effect 
of SES (𝜂𝒑





Table 9.7 WPPSI III FSIQ scores 
Group analysis CWEOE (n=19) Controls (n=18) 
Group Comparison 
MD (95% CI) 
or effect size 
Unadjusted Mean (SD) 98.16 (14.80) 114.11 (12.18) -15.95 (-6.88, -25.03) 
SES Adjustment  
EMM (95% CI) 
98.70 (92.17, 105.22) 113.54 (106.83, 120.26) 𝜼𝒑
𝟐=.23 
Emboldened p<.05  
 
A mixed (split-plot) ANOVA examined group differences across WPPSI III subscales: VIQ and 
PIQ (table 9.8). There was a significant interaction effect between group and WPPSI III subscales 
(Wilks’ Lambda=.89, F(1,35)=4.52, p=.041, 𝜂𝑝
2=.11), with control children scoring significantly 
higher than CWEOE (𝜂𝑝
2=.27). Simple effects tests using pairwise comparisons revealed poorer 
performance in CWEOE compared to controls in VIQ (MD= -18.62 [95% CI -980, -27.45]), and 
in PIQ (MD= -9.56 [95% CI .35, 18.77]). Taken together, controls scored significantly higher in 
VIQ and PIQ compared to CWEOE, and the within-groups relationship between VIQ and PIQ 
was inverse; that is, VIQ was higher, but not significantly so, compared to PIQ in controls but 
vice versa in CWEOE. PSQ was available for children from 4 years of age (n=11 per group). 
CWEOE had lower PSQ score than controls but there was no significant difference between 
groups; MD= -8.09, 95% CI (-18.42, 2.23), p=.118.  








CWEOE (n=19) 96.21 (12.91) 101.11 (15.20) n=11, 98.91 (14.60) 
Controls (n=18) 114.83 (13.54) 110.67 (12.13) n=11, 107.00 (7.50) 
VIQ - Verbal IQ 
PIQ - Performance IQ 








9.2.3 General Cognitive Ability (GCA) 
To remind the reader, the Bayley III Cognition and WPPSI III FSIQ scales were converted to z-
scores in order to compare GCA between groups across the entire age range, as well as to 
assess the impact of age, tool type, and study variables.   
(i) General Cognitive Ability Scores 
The distribution of GCA scores in CWEOE and controls is 
depicted in figure 9.1. CWEOE had significantly poorer 
unadjusted GCA scores compared to controls (table 9.9). 
After adjusting for SES in an ANCOVA, a significant main 
effect of group remained (F(1,75)=23.79, p<.001, 𝜂𝑝
2=.24). 
There was no main effect of SES (𝜂𝑝
2=.004).  In a sensitivity 
analysis (see section 8.7.1), excluding children with Bayley 
III cognition score ≥3 SD below normative mean (n=7), 
did not alter the findings (table 9.9), indicating that 
poorer GCA in CWEOE could not be attributed simply to 
more severe cases of epilepsy.  
Table 9.9 GCA unadjusted and adjusted means 
Group Analysis CWEOE (n=41) Controls (n=37) 
Group Comparison 
MD (95% CI) 
or effect size 
Unadjusted Mean (SD)† -0.80 (1.35) 0.50 (0.83) -1.30 (-0.80, -1.80) 
SES Adjusted EMM (95% CI) -0.82 (-0.46, -1.19) 0.53 (0.14, 0.92) 𝜼𝒑
𝟐=.24 
ǂ Sensitivity analysis; 
SES adjusted EMM (95% CI)  
-0.40 (-0.08, -0.72) 0.56 (0.25, 0.86) 𝜼𝒑
𝟐=.21 
Emboldened p<.001 
† unequal variances t-test 
ǂ Excluding 7 outliers, CWEOE n=34 
 
 
GCA improved with increasing age in both CWEOE (rs=0.41, p=.008) and controls (rs=0.50, 
p=.002). To investigate the possibility that GCA score improved with changes in assessment 
tool type (i.e. Bayley III, WPPSI III 30-47m version, or WPPSI III 48-84m version) rather than age 





per se, assessment tools were factored into linear regression models and compared to a model 
with assessment age only. It was found that tool type did not significantly increase predictive 
power beyond that predicted by assessment age alone, which showed that GCA improved with 
age in CWEOE and controls, rather than tool type.  
Table 9.10 Bivariate analysis of GCA and study variables in CWEOE (n=41) 
Variable Sub-group N Mean GCA (SD) p 
MD (95% CI) 
























.41 0.59 (-2.03, 0.85) 

















.12ǂ .77 (-0.08, 1.62) 



















































.012 𝜂2= 0.24 
EEG 
Normal 








<.001 𝜂2= 0.37 
Assessment age, months                      (median) 41  .008 rs= .41 
Age 1st seizure, months                       (median) 41  .013 rs= .39 
ǂ unequal variances t-test  




The association between GCA and sociodemographic and epilepsy-related variables was 
explored in CWEOE via bivariate analyses (table 9.10). Polytherapy, structural or 
symptomatic/cryptogenic aetiology, major brain abnormality recognised on MRI, presence of 
epileptiform and slow-wave background activity on clinical EEG, and younger age at 
assessment/first seizure were associated with poorer GCA score in CWEOE.   
A standard multiple linear regression model was fitted including variables identified from 
bivariate analyses at the p<.01 significance level. Although EEG status was significant, it was 
not included in modelling due to collinearity with aetiology. Both ILAE classifications were 
modelled separately. Symptomatic and cryptogenic aetiologies were collapsed into a single 
subgroup, as were genetic and unknown aetiologies, due to non-significant differences in 
bivariate analyses. Age at first seizure was selected over age at assessment, due to greater 
clinical applicability.  Gender was also modelled but did not significantly improve model fit, 
and was excluded from final models.   
Models including old and new aetiological classifications were significant (table 9.11 A and B, 
respectively). Model A, including the 1989 classification, explained more of the variance in GCA 
score than the newer classification (R2adj = 42.4% vs 33.9%, respectively).  In the former, 
aetiology (1989) and number of AEDs independently predicted GCA. GCA decreased by 1.05 
SD in children treated with more than one AED (i.e. polytherapy) compared to those untreated 
or on monotherapy. GCA decreased by 0.63 SD with symptomatic/cryptogenic aetiology 
compared to idiopathic aetiology in model B. Age at first seizure was non-significant in both 
models.  
Table 9.11 Regression coefficients for study variables GCA in CWEOE 
A. Model including 1989 aetiology 
 
B. Model including 2010 aetiology 
Variable ß 
95% CI 
p Variable ß 
95% CI 
p 
Lower Upper Lower Upper 
Constant -0.10 -0.54 0.34 .640 Constant -0.36 -0.77 0.06 .090 
0/1 AED vs 
polytherapy 
-1.05 -0.11 -1.99 .030 
0/1 AED vs 
polytherapy 
-1.24 -2.23 -0.24 .016 
Aetiology 
(1989)1 
-0.63 -0.26 -0.99 .001 
Aetiology 
(2010)2 
-1.05 -1.94 -0.17 .021 
Age at first 
seizure 
0.01 -0.01 0.04 .175 
Age at first 
seizure 
0.02 -0.001 .043 .062 






In summary, CWEOE had significantly poorer GCA than control children - which could not be 
explained by differences in SES. Results held equally true for infants and toddlers assessed by 
the Bayley-III (0-29m), and preschool children assessed with the WPPSI-III (≥30m). GCA 
improved with age in CWEOE and controls, whilst poorer GCA in CWEOE was independently 
predicted by structural or symptomatic aetiology, and polytherapy.  
(ii) GCA impairment 
While GCA scores were generated for 41 CWEOE, five CWEOE were qualitatively classified with 
GCA impairment based on unassessability due to previously diagnosed learning, social or 
developmental difficulties (see section 9.2). Thus, data for 46 CWEOE and 37 controls were 
available for the current analysis on GCA impairment.  The prevalence of GCA impairment can 
be found in table 9.12. Of the eight children scoring in the impaired range on the Bayley-III, 
seven had global impairment (i.e. cognitive, language, and motor domain impairment). The 
remaining child had cognitive and motor impairment, with normal language functioning.   
 
Peak GCA impairment was in the first year of life. Figure 9.2 displays the proportion of CWEOE 
with or without GCA impairment by year of age (at first seizure). The proportion of CWEOE 
with GCA impairment <12m (42.1%) was considerably higher, but not significantly so, 
compared to the proportion of children impaired aged 1-4 years (18.5%); FET, p=.10, OR=3.20 
(95% CI [.85, 12.12]).  The difference in percentages between year 0 and 1-4, can be explained 
by the presence of infantile spasms. All seven children with infantile spasms had onset in year 
0, five of which (71.4%) had GCA impairment. For the remaining 12 children with other 
epilepsies, 3 (25.0%) had GCA impairment, closer to the overall prevalence of impairment 
Table 9.12 Cognitive functioning classification by group and tool 
 
Classification 
(SD below mean) 



















Normal (≤1SD) 40.9 (9) 89.5 (17) 62.5 (15) 100 (18) 52.2 (24) 94.6 (35) 
Subnormal (1-2SD) 22.7 (5) 10.5 (2) 16.7 (4) 0 (0) 19.5 (9) 5.4 (2) 
Impaired (≥2SD) 36.4 (8) 0 (0) 20.8 (5) 0 (0) 28.3 (13) 0 (0) 




across all ages (n=8, 20.5%). The odds of impairment was greater for infantile spasms than 
other epilepsies; OR 9.69 (95% CI 1.58, 59.47). 
Figure 9.2 Proportion of CWEOE with/without GCA impairment by age at first seizure 
 
   
Bivariate analyses of GCA impairment and sociodemographic and clinical variables revealed 
that GCA impairment occurred more often in females, and in those with high seizure frequency, 
those on polytherapy, those with both epileptiform and slow-wave background activity on 
clinical EEG, and those with symptomatic/cryptogenic aetiology (table 9.13). All 13 CWEOE with 
GCA impairment had symptomatic/cryptogenic aetiology. There was no significant association 
between GCA impairment and 2010 aetiological classification. Due to modest sub-group 
sample sizes, a multiple linear regression was unsuitable. 
Table 9.13 Bivariate analysis of GCA impairment and study variables in CWEOE (n=46) 
Variable Sub-group 
Impaired N (%) 

























1.0 1.20 (0.11, 12.71) 













Table 9.13 continued 
Variable Sub-group 
  Impaired N (%) 









.003 8.89 (1.98, 39.86) 
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vs idiopathic =  


































Assessment Age, months                        (median) 39 31 p=.10ǂ rs=.24 
Age at 1st seizure, months                       (median) 18 8 p=.11ǂ rs=.24 
*6 children did not have an MRI, and EEG data was unavailable for 2 
† All 5 had epileptiform activity only 
ǂ Mann-Whitney U test 
 
 
9.2.4 Specific Neuropsychological Skills: Memory, Social Perception, and Attention & Executive 
Functioning (NEPSY II) 
The NEPSY II consisted of six subtests which assessed memory, social perception, and attention 
& executive functioning in children ≥36m (section 8.3.1). Of the 22 CWEOE who were age-
eligible for NEPSY II assessment, four children were excluded due to developmental delay (see 
section 8.7.1). 18 (13M:5F) CWEOE (M=50.66, SD=7.83m) and 15 (8M:7F) controls (M=50.66, 
SD=7.71m) completed the NEPSY II subtests. CWEOE and control groups did not significantly 





(i) Memory Scores 
The NEPSY II Memory domain consisted of three memory subtests: Memory for Designs 
(visuospatial memory), Narrative Memory (verbal recall and recognition memory), and 
Sentence Repetition (verbal recall memory). Controls performed better than CWEOE in each 
subtest, although both groups scored within the average ranges - significantly so for Memory 
for Designs and Sentence Repetition (table 9.14). ANCOVAs were conducted to adjust for 
possible effects of SES. In Memory for Designs, a group effect (𝜂𝑝
2=.05) was no longer evident 
when SES (p=.022, 𝜂𝑝
2=.16) was adjusted for. In contrast, after adjustment for SES (𝜂𝑝
2=.10), poor 
performance in CWEOE relative to controls remained in the Sentence Repetition subtest 
(p=.002, 𝜂𝑝
2=.30).   
Table 9.14 NEPSY II Memory subtests with group comparisons 
 
Subtest Group (N) M (SD) MD (95% CI) 
SES adjustment  
EMM (95% CI)  
Memory for Designs 
CWEOE (18) 9.72 (3.21) 
-2.68 (-5.34, -.18) 
10.21 (8.49, 11.93) 
.05 
Controls (15) 12.40 (4.27) 11.81 (9.92, 13.71) 
Narrative Memory 
CWEOE (18) 8.56 (3.24) 
-1.44 (-3.69,  .80) n/a - 
Controls (15) 10.00 (3.02) 
Sentence Repetition* 
CWEOE (17) 8.0 (3.14) 
-4.0 (-6.02, -1.98) 
8.24 (6.89, 9.58) 
.16 
Controls (14) 12.0 (2.15) 11.72 (10.22, 13.21) 
*1 CWEOE and 1 control child did not complete Sentence Repetition due to non-compliance                  
Emboldened= p<.05 
 
(ii) Social Perception Scores 
Social Perception consisted of Affect Recognition and Theory of Mind subtests. One control 
child did not complete the Theory of Mind subtest due to non-compliance. CWEOE scored 
close to the normative mean on both subtests, but significantly lower than control children 
(table 9.15). After adjustment for SES in Affect Recognition, there was no longer a significant 
effect of group (p=.055), or main effect of SES (𝜂𝑝
2=.03). A moderate-large effect size (𝜂𝑝
2=.12), 
however, suggests a noteworthy trend toward group difference. In contrast, a group effect 
remained in the Theory of Mind subtest (p=.014), but not for SES, suggesting that CWEOE are 






 Table 9.15 NEPSY II Social Perception Subtests with group comparisons 
Subtest Group (N) M (SD) MD (95% CI) 
SES adjustment 
EMM (95% CI)  
Affect Recognition 
CWEOE (18) 10.06 (2.29) 
-1.9 (-0.34, -3.55) 
10.18 (9.06, 11.30) 
.12 
Controls (15) 12.00 (2.20) 11.85 (10.62, 13.09) 
Theory of Mind 
CWEOE (18) 9.61 (2.20) 
-2.46 (-0.52, -4.40) 
9.53 (8.20, 10.87) 
.19 
Controls (14) 12.07 (3.17) 12.17 (10.65, 13.70) 
Emboldened= p<.05  
 
(iii) Attention & Executive Functioning Scores 
Attention & Executive Functioning was assessed via the Statue subtest. One CWEOE and one 
control child did not complete this subtest due to non-compliance.  
CWEOE scored significantly poorer than control children (table 9.16). However, after 
adjustment for SES, group was no longer significant (p=.068), albeit with a moderate effect size 
(𝜂𝑝
2=.11), suggesting a trend toward a group difference. There was no main effect of SES 
(𝜂𝑝
2=.08). 
Table 9.16 NEPSY II Attention & Executive Functioning 
Group (N) M (SD) MD (95% CI) 
SES adjusted  
EMM (95% CI)  
CWEOE (17) 8.47 (3.41) 
-2.67 (-0.42, -4.92) 
8.71 (7.20, 10.22) 
.11 
Controls (14) 11.14 (2.54) 10.85 (9.18, 12.53) 
Emboldened p<.05  
 
(iv) Specific Neuropsychological Skills: Scores Summary 
CWEOE consistently scored lower than controls across all subtests of the NEPSY-II. This was 
significantly so for Memory for Designs, Sentence Repetition, Affect Recognition, and Theory 
of Mind (figure 9.3A). After adjustment for SES, a group difference remained in Sentence 
Repetition and Theory of Mind subtests (figure 9.3B), indicating that epilepsy itself remained a 
strong influence on aspects of neuropsychological functioning beyond SES. Whilst group 
differences in Affect Recognition and Attention & Executive Functioning were non-significant 








suggesting that the scores in CWEOE were lower than expected potentially as a result of having 
epilepsy. 
Figure 9.3 Unadjusted and SES adjusted NEPSY II subtest means scaled scores 
A. Unadjusted mean scaled scores and standard deviations (error bars) 
 
B. Mean SES adjusted sclaed scores and 95% confidence intervals 
 
Horizontal grey line represents normative mean                * Group difference p<.05 
AR – Affect Recognition 
Attn/EF – Attention & Executive Functioning 
MD – Memory for designs 
NM – Narrative Memory  
SR – Sentence Repetition 





As a group, CWEOE who completed the NEPSY II had GCA within the normal range (M= -.07, 
SD= 0.98 [range -1.73 to 1.73]) but had lower GCA scores compared to controls (MD= -1.10 
[95% CI -0.48, -1.72]). Thus, it is unclear if group differences observed in the Sentence 
Repetition and Theory of Mind subtests, or trending differences in other subtests, could be 
attributed to an effect of epilepsy or to intergroup differences in GCA. In support of an epilepsy 
effect, a one-samples t-test in CWEOE revealed poorer performance in Sentence Repetition 
(M=8.0, SD=3.14) compared to the test normative mean (M=10.0); p=.018, MD=-2.00 (95% CI 
-0.38, -3.62). However, a similar result was not found in the Theory of Mind subtest (M=9.61, 
MD= -.39 [95% CI -1.48, 0.71]), Affect Recognition (M=9.72, MD= -0.28 [95% CI -1.88, 1.32]), or 
Attention & Executive Functioning (M=10.06, MD= -.06 [95% CI -1.08, 1.19]). These results 
suggest stronger evidence for a disproportionate influence of epilepsy on the Sentence 
Repetition task at this age, beyond any difference in GCA. 
(v) Specific Neuropsychological Skills: Impairment 
No significant differences were found between group prevalences of impairments (scaled score 
≥1.5SD below mean) on the NEPSY-II subtests (table 9.17). Statue, and Sentence Repetition, 
were most notably affected, with 4 CWEOE scoring in the impaired range on the former, and 
four different children on the latter, indicating domain specific impairments.     
Table 9.17 Prevalence of impairment on NEPSY II subtests  
Domain Subtest Group 
Impaired  N (%) 
FET 
No Yes 








0 (0) .11 
Memory  




























0 (0) 1.0 











9.3 Behavioural Functioning 
The previous subsection described and compared the distribution of cognition-based 
psychometric assessment tools in CWEOE and controls. This subsection addresses the results 
of the parent-rated social-emotional behaviour rating scales. Results are structured according 
to the domains of interest and corresponding domain relevant scales, which have been 
described in section 8.3.    
9.3.1 Completeness of the neurobehavioural assessment battery  
Questionnaire return rate was high. Between 90 and 97% of questionnaires were returned by 
those who consented. Of the 46 CWEOE who had, or attempted, face-to-face cognitive 
assessment, only four did not return behaviour questionnaires. Two of these children had 
normal GCA and were neurologically normal. The third had severe global delay, and the fourth 
child was unassessable due to uncooperativeness and social interaction difficulty. This child 
was under investigations from community paediatricians for suspected learning/social 
difficulties. A further three CWEOE had partial completion of the behaviour questionnaires. 
One did not return an ITSEA, one a CEC questionnaire, and one a SES questionnaire.  Of the 37 
controls, four had partial completeness due to non-return of questionnaires or incomplete 
questionnaires. Table 9.18 details the completeness of behaviour assessment questionnaires 
for CWEOE and controls, describing how many returned a questionnaire (n) from those who 
were age-eligible for that questionnaire (N). The table also includes between-group (i.e. 
CWEOE vs Controls) gender and age comparisons for each questionnaire. 
Table 9.18 Behaviour questionnaire assessment completeness 
Assessment Tool 
Completeness n/N (%) Group Comparisons (FET) 
CWEOE Controls Gender Age ǂ 
ABAS II 42/46 (91) 37/37 (100) .37 .80 
ITSEA 9/11 (82) 13/13 (100) .42 .17 
CEC 23/26 (88) 20/20 (100) .76 .39 
BRIEF-P 24/26 (92) 22/22 (100) .77 .28 
SEGC 9/11 (82) 2/4 (50) .46 .81 
M-CHAT 7/7 (100) 11/11 (100) 1.0 .56 
SRS2 22/24 (92) 17/19 (90) .53 .75 
Total 90.07% 96.83% 
ǂ T-test or Mann Whitney U 




9.3.2 Adaptive Behaviour 
Adaptive Behaviour was assessed using the ABAS II (≥1m), and consisted of Conceptual, Social, 
and Practical domain composites scores, and an overall General Adaptive Composite (AC). 42 
CWEOE (25M:17F) and 37 controls (18M:19F) completed the ABAS-II.  
(i) Adaptive Behaviour Scores 
Figure 9.4 displays the unadjusted distributions of AC and adaptive behaviour composite 
domain scores. CWEOE (M=62.13, SD= 14.54) had poorer (i.e. higher) unadjusted AC score 
compared to controls (M=50.18, SD=7.62); MD= 11.95 (95% CI 6.81, 17.08) (unequal variances 
t-test). Likewise, CWEOE had poorer adaptive behaviour across all composite domains. To 
account for possible effects of SES, and due to unequality of variance, a rANCOVA was 
conducted.  After adjustment for SES, poorer AC remained in CWEOE compared to controls; 
F(1,77)=9.02, p=.004, 𝜂2=.11.  
Figure 9.4 Scatter-box plot: Unadjusted ABAS II composite scores 
 
Horizontal grey line represents normative mean 
 
While mean AC was lower in CWEOE regardless of SES, stratifying children by SES revealed that 
the group difference was only seen in those with lower SES (table 9.19), indicating that having 





Table 9.19 Mean AC score by group and SES 
SES Group N Mean (SD) MD (95% CI) 
High SES 
CWEOE 17 56.71 (13.83) 
9.13 (0.50, 18.76) 
Controls 29 50.62 (7.85) 
Low SES 
CWEOE 25 65.81 (14.09) 
25.85 (9.89, 41.80) 
Controls 8 48.58 (6.98) 
Emboldened p<.05 
 
Table 9.20 Bivariate analysis AC and study variables in CWEOE (n=41) 
Variable Sub-group N Mean (SD) P 
MD (95% CI) 
























.17 10.54 (-4.73, 25.82) 
















.34 -4.44 (-13.79, 4.91) 



















































.59 𝜂2= 0.03 
EEG* 
Normal 








.015 𝜂2= 0.20 
Assessment Age, months                               (median) 42  1.0 rs=-0.001 
Age at first seizure, months                            (median) 42  .79 rs=0.042 
*5 children did not have an MRI, and EEG data was unavailable for 2 children  






Bivariate analyses of study variables and AC score in CWEOE revealed poorer adaptive 
behaviour was associated with female gender, lower SES, polytherapy, 
symptomatic/cryptogenic aetiology, and a having both epileptiform and slow-wave 
background activity on clinical EEG (table 9.20). All children with epileptiform and slow-wave 
EEG activity had symptomatic/cryptogenic aetiology. Unlike ILAE 1989 classifications, ILAE 
2010 aetiological classification was not statistically significant. Variables significant at the 
p<.01 level were inputted into a standard multiple linear regression model, with the exception 
of EEG, due to collinearity with aetiology. Gender and SES were included as control terms.  
Aetiology (1989) remained the only significant predictor when gender and number of AEDs 
were adjusted for (table 9.21). The overall model was significant (F(3,38)=7.10, p=.001), 
explaining 31% of the variance in AC score (adjR2). Having a symptomatic or cryptogenic cause 
for epilepsy resulted in a 6.26 point increase in AC T-score, compared to idiopathic aetiology. 
Table 9.21 Regression coefficients for AC and selected variables in CWEOE 




Constant  50.30 43.45 57.15 <.001 
Gender Male vs Female 5.62 -2.41 13.64 .17 




6.26 2.25 10.27 .003 
 
A two-way mixed ANOVA explored the relationship within and between-groups across ABAS 
II composite domains (i.e. Social, Conceptual, and Practical), whilst controlling for SES. Levene’s 
test of equality of variance was violated and an alpha level of .01 was set (Tabachnick and 
Fidell, 2007). There was a significant main effect of ABAS II composite domain (p<.001, 𝜂𝑝
2=.31) 
but not of SES (𝜂𝑝
2=.01), and a significant interaction effect between group and ABAS II 
composite domain (p=.002, 𝜂𝑝
2=.15). To explain, CWEOE scored significantly poorer in the 
conceptual and social domains compared to controls, but there was no between-group 
difference in the practical domain (figure 9.5). Post-hoc within-group comparisons using one-




across domains in CWEOE (p=.013, 𝜂𝑝
2=.20), and across domains in controls (p<.001, 𝜂𝑝
2=.62). 
CWEOE scored higher (i.e. poorer) in the practical domain compared to the social domain, 
whilst in control children, poorer scores were found in the practical domain compared to the 
conceptual and social domains.  
Figure 9.5 ABAS II Composite Domains, means and SDs 
 
 
In summary, CWEOE had significantly poorer general adaptive behaviour than control children. 
ABAS II domain analysis revealed that CWEOE had poorer conceptual and social adaptive 
behaviours than controls, but not practical adaptive behaviour. Exploration of the variance in 
AC in CWEOE revealed that poorer adaptive behaviour was associated with female gender, 
polytherapy, symptomatic/cryptogenic aetiology, low SES, and epileptiform & slow-wave 
activity on EEG monitoring. Aetiology was the only independent predictor after multiple linear 
regression, suggesting that cause of epilepsy is perhaps one of the most important precursors 
to poor adaptive functioning in CWEOE.  
(ii) Adaptive Behaviour Problems 
Fourteen CWEOE (33.3%) scored ≥2SD above the mean, and met criteria for an adaptive 
behaviour problem. No control children had an adaptive behaviour problem. In CWEOE, 




Table 9.22 Analysis of Adaptive Behaviour problems and study variables in CWEOE (n=42) 
Variable Sub-group 
  Problem, n (%) 


































.10 3.33 (0.87, 12.72) 








.040 0.17 (0.03, .90) 






































OR for idiopathic vs 
symptom/crypto 


































OR for both vs 
normal/ epileptiform 
or slow-wave= 22.29 
(2.29, 216.92) 
Assessment Age, months                     (median) 34 36 .88ǂ r=.02 
Age at first seizure, months                 (median) 18 13.5 .98ǂ r=.004 
*5 children did not have an MRI, and EEG data was unavailable for 2 children  
† All 5 had epileptiform activity 
ǂ Mann-Whitney U 






cognitive impairment, cryptogenic/symptomatic aetiology, and EEG status (table 9.22). Those 
with epileptiform activity and slow-wave activity on clinical EEG, were associated with adaptive 
behaviour problem – most of whom had infantile spasms. Those with a family history of 
epilepsy were less likely to have an adaptive behaviour problem. A protective factor here is 
unlikely, and the finding is presumably due to more children with symptomatic/cryptogenic 
aetiologies having an adaptive behaviour problem than those with idiopathic aetiology, who 
are more likely to have a positive family history of epilepsy. 
A direct logistic regression model was fitted using gender, aetiology (1989), and number of 
AEDs, in CWEOE. EEG status and cognitive impairment were not included due to 
multicollinearity. Gender was not a significant predictor, and did not improve model fit. Thus, 
the model with the least amount of variables was preferred. Model including aetiology (1989) 
and number of AEDs was significant (x2(2,42)=21.60, p<.001), and explained between 40.2 (Cox 
& Snell R2) and 55.8% (Nagelkerke R2) of the variance. Number of AEDs (p=.019) and aetiology 
(p=.007) independently predicted an adaptive behaviour problem; being on polytherapy was 
associated with increased odds of adaptive behaviour problem of 32.03 (95% CI 1.76, 584.33) 
compared to monotherapy/no medication, and having symptomatic/cryptogenic aetiology 
increased the odds of an adaptive behaviour problem by 20.99 (95% CI 2.28, 193.31) compared 
to idiopathic aetiology. 
9.3.3 Executive Functioning 
Executive functioning behaviour assessed using the BRIEF-P, and spanned ages 24-63m in this 
cohort. Parents of 24 CWEOE (15M:9F) and 22 Controls (12M:10F) completed the BRIEF-P.  
(i) Executive Functioning Scores 
Mean General Executive Composite (GEC) score was significantly higher in CWEOE than that of 
controls (p=.046), indicative of increased reporting of executive problems in CWEOE (table 
9.23). However, an ANCOVA (data transformed) with SES as a covariate found no main effect 
of group (F(1,43)=2.36, p=.13, 𝜂𝑝
2=.05), or of SES (𝜂𝑝
2=.04), indicating a non-significant 
difference in executive functioning between groups. Moderate effect sizes suggest the 
possibility that executive functioning behaviour may be unduly influenced by both SES and 





Table 9.23 BRIEF-P General Executive Composite means and group comparisons 
Group (N) M (SD) MD (95% CI) 
SES adjustment  
EMM (95% CI) 
CWEOE (24) 57.79 (16.87) 
9.06 (0.17, 17.96) 
56.84 (50.59. 63.09) 
Controls (22) 48.73 (12.53) 49.77 (43.23, 56.31) 
Emboldened p<.05  
 
The inhibit subscale and working memory subscale of the BRIEF-P are associated with ADHD 
(Skogan et al., 2015). Analysis of these individual scales in CWEOE and controls here found a 
significant, unadjusted, group difference in the working memory subscale. CWEOE scored 
significantly higher (i.e. more working memory problems) than controls (MD=8.92 [95% CI 0.59, 
17.26], p=.037). This difference dissipated after adjustment for SES (p=.25). There was no 
significant difference in the inhibit subscale (MD=7.25 [95% CI -1.64, 16.14], p=.11). Of the 
remaining subscales (shift, emotional control, and planning/organising), only the shift subscale 
was of statistical significance (p=.008), and which remained significant after rANCOVA 
adjusting for SES - potentially reflecting rigidity and inflexibility in behaviour across social 
situations in CWEOE. 
(ii) Executive Functioning Problems 
Eight CWEOE (33%) had an executive functioning problem (i.e. T-score ≥65 on the General 
Executive Composite), compared with three (14%) control children. The difference between 
groups was not statistically significant (FET=.17, OR=3.13 [95% CI 0.72, 14.29]). Variables 
associated with executive functioning problems included prematurity and 
symptomatic/cryptogenic aetiology (table 9.24). A regression could not be carried out due to 
quasi-complete separation in the prematurity variable.   
Table 9.24 Analysis of Executive Functioning Problems and study variables in CWEOE (n=24) 
Variable Sub-group 
  Problem, n (%) 






























Table 9.24 continued 
Variable Sub-group 
  Problem, n (%) 
FET OR (95% CI) 
No Yes 























































OR for sympt/crpyt 
vs idiopathic =  


































Assessment age, months                        (median) 50 45 .71ǂ r=.08 
Age at first seizure, months                    (median) 36 29 .52ǂ r=.13 
*5 children did not have an MRI, and EEG data was unavailable for 1 
ǂ Mann-Whitney U 
 
 
9.3.4 Internalising, Externalising, & Social Functioning Domains 
The internalising domain, externalising domain, and social functioning domain consisted of 
scales originating from several questionnaires (figure 9.6). For a detailed explanation, see 
section 8.3.2. The SEGC (ages 1-11m) was included in the social functioning domain only, while 
the scales of the ITSEA and CEC questionnaires were included in the internalising, externalising, 
and social functioning domains. Therefore, the demographics of those who completed the 
ITSEA and CEC questionnaires are described here.  The ITSEA questionnaire was completed by 




(6M:3F) CWEOE and 13 (6M:7F) controls completed an ITSEA questionnaire. 23 (14M:9F) CWEOE 
and 20 (11M:9F) controls completed the CEC questionnaire. Each domain is described below.  
Figure 9.6 Internalising, externalising, and social functioning scales, and inclusive ages  
Domain Scale 0-11m 12-23m 24-35m ≥36m 
Internalising ITSEA Internalising     
CEC Mood/Affect & Anxiety     
 
Externalising ITSEA Externalising     
CEC Inattention/Hyperactivity     




SEGC     
ITSEA Competence     
CEC Social Atypical     
CEC Social Functioning     
 
9.3.4.1 Internalising Behaviour Domain 
Internalising behaviour was assessed via the ITSEA Internalising scale and CEC Anxiety and 
Mood/Affect scales, spanning ages 12-63m – including 32 (20M:12F) CWEOE and 33 (17M:16F) 
controls. 
(i) Internalising Behaviour Domain Scores 
Parents of CWEOE reported more internalising behaviours than controls, but the difference did 
not reach statistical significance (table 9.25). 
Table 9.25 Internalising behaviours; scale means and group comparisons 
Group 
ITSEA Internalising CEC Mood/Affect CEC Anxiety 
Mean (SD) MD (95% CI) ǂ Median p (r) † Median p (r) † 






Controls 45.85 (6.38) 51.0 46.5 
ǂ Unequal variances t-test 





(ii) Internalising Domain Problems 
Internalising problems (T-score ≥65) were more often found in the CEC scales (table 9.26). Of 
the children identified on the CEC, one had an anxiety problem, one had a mood/affect 
problem, and 8 met criteria on both scales. One control child had a CEC mood/affect problem, 
and two had both an anxiety and mood/affect problem. When the domain was considered as 
a whole, CWEOE had significantly more internalising problems; eleven (34.4%) CWEOE had an 
internalising problem compared with three (9.1%) controls; (FET=.017, OR=5.24 [95% CI 1.30, 
21.28).  
Table 9.26 Prevalence of internalising problems with group comparisons 
 Prevalence of problem, n/N (%) 
ITSEA Internalising CEC Anxiety CEC Mood/Affect 
CWEOE  1/9  (11%) 9/23 (39%) 9/23 (39%) 
Controls 0/13 (0%) 2/20 (10%) 3/20 (15%) 
FET (OR [95% CI]) .41 .039 (5.79 [1.07, 31.16]) .10 (2.61 [.62, 10.98]) 
n=number of children with problem, N=total number of age-eligible children 
Emboldened p<.05 
 
Prematurity was the only significant variable associated with a problem in the internalizing 
domain (table 9.27). 
Table 9.27 Analysis of internalising domain problems and study variables in CWEOE (n=32) 
Variable Sub-group 
    Problem, n (%) 










































1.0 1.20 (0.23, 6.34) 












Table 9.27 continued 
Variable Sub-group 
Problem, n (%) 

































































Assessment age, months                        (median) 44 43 .81ǂ r=.04 
Age at first seizure, months                    (median) 28 24 .77ǂ r=.05 
*5 children did not have an MRI, and EEG data was unavailable for 1 
ǂ Mann-Whitney U 
 
 
9.3.4.2 Externalising Behaviour 
The externalising domain consisted of the ITSEA Externalising scale, CEC Defiance subscale, 
CEC Aggression subscale, and CEC Inattention/hyperactivity scale – and included 32 (20M:12F) 
CWEOE and 33 (17M:16F) controls (ages 12-63m).  
(i) Externalising Domain Scores 
Parents of CWEOE reported more ITSEA Externalising and CEC Defiance/Aggression behaviours 
than controls but the differences did not reach statistical significance (table 9.28A). Parents of 
CWEOE reported significantly more problems on the CEC Inattention/Hyperactivity scale 





2=.12), indicating an effect of epilepsy on attention/executive 
functioning in CWEOE. There was no main effect of SES (𝜂𝑝
2=.07).  
Table 9.28 Externalising behaviours; scale means and group comparisons 
A. ITSEA Externalising and CEC Defiance/Aggression 
Group 
ITSEA Externalising CEC Defiance/Aggression 
Mean (SD) MD (95% CI) Mean (SD) MD (95% CI) 
CWEOE 47.78 (9.24) 
4.93 (-2.41, 12.28) 
59.04 (16.04) 
5.14 (-3.99, 14.27) 
Controls 42.85 (4.49) 53.90 (13.18) 
B. CEC Inattention/Hyperactivity 
Group Mean (SD) MD (95% CI) 
SES adjustment  
EMM (95% CI) 
 
CWEOE 61.30 (15.76) 
12.10 (3.74, 20.47) 
60.26 (54.54, 65.98) 
.12 
Controls 49.20 (10.75) 50.40 (44.25, 56.56) 
Emboldened p<.05 
 
(ii) Externalising Domain Problems 
More CWEOE (n=12, 37.5%) met criteria for an externalising domain problem (T-score ≥65) 
compared to controls (n=6, 18%), but the difference was not significant (FET=.10, OR= 0.37 
[95% CI 0.12, 1.16]). Individual scale analysis (table 9.29) revealed a significant group difference 
in CEC Inattention/Hyperactivity problems.  
Table 9.29 Prevalence of externalising problems 




CEC Defiance CEC Aggression 
CEC Inattention/ 
Hyperactivity 
CWEOE  0/9 (0) 6/23 (26) 7/23 (30) 9/23 (39) 
Controls 0/13 (0) 4/20 (20) 3/20 (15) 2/20 (10) 
FET  
OR (95% CI) 
n/a 
.73  
0.71 (0.17, 2.98) 
.29  
0.40 (.09, 1.84) 
.039  
0.17 (0.03, 0.93) 








Prematurity and low seizure frequency were the only study variables that were significantly 
associated with having an externalising domain problem in CWEOE (table 9.30).  
Table 9.30 Analysis of externalising domain problems and study variables in CWEOE (n=32) 
Variable Sub-group 
Problem, n (%) 










































1.0 1.12 (0.25, 4.97) 







































































Assessment age, months                        (median) 30 45 .17ǂ r=.24 
Age at first seizure, months                    (median) 22.5 29 .41ǂ r=.15 
*5 children did not have an MRI, and EEG data was unavailable for 1  






9.3.4.3 Social Functioning Domain 
The social functioning domain was made up of the SEGC, ITSEA Competence scale, and CEC 
Social Functioning and Atypical subscales. All scales included a total of 41 (25M:16F) CWEOE 
and 35 (17M:18F) controls, spanning ages 3-63m. 
(i) Social Functioning Scores  
9 CWEOE (M=62.96, SD=18.22) and 2 controls (M=43.33, SD=0.00) <12m completed the SEGC. 
No formal analysis could be completed due to the small sample size in the control group. 
CWEOE had a median T-score of 73.33 (range 40-80), which is two SDs above the mean, 
reflecting a strong tendency toward atypical social-emotional development in CWEOE <12m.  
Two CWEOE were excluded from group analysis of the ITSEA Competence Scale due to 
incomplete questionnaire responses on the relative subscales which meant a T-score could not 
be generated for the overall scale. Of the data available from the five subscales that make up 
the Competence scale, both children had four subscales scoring in the <5th percentile, with the 
data from the fifth subscale missing. This indicated that these two children were displaying a 
high degree of IITSEA Competence scale problems.  
Table 9.31 Social Functioning; scale means and group comparisons 
A. ITSEA Competence and CEC Social Functioning/Atypical Behaviour scales group comparisons † 
Group 
ITSEA Competence CEC Social Functioning/Atypical Behaviour 
Mean (SD) MD (95% CI) Median p (r) 
CWEOE 59.43 (2.99) 
-4.66 (-11.63, 2.31) 
64.0 
.006 (.42) 
Controls 54.77 (8.41) 47.0 
B. CEC Social Functioning and Atypical subscales group comparisons 
 CEC Social Functioning CEC Atypical Behaviour 




.001 (.53) F(1,42)=10.12, 2=.20 
Controls 47.0 45.0 
† ITSEA: CWEOE n=7, controls n=13; CEC: CWEOE n=23, controls n=20 






Parents of CWEOE reported more abnormal social functioning behaviours across the ITSEA 
Competence and CEC Social Functioning/Atypical Behaviour scales. The difference was not 
significant in the ITSEA Competence scale but was significant in CEC Social 
Functioning/Atypical scale (table 9.31A). Subscale analysis revealed the difference was more 
prominent in the CEC Atypical Behaviour subscale compared to the Social Functioning subscale 
(table 9.31B). A significant group difference in Atypical Behaviour remained after adjustment 
for SES. 
(ii) Social Functioning Problems 
The prevalence of children meeting criteria for a social functioning domain problem (T-score 
≥65) within each scale can be found in table 9.32. More CWEOE met criteria for behaviour 
problems on each scale, except the ITSEA Competence scale. The difference was significant in 
the CEC Atypical scale. Overall, significantly more CWEOE (n=18, 46%) than controls (n=6, 17%) 
had a social functioning domain problem (FET=.01, OR= 4.14 [95% CI 1.41, 12.21]).  
Table 9.32 Prevalence of social functioning problems by scale  
 Prevalence of problems, n/N (%) 
SEGC ITSEA Competence CEC Social Functioning CEC Atypical Behaviour 
CWEOE  5/9 (55.6) 0/7 (0) 7/22 (32) 11/23 (48) 
Controls 0/2 (0) 2/13 (15) 3/20 (15) 2/20 (10) 
FET  
OR (95% CI) 
.46 .52 
.28  
2.64 (0.58, 12.10) 
.009  
8.25 (1.55, 44.02) 
n=number of children with problem, N=total number of age-eligible children 
Emboldened p<.05 
 
Variables significantly associated with Social Functioning domain problems included female 
gender, prematurity, cognitive impairment, and symptomatic/cryptogenic aetiology (table 
9.33). A multivariable logistic regression including all variables could not be completed due to 
quasi-complete separation in the premature, and GCA impairment variables.  
Supplementary analysis of social functioning specific to peer relationships was conducted 
using the SDQ. Parents of children aged 36-63m completed the SDQ Peer Relationship 




problems (i.e. rated as having ‘high’ or ‘very high’ peer problems on the SDQ) compared to 
control children (n=15); 38% vs 13% (OR= 4.00 [95% CI 0.71, 2.56]). There was no statistical 
difference between groups in Prosocial Behaviour (FET=1.0), with 62% of CWEOE and 67% of 
controls rated as displaying typical levels of prosocial behaviour.  
Table 9.33 Analysis of social functioning domain problems and study variables in CWEOE (n=39) 
Variable Sub-group 
    Problem, n (%) 











































.34 2.0 (0.53, 7.54) 






































OR for Symp/crypt 
vs idiopathic =  


































Assessment age, months                      (median) 27 43 .77ǂ r=.05 
Age at first seizure, months                  (median) 18 23 .92ǂ r=.02 
*5 children did not have an MRI, and EEG data was unavailable for 2 





9.3.5 Autism Spectrum Disorder Behaviours 
ASD behaviours were assessed using the SRS-2, a tool measuring social reciprocal behaviour 
in children ≥30m. Risk of having ASD was assessed using classification from the M-CHAT (16-
29m), and cut-off T-score of ≥65 on the SRS-2 (tools and methods described in section 8.3.2). 
The M-CHAT was completed in 7 (4M:3F) CWEOE and 11 (5M:6F) controls, and the SRS-2 was 
completed by 22 (14M:8F) CWEOE and 17 (9M:8F) controls. 
(i) ASD Behaviour Scores (SRS-2) 
SRS-2 Total score and all index scales and subscales in CWEOE were significantly elevated 
compared to controls, although remaining within a standard deviation of the normative mean 
(figure 9.7A). A one-way ANCOVA (log transformed data) revealed a main effect of Group 
(F(1,36)=9.01, p=.005, 𝜂𝑝
2=.20), and a main effect of SES (F(1,36)=15.86, p<.001, 𝜂𝑝
2=.31), with 
those from low SES having more elevated SRS-2 total scores than high SES. Parents of CWEOE 
reported more atypical social reciprocal behaviours (geometric mean=51.88 [95% CI 48.64, 
55.34]) compared to control children (geometric mean=44.67 [95% CI 41.50, 48.19]). A 
significant group difference remained across indices and subscales after adjustment for SES, 
with the exception of Social Awareness (figure 9.7B). 
ASD is commonly associated with cognitive impairment in children with epilepsy (Berg and 
Plioplys, 2012; Tuchman et al., 2010). Consequently a sensitivity analysis was explored using 
ANCOVA (applying log transformation), dropping four cases of CWEOE with cognitive 
impairment (see section 9.5.2 for cognitive impairment assessment). A main effect of group 
remained after SES adjustment (F(1,32)=5.63, p=.024, 𝜂𝑝
2=.15), as did a main effect of SES 
(F(1,32)=15.29, p<.000, 𝜂𝑝
2=.32). Back transformed estimated marginal means for CWEOE were 
50.23 (95% CI 46.77, 53.95), and 44.46 (95% CI 41.30, 47.86) in controls. These findings suggest 
that more ASD behaviours compared to controls cannot be explained by GCA impairment in 
CWEOE.  
Bivariate analyses explored study variables on SRS-2 Total score in CWEOE (all cases; table 
9.34). Higher T-scores (indicative of increased reporting of atypical social reciprocal 
behaviour/higher risk of ASD) were associated with lower SES, prematurity, 
symptomatic/cryptogenic aetiology, and normal EEG status. Although a significant association 




subgroup sample sizes, as it is unlikely that epileptiform activity or slow-wave background 
activity provides a protective factor against the development of ASD behaviour.  
Figure 9.7 SRS-2 indices and subscales means 
A. Unadjusted means and standard deviations (error bars) 
 
B. SES adjusted geometric means and 95% confidence intervals 
 
RRB – Restrictive Interest and Repetitive Behaviour 
SCI – Social Communication Index 






Table 9.34 Analysis of SRS2 Total and study variables in CWEOE (n=22) 
Variable  Sub-group N Mean (SD) P 
MD (95% CI) 
























.001 20.53 (9.51, 31.54) 

















.31 5.58 (-5.85, 17.43) 





















































.27 𝜂2= .17 
EEG* 
Normal 








.018 𝜂2= .36 
Assessment age    .21 rs=-.28 
Age at first seizure    .41 rs= -.18 
*5 children did not have an MRI, and EEG data was unavailable for 1 
ǂ Brown-Forsythe robust test of equality of means 
 
A standard multiple linear regression including aetiology (1989, idiopathic vs 
symptomatic/cryptogenic) and SES in CWEOE was ran. EEG and prematurity could not be 




not included due to collinearity. Aetiology and SES both independently predicted SRS2 Total 
score. Symptomatic/cryptogenic aetiology (ß=10.44, [95% CI 3.22, 17.66]) and lower SES (ß 
=10.75 [95% CI 3.67, 17.81]) resulted in increased SRS-2 Total scores. The overall regression 
model was significant (p<.001) explaining 53% of the variance in SRS-2 Total score (R2adj). 
(ii) Autism Spectrum Disorder Risk 
Eight (32%) of 25 CWEOE and zero of 28 controls, screened with the M-CHAT and SRS2 
questionnaires between the ages 16-63m, were considered at higher risk of ASD. The 
difference in prevalence of children at risk of ASD between groups was significant (FET=.004). 
Four (57%) of seven CWEOE, and 0 of 11 controls screened ‘at risk’ on the M-CHAT 
questionnaire. Four (18%) of 22 CWEOE, and 0 of 17 controls met criteria for ASD risk (SRS2 
Total T-score ≥65) on the SRS2 questionnaire.  
Study variables associated with ASD risk were explored through bivariate analysis in CWEOE 
(n=29). ASD risk was associated with lower SES, prematurity, and lower age at first seizure 
(table 9.35). A multivariable logistic regression could not be completed due to quasi-complete 
separation.  No child from a high SES was at risk of ASD, compared to 47% from a low SES.  
Despite the recognised link between intellectual impairment and ASD, only one of the five 
children with GCA impairment was deemed at risk of ASD. However, the remaining four 
children with GCA impairment had a mean SRS-2 T-score of 61.75 (SD=1.71), which was 
significantly higher than non-GCA impaired children (M=52.61, SD=11.52); p=.004 (unequal 
variances t-test), suggesting that ASD risk is still increased albeit not reaching the pre-defined 
threshold.  
Table 9.35 Analysis of ASD risk and study variables in CWEOE (n=29) 
Variable Sub-group 
ASD risk, n (%) 
FET OR (95% CI) 






































Table 9.35 continued 
Variable Sub-group 
ASD risk, n (%) 
FET OR (95% CI) 








.64 0.36 (0.04, 3.56) 







































































Assessment age, months                      (median) 45 35 .10 ǂ r=.31 
Age at first seizure, months                  (median) 36 13.5 .04 ǂ r=.38 
*5 children did not have an MRI, and EEG data was unavailable for 1 







9.4 Assessment Scores and Neurobehavioural Problems: Summaries 
In the sections above, the distribution of neurobehavioural assessment scores, and estimates 
of the prevalence of neurobehavioural problems, in CWEOE and controls were reported, in 
order to provide a detailed description of the pattern, and group differences in, cognitive and 
behavioural functioning. What follows here is a summary of those findings, and an overview of 
the, psychometrically-based, neurobehavioural profile of CWEOE and controls in South-East 
Scotland.  
9.4.1 Neurobehavioural Scores Summary 
CWEOE had poorer GCA compared to control children (figure 9.8A), even when cases who 
‘floor scored’ on the assessment were excluded (figure 9.8B). Additionally, across every domain 
and scale of the behaviour questionnaires, parents of CWEOE reported more problems, or 
fewer age-appropriate behaviours, compared to controls (figure 9.9). Group differences were 
significant in the scales of adaptive behaviour, executive functioning, inattention/hyperactivity, 
atypical behaviour, and ASD behaviours. After adjustment for SES, significant group differences 
remained in all but executive functioning.  
 
Figure 9.8 GCA scores in CWEOE and Controls 
A. SES adjusted means and 95% Cis B. Sensitivity analysis* means and 95% CIs 
  
 *Outlying cases who scored ≥3SD below mean 







Figure 9.9 Behaviour scales mean/median T-scores (error bars represent standard deviation) 
 
AB – Adaptive Behaviour 
EF – Executive Function 
^ Scale converted and/or inverted 
ǂ Median t-score 
* Significant group difference (p<.05) 
** Group difference remained (p<.05) after adjustment for socioeconomic status 









Figure 9.10 Behaviour assessment scores in CWEOE (idiopathic aetiology only) and controls 
 
Horizontal grey line represents normative mean 
Error bars represent standard deviation  
AB – Adaptive behaviour 





When only CWEOE with idiopathic epilepsy were considered (figure 9.10), elevated scores 
persisted across all behaviour scales. A significant difference was found in ABAS II Adaptive 
Behaviour and CEC Atypical Behaviour scale. As subgroup sizes were smaller, there was less 
power to detect group differences. Nevertheless, a clear pattern of increased reporting of 
abnormal behaviour is persistent even in those without a suspected or known cause for their 
epilepsy, suggesting the early emergence of behaviour problems, or a global impact on 
behavioural functioning influenced by the presence of epilepsy.  
Family history of epilepsy in CWEOE was not significantly associated with GCA or behavioural 
assessment scores throughout the analysis. This relationship was explored further, by 
aetiology, with assessment scores summarised in figure 9.11; (A) children with idiopathic 
epilepsy, and (B) children with cryptogenic/symptomatic epilepsy. Subgroup sample sizes were 
small, and while no significant differences were found, moderate effect sizes of r=.26 and .32 
were noted in CEC scales of Anxiety and CEC Mood/Affect in children with 
symptomatic/cryptogenic epilepsy, respectively. Only a small effect size was seen in children 
with idiopathic epilepsy. This may indicate increased predisposition to, or earlier expression of, 
anxiety or mood problems in children with epilepsy when the cause has a clinically recognised 
lesion or abnormality, or is strongly suspected of one. Note that subgroup scores for the SEGC 
or ITSEA were not included as subgroup sample sizes were less than n≤2 in several cells.  
Figure 9.11 Behaviour assessment scores for children with and without family history of epilepsy by 
aetiology (ILAE, 1989) 
 





B. Symptomatic/Cryptogenic epilepsy mean/median scores (error bars represent standard 
deviation) 
 
Horizontal grey line represents normative mean 
Scale Tools: 
Adaptive behaviour – ABAS II 
Executive functioning – BRIEF-P 
ASD Behaviour – SRS2 
 
Anxiety, Mood/Affect, Defiance/Aggression, 
Inattention/Hyperactivity ,and social Functioning/Atypical 
Behaviour - CEC 
 
9.4.2 Neurobehavioural Problems Summary 
Figure 9.12 Prevalence of neurobehavioural problems 
 







Table 9.36 Prevalence of neurobehavioural problems 
Major 
Domain 




Prevalence of problem (n/N) % 
Group Comparison 
FET (OR [95% CI])  ŧ CWEOE Controls 
Cognition 
General Cognitive Ability Bayley III Cognition/WPPSI III FSIQ 3-63 (13/46) 28% (0/37) 0% <.001 
Memory 
NEPSY II Memory for Designs/ Narrative 
Memory/ Sentence Repetition  
36-63 (4/18) 22% (0/14) 0% .11 (9.62 [0.48, 194.84]) 
Social Perception NEPSY II Affect Recognition/Theory of Mind 36-63 (0/18) 0% (1/15) 7% .46 (0.26 [0.01, 6.90]) 
Attention/Executive 
Functioning 
NEPSY II Statues 36-63 (1/17) 6% (0/14) 0% 1.0 (2.49 [0.09, 65.76]) 
 
Behaviour 
Adaptive Behaviour ABAS II General Adaptive Composite 3-63 (14/42) 33% (0/37) 0% <.001 
Internalising 
ITSEA Internalizing/ CEC Mood/Affect/ CEC 
Anxiety 





12-63 (12/32) 37.5% (6/33) 18% .10 (0.37 [0.12, 1.16]) 
Executive Functioning BRIEF-P General Executive Composite 24-63 (8/24) 33% (3/22) 14% .17 (0.32 [0.07, 1.39]) 
Social Functioning SEGC/ITSEA Competence/CEC Social/Atypical 3-63 (18/39)  46% (6/35)  17% .01 (0.24 [0.08, 0.71]) 
ASD Risk M-CHAT/SRS2 Total 16-63 (8/29) 28% (0/28) 0% .004 
Problem in cognition domain defined as score ≥2SD below mean; Problem in behaviour domain defined as score 
≥1.5SD above mean, with exceptions for ABAS II and SEGC which were ≥2SD above mean 
n=number of children with problem, N=total number of age-eligible children 
ŧ Odds Ratio (OR) cannot be calculated when ≥1 




The prevalence of GCA impairment and behavioural problems are visually depicted in figure 
9.12, and described in detail in table 9.36. CWEOE consistently had more children meeting 
criteria for neurobehavioural problems than controls. This was significantly so in the domains 
of GCA, adaptive behaviour, internalising behaviour, social functioning, and ASD risk. 
Focusing on GCA and behaviour scales, overall, a neurobehavioural problem was found in 63% 
(95% CI 48.6-75.5) of CWEOE, compared to 27% (95% CI 15.4, 43.0) of controls.  No control 
child had a GCA impairment, but a GCA impairment was found in 28% (95% CI 17.3, 42.5) of 
CWEOE. Whilst behaviour problems were evident in 59% (95% CI 44.3, 71.7) of CWEOE, almost 
one quarter had a cognitive and comorbid behavioural problem. A GCA impairment in the 
absence of behavioural problem was rare, at 4% (95% CI 1.2, 14.5). The nature of the problems 
are visually dichotomised in figure 9.13. 
Figure 9.13 GCA Impairment and/or Behaviour Problem by Group 
 
 
To understand the degree of comorbidity across domains, figure 9.14 breaks down the 
information above by detailing the frequency of neurobehavioural problems according to the 
number of domains in which a neurobehavioural problem was identified.  20% of CWEOE had 
a problem in only one domain, compared with 13.5% of control children, while multi-domain 
problems of 3-6 domains were more common in CWEOE. These data demonstrate that the 
high prevalence of problems found in CWEOE is not due to any particular subgroup of children 
scoring consistently in the problem ranges across all tools, but that problems are spread across 




Figure 9.14 Frequency of neurobehavioural problems 
 
 
Risk factors for neurobehavioural problems differed depending on the domain of interest. Risk 
factors identified from bivariate analysis, and from multivariable regressions, are listed in table 
9.37. Symptomatic/cryptogenic aetiology and prematurity were the most common variables 
associated with neurobehavioural problems. 
In several of the predictor variables, within domains, all CWEOE belonged exclusively in the 
problem category. For instance, all prematurely born children met criteria for executive 
functioning problems, social competence problems, and positive ASD risk. Consequently, 
multiple regressions could not be completed due to quasi-complete separation.  
Interestingly, a family history of developmental disability or psychiatric issue was not 
associated with GCA impairment (OR=2.05 [95% CI 0.51, 8.34]), but was associated with ≥1 
behavioural problems in any of the domains of interest, in 100% (n=11) of cases. That is, any 
child with a family history of developmental or psychiatric issue had at least one behavioural 
problem. In contrast, 16 (55.2%) children without any family history of developmental disability 
or psychiatric issue had at least one behaviour problem; FET=.007. Therefore, a positive family 
history may pose a general risk factor for the development of behavioural problems. There was 
no such association with family history of epilepsy, and GCA impairment or ≥1 behaviour 




Table 9.37 Significant (p<.05) risk factors associated with neurobehavioural problems in CWEOE 
Major Domain Domain Bivariate analysis: Risk Factors 
Multivariable analysis:  





Females, polytherapy, high 
seizure frequency, 
symptomatic/cryptogenic 






Females, polytherapy, GCA 
impairment, symptomatic/ 
cryptogenic aetiology, and EEG 
status 
Polytherapy, symptomatic/ 
cryptogenic aetiology (EEG 








Internalising Prematurity n/a 
Externalising 










lower SES, prematurity, and 
lower age at first seizure 
n/a 
 
9.5 ESSENCE criteria 
42 CWEOE (25M:17F) and 37 controls (18M:19F) completed an ESSENCE-Q. Four CWEOE (9%) 
did not return an ESSENCE-Q. 100% of questionnaires were returned by controls. 28 (66.7%, 
[95% CI 51.6, 79.0]) CWEOE and 3 (8.1% [95% CI 2.8, 21.3]) controls scored at least two “yeses” 
or at least three “maybes” and met criteria as potentially having a disorder subsumed under 
the ESSENCE umbrella. These figures are close in approximation to CWEOE who met criteria 
for neurobehavioural problems on the assessment battery, but less so in controls. 29 (63%) 
CWEOE and 10 (27%) control children met criteria for at least one neurobehavioural problem 
(section 9.4.2). This comparison must be treated with caution as ESSENCE disorders were not 




ESSENCE-Q as a pre-screening instrument to identify children who may need further 
investigations (Carlsson et al., 2013; Hatakenaka et al., 2016).  
In control children, there was no statistical difference between those who did not meet 
ESSENCE criteria and those who did, in age, gender or SES.   In CWEOE (table 9.38) no study 
variable, with the exception of symptomatic/cryptogenic aetiology, was significantly associated 
with meeting ESSENCE criteria. This suggests that disorders or problems potentially 
identifiable under the ESSENCE-Q in CWEOE are diverse and have different associated risk 
factors, but, as evidenced in the neurobehavioural assessment, symptomatic/cryptogenic 
aetiology is a potentially broad risk factor for disorders identified under the ESSENCE-Q. 
Table 9.38 Study variables and CWEOE who did (n=28), or did not (n=14), meet ESSENCE criteria  
Variable 
Met ESSENCE criteria, n (%) Group Comparison 
















.18 (2.82 [0.75, 10.57]) 










































































Table 9.38 continued 
Variable  
Met ESSENCE criteria, n (%) Group Comparison 



















Median (IQR) 32.9 (6.9, 56.0) 34.4 (14.4, 45.1) †p=.86, r= .03 
Age first seizure 
(months) 
Median (IQR) 21.0 (4.0, 44.3) 17.5 (6.3, 36.0) †p=.93, r=.01 
Emboldened= p<.05 
*5 children did not have an MRI, and EEG data was unavailable for 2 






10. Neurobehavioural Profile of CWEOE: Discussion 
The aim of this chapter was to describe the neurobehavioural profile of CWEOE using a 
comprehensive battery of cognitive and behavioural assessment tools. These generated group 
level distributions of scores, and estimations of the types, and prevalence, of neurobehavioural 
problems (i.e. GCA impairment and behaviour problems - as defined by the study cut-offs on 
those assessment tools). From the findings of the systematic review (chapter I, section 1.3), this 
is the first study to describe comorbid cognitive and behavioural functioning in a single cohort 
of children with epilepsy during the first five years of life. As hypothesised, the 
neurobehavioural profile of CWEOE was unfavourably different to that of control children. 
Neurobehavioural problems were highly prevalent in CWEOE, exceeding that found in control 
subjects, and were more often multiple in nature. Given the large assessment battery and 
analysis, the study results are discussed by cognitive and behavioural functioning separately. 
10.1 Cognitive Functioning  
10.1.1 General Cognitive Ability  
Cognitive functioning was compromised in CWEOE. In line with other population-based 
studies, GCA was poorer in children with epilepsy compared to control children (Hoie et al., 
2008; Rantanen et al., 2011; Reilly et al., 2014a). GCA was 0.8 SD below test normative mean 
and 1.3 SD below control mean. When ‘floor’ scoring children were excluded, GCA lay 0.4 SD 
below normative mean and 0.96 SD below controls, meaning the poorer performance could 
not simply be attributed to more severe cases of epilepsy. No other published data is available 
for direct comparison to the entire early-onset age range. Instead, the findings can be 
compared to studies of infants/toddlers, and preschool-aged children.  
In CWEOE, GCA score lay in the borderline (i.e. between 1.5 and 2 SD below mean), to low-
average (i.e. between 0.75 and 1.5 SD below mean) range in infants/toddlers, with and without 
floor cases, respectively; and close to the normative mean in preschool children. To the 
candidate’s knowledge, there have been no peer-reviewed journal publications of 
psychometric GCA data in a general population-based cohort of infants/toddlers with epilepsy. 
One study published in a MD dissertation by Eltze in 2010 did provide supportive evidence of 




present study Eltze reported borderline Bayley III Cognition in her population-based cohort of 
infants <2 years with epilepsy in London, UK.  
Preschool CWEOE in the current study scored at normative mean level but which remained 
significantly below that of control children. There are two potential explanations. The first is 
that children from this region of Scotland score higher than the WPPSI III standardisation 
sample, and supports the use of a comparator control group taken from the same population. 
The second is that a larger proportion of control children from a high SES background in this 
study, which is associated with better cognitive status, may have positively distorted the true 
population estimate. However, control children from both a high and low SES scored well 
above the normative mean, and statistical adjustment for SES did not alter between-group 
findings, failing to support that assertion.  As SES based on neighbourhood deprivation may 
not represent an individual’s level of deprivation or socioeconomic characteristics, such as 
parent education, it is possible that control children here were unrepresentative of the 
population. However, neighbourhood level factors influence developmental and psychosocial 
outcomes, and can do so more than individual factors (Duncan et al., 1994; Garner and 
Raudenbush, 1991; Kalff et al., 2001). In further support of the findings here, Rantanen et al. 
(2010) reported on a population-based subgroup of preschool children aged 36-83m with 
uncomplicated epilepsy (i.e. epilepsy without chronic illness or neurological disorder). These 
children had a mean IQ of 94.6 (SD 12.2) which was significantly lower than control IQ despite 
being matched for parental education level. Indeed, older children with epilepsy have been 
found to perform lower than expected based on parent IQ (Walker et al., 2012). In direct 
comparison to Rantanen et al., the preschool CWEOE with idiopathic epilepsy only from the 
current study, who also had no neurological disorders, scored at the normative mean level 
(101.33, SD 14.48), without notable difference between low and high SES children. Taken 
together, findings suggest that preschool-aged children may show average levels of GCA on 
testing, but could be performing lower than peers, irrespective of SES.     
A key factor in describing the cognitive profile of CWEOE was determining the prevalence of 
GCA impairment (i.e. GCA score ≥2 SD below mean). The prevalence of 28% was similar to that 
reported in other population-based studies of older childhood epilepsy (Hoie et al., 2005; Reilly 
et al., 2014a; Sillanpaa 1992; Waaler et al., 2000). Around 40% of children whose epilepsy onset 
began <12m of age had GCA impairment, compared to approximately 20% of children with 
onset during years 1 to 4. The presence of infantile spasms in the first year of life accounted 




early-onset period, in the absence of infantile spasms, poses similar risks to the occurrence of 
GCA impairment. The proportion of children with GCA impairment whose onset was in the first 
year of life here, is less than the 58-82% previously reported elsewhere (Altunbasak et al., 2007; 
Battaglia et al., 1999b; Czochanska et al., 1994; Cormack et al., 2007). These data with higher 
reported proportions were derived from single centre, cross-sectional or special population, 
studies, which are likely to have a biased sample source, and are not generalisable to the overall 
epilepsy population with onset <12 months.  
Referring to preschool-aged children only, Rantanen et al. (2011) reported GCA impairment in 
50% of children with epilepsy, whereas only 21% were impaired here. The epilepsy cohort in 
Rantanen et al. were slightly older, but this was unlikely to account for the discrepancy.  In that 
study, children had active epilepsy, and were seen 38 (2-83) months after epilepsy onset. 
Consequently, that cohort may not have included some children with benign or better 
controlled epilepsies. The proportion of children with symptomatic/cryptogenic aetiologies, 
which is strongly associated with GCA impairment, was 91%, compared to 36% in the present 
study.  Therefore, a higher proportion of symptomatic/cryptogenic aetiology is the most likely 
explanation. Elsewhere, Berg et al. (2008) also found a higher prevalence of GCA impairment 
(33.4%) in their community-based study of persons ≤29 years of age whose onset began at 0-
5 years. Because children were assessed during the early-onset period, and shortly after the 
onset of their epilepsy, in the present study, it is possible that the prevalence of GCA 
impairment may rise with age as the epilepsies evolve in some children. Children with Dravet 
Syndrome, for example, have normal cognitive development before developmental stalling by 
four years of age (Nabbout et al., 2013; Wolff et al., 2006a).  
Whilst GCA was clearly affected in CWEOE, the influence of epilepsy on attention & executive 
functioning, memory, and social perception, in children ≥36m, was not as widely apparent. 
CWEOE did not perform as well as controls on all six NEPSY II subtests, but significantly poorer 
mean scores were only observed in the Theory of Mind and Sentence Repetition subtests. 
Therefore, only selective features of memory and social perception were affected in CWEOE, 
whilst the attention & executive functioning domain was relatively spared. Few studies have 
used the NEPSY in children with epilepsy. Some have used the previous NEPSY version with 
construct differences to the second, and all have used varied subtests and populations (Bender 
et al., 2007; Kolk et al., 2001; Parisi et al., 2012; Rantanen et al., 2010a; Verrotti et al., 2013; Zilli 
et al., 2015). Deficits in the attention & executive functioning domain were observed in all those 




focused on preschool children, and attention & executive functioning was non-significantly 
poorer, it could be argued that attention & executive difficulties have not yet emerged in 
preschool children. That said, almost one quarter of CWEOE had an attention & executive 
impairment compared to zero controls. A moderate effect size at group level was also 
observed, suggesting that attention & executive difficulties are indeed emerging in some 
CWEOE. Because different subtests within the NEPSY I and II are used to evaluate preschool 
children and school-aged children, the findings may be different as a result of using subtests 
with different constructs. A parent questionnaire of executive functioning issued in the present 
study (BRIEF-P) did not reveal significant differences between CWEOE and controls, yet the 
attention/hyperactivity scale of the CEC did. Given that executive functioning deficits are 
common in later childhood epilepsy (Berl et al., 2015; Fastenau et al., 2009; Hoie et al., 2006; 
Jackson et al., 2013), it is possible that differences in the NEPSY II attention & executive 
functioning subtest did not emerge because executive functioning abilities do not mature until 
the end of, or beyond, the early-onset period (Garon et al., 2008).     
In regards to memory, a deficit in Sentence Repetition was seen in this study, and also in a 
study of preschool children with uncomplicated epilepsy (Rantanen et al., 2010). Performance 
on the Narrative Memory and Memory for Designs subtests were comparable to controls in the 
present study, as noted elsewhere (Rantanen et al., 2011; Verrotti et al., 2013; Zilli et al., 2015). 
The Memory for Designs and Narrative Memory subtests reflect visual memory and learning, 
and cued verbal recall, respectively, whereas Sentence Repetition reflects immediate unaided 
verbal recall. Thus, one explanation for the difference between performance on these memory 
subtests is increased task difficulty of the Sentence Repetition task in CWEOE. Age of epilepsy 
onset has the potential to affect brain structure and function differentially, and is another 
possibility (Gonzalez et al., 2014; Hermann et al., 2002; Kaaden et al., 2011). The Sentence 
Repetition task is normed for children 3-6 years, and direct comparison with older childhood 
studies was not possible, with the exception of Zilli et al. (2015), who used an Italian version of 
the NEPSY II with wider age norms. Zilli et al. did not find a memory deficit on the Sentence 
Repetition task, thus providing some support for early age of onset as a potential factor. The 
use of a different language version of the subtest may confound this explanation. Memory 
deficits have been reported in older children with epilepsy using the NEPSY (Bender et al., 
2007; Kolk et al., 2001; Verrotti et al., 2013), and from the evidence presented here, some 
memory deficits are apparent in preschool aged children, but it is difficult to draw any firm 
conclusions about age-related differences in memory performance due to limited studies, and 




In the assessment of Social Perception, Zilli et al. (2015) reported poorer mean Theory of Mind 
scores and Affect Recognition in older children with epilepsy compared to controls. Here, 
CWEOE had poorer Theory of Mind, and a moderate between group effect size was noted in 
Affect Recognition. As discussed later in this section, CWEOE had elevated atypical social 
behaviours, and ASD associated behaviours - a common feature of childhood epilepsy. It 
seems plausible then, that social cognition difficulties, including those underpinning the Social 
Perception subtests, may be features of CWEOE that emerge early and persist into later 
childhood.  
Given that control children performed better than CWEOE across subtests of the NEPSY II in 
this study, as well as that of Rantanen et al. (2010), it suggests that cognitive functions that are 
involved in these specific skills are at least partially affected in CWEOE. This could signify 
emerging problems in CWEOE, or that a detriment to GCA has an overarching impact on more 
specific cognitive functions. This latter explanation cannot, however, account for the 
disproportionate difference observed in Sentence Repetition and Theory of Mind subtests. The 
differentiation hypothesis (Garrett, 1946) states that as children age, a general factor of 
intelligence differentiates to more specific cognitive functions. It is therefore plausible that 
early problems are more difficult to detect due to ongoing specialisation. Nevertheless, a 
consistent pattern of subtle underperformance seen in preschool children here indicates that 
early cognitive functions are measurable, and difficulties may be detectable. Thus, further 
attention from researchers, and likewise, those involved in clinical care or educational policy 
and management, is warranted. 
10.2 Behavioural Functioning 
Having established that cognitive functioning was unfavourably affected in CWEOE, it was then 
shown that behaviour was also widely compromised. Behaviour scores were variable and on 
average, were within one SD of the mean. But a clear pattern of increased levels of abnormal 
behaviour were reported by parents of CWEOE across all domains and scales, even in those 
with idiopathic epilepsy only. This indicates that at least subtle increases in abnormal 
behavioural functioning in those with epilepsy is evident. CWEOE group scores were 
significantly elevated in adaptive behaviour, inattention/hyperactivity, atypical behaviour, and 
ASD behaviours, while 59% of CWEOE compared to 27% of controls met criteria for a behaviour 
problem. This prevalence of behaviour problems is within that previously reported by 




2011a; Davies et al., 2003; Hoie et al., 2008; Lossius et al., 2006; McDermott et al., 1995; Reilly 
et al., 2014a). These studies included children with onset above and below age five, and thus, 
the current study provides a more focused study of problem prevalence during the early-onset 
period itself. A higher prevalence of problems was found across all domains, and significantly 
so in adaptive behaviour, internalising behaviour, social functioning, and ASD risk - indicating 
a similar spectrum of behavioural problems to that found in older childhood studies.  
The pattern of findings described above are reflective of Rodenburg et al’s (2005) findings that 
attention and social difficulties are more prominent, and possibly unique compared to other 
chronic conditions, characteristics of childhood epilepsy. Scores on the Internalising and 
externalising scales, with the exception of inattention/hyperactivity, were not significantly 
different between control children and CWEOE. Rodenburg et al. suggest that family factors 
might play a more influential role in the development of internalising or externalising 
behaviours. Without sibling data the contributory role of epilepsy in the development of 
anxiety and mood problems is uncertain, but the data do suggest that by early childhood 
internalising difficulties are emerging, and that epilepsy may increase individual susceptibility 
to the development of emotional problems. This was seen through a moderate effect size and 
higher problem prevalence in the CEC Anxiety and CEC Mood/Affect scales. CWEOE showed 
increased atypical behaviour, ASD behaviours (reflective of social cognition and 
communication abilities), and peer relationship problems, but comparable prosocial 
behaviours and CEC social functioning. This pattern may reflect the opinion that children with 
epilepsy have poorer social skills and increased peer problems, yet are able to participate in 
social activities to a similar degree as controls (Hamiwka et al., 2011; Rantanen et al., 2012).  
Differences in social cognition were evident in the assessment of ASD behaviour in the current 
study. Both group scores, and the prevalence of those meeting criteria for ASD risk, were 
significantly higher compared to control children. ASD is overrepresented in children with 
epilepsy, with prevalence rates reported between 6-28% (Davies et al., 2003; Berg et al., 2011b; 
Suren et al., 2012; Reilly et al., 2014a; Russ et al., 2012). The data in CWEOE is unclear, although 
there is a known risk in those with epileptic encephalopathies (Brunklaus et al., 2011; Besag, 
2004; Li et al., 2011; Riikonen and Amnell, 1981; Wolff et al., 2006a). In the current study, 32% 
screened positive for ASD risk. This figure was similar to other studies of early and later 
childhood epilepsy who screened for ASD (Clarke et al., 2005; Fisher et al., 2012a). Although 
those studies assessed children in tertiary epilepsy care settings, these data converge to 




epilepsy can express ASD behaviour despite not meeting criteria for a diagnosis of classic ASD 
(Berg et al 2011), and coupled with evidence that ASD features are impairing without meeting 
clinical thresholds even in the general population (Skuse 2009), it is clear that there is a strong 
argument for screening all children with epilepsy to identify those with social communication 
and social cognitive difficulties.  
10.3 Neurobehaviour and Risk Factors 
Sociodemographic and epilepsy-related factors were variably associated with assessment 
scores and neurobehavioural problems. Aetiology had an extensive effect on neurobehavioural 
expression, and the 1989 ILAE classification system was a better predictor of assessment scores 
and neurobehavioural problems than the 2010 classification system. Both systems 
independently predicted GCA impairment, but the 1989 classification was associated with 
several behavioural problems when the 2010 system was not. That said, abnormal assessment 
scores and more problems were associated with structural/metabolic aetiologies as expected, 
but the overall utility of the 2010 categorisation to detect subgroup differences was diluted 
primarily by the transition from cryptogenic classification to the unknown or genetic 
categories. Given that the sample size was moderate, the 2010 classification system may be 
better suited on larger sample sizes. The discussion on risk factors to follow focuses on the 
ILAE 1989 classification system when discussing aetiological factors because of its utility in this 
context, and its clinical applicability. 
In this study, adaptive behaviour was spared in CWEOE with idiopathic aetiologies when 
compared to test normative mean although CWEOE still performed significantly more poorly 
than control children.  The finding of relative sparing in idiopathic epilepsy has been reported 
in children with epilepsy elsewhere (Berg et al 2004; Berg et al., 2013). An unexpected finding 
in the current study was that control children had significantly poorer practical adaptive 
behaviour compared to their respective social and conceptual domains - albeit remaining 
within the average range. Given there was a small standard deviation around the mean, this 
finding may reflect cultural differences between this South-East Scotland sample of control 
children and the ABAS II US normative sample, rather than a difficulty with practical adaptive 
behaviour per se. A discrepancy in scores was found in motor scales between the US and UK 
standardisation samples on the Bayley III (Bayley, 2010), and likewise, any disproportionate 
deficit in the practical domain seen in CWEOE may also have been influenced by sampling 




or uncertainty surrounding questions on the ABAS II, to the candidate. Parents commented 
that they did not allow their children to perform certain actions as queried by the ABAS II 
practical domain (e.g. carrying hot liquids, or using electrical sockets), and their ratings 
reflected this rather than the child’s ability to carry out the action. They also commonly 
reported that they aided the child in certain situations due to fussiness rather than inability 
(e.g. feeding, brushing teeth, dressing, or going to bed), but rated them negatively because of 
this. Nevertheless, this finding did not alter the overall finding that CWEOE had poorer overall 
adaptive behaviour compared to control children, particularly so in children with 
symptomatic/cryptogenic aetiologies. Additionally, it provides further support for the use of 
local comparator control data rather than test normative scores.    
With the exception of aetiology, epilepsy-related variables were rarely associated with 
neurobehavioural problems, suggesting that aetiology is the predominant factor. The 
population was heterogeneous with insufficient sample sizes for sub-syndrome analysis. 
Accordingly this may have impacted the power to detect true effects of these variables should 
they have existed within certain syndromes. That said, epilepsy-related variables are not 
strongly or consistently linked with behaviour problems in the childhood epilepsy literature 
(Dunn & Austin 2004; Ekincini 2008; Otero 2009; Plioplys 2007; Rantanen 2012; Reilly 2011; 
Reilly 2013), suggesting the same could apply to CWEOE.  
Contrary to Berg et al. (2011), we did not find an association, or trend, between family history 
of epilepsy, and behaviour problems in CWEOE. Moderate effect sizes were seen in anxiety and 
mood scores in those with symptomatic/cryptogenic aetiology, where anxiety and mood 
behaviours were reported in those with a positive family history. Sample sizes were smaller in 
these aetiological subgroups, and although there is currently little evidence in the literature 
suggesting a link between structural lesions and anxiety or mood disorders, this relationship 
could be explored further in larger sample sizes of CWEOE.  
Non-epilepsy-related variables including gender, SES, and age, had rare and variable 
relationships with scores or neurobehavioural problems. Prematurity was the exception. It was 
strongly associated with several of the behaviour domains, which reflected the known risk of 
premature birth to behaviour problems (Cassiano et al., 2016). Gender was associated with two 
neurobehavioural problems. More females were identified with GCA impairment and adaptive 
behaviour problems than males. Given the modest sample size, this is likely to be an incidental 




problem, and after multivariable regression in adaptive behaviour, gender was no longer a 
significant independent predictor. A biological explanation of female predominance of GCA 
impairment in CWEOE is unlikely, and may be partly due to the result of the precursors to the 
epilepsy itself. All had symptomatic/cryptogenic causes. And of those with known causes, one 
had epilepsy as a result of a TBI, and two others had lissencephaly – which has no gender 
prevalence bias (de Rijk-van Andel et al., 1991). It is plausible then, that a gender association 
occurred by chance.  
Adverse cognition and behaviour are more common in children from more deprived social 
backgrounds, including those with chronic health conditions (Bradley and Corwyn, 2002; 
Gortmaker et al., 1990), or those with epilepsy (Carson et al., 2015). In this cohort, low SES 
(reflecting higher social deprivation) was not significantly associated with GCA impairment, or 
any of the behavioural problems, with the exception of ASD risk in CWEOE. Odds ratios were 
notably higher in several of the behaviour domains, and modest sample sizes may have masked 
true differences. The finding that all children at risk of ASD were from a low SES was 
unexpected. The association between SES and ASD has inconsistent findings, with reports 
linking ASD with low SES (Burd et al., 1999), high SES (Durkin et al., 2010; Thomas et al., 2012), 
or no relationship (Fombonne et al., 1997; Larsson et al., 2005). Delobel-Ayoub et al. (2015) 
linked ASD and severe GCA impairment with low SES. In children with epilepsy, a relationship 
between ASD and GCA impairment has been established, although the role of SES in this is 
unknown (Berg et al., 2011b; Berg and Plioplys, 2012; Reilly et al., 2014a; Tuchman et al., 2010). 
In the current study, only one child at higher risk of ASD had GCA impairment, with the 
remaining children having variable GCA scores, making this explanation unsatisfactory. West 
syndrome is also associated with ASD (Berg et al., 2011b), but those with Infantile Spasms/West 
Syndrome were too young in the present study to be assessed with the ASD screening tools. 
Therefore, the relationship between ASD and low SES in the current study remains unknown. 
Further evaluation and longitudinal follow-up is needed to corroborate the extent of ASD 
diagnosis, and evolution of ASD behaviour symptoms in this cohort, to make firmer 
comparisons.  
Some evidence indicates that child psychopathology in children with epilepsy is associated 
with psychopathology in the parent (Shore et al., 2002; Shore et al., 2004; Hoare and Kerley, 
1991; Lothman and Pianta, 1993), although this is not always supported (Baki et al., 2004). A 
family history can signify both genetic factors, and family environmental factors, in the 




100% of children with a family history of developmental disability or psychiatric issue screened 
positive for some type of behaviour problem. Only chance levels were observed in children 
without such family history. As the association was non-domain specific, this may indicate a 
general predisposition to behaviour problems with a positive family history. This data requires 
validation in larger studies, but if the finding persists, it could be used as an easily identifiable 
risk factor. Furthermore, the family environment could provide a potential avenue for early 
therapeutic intervention.  
Age of epilepsy onset is consistently associated with cognitive impairment but not behaviour 
in the childhood epilepsy literature (see section 1.4). Here, within the early-onset period, the 
association was weak. For GCA younger age at first seizure was associated with poorer scores, 
but after multivariable regression, age at first seizure was no longer an independent predictor. 
Instead, aetiology was the main predictor, with more structural or symptomatic/cryptogenic 
cases occurring at an earlier age. In the behaviour domains, the association with age was 
weaker still. The assessment of internalising, externalising and social functioning domains 
included assessment by an infant/toddler aged tool, the ITSEA, and a preschool-aged tool, the 
CEC. No infant/toddler tool was available for executive functioning. Neurobehavioural 
problems were found more often in the CEC, the preschool-aged tool. This suggests that 
behavioural problems could emerge with increasing age, particularly during the preschool 
years. However, because no significant relationships were found between age and assessment 
scores on the individual scales, or between age and the prevalence of behaviour problems, it’s 
unlikely that age itself is a driving factor. Differences in scale structure and parent beliefs 
surrounding age-appropriate behaviour is an alternative possibility (Cox et al., 2010), and in 
turn suggests that behaviour problems are likely throughout the early years but which are 
more obvious or easier to discriminate during the preschool years.  
10.4 Neurobehavioural Comorbidity 
Having established that neurobehavioural problems were highly prevalent and widespread, it 
was also important to establish the extent of comorbidity. Whilst the wide spectrum of 
neurobehavioural problems in children with epilepsy is well recognised, few studies have 
provided information on the degree to which problems co-occur within the populations (c.f. 
(Berg et al., 2011a; Caplan et al., 2005; Hoie et al., 2008; Reilly et al., 2014a; Suren et al., 2012). 
Such information is necessary, and this view has been recently championed in children with 




impairment, only 4% had one in the absence of a behaviour problem. Approximately one 
quarter of all CWEOE had GCA impairment and a comorbid behavioural problem, whilst one 
quarter had a behaviour problem in the absence of GCA impairment.  Multi-behavioural-
domain problems were also common and variable in volume. One fifth of CWEOE met criteria 
for a single neurobehavioural problem, while 43% had problems in 2 to 6 domains. This raises 
the possibility of different neurobehavioural phenotypes (Hermann et al., 2007a), who may 
have different associated risk factors. The results here clearly portray a diverse and 
multidimensional neurobehavioural profile, and echoes the sentiment laid down by ESSENCE, 
in that CWEOE require comprehensive evaluation beyond any single neurobehavioural 
dimension that may be the cause for initial investigation. 
Overall, the proportion of CWEOE meeting criteria for cognitive impairment and/or behaviour 
problem was 63%. Control children met criteria for behaviour problems only, and at 27% was 
at the higher end of normal (Brauner and Stephens, 2006). One hypothetical explanation for 
these high figures is that parents had pre-existing concerns about their children which were 
reflected by study entry, and in scoring response styles.  This explanation is unlikely in CWEOE 
in the current study for several reasons. One, there was a high study ascertainment rate, and 
was thus representative of the cohort rather than a sampling bias. Two, the differences between 
CWEOE and controls were consistent in direction across domains, reflecting a general and 
consistent pattern of poorer cognition and behaviour in CWEOE. Three, such a high prevalence 
of neurobehavioural problems in school-aged children with epilepsy has been demonstrated 
recently in the UK using a similar comprehensive assessment - and it is therefore not 
unreasonable in CWEOE. Reilly et al. (2014a) found 80% of children with epilepsy met criteria 
for intellectual impairment and/or a DSM-IV-TR behaviour diagnosis.  Four, behaviour problem 
under-diagnosis has been reported in several studies, albeit in children of older age groups 
(Carson et al., 2015; Ott et al., 2003; Reilly et al., 2014a). This suggests that prevalence rates 
based on diagnoses or medical registries reported in the literature may be higher than 
previously considered. Finally, the multiplicity of neurobehavioural problems with problems in 
1-6 domains indicates that neurobehavioural problems are widespread, and not the result of 
a negative scoring response in a small subgroup of children.  
10.5 Conclusions 
The study has several limitations. The main limitation was a modest sample size with which to 




recommended. Although the study provides important data for policy development in CWEOE, 
the sample nonetheless consisted of a heterogeneous sample of children with epilepsy, and 
sub-syndrome analysis was not possible. Such data on epilepsy syndromes is useful in 
determining syndrome specific profiles (Nolan et al., 2003; Nolan et al., 2004; Fastenau et al., 
2009; Jackson et al., 2013; Kernan et al., 2012), and identifying syndrome specific risk factors 
that are potentially diluted by mixed samples. One possible limitation is the potential 
overestimation of neurobehavioural problems. The operational definitions used here were 
based on validated face-to-face assessment tools and questionnaires. Formal diagnosis of 
neurobehavioural disorders by qualified psychiatrists or clinical psychologists via 
comprehensive clinical investigations is the gold standard approach. However, the assessment 
tools used here are routinely adopted in clinical practice to aid diagnosis, meaning the data is 
based on reliable tools. They can provide excellent discriminant validity (e.g. Reilly et al., 
2014c)) but can also help identify children who meet criteria for a diagnosis but have not been 
identified by clinical services (Ott et al., 2003; Reilly et al., 2014a). These tools also have the 
ability to identify children who do not reach clinical thresholds but may be impaired all the 
same (Gigi et al., 2014; Seltzer et al., 2005; Skuse et al., 2009).   
A final limitation is the difficulty in attributing neurobehaviour to effects associated with 
epilepsy rather than AED medications. AEDs are believed to affect cognition and behaviour, 
yet their degree of influence is uncertain and difficult to untangle from other confounding 
epilepsy-related factors as well as methodological limitations (Loring and Meador, 2004; Ijff 
and Aldenkamp, 2013; Mula and Trimble, 2009). Polytherapy, for example, is more detrimental 
to cognitive outcome than monotherapy (Aldenkamp and Bodde, 2005; Hermann et al., 2010; 
Mula and Trimble, 2009), yet those on polytherapy have chronic, difficult to control seizures, 
high seizure frequency, and structural brain lesions, which are also associated with adverse 
outcomes. In the current study, polytherapy was associated with cognitive impairment, and 
adaptive behaviour problems, but no other behaviour problem. Assessments were made close 
to diagnosis, too early to assess GCA and adaptive behaviour outcomes in those on AED with 
or without seizure control. Nevertheless, an effect of AED in these areas cannot be ruled out. 
Converse to an AED explanation, problems are increasingly reported at or before epilepsy 
onset (Austin et al., 2001; Dunn et al., 2002; Hermann et al., 2006; Hesdorffer et al., 2004; Jones 
et al., 2007; Oostrom et al., 2003) and prior to AED treatment (Goldberg-Stern et al., 2010; Kolk 
et al., 2001; Taylor et al., 2010; Masur et al., 2013), clearly implicating epilepsy and its associated 




This study has a number of strengths. It is the first to provide a comprehensive 
neurobehavioural profile of CWEOE in a population-based sample during the first five years of 
life, and is one of the few to provide details on the multidimensional nature of 
neurobehavioural comorbidities within the same cohort. Rantanen and colleagues (2009; 2010; 
2011) provided valuable data on a population-based cohort of children aged 3-6 years with 
established epilepsy. This study extends that data to a UK population of preschool children, 
including an extended neurobehavioural battery, and adds a new dimension by including 
infants and toddlers, and by focusing on children with recent onset epilepsy as opposed to 
established active epilepsy. The preschool aged-sample in this cohort also reflects the UK 
preschool age prior to formal schooling at age five. The current study also complements the 
CHESS study in the UK (Reilly et al., 2014a) which provided a neurobehavioural profile of 
school-aged children with epilepsy.  As this study investigated recent-onset epilepsy, one of 
its main strengths was providing information prior to any long-term effects of chronic epilepsy. 
This data could form the impetus for earlier detection of neurobehavioural problems, and 
influence strategies for the development of educational/behavioural support as children 
prepare to start school.      
In conclusion, neurobehavioural problems are detectable and highly prevalent in CWEOE. The 
children here had recent onset epilepsy which lends further support to the growing consensus 
that neurobehavioral problems are associated with underlying pathology. Although further 
studies with larger cohorts are required to corroborate these findings, the evidence strongly 
suggests that young children with epilepsy should be considered for further evaluation. As 
problems in the preschool years can persist across childhood and adolescence (Asendorpf et 
al., 2008; Bayer et al., 2011; Bosquet and Egeland, 2006), and that childhood epilepsy is 
associated with adverse psychosocial consequences in adulthood (Camfield and Camfield, 
2009; Camfield and Camfield, 2010; Chin et al., 2011; Jalava et al., 1997; Sillanpaa et al., 1998; 
Wakamoto et al., 2000; Wirrell et al., 1997) (c.f. (Camfield and Camfield, 2014), there is a strong 
case for identification, evaluation, and intervention at the earliest possible time. This may take 
the form of blanket screening of children with new-onset epilepsy via cognitive and 
behavioural screening tools. Even when a single problem has been identified, this study, and 
others, suggest that multidimensional screening should be considered in order to identify all 
potential problem areas, in order to provide a comprehensive treatment approach. As social 
problems are consistently reported and were found in CWEOE, attention may be drawn 
particularly to socially aimed interventions. Not all children with epileptic seizures are brain 




associated with neurobehavioural problems, suggests routine imaging to identify those who 
may be at an increased risk. Finally, parents should be made aware of the potential for cognitive 
or behavioural problems, even when a benign pathology is suspected, so that informed 




Chapter IV.  Eye-gaze Behaviour in Children with Early-Onset Epilepsy 
 
*** 
Chapter IV explores eye-gaze behaviour via eye-tracking as a marker of visual attention and 
neurobehavioural problems in CWEOE and control children. The concept and practicalities of 
eye-tracking is introduced, and its rationale for use in CWEOE is described. Methods used in 
the current study are detailed, which includes the description of five tasks designed to measure 
cognition/memory, attention/inhibition, and social cognition. It was found that, CWEOE 
exhibited abnormal visual attention to naturalistic social scenes, which was related to 
behavioural functioning. Other subtle atypicalities in sustained engagement of attention were 
found, and are discussed. The findings from this exploratory study suggest that eye-tracking 
is viable, particularly in less severe epilepsy, and has the potential to be used to aid in the 






11. Eye-gaze Behaviour in CWEOE: Introduction  
The NEUROPROFILES study was created with the intention of determining the 
neurobehavioural profile of children with early-onset epilepsy (CWEOE; onset ≤4 years). To do 
this, a cohort of CWEOE, with newly diagnosed epilepsy, was identified from the general 
population (Chapter II). The neurobehavioural profile of those who consented for the study 
was determined (Chapter III), with over 60% of CWEOE meeting criteria for cognitive 
impairment and/or a behavioural problem. The types of neurobehavioural problems were wide 
reaching, encompassing almost all domains covered by the neurobehavioural battery, and with 
a high degree of comorbidity. The current chapter was concerned with how control children 
and CWEOE, including those with and without neurobehavioural problems, performed on eye-
tracking paradigms designed to assess some of these cognitive/behavioural areas, in order to 
explore the utility of eye-tracking as tool for identifying neurobehavioural problems.  
In the introduction, the assessment of eye-gaze behaviour using eye-tracking technology is 
explained, as is its rationale for its use in CWEOE. The main aims of the chapter are laid out, 
and an overview of the specific tasks used in this study are outlined. In the subsequent sections, 
further details on each specific eye-tracking task is presented, including individual task 
backgrounds, methods, results, and discussions. In the final section, the findings from all eye-
tracking tasks will be synthesised and discussed.  
11.1 Introduction 
As outlined in the general introduction to this thesis (section 1.5), eye-gaze behaviour, as 
measured through eye-tracking, provides an empirical method of assessing or exploring 
diverse aspects of cognition and behaviour. It has the potential to provide a quick and cost 
effective means of detecting atypical neuropsychological development, and neurobehavioural 
problems. This introduction will briefly outline how eye-gaze behaviour relates to 
neuropsychological processes, followed by a brief introduction to eye-tracking technology 
used in the measurement of eye-gaze behaviour. Lastly, the aims of this chapter are outlined, 
and the neuropsychological areas to be explored through eye-tracking will be specified.  
The brain processes incoming visual information in a highly complex and selective way. These 
processes are driven by physiological and neuropsychological factors which have 




visual pathways (e.g. dorsal stream) that link the retina to brain regions involved in visual 
processing, such as depth and spatial awareness, attention mechanisms, colour and motion 
perception, programmed saccades, object tracking, and smooth pursuit (Greenlee and Tse, 
2008; Grill-Spector and Malach, 2004). Selective or broad injury to any of these areas can 
negatively affect eye-gaze behaviour. For instance, the posterior parietal cortex, superior 
colliculus, and pulvinar (Palmer, 1999) are involved in engaging, disengaging, and relocating 
visual attention, respectively.  Anterior or posterior damage to the pulvinar region selectively 
impairs temporal and spatial vision (Arend et al., 2008). Thus, gaze-behaviour can be 
symptomatic of neural abnormality.  
The visual system selectively attends to information in the visual field. Various models of 
selective attention have been proposed to explain what, how and why humans attend to 
information in the visual field (Heinke and Humphreys, 2005; Itti and Koch, 2001). To 
understand selective attention, an integrative approach involving bottom-up (e.g. saliency 
feature maps) and top-down processing (e.g. task-orientated goals), as well as 
neuromodulators and biomechanics is needed. However, the present study is concerned with 
how neuropsychological functioning and development, in children with epilepsy, affects eye-
gaze behaviour.  Neuropsychological processes that drive eye-gaze behaviour include goals 
and context (Yarbus, 1967; Neider and Zelinsky, 2006), social relevance (Castelhano et al., 2008), 
and memory and expectations (Torralba et al., 2006). Thus, eye-tracking can tap into such 
mechanisms, and act as a cognitive marker for abnormal neuropsychological functioning.   
Abnormal eye movements themselves are regularly used in the diagnosis of neurological 
disorders (Bedell and Stevenson, 2013). In disorders of psychiatry, mental health, 
developmental disorders, and neurodegenerative disorders, eye-tracking is not yet used as a 
diagnostic measure. However, evidence for the potential utility of eye-tracking as a diagnostic 
tool in clinical populations have come from childhood and adult studies in a variety of fields 
including schizophrenia (Benson et al., 2012), anxiety and depression (Armstrong and Olatunji, 
2012), ADHD (Deans et al., 2010; Fried et al., 2014), ASD (Pierce et al., 2011b), and dementia 
(Crutcher et al., 2009). As eye-tracking paradigms are not yet sufficiently sensitive or specific 
enough to offer suitable diagnostic discrimination between clinical groups and similar 
disorders, studies typically perform comparative analysis at the group level. Nevertheless, as 
eye-tracking paradigms and statistical methods evolve, sensitivity will improve. Benson et al. 
(2012), for example, recently found that a probabilistic model predicted schizophrenia with 




A major advantage of eye-tracking is its suitability for use in infant and childhood populations, 
where it has been extensively used to understand the development of visual attention, and 
cognition (Feng, 2011; Gredeback et al., 2010). Research has covered a broad array of topics, 
offering insight into the existence, and development, of mechanisms involving perceptual 
completion, object permanence, oculomotor and saccade production, priming, social 
cognition, language, and memory. Eye-tracking research has also been increasingly used in 
clinical populations in order to understand atypical childhood development, including 
Learning Disability, ADHD, ASD, prematurity, and other developmental and psychiatric 
disorders (Karatekin, 2007).  
Whilst other neurodevelopmental disorders have received interest, eye-tracking has received 
limited attention in children with epilepsy. This may in part be due to the heterogeneous nature 
of epilepsy, including its broad developmental and neurobehavioural spectrum. Nevertheless, 
atypical gaze-behaviour has been reported in children with epilepsy. Asato et al. (2011), for 
example, reported increased response inhibition errors and slower visual reaction times in 
epileptic children from eight years of age. Macchi et al. (2003) found poorer performance in 
children with epilepsy on a backward masking task compared to controls, and Bedoin and 
colleagues (2012) found attentional deficits that were dependent on syndrome, lateralisation 
of epileptic focus, and presence of ADHD in BECTS and Panayiotopoulos syndrome. Recent 
investigations by Djukic and colleagues (Djukic and McDermott, 2012; Djukic et al., 2014; Djukic 
et al., 2012), in children with Rett Syndrome, a neurodevelopmental disorder where the 
majority of children have epileptic seizures, have reported on typical and atypical aspects of 
development. The authors identified typical orientation toward salient and novel stimuli, and 
attention toward complex social stimuli, but also reported atypical gaze toward faces, and 
difficulties with emotional recognition. Taken together, the evidence suggests the validity of 
using eye-tracking in children with epilepsy, including those with developmental and 
communication difficulties. Indeed, an advantage of eye-tracking in children with epilepsy is 
the flexibility of task design which allows targeting of children at all levels of intelligence or 
verbal ability. Eye-tracking provides a blank canvas for task design, and paradigms can be 
created that do not require verbal commands or instructions - ideal for use in infants, or in 
children with communication or learning disorders. Before outlining how eye-gaze behaviour 
will be assessed in CWEOE in the current study, and in what way, it is necessary to provide a 





11.2 Eye-Tracking Technology Mechanics 
The primary function of the eye is to bring into focus that which is of relative importance to 
the observer. Items in the visual field cannot be processed with clarity without coming into 
alignment with the fovea – an area on the retina on the interior rear surface of the eye. The 
retina is covered with photoreceptor cells called rods and cones. Rods need little light to 
function and have resulting low spatial acuity, creating a less defined ‘blurry’ area of the visual 
field known as peripheral vision. Cones require more light, and process colour, with resulting 
high acuity. The fovea has the highest concentration of cones, and thus the greatest sensitivity 
to light. The brain interprets data from the visual field, including the peripheral region, and 
sends signals to the eye on where to move the eye in order to align with the foveal region. The 
act of focusing the fovea on items within the visual field for further processing is known as a 
fixation. 
There are four basic types of eye movements which result in a fixation, or help maintain a 
fixation (Purves et al., 2001). These are saccades, vergence movements, smooth pursuit 
movements, and vestibulo-ocular movements. Saccades are the rapid oculomotor eye 
movements made between fixations. No object in the visual field can be registered on the 
fovea during a saccade. Vergence is a corrective movement made by the eyes in which each 
eye rotates along the vertical plane toward one another (i.e. convergence) as an object gets 
closer to the observer, or when they rotate away from each another (i.e. divergence) if the 
object is further away, in order to bring that object into focus. Smooth pursuit is when the eyes 
keep track of an object that is in motion by following it with smooth steady focus, as opposed 
to intermittent saccadic movements. Vestibulo-ocular movements are those initiated by the 
vestibular system to keep the gaze steady in the context of head movements. It prevents 
objects being lost from focus as the head moves. Fixations and saccades are typically the 
primary aim of behavioural research, and are the focus of the current study. 
Eye-trackers have been in use for over 100 years (Duchowski, 2007; Holmqvist et al., 2011; 
Young and Sheena, 1975), and were developed to study eye movements and eye-gaze 
behaviour, with different eye trackers and methods better suited to certain tasks or 
environments. Eye-trackers can be divided into four main types (Duchowski, 2007): (1) Eye-
attached; a highly invasive method of attaching a metal coil to the eye that produces an 
electromagnetic signal in response to eye movements. It is accurate, and can detect even 




given its invasiveness. (2) Electrooculography; uses electrodes placed around the eye to 
measure electrical signals produced by physical movements of the eye. It is minimally invasive, 
and has the advantage of being used when the eyes are closed. However, this method is 
inaccurate in regard to the location of gaze fixations. (3) Photo/Video-oculography; uses 
mounted cameras (including infrared cameras) which record eye movements by tracking the 
pupil - which has been illuminated by the tracker. When applied in research, a coder will often 
judge the direction of eye movements based on captured video, in order to relate eye-gaze to 
visual stimuli. Thus, this method may be prone to human error, and will likely have poor spatial 
accuracy for fixation points. (4) Pupil centred corneal reflection (PCCR); Corneal reflection is 
the dominant technique in modern history (Holmqvist et al, 2011), and is discussed in further 
detail below. 
In PCCR based eye-trackers, infrared light is emitted by the tracker, which is reflected off the 
cornea and pupil (known as Purkinje images 1 and 4). Images are captured by the tracker and 
a vector is created based on the relative position of these reflections to one another. The 
direction of the vector in combination with other geometric features of the eye captured by 
the tracker are used to calculate gaze direction with high accuracy. Advanced PCCR eye trackers 
use two methods of corneal illumination: dark and bright. Each have advantages and 
disadvantages based on the characteristics of the participants, or environmental conditions. 
Bright pupil eye-tracking places illumination close to the optical axis of the imaging device, 
which causes the pupil to appear lit up. In dark pupil tracking the illumination is placed further 
away from the optical axis, and the pupil remains dark. Modern eye-trackers may use both 
methods. One major advantage of PCCR over other eye trackers is the ability to estimate 
fixation points with high accuracy as the participant concurrently views a visual stimulus. 
Software then interprets the data and produces meaningful temporal and spatial data with 
which eye-gaze behaviour can be mapped directly onto the viewed stimuli. Another major 
advantage is the versatility with which they are produced. PCCR eye trackers are available 
mounted onto head gear, on glasses, in built-in desktop monitors, or via remote units (figure 
11.1). They are, however, not without their limitations. The major disadvantage of remote eye-
tracking units in infants and young children is data loss (Haith, 2004). Children are often 
distractible, turning attention away from the display, perform excessive head movements, or 
‘scrunching’ their eyes, reducing eye data capture. However, this disadvantage is outweighed 
by their benefit in infant and childhood populations, as they require no physical apparatus 
attached to the child. Accordingly, a remote PCCR eye-tracker was the preferred choice for the 




PCCR eye trackers typically involve a participant viewing a static image, video, or interactive 
stimuli, presented on a monitor attached to the tracking device which has been calibrated to 
the participant (figure 11.1) – although mounted glasses offer eye-tracking in real world 
situations. The eye tracker software calculates x/y coordinates and temporal data for fixation 
points, with which a number of metrics can be produced for analysis. Total Fixation Duration 
(TFD) and Time To First Fixation (TTFF) are two common fixation metrics reported in studies of 
cognitive development. These metrics are approximate measures for how important or relevant 
a particular element within the stimuli is to the observer, and are those used in statistical 
analysis in the present study. Viewing something more often, or for longer, is indicative of 
more detailed processing. Eye-tracking software can also produce visual outputs to 
conceptualise eye-gaze data, such as fixation maps or heat maps (figure 11.2), to visually 
represent individual or group data. The quantitative statistics produced from the eye-tracking 
metrics are then used for statistical analysis. 
Figure 11.1 Remote eye tracker Figure 11.2 Heat map 
  
PCCR eye tracker and child observer  Heat maps indicate the proportion of time fixating for 
an individual, or group. The spectrum runs from 
green to red, with longer average durations signified 
by red, and shorter durations by green. 
 
11.3 Eye-Tracking Battery Overview 
The CWEOE and controls enrolled onto the NEUROPROFILES study were a heterogeneous 
group, consisting of infants, toddlers, and pre-school children, with varying levels of 
development and cognitive ability. In order to reduce outcome bias, the eye-tracking tasks 
used in the study were chosen, and the battery was administered, in a standardised manner 
for the entire cohort. This scenario was possible with eye-tracking, given the freedom of the 




eye-tracker was a remote PCCR device, allowing accessibility for all children. Tasks were 
selected that required no verbal instructions, so as to be suitable for infants and preverbal-
children as well as those with learning or communication difficulties.  
There are a broad spectrum of neurobehavioural problems in children with epilepsy in general 
(Rantanen et al., 2012; Reilly et al., 2013; Rodenburg et al., 2005; Lin et al., 2012a). Three of the 
most prominent neurobehavioural domains associated with childhood epilepsy are General 
Cognitive Ability (GCA), attention, and social problems. Similarly, in the NEUROPROFILES study, 
CWEOE had a broad spectrum of neurobehavioural problems, including GCA impairment, 
inattention/hyperactivity problems, and social cognitive and social functioning problems (see 
chapter II for detailed description).  The eye-tracking tasks chosen for the study were based on 
visual attentive mechanisms associated with these three domains. As yet, no standardised eye-
tracking measures with psychometric properties exist for the diagnosis of cognitive or social 
behaviour problems. Instead, eye-tracking tasks were selected based on the theoretical 
relationship between the visual attention mechanism elicited during the task, and the 
behavioural outcome of interest. Five tasks were selected, and were assigned to one of three 
domains; cognition/memory, attention/inhibition, and social cognition. The structure is 
outlined in table 11. Each of the domains, and tasks selected, will be discussed in more detail 
in sections 13, 14, and 15, respectively - complete with background, methods, results, and 
discussion. General methods that apply to all tasks are described in section 12. 
Table 11 Eye-tracking tasks by neurobehavioural domain 
Domain Eye-Tracking Task Overview 
Cognition/Memory 1. Memory Task 
Visual paired comparison paradigm assessing 
incidental recognition memory. Associated with GCA. 
Attention/Inhibition 
2. Oculomotor Control Task 
Saccadic inhibition task. Also measures production of 
antisaccades. 
3. Spatial Negative 
    Priming Task 
Negative priming task assessing selective attention 
with spatial inhibition. 
Social Cognition 
4. Face Scanning Task 
Selective preference for facial features during free 
viewing of neutral faces. 
5. Social Preference Task 





11.4 Primary Aims and Hypotheses 
As outlined in chapter I, epilepsy is associated with a high prevalence of neurobehavioural 
problems, and the initial goal of treating or preventing any adverse condition is to identify it 
at the earliest possible time. Early intervention for cognitive and behavioural problems is 
advantageous (see section 1.1), and eye-tracking is one tool that could potentially identify 
problems at an early stage through simple viewing tasks. Therefore, the primary aim of this 
chapter was to explore eye-gaze behaviour as a potential marker of neurobehavioural 
problems in CWEOE.   
To meet that primary aim, the relationship between psychometric assessment scores from 
neurobehavioural assessment tools, and eye-gaze behaviour in the eye-tracking tasks listed 
above, were statistically evaluated in CWEOE, and typically developing control children. This 
included an evaluation of linear relationships between outcome variables from eye-gaze tasks 
and neurobehavioural tools, and eye-gaze performance between those CWEOE with, and 
without, neurobehavioural problems. Prior to analysis including neurobehavioural assessment, 
broad group differences in eye-gaze behaviour between CWEOE and controls were explored, 
with the intention of determining if there was a general effect of having epilepsy on eye-gaze. 
Given that epilepsy is a heterogeneous condition with variability in the prevalence of 
neurobehavioural problems, it was hypothesised that CWEOE would exhibit eye-gaze 
behaviour similar to that of controls across eye-tracking tasks, but with greater variability in 
performance. It was expected that CWEOE with neurobehavioural problems would exhibit 
abnormal gaze behaviour compared to CWEOE without neurobehavioural problems. 




12. Eye-gaze Behaviour in CWEOE: General Methods 
Methods that apply to all five eye-tracking tasks are presented here, with an overview of 
statistical analysis for all tasks. Methods relevant to specific tasks are detailed in the relevant 
domain sections; cognition/memory in section 13, attention/inhibition in section 14, and social 
cognition in section 15. 
12.1 Participants 
75 CWEOE and 52 control children were identified and consented into the NEUROPROFILES 
study, and were eligible to participate in eye-tracking (see chapter I, section 2 for identification 
and recruitment methods, including consent procedures). All children who completed eye-
tracking partook in the neurobehavioural assessment battery which has been described in 
chapter II, section 9. 
12.2 General Procedure 
Children completed eye-tracking after the face-to-face elements of the NEUROPROFILES 
assessment battery (i.e. Bayley III, WPPSI III, and NEPSY II).  As described in Chapter II, not all 
children completed neurobehavioural assessment and eye-tracking in one session. Some 
completed eye-tracking in a separate session. Additionally, several children were nervous or 
uncooperative upon arrival, and eye-tracking was completed first, in order to complete the 
assessment battery and also to help the child relax prior to neurobehavioural assessment. The 
estimated completion time for eye-tracking was approximately 20-30 minutes including short 
breaks between tasks. 
Children sat alone or on their parent’s/carer’s lap (herein referred to as parents) 50-60cm from 
the monitor. Toddlers and preschool children were informed verbally by the candidate that 
they would be watching some pictures and animations. No task specific instructions were given 
in order to maintain standard operating protocol for verbal and nonverbal children. To 
promote engagement and sustained attention, verbal encouragement was given to those 
children who required it by the candidate. General statements were chosen that would not 
influence the direction of gaze (e.g. “What’s happening here?”, “Wow, look at that!”, “What did 




required, or to direct the child’s attention back to the monitor if the child became inattentive 
and was unresponsive to the candidate. 
The five eye-tracking tasks – outlined in section 11.1.3, and detailed in subsequent sections - 
were presented across four presentation blocks, which allowed breaks between presentations 
to minimise attentional fatigue. The Spatial Negative Priming (SNP) Task and Oculomotor Task 
were each presented in blocks one and two, respectively. The Memory Task, Face Scanning 
Task, and Social Preference Task were amalgamated into blocks three and four. Each of these 
two blocks consisted of stimuli from all three tasks. A similar approach was used in Gillespie-
Smith et al. (2016), and Telford et al. (2016). Initially tasks in the two blocks were ordered 
randomly, but observations suggested that attention was being moderately reduced or lost 
after presentation of the Memory Task, particularly in older children. Subsequently the Memory 
Task stimuli were re-ordered to be presented at the end of each of those two blocks. Thus, 
Face Scanning Task stimuli were presented at the beginning of block three, followed by Social 
Preference Task stimuli, then Memory Task stimuli. In block four, the order was switched so the 
Social Preference Task stimuli would be viewed first, followed by Face Scanning stimuli then 
Memory Task stimuli. Approximately half of the children in the study were administered the 
initial order, and half the adjusted order. Anecdotally, children displayed a reduction in overt 
signs of fussiness (e.g. fiddling, getting off seat, or expressing verbal dissatisfaction) during the 
adjusted presentation order. All four blocks were administered in a random order across 
participants. Breaks were administered between blocks if necessary. Calibration was performed 
at eye-tracking onset, and after any prolonged break.  
Visual acuity and visual field was assessed as a control measure. Visual acuity was assessed in 
children <18 months using Keeler Acuity Cards (Keeler Ltd. Windsor, UK).   A novel locally 
developed visual field test (Murray et al., 2009) was carried out in all children to assess for 
visual field deficits. No child with successful calibration had visual acuity/field deficit. One child 
wearing corrective lenses, had successful calibration.  
12.3 Eye-tracker and Fixation Filter 
Eye movements were detected using a Tobii x60 eye-tracker, which tracks both eyes to a rated 
accuracy of 0.3° at a data rate of 60 Hz. Eye-tracking stimuli were presented in Tobii Studio 
3.2.2, and displayed on an LCD monitor with a screen size of W40.8cm and H25.0cm, and 




procedure as standard with Tobii Studio. During calibration the child tracks a coloured circle 
as it moves to five calibration points situated at standard uniform positions around the screen. 
Infant calibration is a semi-automated alternative, available in Tobii Studio, and uses large 
animations at each calibration point instead of a coloured circle. Infant calibration was 
performed when the child could not sustain attention to the regular calibration procedure, 
having resulted in failed calibration.   
The latest Tobii fixation filter, the I-VT, was used to determine fixation data. The I-VT filter uses 
averaged binocular eye data, interpolation at 75 milliseconds (ms), with minimum fixation 
duration of 60ms. Multiple-fixations within 75ms and 0.5° are counted as single fixations 
(Olsen, 2012).  
Fixation data was captured on manually drawn areas of interest (AOI); the size and dimensions 
of which was determined by the user (section 12.5.1). Tobii Studio collects X Y coordinate data 
and a time stamp – with which spatial location and temporal order of fixations can be 
determined. AOIs were predefined 2D physical regions of space marked on visual stimuli using 
Tobii Studio’s definition tools. In a dynamic stimulus, such as a movie animation or series of 
images within a single trial, the AOI can be ‘active’ or ‘inactive’. Fixation data is captured only 
during the active phase of the AOI. In this way, fixation data can be collected for when it is 
appropriate to gather, such as after the appearance of a target stimulus or cue for example.  
12.4 Interstimulus Interval Stimuli 
Individual task stimuli are described in the relevant task methods sections. Stimuli used during 
the interstimulus intervals (ISI), i.e. the time period between trials or between presentations of 
stimuli within trials, consisted of animated objects (e.g. rotating rattle) paired with non-distinct 
sounds presented at the centre of the screen. These stimuli were uploaded directly from Tobii 
Studio. ISI stimuli were used to maintain attention, and to improve standardised presentation 
by orienting eye-gaze to the centre of the screen prior to trial/stimulus onset.   
12.5 General Analysis 
12.5.1 Areas of Interest (AOI) 
An AOI is constructed in order to capture gaze data directed toward an object of interest, or 




AOIs. An aim of constructing an AOI is to find balance between fixations which are truly 
intended for the target location- including those fixations that may fall outside of it -, and 
fixations that fall outside the target location and were not intended for that target (Orquin et 
al., 2016). As yet, there is little guidance or standardised approach toward the construction of 
AOIs, with most studies manually drawing AOIs to researcher-defined shapes and sizes 
(Hessels et al., 2016; Holmqvist et al., 2011; Orquin et al., 2016).  Different sized AOIs can lead 
to different statistical results in some cases (Hessels et al., 2016; Orquin et al., 2016), but this 
may also depend upon the nature of the stimulus itself (e.g. stimulus complexity, or object 
sparseness) (Orquin et al., 2016).  In addition, the accuracy of fixations as detected by an eye 
tracker can be compromised by the inaccuracy of programmed saccades themselves (Palmer, 
1999), and by the accuracy and success of the eye-tracker and its calibration procedures. It 
could be argued that inconsistencies in calibration accuracy may be expected more so in very 
young children for the same reasons described in the introduction to this chapter. Accuracy in 
the capture of fixations truly intended for the target can be supplemented by increasing the 
AOI boundary beyond the object to create a buffer zone (Holmqvist et al., 2011). Increased 
boundaries are preferred when target objects where distal from one another (Orquin et al., 
2016).  AOI sizes for the current study were manually constructed, allowed for buffer zones, 
and were defined a priori, to avoid any potential preferential result bias as a result of a 
posteriori analysis of multiple AOI sizes. The location of AOIs were guided by previous research 
where appropriate. 
AOIs for each task are illustrated in figure 12. Tasks using AOIs that competed for attention 
employed AOIs of equal size in order to avoid potential spatial bias. Specifically, the Memory 
Task and Social Preference used a forced choice design, with the AOIs splitting the selection 
equally between two halves of the screen. This design has been used previously (Fletcher-
Watson et al., 2008; Gillespie-Smith et al., 2016; Telford et al., 2016), and was considered 
acceptable given that each half of the screen was considered the target, as opposed to the 
specific objects within each half. The SNP Task AOIs used the natural topography of the display 
grid in order to define AOI size whilst allowing a reasonable buffer margin. The Oculomotor 
Task used equal sized AOIs that became temporally activated after offset of the central stimulus 
(i.e. smiling sun). The original authors of the task used video recording to code gaze direction 
(Scerif et al., 2005), and therefore larger AOIs were preferred to maximise false negatives, and 





Figure 12 Examples of task specific areas of interest (AOIs) 
1(A) 1(B) 
1 - Memory Task stimuli (A) were divided into two equal AOI halves (B) 
2(A) 2(B) 
2 – Social Preference Task (A) was divided into two equal halves (B), with the addition of AOIs for the 
child/children (2B green) and head region (2B light blue). Fixation data was captured by each AOI regardless 
of AOI overlap.  
3(A) 3(B) 3(C) 
3 – Face Scanning Task AOIs were analysed by central facial region and peripheral facial features (B), with 
further analysis of the central features individually (eyes, nose and mouth, fig. C). 
4(A) 4(B) 
4 – Oculomotor Control Task stimuli (A) AOIs were situated over target and cue regions (B). Note that AOIs 
only became active at cue onset. Note that figures are for illustration purposes. The central stimulus, cue, and 





Figure 12 continued  
 5(A) 5(B) 
5 – Figure 5A illustrates the probe condition of the Spatial Negative Priming Task, with AOIs superimposed on 
the respective grids (5B). AOIs became activated immediately following probe onset. 
 
In the Social Preference Task, AOIs were additionally crafted for child/children regions and 
head regions to explore within-social scene eye-gaze preferences for persons (Buswell, 1935). 
AOI boundaries extended approximately 1-1.5° of visual angle around the AOIs in order to 
minimise false positives from fixations toward other items in these naturally complex scenes, 
whilst simultaneously accounting for inaccuracy. AOI selection on the Face Scanning Task was 
founded on Chawarska and Shic (2009) AOIs in typically developing and ASD children. AOIs 
were created for central facial features (i.e. eyes, nose, and mouth) and peripheral facial 
features (i.e. hair, ears, forehead, cheeks, and neck). As facial dimensions differed between 
stimuli, new AOIs was manually drawn for each target within the stimulus, using a rectangular 
AOI tool in an effort to maximise a standardised approach. As previously employed in 
Chawarska and Shic (2009), AOIs touched but did not overlap.  
12.5.2 Image-wise Analysis 
Three tasks were locally-created and novel: Memory Task, Social Preference Task, and Face 
Scanning Task (Gillespie-Smith et al., 2016; Telford et al., 2016). Prior to main analyses, image-
wise analysis was carried out using t-tests or Mann-Whitney-U tests, depending on normality, 
to explore image bias (e.g. bias for male or female faces), or to identify individual images with 
disproportionate gaze data. Analysis was conducted for the sample as a whole, and for CWEOE 
and controls separately. The proportion of TFD was compared for: (1) Memory Task; right vs 




Males vs Females. There were no disproportionate patterns of visual attention identified, 
indicating that image types were equally as attractive, and image position did not bias 
direction of gaze. Thus, all images were analysed together.  
12.5.3 Eye-Tracking Metrics 
Tobii Studio (v3.2.2) has a number of eye-tracking metrics. These include the number of 
fixations before fixating an AOI, the time from stimulus onset to first fixation (time to first 
fixation, TTFF), the duration of the first fixation, the number of fixations on each AOI (fixation 
count), the total time duration of fixations within an AOI regardless of the number of fixations 
(total fixation duration, TFD), the duration of time spent in each AOI including time not fixated 
(visit duration), the number of visits to each AOI independent of fixations (visit count), the 
percentage of subjects who fixated an AOI (percentage fixated), and other metrics based on 
mouse clicks before, or within, an AOI.  
The two metrics deemed most appropriate for the purposes of the current study were TFD, and 
TTFF. In addition to saccade programming, the duration of a fixation is thought to correspond 
to the amount of perceptual and cognitive load and processing (Just and Carpenter, 1980; 
Meghanathan et al., 2014; Pannasch et al., 2011). Thus, TFD can be used as a measurement of 
attentional importance when assessing the selection of competing stimuli, and thus visual 
preference. Indeed, studies show, for example, that increased fixation duration is associated 
with visual decision making (Glaholt et al., 2009), and consumer choice (van der Laan et al., 
2015) in adults, and novelty and social preferences in infants (Burbacher and Grant, 2012); 
Gillespie-Smith et al., 2016). Therefore, TFD was used in the present study to assess preferential 
selection between competing AOIs.  
TTFF is the latency from stimulus onset to the first fixation within an AOI. It is a useful metric 
in determining reaction times, intervals between spatial or temporal events, or in 
understanding immediate preferences. In this latter respect, TTFF may be used as a proxy for 
attentional priority in naturalistic scenes (Fletcher-Watson et al., 2009), where the AOI viewed 
first (i.e. quickest) could be considered to hold immediate relative importance to the observer. 
In the present study, TTFF was used in this way for the Face Scanning Task and Social Preference 
Task, and to calculate dependent variables in the SNP Task and Oculomotor Control Task. 




It can be argued that using TTFF to assess which AOI subjects attended to first on average is 
liable to error. Across n trials, disproportionately small or large latencies can distort the latency 
of the sample mean. An alternative, and novel, method of identifying attentional priority, 
developed by the candidate, was based on the proportion of first fixations made to each AOI. 
Termed ‘first fixation preference’ here, the first AOI fixated within each trial, based on TTFF, was 
manually recorded, and the total number of first fixations toward each AOI across trials was 
calculated for each child. The proportion of first fixations to each AOI within a task stimulus 
was then expressed as a percentage of the total number of trials the child completed. As this 
ascertains how often an AOI is looked at first, it could be considered a more reliable measure 
than TTFF latencies alone, which ascertain more definitively how quickly an AOI is viewed.  
12.5.4 Data Cleaning Procedures 
Prior to analysis, the data was expurgated to remove or amend unsuitable data via the 
following procedures.  Trials with a TTFF <100ms post trial onset represent pre-programmed 
saccades (Liversedge and Findlay, 2000), and were replaced with the next subsequent fixation 
point post 100ms. Using the gazeplot, through the visualisation tab of Tobii Studio, it was 
possible to determine this first “true” volitional fixation. This method was devised by the 
candidate, and was applied in Telford et al. (2016). 
Average fixation duration during natural scene viewing is highly variable (Henderson, 2003). 
Trials with a total fixation duration time of <500ms were excluded (Fletcher-Watson et al., 2008; 
Fletcher-Watson et al., 2009; Gillespie-Smith et al., 2016; Telford et al., 2016) as they may 
represent only brief attention to a scene that may have been pre-programmed and 
unrepresentative of true stimulus-goal fixation preferences. 
An individual child’s data on the Memory Task, Social Preference Task, and Face Scanning Task 
were included in analysis if there was eye-gaze data available for at least 33% of trials after 
data cleaning procedures were applied. This standardised cut-off point was chosen by the 
candidate to ensure representative natural eye-gaze behaviour, and reduce bias resulting from 
data obtained from children who were inattentive to the specific task. Two tasks, the 
Oculomotor Control Task and SNP Task, had task specific exclusion criteria, due to the 
sequential nature of data collection required during these tasks. That is, eye gaze data were 
only meaningful when certain criteria where met during each stage of the trial. During the 




<40% of trials in the first half of trials, or if <12 trials were scorable (Johnson, 1995). Individual 
trials were excluded if the child’s gaze was not fixated on the central stimulus prior to the onset 
of the cue. As explained in section 13, the SNP Task is based on the suppression of one spatial 
location and the simultaneous selection of another. To ensure this occurred, SNP Task trials 
were excluded if there were no looks toward the prime display, if the target animation in prime 
display was not fixated, if the distractor was fixated in the prime display, if distractor was fixated 
first during probe display, and when gaze was not maintained from prime to probe displays 
(Amso and Johnson, 2005). 
12.5.5 Attention to eye-tracking Tasks and Battery 
To exclude the possibility that any potential group differences in eye-gaze behaviour could be 
attributed to differences in general visual attention, rather than group differences in eye-gaze 
behaviour, general attentiveness to the tasks and eye-tracking blocks were measured in two 
ways. The first was based on the percentage of the total number of trials that were included in 
analysis after exclusion criteria above were applied. Meeting inclusion criteria was a reflection 
of general attention to trials. The second method was based on the Tobii Studio eye-tracking 
metric of samples collected, which pertained to general attention to the eye-tracking blocks, 
and quality of data collected by the eye-tracker (Tobii Studio 3.2, user manual). It is a 
combination of the eye-tracker’s success in tracking eye position and movement, and the time 
spent looking at any particular block of trials. The quality of the sample is affected by how 
often the tracker can record one or both eyes. A sample collection of 50%, for example, might 
indicate 100% tracking with one eye, 50% collection with both eyes, or a combination of both. 
T-tests or Mann-Whitney U tests were used to compare attention in CWEOE vs controls, in 
order to determine if group differences existed in attention to the eye tracking battery.  
12.5.6 General and Task Specific Analysis 
Normality was assessed according to Shapiro-Wilk test and upon visual inspection of 
histograms and QQ-plots. T-tests and ANOVAs were used to assess group differences in gaze 
behaviour when data was normally distributed, and Mann-Whitney U/Wilcoxon signed rank 
tests and Kruskal-Wallis/Friedman tests when data followed a non-normal distribution. 
Relationships between gaze behaviour and sociodemographic variables or neurobehavioural 




variables, and t-tests or Mann-Whitney U tests for categorical variables. FET was applied for all 
2x2 or 2x3 contingency tables comparing sub-group comparisons of nominal variables. 
Table 12.1 Analysis of attentional importance and priority by task 
Task Between-group outcome Dependent Variable(s) 
Memory Task Preference for ‘familiar’ vs ‘novel’ shapes 




Extent of inhibition of reflexive saccades 
Percentage of trials with look toward cue; 
first half vs second half of trials* 
Saccade type produced 




Presence of negative priming  
Latency to target in ‘repeated distractor’ 
vs ‘control’ trials*  
Social Preference 
Task 
Preference for ‘social’ vs ‘non-social’ scenes 
Fixation Preference/ First Fixation 
Preference 
Time spent fixating children and head 
regions 




Preference for ‘central’ vs ‘peripheral’ 
features 
Fixation Preference/ First Fixation 
Preference 
Preference for eyes, nose, and mouth 
regions 
Fixation Preference/ First Fixation 
Preference 
*Dependent variable derived from time to first fixation (TTFF) 
ISI – interstimulus interval 
 
A summary of analyses and outcome variables for each of the five eye-tracking tasks can be 
found in table 12.1, and described in context in the relevant sections to follow. Several tasks 
(i.e. Memory Task, Social Preference Task, and Face Scanning Task) were primarily focused on 
the preference for one AOI versus a competing AOI. As such, a common dependent variable 
was calculated and is introduced here. This variable was labelled ‘fixation preference’, and was 
calculated as the difference in mean TFD, expressed as a percentage of TFD to the whole scene, 
for one AOI minus the TFD of the competing AOI.  Expressing mean TFD as a percentage 
standardised data by taking individual variation in total fixation duration to the overall stimulus 
into account. Fixation preference allowed the production of positive and negative directional 




familiar shapes) or social preference (Social Preference Task: social image vs non-social image) 
against chance levels (i.e. fixation preference of 0). As reasoned earlier, for the purposes of this 
study, fixation preference was considered a measure of attentional importance, and first 
fixation preference as a measure of attentional priority. TFD and TTFF were used to calculate 
dependent variables for the Oculomotor Task and SNP Task. 
12.5.7 Neurobehavioural Assessment Analysis 
One intention of eye-tracking in the current cohort was to explore the association between 
eye-gaze behaviour and neurobehavioural outcomes in CWEOE and controls. This was done in 
order to explore the potential utility of eye-tracking as a predictive tool for cognition and 
behaviour, and for the identification of those meeting criteria for neurobehavioural problems.  
All children completed a neurobehavioural battery of cognitive and social-emotional 
behaviour tools as part of the NEUROPROFILES study (see chapter II). The dependent variable 
of each eye-tracking task was correlated with General Cognitive Ability (GCA, i.e. z-score 
derived from Bayley III Cognition scale or WPPSI-III FSIQ, ages >1m), and with the most 
relevant neurobehavioural tools (table 12.2), in order to establish any linear relationships. In 
addition, the dependent variables were compared between children meeting criteria for 
neurobehavioural problems and those who did not, including those at lower or higher risk of 
ASD (≥16m).  
Table 12.2 Eye-tracking tasks and relevant neurobehavioural assessment tool 
Task Neurobehavioural Tool (age coverage, m) 
Memory Task NEPSY-II: Memory for Designs; Narrative Memory; Sentence Repetition (≥36) 
Oculomotor Control Task 
1. CEC Inattention/Hyperactivity (≥24) 
2. NEPSY-II Statues (≥36) 
3. P-BRIEF GEC (≥24) 
4. ITSEA Externalising (12-23) 
SNP Task 
Social Preference Task 1. Social Functioning (i.e. Social-
Emotional Scale (1-11); ITSEA 
Competence (12-23); or CEC Social 
Functioning (≥24)) 
2. NEPSY-II Affect Recognition (≥36) 
3. NEPSY-II Theory of mind (≥36) 
4. SRS2 Communication & Interaction 
Index, and SRS2 Total (≥30) Face Scanning Task 





13. Preface to Individual Eye-Tracking Tasks and Results 
As outlined at the beginning of this chapter, the eye-tracking battery consisted of five tasks: 
Memory Task, Oculomotor Control Task, SNP Task, Face Scanning Task, and Social Preference 
Task. The remainder of this chapter describes each of these five tasks in turn, and is organised 
by domain: cognition/memory (section 14), attention/inhibition (section 15), and social 
cognition (section 16). Backgrounds, methods [not covered in section 12], and results are 
presented, along with a discussion for each of the three domains. This is followed by a general 
discussion of the eye-tracking battery. Preceding sections 14-16 is an overview to the children 
who completed the eye-tracking battery - including epilepsy characteristics -, and an analysis 
of attentiveness to the eye-tracking battery.  
13.1 Participants  
Figure 13 Eye-tracking Exclusion Flow Chart 
 





Of the 75 CWEOE and 52 controls who were eligible for eye-tracking (i.e. consented for the 
study and had neuropsychological assessment), 47 CWEOE and 41 controls completed the eye-
tracking battery. 28 CWEOE and 11 controls did not complete the battery (figure 13). Of those 
who attempted eye-tracking but no data could be gathered, two control children and 14 
CWEOE could not be calibrated. The reason for unsuccessful calibration in controls was 
unknown. In CWEOE, calibration was not successful due to visual impairment, uncooperative 
or hyperactive behaviour, developmental delay or psychomotor difficulties leading to poor 
attention, and unknown reasons.  
CWEOE (n=28) who did not complete the eye-tracking battery had a significantly different 
clinical profile than those who did. They were younger (Median=16.31 [IQR 7.12 – 41.55]m, 
p=.016), were more likely to have symptomatic epilepsy (FET=.004) or structural/metabolic 
aetiology (FET=.03), had a major brain abnormality on MRI (FET=.017), had a higher seizure 
frequency (FET=.042), and were on more than one AED (FET=.028). Six of the 7 infants who 
were born prematurely did not receive eye tracking.  This suggests that the results presented 
were more likely to be gathered from children with less severe epilepsy. 
47 (32M:15F) CWEOE and 41 (19M:22F) controls successfully completed eye-tracking. Median 
age at assessment was 37.85m (IQR 17.25 - 51.19) in CWEOE, and 27.60m (15.59 – 48.71) in 
controls. Groups did not significantly differ in age (p=.42, r=.09). Gender difference was 
marginally non- significant (FET=.052).  
The aetiological composition of the CWEOE cohort, and syndromic classification (Berg 2010), 
are reported in tables 13.1 and 13.2, respectively. In terms of antiepileptic drug therapy (AED), 
15% of CWEOE were not on an AED at the time of assessment, 79% were treated with 
monotherapy, and 6% polytherapy. 
Table 13.1 Aetiological Classification ILAE 1989 and 2010 
ILAE Classification Aetiology n (%) 

















Table 13.2 Epilepsy classifications according to Berg et al (2010) 
Classification Syndrome N=47 
Electroclinical 
Syndromes 
Infancy West Syndrome 2 (4.3%) 
Benign Infantile Epilepsy 4 (8.5%) 
Childhood Panayiotopoulos 1 (2.1%) 
Childhood Absence Epilepsy 6 (12.8%) 
Generalised Epilepsy with Febrile Seizures + 2 (4.3%) 
Distinctive Constellations Genetic Generalised Epilepsy 9 (19.1%) 
Genetic  Focal Epilepsy 3 (6.4%) 
Other Structural-Metabolic Causes 
Focal Epilepsy 4 (8.5%) 
Generalised Epilepsy 1 (2.1%) 
Epilepsies of Unknown Cause Generalised Epilepsy of Unknown Origin 6 (12.8%) 
Focal Epilepsy of Unknown Origin 7 (14.9%) 
Unclassified 2 (4%) 
 
 
13.2 General Attentiveness to the Eye-Tracking Battery 
The percentage of trials included in analysis – for the Memory task, Oculomotor Control Task, 
Face scanning task, and Social Preference task - in CWEOE (median= 79.17 [IQR 63.89 – 91.67]) 
was not significantly different to that of controls (median= 83.33 [IQR 71.88 – 91.49]) (p= .67, 
r= .05). More specifically, there were no significant differences between CWEOE and controls 
in any of the tasks. Similarly, the mean percentage of samples collected across eye-tracking 
blocks were not significantly different between CWEOE (M=53.82, SD=16.70) and controls 
(55.78, SD=17.43); MD=-1.96 (95% CI -9.20, 5.27). Taken together, CWEOE and controls 
displayed similar levels of attention to trials, and across the eye-tracking blocks. CWEOE (M= 
62.48, SD= 15.17) had significantly more CEC inattention/hyperactivity behaviours than 




poorer behavioural-level attention, visual attention was not affected. Thus, the eye-tracking 
tasks were suitable in this population.  The percentage of inclusive trials and percentage of 
samples collected were not correlated with age - indicating that the eye-tracking tasks 
captured attention equally well at all ages, and analysis of the battery was applicable for the 
entire sample. 
Of the 47 CWEOE and 41 controls who were able to carry out eye tracking, not all were included 
in each specific task analysis after exclusion criteria was applied (exclusion criteria detailed in 
section 12.5.4). Table 13.3 lists the number of children whose data were included in each task. 
The number of children included in data analysis for each task was highly variable, and was 
dependent on task specific inclusion/exclusion attentional demands for each task, which are 
detailed in each subsequent section below. 
Table 13.3 Children included in analysis after exclusion criteria applied 
Task 
Included N (%) 
CWEOE Controls 
Memory Task 32 (68) 21 (48) 
Oculomotor Control Task 27 (57) 33 (80) 
SNP Task 14 (30) 23 (56) 
Social Preference Task 47 (100) 38 (93) 





14. Cognition/Memory Domain 
The analysis of cognition in eye tracking was focused on memory, using a visual paired 
comparisons paradigm. This is described below.  
14.1 Memory Task: Background 
Memory problems are common in children with epilepsy (Menlove and Reilly, 2015), and have 
been found in children as young as three years of age (Danielsson and Petermann, 2009; 
Rantanen et al., 2010a). Problems have been found in both verbal and visual memory and occur 
across epilepsy syndromes (Fastenau et al., 2009), differing in severity (Jackson et al., 2013; 
Nolan et al., 2004). Memory problems in verbal children and adults are identifiable through 
anecdotal report, and via standardised self-report and performance assessment. In very young 
children it is more difficult to formally assess memory due to the immature development of 
executive functions, and verbal ability. The visual paired comparisons design (VPC) (Fantz, 
1964) is one method by which memory can be partly assessed, and which has been successfully 
and commonly used in infants. VPC designs measure visual preference between sets of paired 
images, one familiar to the child, and one novel.  Preference for the novel stimulus is thought 
to reflect successful memory encoding and retrieval of the familiar stimulus, as the visual 
system preferentially selects new information over known information. Performance on VPC 
designed tasks in infancy has been associated with working memory ability by age 11 (Rose et 
al., 2012), indicating the utility of the task as a predictive memory tool.  
Memory ability is correlated with intelligence (Ackerman et al., 2005), and performance on VPC 
designed tasks may be potentially indicative of GCA. Indeed, novelty preference within the first 
year of life has been associated with developmental outcome by age two or three years of age 
(Rose et al., 2005), and IQ at 21 years (Fagan et al., 2007). Although these were moderate 
associations, indicating limited applicability, these results signify the usefulness of VPC design 
in assessing memory and GCA in very young populations where standardised and validated 
memory instruments are extremely scarce. Additionally, performance on VPC designed tasks 
are adversely affected in clinical groups such Down’s Syndrome (Miranda and Fantz, 1974), and 
preterm infants (Rose, 1983; Rose et al., 2005), also signifying its use as a cognitive biomarker 




The aim of the current study was to assess incidental recognition memory in CWEOE and 
controls, through preferential visual selection in a VPC eye-tracking task. And to assess if task 
could identify CWEOE with GCA (ages ≥1m) or memory impairment (ages ≥36m). Childhood 
epilepsy is often accompanied by speech/communication impairment or learning disability, 
and it was anticipated that some CWEOE may also have had these conditions. The VPC-based 
memory task selected for the current study was a novel and locally developed for a pilot study 
of typically developing infants (Gillespie-Smith et al., – memory task results unpublished). It 
was chosen because it did not require verbal instruction or direction, increasing its applicability 
and standard operating protocol across infants and other nonverbal children with epilepsy.  
As epilepsy has a heterogeneous neurobehavioural profile, it was hypothesized that CWEOE 
would display a novelty preference but with a weaker preference compared with that of control 
children. It was also hypothesised that those CWEOE with GCA or memory impairment would 
exhibit weaker, or absent, novelty preference than other CWEOE.  
14.2 Memory Task: Methods 
The original version of the Memory Task constructed by Gillespie-Smith and colleagues 
contained highly variable, and non-standardised, ISI timings. The task was then corrected to 
standardise ISI timings, and stimuli were modified to increase attention grabbing properties. 
This modified design substituted static images with animated images. Accordingly, data 
collected with the original design (pre-July 2014) were excluded, and only data from the 
modified design were used in the final analysis, and the design of which is described here.  
The Memory Task followed a VPC design to assess eye-gaze preference for novel or familiar 
shapes. Each trial consisted of a familiarisation phase, where a set of three same-coloured 
shapes were presented, followed by an ISI of 2, 5, or 8 seconds to explore processing time 
(Gillespie-Smith et al., unpublished), and a test phase, where the familiar shapes were paired 
with novel shapes. The trial process is illustrated in figure 14.1. There were a total of 9 trials, 
allowing three trials per ISI delay, delivered across two blocks of the eye-tracking battery. 
Stimuli were presented on a white rectangle (840x362 pixels), and the remainder of the screen 
border was black. Stimuli consisted of 18 different coloured angular or curved shapes (e.g. 
squares, rhombus, stars, or clouds).  Familiar and novel objects were presented on one equal 




continuously for 20 seconds to allow habituation (Frick and Richards, 2001). Shapes were 
presented on the left half of the white rectangle on five trials, and right in the remaining four, 
in a pseudorandom order across trials. Test phase included the familiar (habituated) shapes, 
with novel shapes presented on the contra half of the white rectangle. Location of familiar 
shapes remained constant across phases. Colour of familiar and novel shapes differed to aid 
visual discrimination. Each object animated (i.e. rotated or luminance faded then returned in 
cyclical manner) in turn sequentially from top to bottom and was paired with a non-distinct 
sound in order to promote the capture of attention. In test phases, objects in the familiar and 
novel categories animated in the same way and in the same sequence. Test phases lasted 5 
seconds. Trials were manually ordered by ISI in order to minimise risk of attentional drop-off. 
Trials in block one consisted of ISIs at 2, 5, 5, 5, and 8 seconds, and 2, 8, 2, and 8 seconds in 
block two. 
Figure 14.1 Memory Task 
 
ISI – Interstimulus interval 
s - seconds 
 
Statistical analysis, AOIs, and metrics were described in section 12.5. Two dependent variables 
were acquired: (1) first fixation preference; which was the proportion of total trials where either 
the familiar or novel shapes were viewed first during the test phase, and (2) fixation preference; 
which was the proportion of total looking time toward the novel minus the familiar shapes. 
The former was considered a marker of attentional priority, and the latter, a marker of 




repeated for each ISI. Lastly, fixation preference was compared with neurobehavioural 
measures of memory (see section 12.4.7). Neurobehavioural tools assessing memory were only 
available for children ≥36m of age. 
14.3 Memory Task: Results 
Participants 
32 CWEOE (68%) and 21 controls (48%) were included in Memory Task analysis. 7 CWEOE and 
17 controls had completed the initial version of the Memory Task and were therefore excluded 
from analysis. 8 CWEOE and 3 controls who attempted the current version of the Memory Task, 
did not meet inclusion criterion (i.e. ≥33% of trials included). There were no significant 
differences in sociodemographic or clinical characteristics between those CWEOE who did, or 
did not, meet inclusion criteria. 
Table 14 Group comparisons of GCA z-scores, and NEPSY II memory scaled scores 
 GCA NEPSY II 







CWEOE 30 -.11 (.87) 17 9.71 (3.29) 9.18 (2.88) 9.00 (2.99) 
Controls 21 .60 (.70) 9 12.11 (4.51) 10.89 (3.14) 11.75 (2.87) 
Emboldened p<.05 
 
GCA and NEPSY II memory scores are reported in table 14. Control children had significantly 
higher GCA score (MD=-.70 (95% CI -1.16, -.24), p=.004), and Sentence Repetition (MD= -.2.75, 
95% CI -.10, -5.40), p=.04), but comparable Memory for Designs and Narrative Memory. 
First Fixation Preference 
Across all trials, control children looked first more often toward the novel shapes compared to 
the familiar (M=65% vs 35%, p=.002), but CWEOE did not (M=55% vs 45%, p=.20).  However, 
the between group difference was not statistically significant (MD= -19.89%, 95% CI [-42.15, 
2.37], p=.08), indicating considerable variability in first look preferences. A significant positive 
correlation was found between the proportion of first looks to the novel stimuli and age in 




first at the familiar shapes during the first years of life, but a consistent preference for the novel 
shapes across age in controls. Exploration of ISI conditions revealed that the novelty preference 
exhibited in controls, but not in CWEOE, existed only at the 2s ISI. Here, controls looked first 
more often at the novel shapes compared to CWEOE (p=.02) - who displayed no clear 
preference. In the 5s and 8s ISI conditions, there were no significant within- or between-group 
differences in first fixation preference. There was no significant association with gender. To 
summarise, controls exhibited a first fixation preference toward the novel shapes but only at 
2s ISI. CWEOE showed no first fixation preference toward novel or familiar shapes across ISI 
conditions, but did show a tendency toward looking first at the familiar shapes more often in 
infancy. 
Fixation Preference: Across All Trials 
CWEOE (M=19.00%, SD=24.38) and controls (M=20.82%, SD=20.91) spent a similar duration 
of time fixating the novel shapes compared to the familiar shapes (figure 14.2); MD= -1.83% 
(95% CI -14.84, 11.19). This equated to a mean total fixation duration toward the novel shapes 
of 59.5% for CWEOE, and 60.4% for controls, meaning that both CWEOE (t(31)=4.41, p<.001) 
and controls (t(20)=4.56, p<.001) displayed a novelty preference above chance levels. This 
signified successful memory recognition in CWEOE and controls. Across both groups, fixation 
preference was positively correlated with age at assessment (rs=.38, p=.005), but was not 
associated with gender (MD=3.61 [95% CI -9.38, 16.59]), signifying increased attentional 
importance to novel shapes with increasing age. 
Figure 14.2 Memory Task bar chart: Mean fixation preference 
 




Fixation Preference: by ISI 
Analysis of fixation preference at 2s, 5s, and 8s using a two-way repeated measures ANOVA 
found no main effect of group (𝜂𝑝
2=.003), or ISI (𝜂𝑝
2=.03), and no group*ISI interaction effect 
(𝜂𝑝
2=.05), meaning that both CWEOE and controls displayed similar fixation preferences at each 
interval delay. Mean between-group difference in fixation preference at 8s ISI showed a trend 
towards statistical significance (MD=19.55%, p=.057) but confidence intervals overlapped 
implying significant within-ISI variability (figure 14.3). Fixation preference was highly similar at 
2s ISI (MD=5.35%), and at 5s ISI (MD=6.36%).  
Figure 14.3 Mean fixation preference by ISI  
 
Error bars represent 95% confidence intervals 
 
Within-group fixation preferences were directly assessed via one-sample t-tests.  Both CWEOE 
and controls exhibited a significant novelty preference at each ISI, with the exception of CWEOE 
at the 8s ISI (t(31)=1.66, p=.11). Taken with the above, unlike controls, CWEOE had an absence 
of recognition memory at an interval of 8s, but a group difference was absent due to 
considerable variability in performance. The absence of novelty preference at 8s ISI is 
potentially suggestive that recognition memory differences may exist at larger ISIs in CWEOE. 





Fixation Preference and Neurobehavioural Data 
As both CWEOE and controls showed a novelty preference across all trials, analysis was 
conducted on all children together. There was no correlation between fixation preference and 
GCA (n=51, r=.14, p=.33), even when age was controlled for (r=.07, p=.62). Additionally, there 
was no correlation between fixation preference and NEPSY II measures of memory in children 
≥36m (n=26); Narrative Memory (r=-.27, p=.19), Sentence Repetition (r=-.25, p=.24), or 
Memory for Designs, although a moderate correlation was noted (rs=-.38, p=.059). There were 
insufficient sample sizes of children who met criteria for GCA impairment or memory problems 
to make sub-group comparisons with fixation preference. Two CWEOE had GCA impairment, 
with fixation preference scores of -23.90% and 25.94%. One CWEOE had impairment in NEPSY 
II Memory for Designs, three on Sentence Repetition, and one on the Narrative memory, 
scoring 24.90, 32.09, and 32.98% respectively – scores above the CWEOE mean (19.0%). From 
the available data, the eye-tracking Memory Task does not adequately predict 
neurobehavioural measures of GCA and memory in the 0-4 year age group. As the task was 
originally designed for infants, it is unclear if a lack of relationship with GCA or NEPSY II 
measures of memory and fixation preference is due to ceiling effects, or because the task itself 
does not sufficiently tax memory or GCA in children ≤4 years. There were insufficient numbers 
of children <12m of age to explore relationships between fixation preference and GCA in 
infancy only. 
14.4 Memory Task: Discussion 
The Memory Task assessed incidental recognition memory through selective visual attention 
for familiar versus novel shapes. Contrary to expectations the results revealed that both control 
children and CWEOE displayed a novelty preference to a similar degree. This signified typical 
recognition memory over short periods of time. Despite a group difference in GCA, fixation 
preference between groups remained similar. There was no significant correlation between 
fixation preference and GCA, suggesting that fixation preference was independent of GCA. The 
correlation of .14 found here was weaker compared to that found in Rose et al. (2005) and 
Fagan et al. (2007). There are two possible contributing factors. First, Rose et al. and Fagan et 
al. included, in part or in whole, pictures of faces in their stimuli. Although debated (Gauthier 
et al., 2014), face recognition may involve unique neural correlates (Kanwisher et al., 1997), that 
may influence memory performance. Second, both studies assessed 6-12 month old infants on 




related functional differences in face and object recognition are likely (e.g. Gathers et al., 2004), 
and age-related increases in task complexity may be required in order to negate ceiling effects 
and match cognitive ability to older children.  
There was one subtle nuance noted in the Memory Task. There was a first fixation preference 
for novel shapes in control children at 2s ISI but not CWEOE – where controls viewed the novel 
image first more often than CWEOE. A first fixation novelty preference was absent in either 
group at 5s and 8s ISI, suggesting that all children needed to compare paired images and 
retrieve representations from longer term memory. Previous work has found sudden decay in 
short-term memory after approximately five seconds (Cowan et al., 1997; Ricker and Cowan, 
2010), and in the current study, this might suggest that at a 2s interval control children 
maintained a visual representation of the familiar shapes in short-term memory, improving the 
accuracy of swiftly detecting the novel stimulus. This was absent in CWEOE and may indicate 
an extremely subtle deficit in the rate at which visual objects decay from immediate short-term 
memory. 
There was a lack of correlation between performance on the Memory Task and 
neurobehavioural measures of memory, or GCA (GCA discussed above). There were limited 
sample sizes to robustly test the validity of the Memory Task to discriminate those CWEOE with 
cognitive impairment or memory problems. Based on the small number of results available, 
there was a lack of supporting evidence for any strong association. The lack of a strong and 
significant correlation between NESPY II memory scores and fixation preference suggests that 
this manifestation of the VPC task was not an adequate assessor of memory in children ≥36m. 
It should be noted that a moderate correlation was found between fixation preference and 
NEPSY II Memory for Designs. This might potentially indicate better task applicability to visual 
memory than memory or cognition as general constructs, as may be expected given the nature 
of the task.  
Several factors should also be considered when considering the results of the Memory Task. 
Firstly, the Memory Task was made up of a small number of trials at each ISI (three in each), 
and there may have been insufficient trials to detect group or sub-group differences at 
different ISI delays. Secondly, the Memory Task was originally designed and developed for 
infants which raises the possibility that the Memory Task was too simplistic to detect memory 
problems in children up to four years of age. Indeed, memory development across infancy to 




span (Gathercole, 1999), and long-term memory (Hayes et al., 2002), and more complex design, 
or tasks with age-appropriate memory loading should be implemented. Lastly, CWEOE 
displayed a decrease in novelty preference with longer ISIs, with no novelty preference at the 
longest ISI. Although there was no statistically significant difference between CWEOE and 
controls, difficulties in long-term memory consolidation have been found in children with 
idiopathic epilepsy (Gascoigne et al., 2012), and it does raise the question of how memory 
performance in CWEOE could be affected at longer delays.  
In conclusion, the Memory Task provided evidence that children up to four years of age display 
a novelty preference in a simple object-based VPC task.  VPC based eye-tracking designs can 
therefore be successfully used in infants and preschool children with epilepsy. Visual 
recognition memory over very short delays is not impaired in CWEOE, although further 
research and evaluation is required with manipulation of experimental design, including 
increased trial volume, length of ISI, and age-appropriate memory loading. Nevertheless, the 
methods and results from the current study can be used as a platform from which to base 
future experimental design. Finally, eye-gaze behaviour assessment in children with epilepsy 
is a worthwhile pursuit given that cognition and memory is commonly impaired in children 
with epilepsy. There are limited memory measures in the early-onset age, and eye-tracking 





15. Attention/Inhibition Domain 
Attention problems, including Attention-Deficit Hyperactivity Disorder (ADHD) are a highly 
prominent feature of childhood epilepsy (Chou et al., 2013; Davies et al., 2003; Reilly et al., 
2014b; Rodenburg et al., 2005). ADHD is detectable in preschool children, and can persist into 
later childhood causing detrimental academic, functional, and social outcomes (Lahey et al., 
2004; Washbrook et al., 2013). Similarly, other types of attention related functions, such as 
working memory (Reilly et al., 2015b; Myatchin and Lagae, 2011; Myatchin et al., 2009) and 
executive functioning (Hoie et al., 2006; Parrish et al., 2007; Pulsipher et al., 2009) are commonly 
impaired in childhood epilepsy, and impact social and academic achievement. Improving 
attentional control may produce positive cascade effects in related cognitive functions (Wass 
et al., 2012), providing significant justification for the early identification of attention problems 
in CWEOE. 
Attention is a theoretical construct that consists of four broad processes (Knudsen, 2007): 
working memory, top-down sensitivity, competitive selection, and automatic bottom-up 
filtering. These processes are embedded in visual attention - as is eye biomechanics (Itti and 
Koch, 2001) – and here we are concerned with competitive visual selection. One important 
function of visual selection is inhibition. Inhibition refers to covert and overt processes that 
selectively impede areas of visual space, stimulus features, or prevent programmed eye 
movements, in order to allow the selection of competing targets (see Itti & Koch, 2001; 
Knudsen, 2007; Müller and Krummenacher, 2006, for reviews of selective attention). Inhibition 
of return, for example, is a well-known phenomenon whereby a previously attended location 
in visual space is covertly suppressed, leading to a delay in return to that location. An 
antisaccade is a top-down inhibitory mechanism of visual attention, involving prefrontal and 
parietal pathways (McDowell et al., 2002; McDowell et al., 2008; Schaeffer et al., 2013). In 
antisaccade paradigms covert attention is drawn toward a cue, and the observer must actively 
inhibit the ensuing reflexive saccade to that cue in lieu of a competing saccade in the opposite 
direction. Tapping into inhibitory aspects of visual attention is one potential avenue in eye-
tracking research for detecting attention problems in CWEOE. Children with ADHD, for 
instance, show broad oculomotor control difficulties, particularly with saccadic inhibition 





To the candidate’s knowledge, eye tracking has not been used to detect attention problems in 
children with epilepsy. In the NEUROPROFILES study, inhibitory aspects of attention were 
explored in CWEOE and controls using two inhibitory based eye tracking tasks. One, the 
Oculomotor Control Task, assessed inhibition of reflexive saccades, and production of 
antisaccades; and the second, the SNP Task, was a spatial negative priming paradigm where 
visual inhibition and simultaneous target selection was assessed. Performance on these tasks 
was related to neurobehavioural measures of attention and executive functioning.  
15.1 Oculomotor Control Task 
15.1.1 Oculomotor Control Task: Background 
The Oculomotor Control Task assessed the inhibition of reflexive saccades and the production 
of antisaccades by following the paradigm and procedure described by Scerif et al. (2005).  A 
reflexive saccade is an automatic shift in gaze toward a particular location or object. Children 
as young as 4 months can inhibit reflexive saccades (Johnson, 1995), which is a vital component 
of visual selection. Inhibiting a gaze shift to something in peripheral vision allows continued 
visual attention to be placed on a preferred stimulus, or to produce a shift in an opposing 
direction. Scerif et al. (2005) found that children from 8 to 38 months, like those in Johnson 
(1995), implicitly learned to inhibit saccades toward a peripheral cue across trials. The authors 
failed to find the same effect in children with Fragile X syndrome – a chromosomal disorder 
with increased risks of attention problems (Cornish et al., 2004) – which provided evidence that 
this task was successful in detecting atypical gaze behaviour in a clinical population of children 
with known attention problems. 
As mentioned in the introduction to this section, inhibition of saccades and antisaccade 
production errors are commonly reported in children with ADHD (e.g. Munoz, 2003); and one 
of the goals of this study was to identify children with attention problems, including ADHD. 
Young infants do not produce antisaccades (Johnson, 1995; Scerif et al., 2005), but Scerif et al. 
(2005) found that toddlers did so from around 20 months of age. As well as inhibiting reflexive 
saccades toward the peripheral cue, the children in Scerif et al. produced antisaccades by using 
the cue as a signal to direct gaze toward the contralateral half of the screen in anticipation of 
a visual reward (i.e. coloured circle and cartoon animation).  The children with Fragile X 
produced antisaccades despite difficulty with inhibition, indicating that the task could detect 




The authors suggested that Fragile X and ADHD share a commonality in that both disorders 
affect frontostriatal pathways. Similarly, frontostriatal pathway disruption has been proposed 
as a mechanism for executive dysfunction in temporal lobe epilepsy (Riley et al., 2011), whilst 
imaging studies of children with epilepsy and attention problems have also implicated frontal 
regions, as well as parietal and insular regions (Bechtel et al., 2012; Dabbs et al., 2013; Killory 
et al., 2011). Neurological deficits observed in children with epilepsy and neurobehavioural 
problems may echo those observed in those with problems but without epilepsy (Bechtel et 
al., 2012), suggesting that children with epilepsy and attention problems may display similar 
atypicalities in visual attention as children without epilepsy. 
The task described in Scerif et al. (2005) was replicated for the current study for the reasons 
outlined here; it has been validated in infants and preschool aged children, including a clinical 
population of young children. The task targets inhibitory mechanisms of saccadic control, and 
the production of antisaccades – two factors known to be affected in those with attention 
problems. The task relies on implicit visual attention and learning, and is therefore suitable for 
young nonverbal and preverbal children. Thus, its administration can be standardised across 
the NEUROPROFILES cohort.  Given that the cohort was heterogeneous in epilepsy 
characteristics as well as neurobehaviourally, it was hypothesised that CWEOE would display a 
less dramatic increase in inhibition of reflexive saccades across trials, and which would be 
related to behavioural measures of attention. It was also hypothesised that the number of 
antisaccades produced by CWEOE would be less than control children, and which would be 
negatively correlated with behavioural attention measures. 
15.1.2 Oculomotor Control Task: Methods 
The Oculomotor Control Task replicated the paradigm design and timing used by Scerif et al. 
(2005, adapted from Guitton et al., 1985).  The task evaluated inhibition of reflexive saccades 
toward an unenticing cue by determining the change in proportion of overt looks toward that 
cue from one half of trials compared to the second half of trials. The number, and type, of 
saccades toward a contralateral salient target were also calculated. These included reactive 
saccades, corrective saccades, and antisaccades.  
In replication of Scerif et al., each trial was made up of a central fixation stimulus, cue, target, 
and reward. Trial sequence is illustrated in figure 15.1, with each trial lasting 6700ms. The 




white background for 2000ms accompanied by a short beep sound, to orient the child’s 
attention toward the centre of the screen. The stimulus, subtending 20° of visual angle, either 
rotated or zoomed in and out. A brief 100ms cue (black circle, 5.5°) appeared immediately 
post-central stimulus offset, 18° either to the right or the left of the central stimulus. A blank 
screen was presented for 600ms followed by the target (i.e. a coloured circle) which zoomed 
in and out (6°-9.25°) for 1500ms. The target appeared contralateral to cue presentation and 
was immediately followed by a colourful reward (i.e. cartoon image of an animal or object) 
subtending 20° and lasting 2500ms.  The reward was paired with a sound (e.g. clapping, car 
horn, animal noise). On half of trials the cue was presented on the right side, and half on the 
left, with target and reward on the contralateral half. Each subsequent trial was presented 
immediately following reward offset. Trials were presented in a randomised order across 
participants to negate any ordering bias.  
Figure 15.1 Oculomotor Control Task: trial sequence 
 
 
The task paradigm and timing replicated Scerif et al., whilst the individual stimuli and trial 
animations were constructed by the candidate, following the same structure (i.e. circles, child-
friendly rewards, etc) set out by the authors. Nineteen reward stimulus images were selected 
and downloaded from http://all-free-download.com/. Child friendly images that were 




were designed, and individual animations (i.e. rotating or zooming stimuli) were built, in 
paint.net (v3.5), and animated using Windows Movie Maker (v16.4). Each trial was then 
converted to AVI movie format. Stimuli size was determined based on degrees of visual angle 
reported in Scerif et al. Target stimuli colour varied to promote attention. 
Scerif and colleagues used 32 trials with an average loss rate of 5 unusable trials per child. The 
minimum number of trials required for analysis in their study was 12. The number of total trials 
in the current study was reduced to 24 in order to attain a reasonable 50% trial-target minimum 
while reducing overall test load. All 24 trails were viewed consecutively in one block. 
General statistical analysis was described in section 12.4.6. To assess inhibition of reflexive 
saccades, the dependent variable was the change in percentage of trials with a saccade toward 
the cue, as determined by a fixation on the cue AOI, from the first half of trials to the second 
half (i.e. % of cue looks in second half of trials - % of cue looks first half of trials). As the number 
of successfully completed trials varied between participants (see section 12.4.4 for criteria), the 
halves were based on the total number of trials per individual. When there was an uneven 
number of trials, the last trial was excluded. The type of saccade (reactive, corrective, or 
antisaccade), and proportion produced, toward the target was also ascertained, with particular 
focus on antisaccade production. An antisaccade was an anticipatory look toward target up to 
100ms post target onset (Scerif et al.) without a preceding look toward the cue. A corrective 
saccade was a look toward the cue followed by a look toward the target up to 100ms post 
onset. A reactive saccade was a look toward the target preceding a look toward the cue. 
Analysis was planned for the percentage of cue change, and proportion of saccades produced, 
between groups (CWEOE versus controls), as well as the relationship between performance 
and age, and neurobehavioural scores on tools of attention and executive functioning (see 
section 12.4.7 for tools used).  
15.1.3 Oculomotor Control Task: Results 
Participants 
27 (19M:8F) CWEOE (57% of total N), and 33 (15M:18F) controls (80% of total N), were included 
in analysis. CWEOE, median age 37.85 [IQR 17.25 – 51.19] months, and controls, median age 
25.96 [IQR 16.51 – 50.18] months, did not statistically differ in age (p=.67, r=.06) or gender 




significantly correlated with the main outcome variable, change in cue looks (r= -.03), and was 
therefore not factored into between-group analysis as a control variable.  
Of the 20 CWEOE who did not reach inclusion criteria, 13 (65%) had <12 scorable trials, and 7 
(35%) had <40% looks toward cue in the first half of trials.  There was no difference in age 
(p=.98, r=.003), gender (FET=.76), or GCA (MD= .32, 95% CI [.86, -.22], p=.23), between those 
CWEOE who were or were not included in analysis. Additionally, there were no differences in 
their clinical characteristics; aetiology (1989 or 2010 ILAE classifications), seizure frequency, 
seizure origin, MRI status, EEG status, number of AEDs, or GCA impairment. The reason why 
some children did not meet inclusion criteria could not be attributed to general attention to 
this specific task. The average total fixation duration to the stimuli (MD=.63 [95% CI -.24, 1.50] 
seconds, p=.15), and average number of fixations per trial (MD=1.48 [95% CI -.23, 3.18, p=.09]), 
were not significantly different between those who met or did not meet criteria. All CWEOE 
had adequate visual field assessment, therefore, it is plausible that CWEOE who did not meet 
inclusion criteria simply did not, or could not, adequately maintain attention to the task 
animation sequence often enough. In other words, they were more likely to disengage from 
key elements of the trial and look elsewhere, and thus meet exclusion criteria.  
Of the 8 control children (median age 30.62 [IQR 9.35 – 42.60] months), who were not included 
in analysis, 6 (75%) had <12 scorable trials. Two (25%) controls completed an earlier version of 
the task which had a technical fault with playback and which could not be scored.  There was 
no significant demographic differences between controls who were or were not included in 
analysis; age (p=.66, r=.07), gender (FET=1.0), or SES (FET=1.0). 
Inhibition of Reflexive Saccades: Percentage Change in Cue Looks 
CWEOE and controls looked less often 
at the cue in the second half of trials 
compared to the first (table 15.1). A 
two-way mixed ANOVA revealed a 
significant main effect of trial half (F 
(1,58)=13.89, p<.001, 𝜂𝑝
2=.19), but no 
main effect of group (𝜂𝑝
2=.003) or interaction effect (𝜂𝑝
2=.015). That is, both groups of children 
implicitly learned to inhibit reflexive saccades toward the cue to a similar degree. 
Table 15.1 Percentage of trials with fixations on cue 
 
First half trials 
mean % (SD) 
Second half trials 
mean % (SD) 
CWEOE (n=27) 69.37 (16.49) 60.5 (24.23) 




 The percentage change in looks toward the cue across trial halves was not significantly 
associated with gender (MD=9.20% [95% CI -3.43, 21.84]). Scerif et al. (2005) found a significant 
correlation between increasing age and a reduction in cue looks during the second half of trials 
in their analysis – signifying improved saccadic inhibition with age. However, no correlation 
was found between age and percentage of cue looks in the second half on trials in the present 
study (rs= -.19, p=.15), nor was there a correlation present between age and percentage of cue 
change (rs=-.02, p=.91 [group comparison illustrated in figure 15.2]) – which took individual 
performance into account.  
  
Figure 15.2 Scatterplot: Age and 
percentage cue change by group 
 
A comparison of cue change from first 
half of trials to second half in CWEOE 
(blue), and controls (green). Negative 
direction indicates a decrease in cue 
looks from first half of trials to second 
half of trials. Dashed vertical line 








The reason for this between study discrepancy is unclear, although the present study had a 
slightly larger sample size, and included children up to 63m, compared to 38m in Scerif et al. 
When only children <40m were included in analysis, there was a moderate but significant 
correlation of rs=-.35, p=.04 (n=35), indicating that decreasing cue looks were moderately 
associated with increasing age. This result suggests that the Oculomotor Control task may be 
more sensitive to age changes in children <40m. Children >40m exhibited a decrease in looks 
toward the cue in the second half of trials (65.9% to 56.9%) albeit non-significantly, on account 
of looking less toward the cue during the first half of trials. It is important to note that two-
way ANOVA measuring cue change from the first to second half of trials, and the associations 
with neurobehavioural tools (described below), using only children <40m, were repeated with 
no change in findings. This indicates that the task remains suitable for the children in this 
cohort, but may be more demanding on inhibitory mechanisms in younger children. 
Inhibition of Reflexive Saccades: Relationship with Neurobehavioural Tools 
Percentage change in cue looks was not correlated with psychometric scores on 
neurobehavioural tools measuring attention and/or executive functioning (table 15.2) – 
meaning that the degree of reflexive saccadic inhibition was not a marker of the behavioural 
manifestations of attention or executive function, as measured by these neurobehavioural 
tools. 
Table 15.2 Correlation coefficients for cue change and attention/executive functioning scales 














Coefficient rs= .07 r= .11 r= .10 r= .03 rs= -.27 
BRIEF GEC – Behaviour Rating Inventory of Executive 
Function General Executive Composite 
CEC – Conners Early Childhood  
ITSEA – Infant Toddler Social Emotional Assessment 
NEPSY – Developmental Neuropsychological 
Assessment 
 
Similarly, percentage cue change on the Oculomotor Control Task was not significantly 
associated with executive functioning or inattention/hyperactivity problems (table 15.3). The 
number of children classified with a neurobehavioural problem in attention/hyperactivity or 




Oculomotor Control Task as an identification tool for attention or executive problems. 
Nevertheless, based on the data here, the Oculomotor Control Task was not sensitive enough 
to discriminate children with attention/hyperactivity or executive functioning problems. No 
child included in the Oculomotor Control Task met criteria for an ITSEA externalising problem, 
whilst only one child had cognitive impairment. As such, no further analysis could be 
completed using those tools. 




N Mean MD 95% CI 
Executive Functioning † 
No 29 -16.17 
-21.72 -47.75, 4.30 




No 24 -12.86 
-5.83 -27.06, 15.40 
Yes 7 -7.03 
† P-BRIEF General Executive Composite 
ǂ Conners Early Childhood Restless Index or Inattention/Hyperactivity scale 
 
Saccades Toward Target: Reactive, Corrective, and Antisaccades 
Contrary to Scerif et al. (2005), CWEOE and controls here did not produce antisaccades or 
corrective saccades (<1% across all trials). Children invariably produced reactive saccades 
toward the target, suggesting that they did not implicitly learn the association between target 
and cue locations, or that they did learn this association but could not produce corrective or 
antisaccades.  
Table 15.4 Median latency to target (seconds) 
 1st half trials 
Median [IQR]  




CWEOE (n=27) 1.38 [1.15 – 1.78] 1.66 [1.26 – 2.50] .009 (.34) 





Time to target was expected to be longer during the second half of trials as reflexive inhibition 
improved, and antisaccades were produced – viz through additional steps in saccadic 
programming. The latency to target [from cue onset] for CWEOE and controls is listed in table 
15.4. Both CWEOE and controls took longer to fixate on the target location in the second half 
of trials compared to the first. This was significant in CWEOE only, but there was no significant 
difference in latency change between groups (U=370.5, p=.27, r=.14), indicating the strength 
of the difference was small. In contrast, when only children <40m were included, the difference 
in latency between groups was significant (U=85.5, p=.04, r=.35). As only reactive saccades 
were produced, the additional latency in time to target in the second half of trials could be 
attributed to the impact of reflexive inhibition, meaning that reflexive inhibition came at an 
increased cost in the production of a subsequent saccade in CWEOE <40m.   
Summary 
CWEOE and control children exhibited a reduction in saccades toward the cue from the first 
half of trials to the second half of trials – indicating an increase in inhibition of reflexive 
saccades. Cue change was not correlated with age, except when only children <40m were 
considered. Additionally, the time to target was significantly longer during the second half of 
trials in CWEOE <40m of age, compared to controls, suggesting that inhibition came at an 
increased cost to CWEOE <40m. Whilst reflexive inhibition was not affected by the age of this 
cohort, the results in children <40m suggest the Oculomotor Control task may be more 
demanding in this age group, and thus, more appropriate. Contrary to Scerif et al. (2005), 
CWEOE and controls did not produce antisaccades at any age. Lastly, the Oculomotor Control 
Task was not associated with neurobehavioural scores, or children with neurobehavioural 
problems signifying that this visual attention based task was not directly related to attention 
or executive functioning at the behavioural level, as measured by these neurobehavioural tools. 
15.2 Spatial Negative Priming (SNP) Task 
15.2.1 SNP Task: Background 
A basic facet of the human visual system is the ability to inhibit particular regions of visual 
space and instead attend to more preferred locations. SNP describes paradigms in which 
saccadic latencies are slower, or less accurate, to spatial locations which have been actively 
supressed.  In SNP paradigms a target object and distractor are presented in a prime display, 




(control trial), or in the previously ignored space occupied by the distractor during the prime 
display (repeated distractor trial). The reasons for this location-related negative priming effect 
are not well understood (Frings et al., 2015) but hinges on inhibitory mechanisms or retrieval 
mechanisms.  
SNP effects have been evidenced in infants from 9 months of age and in adulthood (Amso and 
Johnson, 2005; Amso and Johnson, 2008; Wright et al., 2005). SNP appears to function normally 
in those with ASD (Brian et al., 2003) but it is unclear if children with attention or executive 
functioning difficulties display atypical negative priming. ADHD is a disorder conceptualised 
by an impairment in the ability to inhibit responses or control conflicting responses (Barkley, 
1997).  There are mixed-results in non-spatial visual-auditory negative priming in ADHD (e.g. 
Gaultney et al., 1999; Nigg et al., 2002), that may be potentially and partially explained by the 
presence of other comorbid conditions (e.g. mood or conduct disorder) (Pritchard et al., 2008). 
As spatial-based and identity-based negative priming may involve different mechanisms 
(Frings et al., 2015), it may be useful to explore SNP in children with ADHD or other attention 
related difficulties. As mentioned previously, epilepsy commonly involves attentional 
(Rodenburg et al., 2005), and executive difficulties (e.g. Parrish et al., 2007), with a high 
prevalence of ADHD (Chou et al., 2013). In the present study SNP was explored in CWEOE 
compared to controls, and it was hypothesised that CWEOE with attention difficulties would 
display a marked reduction or absence of SNP.  
Therefore, the objectives of the SNP task in the current study were to: (1) determine if CWEOE 
display atypical SNP compared to controls, and (2) explore the relationship between SNP and 
behavioural manifestations of attention and executive functioning as measured by 
neurobehavioural assessment tools.  
15.2.2 SNP Task: Methods 
The SNP task in the current study was a procedurally modified version of the paradigm created 
by Amso and Johnson (2005; 2008), designed to extend their findings in 9m old infants and 
adults to typically developing children 0-4 years of age, and in a cohort of CWEOE. In this task, 
children and adults viewed a 2D grid with a target and distractor. There were two displays 
during each trial, a prime and a probe. In the prime, a target and distractor were presented in 
a grid, before the target shifted to a new location in the probe display.  There were two types 




repeated-distractor trial where the target moved to the location previously occupied by the 
distractor. Amso and Johnson found slower latencies to repeated-distractor trials, illustrating 
spatial negatively priming. 
Figure 15.3 Spatial negative priming repeated distractor and control trials 
 
ISI – Interstimulus interval 
 
The SNP Task stimuli and procedure in the current study were replicated from Amso and 
Johnson, and is visually illustrated in figure 15.3. At the beginning of each trial a central fixation 
stimulus (i.e. bright smiling cartoon sun) was presented for 1500ms to orient the child to the 
centre of the screen, and to signify a new trial. The central fixation stimulus subtended 20° 
degrees of visual angle and either rotated 360° or zoomed in and out. In the prime display, 
children freely viewed the 2D grid (each of the 4 target grids were 7cm2, with total grid size of 
H21cm x W21cm,) with target object (e.g. animated cat, bus, or rattle, subtending 18-20° 
degrees of visual angle) and distractor (i.e. unanimated grey diamond, 20° degrees of visual 




to fit in line with similar methods employed in other SNP paradigms. In the probe, the target 
and distractor shifted grid locations to previously unoccupied locations (control trial), or the 
target shifted to the location previously occupied by distractor (repeated-distractor) while the 
distractor shifted to an entirely new location. Prime and probe displays were presented for 
2000ms each and were separated by an ISI comprised of a blank black screen. 
There were 32 trials in total; 16 repeated distractor trials and 16 control trials. Trials were 
divided equally into the two ISI conditions of 100ms or 600ms. Amso and Johnson (2005; 2008) 
originally presented 48 trials, exploring three ISIs of 67, 200, and 550ms. Given the overall 
heavy task load on children in the current study, an effort was made to reduce the overall 
number of trials by selecting only two ISIs. In their study, 9m old children did not display an 
SNP effect at the 67ms ISI but did so at 200 and 550ms.  For the current study an ISI of 100ms, 
the lowest interval possible using Tobii Studio, was selected, together with an upper ISI of 
600ms (Amso, personal communication 29/05/2013). As an SNP effect was found at 550ms, it 
was expected to be found at 600ms. It would be unlikely that a difference of 50ms would 
negate an SNP effect, given that inhibition of return lasts over 1000ms (Klein, 2000). Children 
were exposed to both ISI conditions to explore between-group and repeated measures 
performance across ISI conditions. 
Stimulus design was derived from Amso and Johnson (2005). Animated target objects were 
uploaded from Tobii Studio, and were the same as those used by Amso and Johnson. The 
central fixation stimulus was downloaded from http://all-free-download.com/, and was chosen 
by the candidate based on its bright, colourful, and child-friendly enticing nature.  The grid 
and distractor were created by the candidate, mimicking Amso and Johnson, using paint.net 
(v3.5), Microsoft Powerpoint 2010, and animated in Windows Movie Maker v16.4. Files were 
converted to AVI format for use in Tobii Studio.  
General statistical analysis was described in section 12.4.6. The dependent variable was latency 
to target in the probe display in the control trial compared to the repeated distractor trial. 
Wilcoxon signed rank tests were used to compare within-group differences in target latency 
due to skewed data. Between-group (i.e. CWEOE vs controls) differences in latency to target, 
within each ISI condition, were carried out by subtracting the control trial latency from the 
repeated distractor trial latency, and applying Mann-Whitney U tests.  Within- and between-




were also planned between latency to target and performance on attention and executive 
functioning behavioural tools described in section 12.4.7. 
15.2.3 SNP Task: Results 
Preliminary analysis of 14 CWEOE and 23 control children revealed a high percentage of trial 
exclusion following inclusion/exclusion criteria (see section 12.4.4). The percentage of trials 
included in analysis was considerably lower in CWEOE (Median=31.25%) and controls 
(M=59.38%) than the average of the remaining four tasks (Median=79.19% and 83.33%, 
respectively). This potentially indicated age inappropriateness of the task, and/or poor ability 
to capture and maintain attention. Observationally, children were less attentive to the overall 
eye-tracking battery and displayed more signs of fatigue and irritation (e.g. fidgeting, getting 
out of seat, verbal complaints). For these reasons, and given the large assessment battery, the 
SNP Task was discontinued, and no further data was collected. Analysis of excluded trials found 
no significant between-group differences in the reasons for trial exclusion, although 
percentage of probe displays that were not attended to at all was moderately higher in CWEOE 
(68% [IQR 51.42, 77.38]) compared to controls (52% [IQR 29.13, 66.67]); p=.054, r=.32.  
Figure 15.4 Median latency between control and distractor trials 
 
Latency was measured from trial onset 
 
Based on the data collected, there was no SNP effect identified in CWEOE or controls. That is, 




the control trials in either ISI condition (figure 15.4). This was in contrast to Amso and Johnson 
(2005; 2008). Additionally, there was no significant between group difference in the change in 
latency to target from control trial to repeated distractor trial (i.e. control trial latency – 
repeated distractor trial latency) (table 15.5). Nor was there a significant correlation with age 
and change in latency to target in either ISI, in CWEOE or controls. In other words, performance 
on the SNP Task was similar between CWEOE and controls. Analysis with neurobehavioural 
tools were not completed due to an absence of SNP. 







CWEOE (n=12) 90 (-328, 333) 170 (-170, 280) 
Controls (n=23) -40 (-130, 60) 35 (-150, 240) 
*Group comparison 
p-value (r) 
.35 (.16) .62 (.09) 
*Mann-Whitney test   
 
15.3 Attention/Inhibition Discussion 
Two eye-tracking tasks were used to explore inhibitory mechanisms of visual attention in 
CWEOE compared to typically developing controls, and to relate potential atypicalities in visual 
attention to attention/hyperactivity and executive functioning at the behavioural level. 
Findings revealed that CWEOE and controls produced comparable results in both eye tracking 
tasks, and which were not associated with neurobehavioural measures of attention and 
executive functioning, where applied. That said, the SNP Task failed to elicit SNP in control 
children or CWEOE, which may have been due to task inappropriateness for this age group. 
Therefore, an understanding of the functioning of SNP in CWEOE remains unclear. Several 
other issues arose from the study and will also be discussed; the first was a lack of relationship 
between the Oculomotor Control Task and neurobehavioural tools. The second was an absence 
of antisaccades during the same task. And thirdly, as mentioned above, the SNP Task did not 
elicit a negative priming effect in controls or CWEOE. These latter two issues have may have 




abnormalities in gaze behaviour were noted in CWEOE during both tasks, but which were not 
derived from the intended design of the task. These are also discussed further below. 
CWEOE displayed inhibition of reflexive saccades to a similar degree as controls during the 
Oculomotor Control Task. This was expected in this CWEOE cohort given its heterogeneous 
clinical and neurobehavioural presentation. However, task performance was not associated 
with neurobehavioural measures of attention/hyperactivity or executive functioning, contrary 
to expectation. This meant that inhibitory aspects of visual attention, as measured by these 
particular eye-tracking tasks, were not directly related to functioning at the behavioural level. 
This was a prospective study, and one of the major limitations as a result, was a small number 
of children who met criteria for an attention/hyperactivity, or executive functioning, problem 
being enrolled for the study, and having successful eye-tracking. Nevertheless, correlations 
with test measures were small, corroborating evidence of weak relationship. There is another 
caveat to consider when interpreting a lack of relationship between the Oculomotor Control 
Task and neurobehavioural tools. Inhibition errors have been associated with ADHD, yet it is 
unknown if the children who met criteria for an executive functioning problem or 
attention/hyperactivity problem in this sample would also have met clinical criteria for ADHD. 
It is possible that attention difficulties in this sample may be different in their neural 
underpinnings compared to classic ADHD.  Therefore the task may not have been suited to 
detecting attention difficulties in this population.  
An unexpected finding from this study was that antisaccades were not produced in the 
Oculomotor Control Task in typically developing control children (or CWEOE) - a contradictory 
finding to that of Serif et al. (2005). The reason for this is unknown, although differences in 
data collection may be a possibility. Scerif et al. recorded and coded gaze direction through 
video recordings of eye movements. This method may be liable to human error. However, 
interrater reliability - on a sample of trials - produced a Cohen’s Kappa coefficient of 1.0 (Scerif 
et al. 2005), and is unlikely to be the explanation. The natural development of antisaccades 
during childhood is unclear, although there is evidence that development remains immature 
even by five or six years of age (Munoz et al., 1998; Munoz, 2003), and does not reach adult 
levels until adolescence (Munoz et al., 2003). The eye movements detected in Scerif et al. may, 
possibly, not have been antisaccades. Because video coding relies on the physical direction of 
a moving eyeball to donate gaze direction and point of regard, these movements may have 
reflected microsaccades rather than true saccades. Microsaccades can have the same 




brief fixation durations (Martinez-Conde et al., 2009). Therefore, it is unclear if the antisaccades 
produced in Scerif et al. were true anticipatory saccades or involuntary brief oculomotor shifts. 
The authors found a positive correlation between the number of antisaccades and age, 
suggesting that eye movements were occurring in response to developmental maturity. 
However, microsaccades also increase with age (Port et al., 2016). The fixation duration 
parameter used in Tobii Studio for the current study (i.e. ≥60ms) would not have recorded a 
typical microsaccade, and may explain the difference in findings. Alternatively, it is also 
plausible that an infant’s or preschooler’s anticipatory saccade may take a different form than 
that of older children or adults, and the contradictory results found here as compared to 
previous work advocates the need for further clarification on antisaccade production in infants 
and young children.  
It is unclear why an SNP effect was observed in Amso and Johnson (2005; 2008) but not in the 
current study. Our task differed from that of Amso and Johnson, in that the distractor was 
presented in the probe condition. Previous research has reported quicker latencies toward 
probe target in repeated distractor trials in the absence of a distractor compared to its 
presence (Neill et al., 1994). One explanation, therefore, may have been a weaker negative 
priming effect in the presence of the probe distractor. However, negative priming may still 
have been expected (Neill et al., 1994), yet no trend was observed. Another potential 
explanation may have been due to the relaxation of selection state (Tipper and Cranston, 1985). 
The selection state is when there is a balance of excitatory and inhibitory processes that keep 
one spatial location supressed, and another activated. Relaxation of the selection state may 
have occurred given that the probe distractor could be easily distinguished from the target, 
which may not have provided sufficient excitation to maintain the state. The SNP Task was 
validated in infants and adults (Amso and Johnson 2005; 2008), and its validity in preschool 
aged children had not been attained. A third reason for an absence of SNP might simply be 
explained by task unsuitability in toddlers and preschool aged children. There were not enough 
infants under one year of age to provide age sub-group analysis, but the low number of 
successful trials leading to the discontinuation of the SNP Task may be an indicator that the 
task did not capture attention in the intended way. The stimuli or process may not have been 
exciting enough for this age group, or not novel enough to maintain sustained attention. As 
explained in the methods section, the sight change in ISI timings were not expected to negate 




Signs of potential attention deficits in CWEOE were found during the SNP Task and 
Oculomotor Control Task. Neither related directly to the original aims of the paradigms, and 
therefore explanation of their causes and interpretations are limited. Nevertheless, they do 
highlight possible deficits in attention that may form the basis of future experimental design. 
The SNP Task was discontinued after preliminary analyses revealed a low trial success rate. That 
rate was considerably lower in CWEOE compared to controls. This should not have been 
expected given that general attentiveness to the remaining four tasks of the battery were 
comparable between CWEOE and controls (section 13.3). The SNP task had more stringent trial 
exclusion criteria than other tasks on account of its design, and necessity to maintain sustained 
and sequential attention across prime and probe displays. Although marginally non-
significant, CWEOE looked less at the probe display than controls, suggesting that the trial 
length and/or ISI was enough to cause sufficient distraction to disengage from the stimulus or 
disrupt underlying processes. This is suggestive of a difficulty in sustained attention, a 
component of attention commonly reported in children with epilepsy (Kavros et al., 2008; 
Killory et al., 2011; Sanchez-Carpintero and Neville, 2003). This finding was not reflected in the 
analysis of general attention to the trials and eye tracking battery because three of the 
remaining four tasks (Memory Task, Social Preference Task, and Face Scanning Task) did not 
rely on sustained sequential attention, and were unaffected by off-AOI or off-screen fixations. 
In a similar manner to the SNP Task, a greater number of CWEOE were excluded from the 
Oculomotor Control Task analysis than control children. Exclusion criteria in this task was also 
based on sustained attention across sequential within-trial stimuli presentation. The exclusion 
criteria here were less stringent than the SNP Task, and did not have the same level of trial 
dropout. But the pattern observed across these two tasks suggests a possible impairment in 
sustained visual attention in CWEOE.  
A second potential abnormality in visual attention identified in CWEOE was found in the 
Oculomotor Control Task. CWEOE <40m took significantly longer to fixate the target in the 
second half of trials compared to the first, whereas control children did not. Coupled with 
increased inhibition of reflexive saccades toward the cue, longer latency to target was 
explained as a function of the additional information processing step involved in cue inhibition. 
As only reactive saccades were observed, the slower latency to target may have been explained 
by a need for additional time to either program or execute the saccade toward target. This 
finding is tentative given the task design was not created to specifically address that question, 




been reported in children with epilepsy (Reilly et al., 2015b; Sherman et al., 2012), which would 
lend support to this finding. 
The findings presented here are based on exploratory work in a heterogeneous population of 
CWEOE. Therefore the results are limited in their interpretability to specific epilepsy syndromes, 
who may present with component specific deficits in attention (Sánchez-Carpintero and 
Neville, 2003). As stated above, this was a prospective cohort of CWEOE, who were assessed 
for behavioural level attention and executive problems using, primarily, behaviour rating 
scales. There is only moderate correlation between performance-based and rating-based 
measures of attention (Mahone, 2005), and it remains to be seen if the Oculomotor Control 
Tasks draws closer relationship to performance-based tools. One performance-based tool used 
in the current study (NEPSY II Statues) was only applicable to children ≥36m old and showed 
a stronger, albeit non-significant, moderate correlation. Attention tools are very limited in 
preschool aged children, particularly in children under four years (Mahone, 2005; Mahone and 
Schneider, 2012). But it may be of interest to replicate the study in a verbal preschool 
population with performance-based measures of attention. This would have an additional 
benefit. The Oculomotor Control Task paradigm was not an antisaccade task in the classic 
sense, in that children were not told to look in the opposing direction from the cue. Replicating 
the task, or other antisaccade paradigm, with verbal children would allow further exploration 
of antisaccade generation in children with epilepsy and its relationship with rating or 
performance-based measures of attention and executive functioning. 
In conclusion, the attention/inhibition based eye-tracking tasks used in the current study had 
mixed success. Reflexive inhibition was found in CWEOE and controls but not antisaccades, 
whilst the SNP Task was discontinued due to poor attention, and did not elicit SNP. 
Nevertheless, the tasks have highlighted some potential areas of further investigation in 
CWEOE. Furthermore, the tasks raised issue with the measurement of antisaccade production 
in typically developing children that requires further investigation. In spite of some limited 
methodological differences in the eye-tracking tasks applied, the methodological points raised 
in this study, namely age-appropriateness of paradigm design, probe distractor placement in 





16. Social Cognition Domain 
There is no clear and agreed upon definition of social cognition (Fiske and Mcrae, 2012), but it 
is defined here as the complex set of cognitive processes that underlie and influence social 
interaction. Social attention, which “can be considered as attention (orienting, focusing, and 
disengagement of visual systems) in the context of social streams of information” (Salley and 
Colombo, 2016, p689), assessed through eye-gaze behaviour, was used here as a marker for 
social cognition. Two naturalistic free viewing tasks were used: (1) Social Preference Task, and 
(2) Face Scanning Task. Each are discussed separately in the following sub-sections, whilst the 
rationale for using social attention tasks in CWEOE is outlined below. 
Social problems are more common to childhood epilepsy compared to other chronic illnesses 
(Rodenburg et al., 2005), and social cognitive difficulties may underlie those social problems 
(Kennedy and Adolphs, 2012; Semrud-Clikeman, 2007). Identifying children with social 
problems at the earliest possible time is advantageous to successful intervention (section 1.1). 
Eye tracking provides an opportunity to assess social cognition through social visual attention 
in order to help understand where social cognitive difficulties may lie in CWEOE, and identify 
those with social functioning problems for earlier intervention.  
ASD is a well-known neurodevelopmental disorder characterised by deficits in social attention 
and social interaction (Falck-Ytter et al., 2013; Johnson et al., 2016), and has received much 
attention in eye-tracking research. ASD is overrepresented in childhood epilepsy, with 
approximately 5% of children with epilepsy receiving an ASD diagnosis (Suren et al., 2012). 
Therefore, it may be possible to identify children at risk of ASD using eye-tracking based social 
attention tasks. Interestingly, the frequency of positive screens using ASD sensitive 
questionnaires can be as high as 47% (Clarke et al., 2005; Fisher et al., 2012), suggesting that a 
higher volume of children may have social communication or interaction difficulties, but which 
may not meet criteria for ASD. Deficits in social communication in the general population can 
be functionally impairing (Skuse et al., 2009), and highlights the need to identify children with 






16.1 Social Preference Task 
16.1.1 Social Preference Task: Background 
Evidence suggests that infants who atypically attend to social information within a scene later 
develop ASD (Chawarska et al., 2012; Chawarska et al., 2013). Indeed, atypical attention and 
gaze patterns toward people and faces, compared to typically developing children, appears to 
be a feature of ASD (Falck-Ytter et al., 2013). There is also a tendency for children with ASD to 
prefer objects rather than faces (Pierce et al., 2011a; Sasson and Touchstone, 2013). However, 
Wilson, Brock, & Palermo (2010) found that both typically developing children and children 
with ASD preferred to orient toward people within social scenes when compared to objects, 
but typically developing children spent significantly more time looking at people than the ASD 
children. Fletcher-Watson et al. (2009) investigated gaze attention toward two competing 
natural scenes, some of which contained people (social scene) and others without (non-social 
scene), in adults with and without ASD.  Adults with ASD, like controls, preferred the socially 
informative scene, being particularly drawn to the person within the social scene. However, 
Fletcher-Watson et al. noted a difference in how quickly the subjects fixated to people within 
the social scene, a reflection of attentional priority, where those with ASD took longer to fixate 
the person than typically developing adults.  
Recently, premature infants, who are at higher risk of ASD, displayed differences in fixation 
duration compared to typically developing infants, on an adapted version of the task used by 
Fletcher-Watson et al. (Telford et al., 2016). Therefore, the task may be sensitive to atypical 
social cognitive development, and the NEUROPROFILES study adopted that child-adapted task, 
with the aim to assess eye-gaze behaviour toward social and non-social naturalistic scenes in 
CWEOE compared to control children. Performance was also related to behavioural measures 
of social cognition and social functioning. It was hypothesised that CWEOE would display a 
preference for social scenes, but those with social functioning problems, or those at risk of 
ASD, would display atypical gaze behaviour by showing reduced attentional priority and 
reduced fixation duration to social stimuli. 
16.1.2 Social Preference Task: Methods 
The Social Preference Task was a novel, locally designed paradigm, which assessed visual 




from an adult version of the task (Fletcher-Watson et al., 2008; Fletcher-Watson et al., 2009). 
The Social Preference Task was validated in typically developing infants (Gillespie-Smith et al., 
2016; Telford et al., 2016), and in preterm infants (Telford et al., 2016), aged 6-12m. As older 
children with ASD have displayed abnormalities in social scene viewing tasks (Wilson et al., 
2010), the Social Preference Task was deemed suitable to administer in the current infant and 
preschool-aged cohort. The stimuli consisted of photographs of real-world scenes taken locally 
by the developers. There were six real world scenes with two versions of each: one with 1-2 
children (i.e. social scene), and one without children (i.e. non-social scene). Trials consisted of 
social and non-social scene pairs presented in a counterbalanced pseudorandom order. 
Images were never presented in a pair with their real world sibling in order to increase overall 
scene complexity and avoid a reduction in image competition. Stimulus pairs were presented 
side by side (figure 16.1), with a combined on-screen size of W24.0cm x H17.0cm. There were 
a total of 12 trials, six in each block. Each trial was presented for 5s (Gillespie-Smith et al., 2016).  





Image (A) depicts an example of a social & non-social scene pair. Image (B) depicts the same real world scenes 
as in (A), but with social & non-social content reversed. 
 
General statistical analysis was laid out in section 12.4.6. Attentional priority and attentional 
importance were assessed for competing scenes (social versus non-social scene) as a measure 
of social preference, using first fixation preference, and fixation preference, respectively. 
Fixation preference was calculated as the % of TFD on the social image, compared to the whole 
scene, minus % of TFD to the non-social image. Fixation preference score was associated with 
sociodemographic variables (age and SES), and neurobehavioural data. Additionally, the social 




total time spent fixating the social image) toward the child/children, and the head regions 
within the scene. 
16.1.3 Social Preference Task: Results 
Participants 
After trial exclusion criteria was applied, 47 CWEOE (100%) and 38 controls (93%) were included 
in analysis; three control children (2M:1F) aged 3-28m had <33% of scorable trials, and were 
excluded.  
Social Preference: Fixation Preference and First Fixation Preference 
Both CWEOE (t(46)=11.55, p<.001) and controls (t(37)=12.52, p<.001) displayed a significant 
fixation preference for the social image (i.e. the image including a child or children) (figure 
16.2). This preference was stronger in control children compared to CWEOE (MD= -8.77 [95% 
CI -0.22, -17.33], p=.045). Mean fixation preference in CWEOE was 32.43% (SD 19.25), and 
41.20% (SD 20.29) in controls, which equated to a mean percentage of TFD on the social image 
of 66.21% (SD 9.62) in CWEOE and 70.60% (SD 10.15) in controls. Similarly, both CWEOE and 
controls looked first toward the social scene more often than the non-social scene, but controls 
did so more often than CWEOE (MD= -15.00 [95% CI -3.41, -26.60], p=.012). 
Figure 16.2 Bar chart: Fixation preference  
 
Error bars represent standard deviation 




Social Preference: Relationship with Sociodemographics, and Neurobehavioural Scores 
Exploration of sociodemographic and neurobehavioural data revealed significant within-group 
associations between fixation preference and age, social functioning, and GCA, but not SES or 
ASD behaviours (table 16.1).  











SES (High vs Low) 
MD (95% CI) 
CWEOE (n=47) -.04 .43** .33 .18 .02 (-11.41, 11.46) 
Controls (n=38) -.52** .24 -.06 -.36* 7.19 (-7.54, 21.91) 
*p<.05, **p<.01, ***p<.001 
† Social functioning = SEGC/ITSEA competence/CEC Social functioning scale (CWEOE n=42, controls n=36) 
ǂ SRS-2 Total Score (CWEOE n=26, Controls n=16) 
 
All variables significantly associated with fixation preference (i.e. age, social functioning, and 
GCA) were factored into multiple linear regression analysis. Interaction variables were also 
modelled. GCA was not a significant independent predictor when factored into multivariable 
models, and did not improve model fit, and was therefore dropped. The final model including 
group, age, group*age interaction, and social functioning was significant (F(4,73)=8.68, 
p<.001), explaining 28.5% (R2adj) of the variance in fixation preference. All variables 
independently predicted fixation preference (table 16.2). The model indicated that CWEOE 
looked less toward the social image than controls overall (B= -36.37), but there was also an 
influence of age, where children looked less at the social image with increasing age (B= -.70).  
The group*age interaction revealed that control children had a strong fixation preference for 
the social image at a younger age but looked less toward that image with increasing age. 
CWEOE did not (figure 16.3).  Despite considerable variability, the pattern of fixation preference 










p-value Lower Upper 
Constant 37.34 13.61 61.06 .002 
Group: Controls vs CWEOE -36.37 -19.10 -53.63 <.001 
Age (m) -0.70 -0.36 -1.04 <.001 
Group*Age interaction 0.74 0.30 1.18 .001 
Social functioning T-score 0.55 0.18 0.91 .004 
 
Figure 16.3 Social Preference Task fixation preference and age 
  
Control children (green, left), and CWEOE (blue, right) 
 
Higher social functioning scores, as measured via social functioning questionnaires, indicate 
poorer social functioning. Thus, with a Beta of 0.55, poorer social functioning was 
independently associated with increased fixation preference toward the social scene. It can 
therefore be taken that increased social scene fixation preference is, as measured in this 
particular task, indicative of less advanced, or poorer, social functioning.  
Social Preference and Neurobehavioural Problems 
Data on the relationship between fixation preference and those who met criteria for 
neurobehavioural problems (details of which were described in section 12.4.7) is presented in 
table 16.3. Only one CWEOE met criteria for NEPSY II Affect Recognition and Theory of Mind 




impairment, social domain problems, and those at higher risk of ASD had larger fixation 
preferences for the social image. This was significant for those with GCA impairment and social 
domain problems. 
Table 16.3 Fixation preference in CWEOE with and without neurobehavioural problems  
 
Age range Problem (n)* 
Fixation Preference 
% (SD) 
MD 95% CI p 





-26.04 (-48.07, -4.00) .02 





-12.89 (-24.99, -0.78) .038 





-8.53 (-25.63, 9.10) .34 





- - - - 





- - - - 
* The total number of  children included is dependent on age-range of tool 
 
Child/children and Head Region Analysis 
CWEOE (N=47, M=14.41%, SD=9.33) and controls (N=38, M=15.27%, SD=9.93) spent a similar 
proportion of time within the social image fixating the head region (MD= -0.86% [95% CI -
5.03, 3.30], p<.68), although controls (M=34.72%, SD=13.96) spent more time fixating the 
child/children than CWEOE (M=28.06%, SD=12.44); MD= -6.66% (95% CI -0.96, -12.36), p=.023. 
This indicates a reduced attraction to socially relevant stimuli in CWEOE. Control children 
fixated less on the child/children region with increasing age (rs=-.52, p=.001), but CWEOE did 
not (rs= -.04). This followed the same pattern observed toward the social scene itself, and 
supports the assertion that eye-gaze behaviour to the social scene is driven by the 
child/children.   
Summary 
Control children exhibited a stronger social fixation preference during infancy which reduced 
linearly by preschool age, and which coincided with time spent looking at the child/children 




mature social cognitive development; hence, a stronger social preference in infancy, that 
reduced with age, and why poorer social functioning scores were related to increased social 
fixation preference. CWEOE also displayed a social fixation preference, but this was weaker 
than controls, with no age-related correlation, suggesting a significant reduction in attraction 
to socially relevant information during the earlier years. CWEOE spent proportionately less time 
looking at the child/children regions. Taken together, CWEOE exhibited abnormal gaze 
behaviour toward socially relevant stimuli, as a function of being less drawn toward 
child/children within the social scene. The Social Preference Task was not sensitive toward ASD 
behaviour in this early-onset cohort, but was related to social functioning as measured by 





16.2 Face Scanning Task 
16.2.1 Face Scanning Task: Background 
The face is a socially pertinent stimulus that conveys important communicative information 
such as gender, mood, and intention.  In humans, the face is of particular social importance, 
being processed by a specialised brain region known as the fusiform face area (Kanwisher et 
al., 1997), and with development occurring earlier than body perception (Slaughter et al., 2002). 
Newborns, only minutes to hours old, prefer the face to face-like representations (Goren et al., 
1975; Johnson et al., 1991; Maurer and Young, 1983), with face processing becoming 
increasingly specialised over the first months of life (Simion et al., 2007). The eye region of the 
face is of particular social importance, with newborns showing a preference for faces with eyes 
open compared to eyes closed (Batki et al., 2000), and with a preference for eyes rather than 
mouth by infancy (Gillespie-smith et al., 2016; Telford et al., 2016). 
Visual preference for social information is atypical in children and adults with ASD, including 
gaze behaviour toward faces (Boraston et al., 2008; Chawarska et al., 2012; Chawarska et al., 
2013; Dalton et al., 2005; Jones et al., 2008; Klin et al., 2002; Pelphrey et al., 2002).  In a study 
investigating the processing of neutral static faces, Chawarska and Shic (2009) reported normal 
face scanning in two year old typically developing children and ASD children. However, 
children with ASD spent more time looking at outer-facial features (i.e. hair, cheeks and 
forehead) than typically developing children. This atypical fixation preference was more 
pronounced in 4 year old children with ASD, who looked at the eyes, nose and mouth regions 
less so than even their younger counterparts.  
Recently, Telford et al., (2016) found gaze behaviour differences in facial scanning between 
typically developing infants, and infants born pre-term. Social communication difficulties are 
common in preterm children, yet only 1-8% develop ASD (Johnson et al., 2010; Kuzniewicz et 
al., 2014), suggesting face scanning may be a marker of social communication difficulties. As 
social problems including ASD are common in children with epilepsy, it is therefore of interest 
to explore face scanning in CWEOE. The fundamental model of viewing static neutral faces, as 
used by Chawarska and Shic (2009) and Telford et al., (2016), was adopted for this study as a 
base measure of face processing - as other factors such as emotion, context, or speech can 
influence gaze behaviour (Sasson and Touchstone, 2014; Shic et al., 2013; de Wit et al., 2008). 




CWEOE, and to determine to what extent gaze behaviour was related to behavioural measures 
of social cognition and problems, or risk of ASD. It was hypothesised that CWEOE would display 
typical eye gaze behaviour, but those at risk of ASD or with social problems would display 
atypical eye-gaze behaviour. 
16.2.2 Face Scanning Task: Methods 
The Face Scanning Task entailed free-viewing of photographs of human faces. Similar design 
has been used in infants (Gillespie-Smith et al., 2016; Telford et al., 2016), and preschool 
children (Chawarska and Shic, 2009). The task used six photographs (3 male and 3 female) of 
adult faces presented on a blue background, selected from the 2D face database at the 
University of Stirling (http://pics.psych.stir.ac.uk). Emotional expressions and direction of eye-
gaze influence facial and neural processing (e.g. Hoehl and Striano, 2008; Leppanen et al., 
2007). Therefore, emotionally neutral faces with direct gaze were selected as a baseline 
measure of face processing. The specific faces used were validated in a cohort of typically 
developing infants (Gillespie-Smith et al., 2016). Photographs were displayed on a computer 
screen at 16cm x 21.5cm. The task consisted of 6 trials, with three trials in each block.  Each 
trial lasted 10s with an ISI of 4s (Gillespie-Smith et al., 2016).  
General statistical analysis was described in section 12.4.6. Previous research has found fixation 
preference for central facial features (Chawarska and Shic, 2009), and for eyes compared to 
mouth (Gillespie-Smith et al., 2016). Therefore, analysis was focused on fixation preference and 
first fixation preference to: (1) central facial features (i.e. eyes, nose, and mouth) vs peripheral 
facial features (i.e. hair, forehead, ears, cheek, chin, and neck); and (2) within central features 
(i.e. eyes vs nose vs mouth), with focus on eyes vs mouth. AOIs for facial features were 
illustrated in 12.5.1. Both within- and between-group analysis was conducted for fixation 
preferences and first fixation preferences. Fixation preference was associated with 
neurobehavioural measures of social cognition and functioning, and compared between those 
with and without neurobehavioural problems in CWEOE (see section 12.4.7). For the purposes 
of comparisons to age and neurobehavioural tools/scales, fixation preference scores were 
calculated by subtracting the TFD on one face region (e.g. peripheral face features) - as a 
proportion of TFD to the entire image -, from the proportion of TFD on the competing region 





16.2.3 Face Scanning Task: Results 
46 CWEOE (98%) and 41 controls (100%) were included in analysis. One CWEOE had fixation 
data available for only one trial, and was therefore excluded from analysis.   
Central Facial Features vs Peripheral Features  
Compared to one another, CWEOE and controls spent a similar proportion of time fixating on 
the central features, peripheral features, and rest of the image (p=.67, r=.05) (figure 16.4). 
Within-group analysis found that fixation preference (i.e. proportion of time spent fixating 
central features – peripheral features) in CWEOE (Median=53.31% [IQR 9.82, 72.55]) and 
controls (Median=51.99% [IQR 9.13, 63.21]) was stronger for central facial features compared 
to peripheral features. Both CWEOE (Median=67% vs 17%; p<.001) and controls (Median=75% 
vs 17%; p<.001) also fixated first more often on the central features than peripheral features. 
There was no significant relationship between fixation preference and age, or first fixation 
preference and age, in CWEOE or controls.  
Figure 16.4 Percentage of fixation duration to facial feature regions 
  
Median percentage of fixation duration by group (left) and corresponding regional AOIs (right). 
 
Central Feature Analysis (Eyes, Nose, and Mouth) 
Analysis of fixations toward the eyes, nose and mouth regions revealed significant within-




the nose or mouth regions (figure 16.5). Controls fixated the nose region longer than CWEOE 
(p=.036, r=.23), but looked at the eye and mouth regions to a similar degree.  CWEOE (
=20.78, p<.001) and controls ( =6.27, p=.043) looked first more often toward the eye region 
compared to the nose or mouth regions, with no between-group differences. There were no 
significant correlations between fixation preference and age, or first fixation preference and 
age, in either CWEOE or controls. 
Figure 16.5 Median percentage of fixation time on eye, nose, and mouth regions 
 
Median fixation duration to eyes, mouth, and nose regions (left), and corresponding regional AOIs 
(right). 
 
Neurobehavioural Assessment Scores and Facial Feature Processing 
Spearman’s rank coefficients for correlations between social behaviour tools/scales (i.e. Social 
functioning, ABAS-II Social Composite, NEPSY-II Affect Recognition, NEPSY-II Theory of mind, 
SRS2 Communication & Interaction Index, and SRS2 Total) and fixation preference to central 
facial features were small, ranging between .05 and .24. Likewise, correlations with fixation 
preference to the eye region (i.e. proportion of TFD on eye region – proportion of TFD on 
mouth region) ranged between .02 and .28. No correlations were statistically significant. 
Additionally, there was no significant correlation between fixation preference and GCA score, 
meaning that neither parent-reported social functioning behaviours nor GCA was related to 





Table 16.4 Central/peripheral fixation preference and neurobehavioural problems in CWEOE 
 Age range Problem (n) Median (IQR) p r 
GCA impairment ≥1m 
No (43) 
Yes (3) 
55.17 (18.12, 73.01) 
6.72 (-33.32, n/a) 
.15 .21 
Social Domain problem ≥1m 
No (29) 
Yes (13) 
55.17 (7.93, 72.70) 
53.64 (15.97, 69.63) 
.90 .02 
ASD Risk ≥16m 
Lower (29) 
Higher (6) 
55.17 (8.79, 72.70) 
46.44 (-20.55, 71.47) 
.90 .02 
NEPSY II Theory of Mind Problem ≥36m 
No (22) 
Yes (1) 
- - - 
NEPSY II Affect Recognition Problem ≥36m 
No (22) 
Yes (1) 
- - - 
* The total number of  children included is dependent on age-range of tool 
 
Table 16.5 Eyes/mouth fixation preference and neurobehavioural problems in CWEOE 
 Age range Problem (n) Median (IQR) p r 
GCA impairment ≥1m 
No (43) 
Yes (3) 
55.22 (3.48, 80.60) 
-13.72 (-70.18,n/a) 
.068 .27 
Social Domain problem ≥1m 
No (29) 
Yes (13) 
55.22 (4.10, 78.09) 
19.12 (-6.82, 79.18) 
.78 .04 
ASD Risk ≥16m 
Lower (29) 
Higher (6) 
30.67 (-2.81, 78.18) 
51.98 (34.13, 87.30) 
.24 .20 
NEPSY II Theory of Mind Problem ≥36m 
No (22) 
Yes (1) 
- - - 
NEPSY II Affect Recognition Problem ≥36m 
No (22) 
Yes (1) 
- - - 
* The total number of  children included is dependent on age-range of tool 
 
Analysis of those with and without neurobehavioural problems in CWEOE revealed that fixation 
preference for central/peripheral facial features (table 16.4) or eye/mouth regions (table 16.5) 
was not significantly different. Sample sizes of those with GCA impairment or those at higher 
risk of ASD were small, and results should be treated with caution. Based on the data available, 
the Face Scanning Task was not a sensitive marker of social behavioural development in 
CWEOE, and did not identify those with neurobehavioural problems. It is important to reiterate 




it is also important to note that several of the behaviour tools were not applicable to infants 
(i.e. NEPSY II, MCHAT, and SRS2), and it is unclear how effective the Face Scanning Task is to 
this age group. 
16.3 Social Cognition Discussion 
Much previous work has focused on social attention in children with ASD. Here, we extended 
that growing body of work to focus on children with epilepsy, a disorder known to have 
increased risk of social problems including ASD. The CWEOE cohort here had poorer levels of 
social functioning, and it was hypothesised that performance on the social attention eye-
tracking tasks would be atypical in those children meeting criteria for social problems, and 
those at higher risk of ASD. The results of the Social Preference and Face Scanning tasks 
provided a slightly more complex picture of social attention in CWEOE. Visual social attention 
atypicalities were dependent on the nature of the social stimulus. Namely, CWEOE with social 
problems or those at risk of ASD viewed faces normally, but at the group level, CWEOE had 
atypical gaze behaviour toward social scenes compared to non-social scenes. This latter finding 
was independently influenced by age and social functioning, both of which point toward 
abnormal social cognitive development in CWEOE. 
Gaze behaviour in control children echoed that found in previous research of typically 
developing children. Control children preferred more socially relevant features of faces (i.e. the 
central features), particularly the eye region when compared to the mouth. This replicated 
previous findings in infants (Gillespie-Smith et al., 2016; Telford et al., 2016), and toddlers and 
preschool children (Chawarska and Shic, 2009). In the Social Preference Task, control children 
displayed attentional priority and attentional importance toward socially relevant scenes, 
which was driven by attention toward child/children within the scene. This has previously been 
noted in typically developing infants (Gillespie-Smith et al., 2016; Telford et al., 2016), and 
adults (Fletcher-Watson et al., 2009).  
Whilst it was hypothesised that CWEOE with poor social functioning would display atypical 
social attention, the same was not expected in CWEOE as the whole. CWEOE’s gaze behaviour 
in the Social Preference Task may therefore point toward a global immaturity in social cognitive 
development. Control children had a strong preference for the social scene in infancy, which 
reduced linearly with increasing age. This pattern was absent in CWEOE, with infants and older 




with age in controls may indicate that the task stimuli were not sufficiently complex enough 
to elicit prolonged gaze attention in typically developing toddlers/preschool children. 
Conversely it may reflect differences in age-related visual importance and processing. In any 
case, the fact that age was independently related to fixation preference suggests that the 
absence of that pattern in CWEOE was reflective of abnormal social attention.   
It is unclear why CWEOE spent proportionately less time fixating the child/children within the 
social scene than controls.  Attention to the child/children was the driving force behind the 
pattern of age-related gaze behaviour seen in control children. Time spent fixating on the head 
region was similar between groups, and results from the face scanning task clearly 
demonstrated typical attention to the face and eyes in controls and CWEOE. Therefore, 
orientation to the child/children themselves within the social scene may have a different 
gravitas than that of faces. As previously described, typically developing infants are drawn to 
social stimuli, and it is plausible that with age and advancing visual and cognitive development, 
that children may have shown an increased interest in scene context and objects within the 
social and competing non-social scenes. However, this could not be directly assessed in the 
current study because the stimuli were not designed for this purpose. Nevertheless, it does 
raise the possibility that CWEOE attend atypically to non-facial social stimuli (i.e. whole bodies). 
Therefore, one possibility is that CWEOE had less interest in child/children because the body 
had less social relevance to them. Bodies are socially informative, and the detection and 
recognition of faces and bodies may be served by different networks that develop at different 
age-related stages (Slaughter et al., 2004). Therefore, a second, and perhaps not mutually 
exclusive possibility, is that CWEOE have immature neural networks involved in body 
recognition, or processing.  Given the absence of an age-related pattern of fixation preference 
in CWEOE, an alternative explanation may be offered. That being the presence of a dual age-
related pathology rather than a global explanation. That is, there may have been a reduction 
in attention to the social scene in infants (i.e. social orientation), and an abnormal increase in 
social scene engagement in older children (i.e. attentional disengagement) – and this could be 
explored with future task manipulation.  
Eye gaze behaviour in the Social Preference Task and Face Scanning Task was not associated 
with ASD behaviours, nor was performance different in those at higher risk of ASD. Thus, the 
eye-tracking tasks employed here were not effective predictors of those at risk of, or displaying 
behaviours associated with ASD. Several studies have now reported typical scanning of static 




et al., 2007). Children with ASD (or those at risk of ASD) may be drawn toward socially salient 
features in a similar way to typically developing children when viewing static images, but 
evidence suggests that gaze behaviour may differ when non-static stimuli are used. Speer et 
al. (2007) gave children with, and without ASD, static and dynamic social stimuli and found that 
atypical eye-gaze behaviour in ASD was only found for dynamic social stimuli. Similar 
abnormalities in face viewing in children with ASD using dynamic stimuli have been found 
elsewhere (Jones et al., 2008; Jones and Klin, 2013; Klin et al., 2002).  Wass et al. (2015) found 
abnormalities in fixation duration to static social images related to presence of ASD, but when 
developmental level was considered, the role of ASD was no longer significant. This suggests 
that abnormal eye-gaze behaviour toward social stimuli may, alternatively, be a function of 
development rather than ASD. In support of this, Telford et al., (2016), using the same eye 
tracking tasks as in the current study, in addition to others, found that preterm infants spent 
less time looking at social stimuli than term infants. Thus, a lack of relationship between 
fixation preferences and ASD in the current study may be due to the use of static images, or 
because the CWEOE displaying ASD behaviours had sufficient neurological developmental. 
Interestingly, those CWEOE with GCA impairment, which may reflect poor general 
development, had increased fixation to the social image in the Social Preference Task 
compared to those with normal GCA – and perhaps offers supportive evidence of abnormal 
social gaze behaviour in those with poorer neurological development as opposed to 
neurological maldevelopment associated with ASD. One limitation of the current study was 
the tool used to measure ASD behaviour as a continuous variable (i.e. SRS-2) was available 
only for children from 36 months of age, and it was therefore not possible to correlate fixation 
preference in younger children with ASD-type behaviours. That said, no relationship was found 
between fixation preferences and ‘risk of ASD’, as measured through the SRS-2 and M-CHAT, 
which was applicable to children from 16 months of age. It should also be noted that the 
CWEOE included in the eye-tracking study tended to have less severe epilepsy, and the findings 
may only apply to less developmentally impaired children with ASD behaviours.   
Interestingly, measures of social functioning used in the present study independently predicted 
fixation preference in the Social Preference Task. The social functioning construct used in this 
study was a reflection of social skill development, peer relationships, social engagement, and 
social temperament. Given that ASD behaviour was not associated with fixation preference, the 
findings then lend support to the notion that this task reflected a different social construct 
than that measured through ASD assessment tools. The same relationship was not found in 




attention. In the Social Preference Task, typically developing children fixated less toward the 
social scene with age, suggesting that, in this particular task, increased social preference was a 
marker of developmental immaturity. It makes sense, therefore, that poorer social functioning 
was related to increased fixation duration the social scene. Despite the evident relationship 
between social functioning and social preference, regression modelling revealed that social 
functioning, age, and epilepsy accounted for only 29% of the variance in fixation preference. 
This indicated that other unknown factors contributed toward gaze behaviour in the social 
preference task. As argued above, developmental level may also be one of those factors. 
Nevertheless, it is promising that such a task may be capable of identifying young children 
with social functioning problems.    
One limitation of the eye-tracking tasks used here was that they had been originally created 
for infants, and perhaps lacked the developmental appropriateness to adequately assess social 
attention in toddlers and preschool children.  Despite clear differences between CWEOE and 
controls in the Social Preference Task, the pattern of age-related gaze behaviour observed 
adds complexity to the interpretation, and future research should explore age related 
differences in social attention by manipulation of task design.  Nevertheless, the eye tracking 
tasks used here have provided useful insight. Namely, that CWEOE display atypical attention 
to social scenes involving young children, but scan faces in a typical fashion. This suggests that 
CWEOE have underdeveloped social cognition, and that eye-tracking tasks such as the Social 
Preference Task may be useful tools in the early identification of children with cognitive 
impairment or poor social functioning. As mentioned previously, the tasks were not effective 
predictors of ASD, but that conclusion is somewhat tentative given the age restriction of the 
ASD tools. Therefore, it would be informative to follow infants longitudinally and relate their 
fixation preferences to ASD scores in the future. With particular regard to face scanning, future 
research in CWEOE could also assess other aspects of face scanning to dynamic stimuli, and 
emotional expression recognition. A number of studies have found impaired facial identity and 
emotional recognition in various childhood and adult epilepsy syndromes (Gomez-Ibanez et 
al., 2014; Golouboff et al., 2008; Lunn et al., 2015; Meletti et al., 2003; Meletti et al., 2009). Facial 
and emotional recognition is a valuable social skill (Harrigan, 1994), and deficits can be 
reflective of developmental disorder or social communication difficulties (Lunn et al., 2015; 
Uljarevic and Hamilton, 2012). It is therefore worth exploring in CWEOE. 
In conclusion, the social attention based eye tracking tasks used here are the first in CWEOE, 




problems may be a hallmark of childhood epilepsy (Rodenburg et al., 2005), and eye tracking 





17. Eye-gaze Behaviour in CWEOE: General Discussion 
The aim of this chapter was to explore eye-gaze behaviour in a cohort of CWEOE, with 
particular focus on exploring the potential of eye-gaze behaviour as a marker of 
neurobehavioural problems. In doing so, this is the first study to use eye-tracking in infants, 
toddlers, and pre-schoolers with epilepsy. The study focused on three broad domains: 
cognition/memory, attention/inhibition, and social cognition, using five tasks designed to 
measure certain aspects of visual attention associated with each domain. As a group, CWEOE 
showed largely similar gaze behaviour to that of typically developing control children. 
However, several issues were found that result in the conclusion that CWEOE do indeed display 
abnormalities in visual attention.  In the most poignant, CWEOE were found to display 
abnormal visual attention to naturalistic social scenes containing child/children. This finding 
was related to behavioural measures of social functioning, and has therefore shown promise 
of clinical applicability. CWEOE were also found to have a slight delay in the speed at which a 
new stimulus was fixated following active inhibition. This finding was not related to the speed 
at which CWEOE could produce a typical prosaccade, which appeared to be normal, but with 
cost of information processing after saccadic inhibition. This was an incidental finding, and one 
which was not the initial subject of investigation. Likewise, indirect evidence from the study 
also pointed toward impaired sustained attention within trials in CWEOE, despite normal 
general attention to the battery.  
This study was exploratory in nature with methodological considerations that require further 
refinement, but nevertheless, it does point out that eye-tracking in infants and young children 
with epilepsy is possible, that abnormalities are evident, and that it is of potential use as a 
marker for neurobehavioural problems. Identifying such abnormal eye-gaze behaviour is of 
interest from a neuroscientific, psychological and clinical perspective. Such data are 
informative in understanding the underlying cognitive processes involved in visual attention 
in children with epilepsy, the influence these processes may have on behaviour and learning, 
and the application to clinical diagnosis and markers of change. Social problems, for instance, 
are common, and possibly core manifestation of childhood epilepsy (Rodenburg et al., 2005). 
Accordingly, the findings of the current study may be indicative of early markers of impaired 
or immature social cognition, even at such an early age. They may also act as a marker of 
problems at the behavioural level, as evidenced by the association between fixation preference 




One of the main goals was to indeed identify children with neurobehavioural problems 
through eye-gaze behaviour. Whilst that proved successful in the Social Preference Task, the 
remaining tasks were not sensitive to their respective neurobehavioural measures. This lends 
further support to the notion that the eye-tracking tasks were independent, and were not 
simply measuring visual attentive systems associated with an epileptic brain. The reason why 
those with neurobehavioural problems were not discriminated in the remaining tasks may have 
been influenced by two factors. First, there were limited numbers of children who met criteria 
for neurobehavioural problems to robustly assess the validity of those relationships. This was 
case for most of the tools used to determine problem behaviour, where only a small number 
of children met problem criteria. This was a prospective study, where the cognitive and 
behavioural status of the children were unknown prior to study enrolment, and replication of 
the analysis with greater sample sizes of children with problem behaviours would be advised 
before drawing any firm conclusions. Second, and alternatively, the mechanisms of visual 
attention involved in those eye-tracking tasks may not have been related to the respective 
neurobehavioural tools. The memory task for instance was a proxy for GCA (Rose et al., 2005; 
Rose et al., 2012; Fagan et al., 2007), yet it had only a weak correlation with it. Nor was it 
correlated with memory measures except for a moderate correlation with a visuospatial 
performance-based tool, the NEPSY II Memory for Designs. This task, and the others, may have 
been expected to discriminate children with neurobehavioural problems if a stronger 
relationship had been identified via correlations with those tools. As this wasn’t the case, it is 
unlikely that given larger numbers the eye-tracking tasks would have been greatly different. It 
is also possible that other neurobehavioural tools of cognition and behaviour may provide a 
stronger correlation, and this could be explored in future work.  
This study was limited through several methodological considerations. The cohort of CWEOE 
was prospectively gathered, and consisted of a heterogeneous population with variable verbal 
abilities, ages, and clinical characteristics. As a result, the eye-tracking findings are limited to a 
population of mixed epilepsy syndromes and presentations. Many of the more severely 
affected CWEOE were not successfully eye-tracked or enrolled, and the results are therefore 
more applicable to those less severely affected by the condition. This is understandable given 
that severe epilepsy, particularly in the very young, is often accompanied by developmental 
impairment or visual impairment, making it difficult for the child to orient themselves to the 
task, as well as achieve successful attention and calibration. West Syndrome for instance 
encompasses both developmental regression and visual impairment (Jambaque et al., 1993), 




eye-tracking. Although this does not discredit the results, it must be made clear that the results 
are not generalisable to the entire CWEOE population, particularly the more developmentally 
compromised. In fact, it is encouraging that eye-tracking is successful in infants, toddlers, and 
pre-schoolers with epilepsy, and that it can detect abnormalities in those less severely affected, 
who may indeed have more subtle cognitive or behavioural problems.  
As mentioned previously, the eye-tracking tasks were selected based on their intended 
psychophysiological mechanisms, and applicability to a developmentally mixed cohort. As 
such, they may not always be suitable for certain age groups - as was suspected to be the case 
in the SNP Task. Eye-tracking itself is still very much in early development in terms of its 
applicability to neuropsychological understandings, the clinical context, or as a diagnostic tool. 
Eye-tracking paradigms are not yet commercially available, nor do they have validated 
psychometric properties. In the present study, the Memory Task, Social Preference Task, and 
SNP Task were created for use primarily in infant populations, and as such may not have been 
best-suited for toddlers or preschool children. It is possible that null findings were due to task 
simplicity, and more cognitively demanding tasks may return different results. Abnormal 
behaviour to that of controls was observed in the Social Preference Task, and it may be the 
case that further evolution and refinement of these tasks may produce alternative results.  
Naturally, future research in CWEOE could build on the work presented here. Namely by using 
more complex or cognitively demanding paradigms to gauge memory, social cognition, and 
attention in toddlers and preschool aged children. For example, the Memory Task used a VPC 
design of two competing stimuli. The stimulus design could feature increasingly discrete visual 
differences, or stimulus capacity could be increased to three or more items. It would also be 
advantageous to follow-up the existing cohort in order to track the trajectory of development 
in relation to their present eye-gaze behaviour. Rose et al. (2005; 2012), and Fagan et al. (2007), 
for example, have associated early eye-gaze behaviour with later working memory ability and 
cognitive development. Future research into CWEOE could also explore paradigms targeted at 
assessing the visual components of attention. As was evidenced by this study, CWEOE might 
have difficulty with sustained visual attention, which could potentially be a marker for attentive 
difficulties or school achievement for example. Finally, this was a heterogeneous population of 
epilepsy types and presentations. Epilepsy syndromes can present with differing 
neurobehavioural profiles, and future research should also take this into consideration by 




To conclude, this study was exploratory, and serves as a first step in the study of eye-gaze 
behaviour in CWEOE. It has discovered a basic abnormality in how CWEOE view natural social 
scenes, which may help in the study of underlying mechanisms involved in social cognition 
and the development of social problems in children with epilepsy. The study also provided 
contradicting data on antisaccade production, and issues involving SNP, in typically developing 
children, which will be of interest to visual attention researchers. Whilst eye-tracking is an 
evolving technology, and its clinical application is only emerging, eye-tracking itself is a highly 




Chapter V. Conclusions 





This research study was created in order to understand the neurobehavioural burden of early-
onset epilepsy. Given that a detailed description of the sociodemographic and clinical 
characteristics of early-onset epilepsy itself was provided, the findings presented here can be 
seen as truly representative of the early-onset epilepsy population. The addition of eye-
tracking as a marker of neurobehavioural problems may provide the beginnings of a new 
direction of exploration with which neurobehaviour could be understood and problems 
detected in CWEOE. 
This was the first population-based study in Scotland describing the sociodemographic and 
clinical characteristics of CWEOE, estimating the incidence of CWEOE and West Syndrome, and 
determining the risk factors for early-onset epilepsy. Thus, the results here provide up-to-date 
data in the UK, and new data in Scotland. Likewise, and to the candidate’s knowledge, this was 
the first population-based study which has focused on a general cohort of children with 
epilepsy under the age of five years which has provided a detailed description of the patterns 
of cognitive and behavioural functioning of that population. Although several studies have 
provided data on children whose onset began in the first five years of life, the systematic review 
in section 1.3 revealed that very few had provided data during those first five years. Thus, this 
study has provided valuable data on cognition and behaviour in CWEOE during the early years, 
and compliments those conducted later in childhood.  
The central hypothesis of this study was that CWEOE would have an abnormal 
neurobehavioural profile compared to the general population. That is, poorer cognitive 
functioning and more problematic social-emotional behaviour compared to controls, as well 
as having a greater prevalence of neurobehavioural problems. The findings of this study 
support that assertion, and notes that although some neurobehavioural domains appear to be 
affected more so than others in the general CWEOE population, the risk of neurobehavioural 
problems remained high throughout. As such, this study has highlighted the increased 
vulnerability to cognition and behaviour in individuals with epilepsy during this age.  
As a result of the findings in this study, there are a number of possible implications that require 
addressing.  The first is that a higher risk of epilepsy was found in white-European and Asian 




for further research and the formulation of preventative strategies for these particular 
populations within the health community.  
Second, the high degree of neurobehavioural problems identified in this cohort necessitate 
closer scrutiny of how the early-onset epilepsy population is managed. Psychiatric diagnoses 
are more common in school-aged children compared to preschool aged children (Merikangas 
et al., 2009; Wichstrom et al., 2012). However, this may be partly driven by the inherent difficulty 
in distinguishing normal from abnormal behaviour in very young children but is also likely due 
to attitudes and beliefs by health care professionals toward the measurement and judgement 
of abnormal behaviour in very young children. There may be a tendency to dismiss problem 
behaviours in the young as temporary, yet contradictory evidence on the pervasiveness of 
neurobehavioural problems, reported in the section 1, and the results reported as a result of 
the current study suggest that these concerns should not be so quickly dismissed. Therefore, 
this has implications for policy and practice pertaining to the care and management of CWEOE. 
This is particularly relevant in Scotland, where over the last decade there has been a focus on 
policy aimed at improving development and mental health across infancy and the early years, 
with an aim to increase awareness, provide integrative holistic services, and identify individuals 
and groups at risk (Geddes et al., 2010; Puckering, 2007; Scottish Executive, 2005; Scottish 
Government, 2008). In addition, parents could be made aware of the possible risks to cognition 
and behaviour upon presentation of epilepsy when under clinical care. Thus providing 
opportunity for behavioural monitoring, as well as parental education in behavioural 
management. Furthermore, the fact that neurobehavioural problems were identified at an early 
age provides a strong case for early intervention in CWEOE. As noted in chapter I, section 1, 
the early identification of problems is highly beneficial for earlier and successful interventions. 
Such early childhood interventions are advocated by the Scottish Government (Geddes et al., 
2010; Scottish Government, 2008), and the results found here suggest that CWEOE should be 
considered as an at risk group for early intervention. 
Third, a high degree of comorbidity was found in CWEOE, the nature of which varied 
considerably. Comorbid problems in childhood epilepsy are under-recognised and often go 
untreated (Carson et al., 2015; Ott et al., 2003; Reilly et al., 2014a), making the case for 
identification more pertinent. The findings of this study, and others in later childhood, strongly 
suggest the need for multi-dimensional screening. As mentioned previously in this thesis, 




routine clinic. A comprehensive understanding of the child’s needs is essential in order to 
provide targeted and holistic care.   
Finally, the early detection of neurobehavioural problems in children was an issue raised at the 
beginning of this thesis. It was explained that there is a current lack of standardised and 
validated diagnostic tools at this age. One of the aims of this study was to explore eye-tracking 
as a marker of neurobehavioural problems in CWEOE. The results here suggest that eye-
tracking is a viable technology worthy of further exploration and refinement, but one that may 
be more suited to those with less severe epilepsy. That said, eye-tracking is an evolving 
technology, and creative use of different hardware formats and eye-tracking paradigms may 
yet prove to be more suitable. Furthermore, the use of eye-tracking as a screening tool for 
neurobehavioural problems could offset the need for blanket screening using standardised 
assessment methods. 
Limitations and Future Directions 
The limitations and directions for future research of individual aspects of this study have been 
reported in the relevant chapters. Several wider issues are briefly described here.  
In the introduction to this thesis it was argued that early-onset of epilepsy was an independent 
risk factor for neurobehavioural problems. Whilst this study has shown that abnormal 
cognition and behaviour is detectable, and that neurobehavioural problems are highly 
prevalent in CWEOE, it was beyond the scope of this study to directly compare these findings 
to older children with epilepsy in South-East Scotland. Therefore, it would be beneficial to 
follow up the current cohort to track the natural history of neurobehavioural problems in 
CWEOE over time, which currently remains unclear.  Children were assessed near the onset of 
their disease, and following the development of these children over time would allow closer 
examination of the effects of chronic seizures, duration of epilepsy, seizure remission, and AED 
use on cognition and behaviour by later childhood.  
The high rate of comorbidity, and evidence of problems at the beginning of the disease, also 
suggest that underlying factors contribute toward the neurobehavioural profile of CWEOE. 
Imaging studies have provided strong evidence that cortical abnormalities are present at distal 
sites from seizure locus. Temporal lobe epilepsy, for example, is typically characterised by a 




volumetric reductions have been found in temporal, parietal, and occipital cortices, as well as 
sub-cortical structures within, and extra to, the temporal lobes – and in hemispheres both 
ipsilateral and contralateral to the side of seizure focus (Keller and Roberts, 2008). The brain 
has billions of connections and cognitive functions operate on a network basis rather than via 
discrete structures (McIntosh, 2000; Price and Friston, 2005). Abnormal activation of synaptic 
projections coming from the initial site of epileptic lesion (Avanzini et al. 2014), may be one 
potential explanation of widespread brain abnormality and cognitive deficits. As no imaging 
studies have focused on CWEOE, it would be informative to explore the links between brain 
function and structure in CWEOEO and the presence of neurobehavioural comorbidities.   
Eye-tracking was used on an exploratory basis in this cohort, and the tasks used in this study 
where chosen due to their applicability across a relatively diverse age group made up of 
differing age-related developmental and verbal abilities. Eye-tracking was successfully 
employed in this age group approaching it in this way. However, the findings here also suggest 
that certain tasks may be more suited to certain ages, and it is therefore recommended that 
future studies take this into consideration.   
Concluding Comment 
It can be argued that the body of work contained in this thesis has met its goal in contributing 
to the existing knowledge base, whilst meeting its primary aims and objectives. 
NEUROPROFILES has (1) estimated the incidence of early-onset epilepsy, (2) described the 
neurobehavioural profile of CWEOE, and explored risk factors for neurobehavioural problems, 
and (3) explored eye-tracking as a marker of neurobehavioural problems in CWEOE. In doing 
so, it has contributed toward the existing childhood epilepsy literature, by providing unique 
data on an understudied group of children. These findings may also provide new and 
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Appendix A – Search strategy for systematic review (chapter I, section 1.3) 
Databases: (i) Medline (Ovid), (ii) Embase (Ovid), (iii) PsycINFO (Ovid), (iv) Web of Science 
(Thomson Reuters), and (v) CINAHL (EBSCOhost). 
Search term targets: Children, epilepsy, cognition, and behaviour. 
Search strategy by database:  
(i) Medline 
‘Advanced Search’ selected, and ‘Match term to subject heading’ checked (years 1970 – 
current). Terms; 
1. Subject heading terms; 
- Epilepsy (includes seizures and seizure disorders) 
- Preschool (subselect child preschool, child, infant) 
- Minors 
- Mental Processes (subselect cognition/executive function/learning [subselect memory]/Theory of 
mind/thinking/perception) 
- Intelligence 
- Psychological Tests (subselect intelligence tests(exp)/language tests/neuropsychological 
tests(exp)/psychometrics) 
- Psychology (subselect child psychology and child psychiatry) 
- Neuropsychology 
- Mental Disorders (subselect anxiety(exp)/impulse control/mood [expand ‘mental disorders 
diagnosed in childhood’ and select anxiety/attention(exp)/child behavior disorders/child 
development disorders [expand and select Asperger/autistic 
disorder]/communications/developmental disorder/learning disorder/intelligence 
disorder/motor/mutism/react/schizophrenia/stereo dis) 
- Comorbidity 
- Child Development  
- Neurobehavioral Manifestation (subselect communications/memory/intellectual 
disability/psychomotor disorders) 
-- Behavior (subselect Behavioral symptoms [subselect affective/aggression/depression/obsessive 
behavior/stress)) child behavior [select infant behaviour]/communications/impulsive 







2. Title and abstract free-text searches; 
- epilepsy.ti OR epilepsy.ab 
- children.ab. OR children.ti. OR infant*.ab. OR infant*.ti. OR toddler*.ab. OR toddler*.ti. OR preschool*.ab. 
OR preschool*.ti. 
- cogniti*.ab OR cogniti*.ti 
- behaviour.ti OR behaviour.ab OR behavior.ti OR behavior.ab 
 
Main search supplemented with title and abstract free-text search of ‘Ovid Medline In-Process 
& Other Non-indexed citations’ for non-indexed items posted in last six months. Search terms 
were: epilep*, child*, cognit*, and behavio?r.  
(ii) EMBASE  
‘Advanced Search’ selected, and ‘Match term to subject heading’ checked (years 1970 – 
current). Terms; 
1. Search terms; 
- Epilepsy (subselect seizure, epilepsy, and convulsion) 
- Infant 
- Toddler (subselect child) 
- Newborn 
- Minor (person) 
- Intelligence (expand and select intellect/intelligence quotient) 
- Psychologic Test 
- Neuropsychological test 
- Cognitive defect 
- Cognition (subselect attention/cognitive reserve/executive function/learning/memory/mental cap/mental 
development/mental performance/social cognition/Theory of mind/thinking) 
- Mental deficiency (subselect intellectual impairment) 
- Psychophysiology (subselect attention/sensorimotor function) 
- Behavior (subselect behaviour/adaptive behaviour/aggression/antisocial behaviour/child 
behaviour/emotion/”inhibition(psychology)”/misconduct/motor activity/psychological aspect/psychosocial 
dev/social behavior) 
- Psychology (uncheck psychology and select child psychology & developmental psychology) 
- Neuropsychology 
- Mental disease (expand uncheck mental disease and subselect anxiety disorder/autism/behavior 
disorder/emotional disorder/learning disorder/memory/mental deficiency/mood/thought disorder) 
- Child Development (subselect postnatal development) 
- Comorbidity 






2. Title and abstract free-text searches; 
epilepsy, children, infant*, toddler*, preschool*, cogniti*, and behavio* 
 
(iii) PsycINFO  
‘Advanced Search’ selected, and ‘Match term to subject heading’ checked (years 1970 – 
current). Terms; 
1. Search terms; 
- Epilepsy (subselect epileptic seizures) 
- Seizures 
- Encephalopathies 
- Infant development (subselect neonatal development) 
- Child development (subselect early childhood development) 
- Preschool Students (subselect nursery school and kindergarten) 
- Cognition (subselect cognitive development, cognitive impairment, and cognitive processes) 
- Cognitive ability (subselect spatial ability/verbal ability/cognitive processing speed/executive function) 
- Metacognition (subselect comprehension/memory/learning) 
- Intelligence (subselect intelligence quotient, intellectual development/reasoning/thinking) 
- Intellectual development disorder (subselect adaptive behaviour) 




- Attention deficit disorder (subselect ADHD/impulsiveness/ODD) 
- Mental disorders (subselect autism/impulse/PDD) 
- Social Behavior (subselect aggressive behavior/prosocial behavior/social cognition/social perception/social 
skills) 
- Behavior (subselect adaptive behaviour/ antisocial behaviour) 
- Behavior disorders (subselect aggressive behaviour/behaviour problems/conduct disorder) 
- Emotional states (subselect anxiety/depression/fear /emotional disturbances) 
- Child psychopathology (subselect child psychiatry/child psychology) 
- Neuropsychology 
- Learning disabilities 
- Memory (subselect episodic/long term/short term/spatial/verbal/visual) 
- Comorbidity 
- Language disorders (subselect communication disorders/specific language impairment/language 
delay/speech disorders) 
2. Title and abstract search terms; 





(iv) Web of Science  
Search using free-text search under ‘advanced search’ (years 1970 – 2014); 
Free-text search terms; 
- Epilep* 
- “Pediatric epilepsy” 
- “Childhood Epilepsy” 
- “Epilep* Encephalopath*” 





- Cognition (gets a lot of irrelevant hits) 
- “Intellectual Impairment” 
- “Cognitive-Intellectual-Performance” 
- “Executive Function*” 
- “Cognitive function*” 
- “Cognitive assessment” 
- IQ 
- “neuropsychology” 
- “neuropsychological function” 
- Intelligence 
- “Processing speed” 
- “Cognitive ability” 
- “Verbal Ability” 
- “Non-verbal ability” 
- Neurobehav* 
- “Neurobehavio$ral Comorbidit*” 
- “Psychiatric Comorbidity” 
- Psychopathology 
- Comorbid* 
- Behavio$r (returns a lot of  hits) 
- “Behavior disorder” 
- “Social behaviour” 
- “specific language impairment” 
- “speech disorder” (or) 
- “Communication disorder” (or) 
- “Language impairment” (or) 
- “Attention deficit hyperactivity disorder” (or)  
- ADHD 
- “Conduct Disorder” 
- “Social Cognition” 
- “Autism Spectrum Disorders” 
- Anxiety 
- Depression 
- “Memory Impairment” 
 
(v) CINAHL Plus (years 1970-2014) 
Search using CINAHL Headings and free-text searches; 
1. Search using CINAHL headings; 
- Epilepsy (exp) 
- Child (expand and select Child, Preschool and Infant [expand and select Infant, Newborn (exp)] 
- Cognition (expand and select learning, perception, thinking, memory [expand and select short term and 
recognition]) 
- Cognition disorders 
- Intelligence 




- Language disorders (expand and select speech disorders) 
- Behavior (expand and select Child behaviour [expand and select Infant Behavior], Social Behavior, Emotions 




- Autistic Disorder 
- Mental Disorders (expand and select Mental Disorders Diagnosed in Childhood [expand and select ADHD, 
Child Behavior Disorders, Child Developmental Disorders (exp), Communication Disorders (exp), Developmental 
Disabilities, Learning Disability]) 
2. Free-text title and abstract search terms; 
Epilep*, Children, toddler*, infant*, preschool*, cogniti*, “executive function*”, intelligence, IQ, “verbal 
ability”, “non-verbal ability”, memory, learning, language, speech, behavior, behaviour, neurobehavio*, 










Parent Information Sheet  
 
Study Title: NEURO-PROFILES – Neurodevelopment in Preschool Children Of Fife and 
Lothian Epilepsy Study 
 
You and your child are invited to take part in this research study on children with epilepsy. 
Please read through the information sheet before deciding if you would like to part. Contact 
details will be provided should you require more information. Thank you for taking the time 
to read this information sheet.  
 
Who is conducting the study?  
The study is being conducted by researchers from the University of Edinburgh in 
collaboration with colleagues from NHS Lothian and Fife.  Further information about these 
organisations can be found in the “More Information” section.  
 
What is the aim of the study? 
We aim to investigate how epilepsy affects children in ways other than just seizures as some 
children also have behavioural or thinking difficulties. These difficulties can often go 
unrecognised or untreated. The aim of this study is to be the first of its kind to determine 
what kind of difficulties children with epilepsy have, how common they are, and factors that 
might contribute to them. 
 
What we hope to achieve 
By performing studies like these we hope to ultimately improve the overall care and 
treatment for children with epilepsy and their families.  This will be done by using the 
findings to influence policies on epilepsy care and practice, and by improving treatment 
guidelines and educational resources.  
Why have I been invited? 
You have been invited because we hope to assess every child under the age of five with 




council areas or have received part of their care through a hospital in these regions. You have 
been identified through the Lothian and Fife NHS epilepsy network. We also hope to assess 
children without epilepsy for similar thinking and behavioural difficulties. 
 
Do I have to take part? 
You do not have to take part. If you decide not to take part this will not affect you or your 
child’s legal rights and it will not affect the quality of care your child will receive. 
 
What will happen in the study? 
We will ask you some questions about your child and to complete some questionnaires. 
These questions may include how your child is affected by epilepsy and aspects of your 
child’s behaviour. The questionnaires measure things like attention, mood, how a child 
behaves in social situations, and how they develop adaptive skills during childhood. You will 
be invited to the Royal Hospital for Sick Children, Edinburgh, Queen Margaret Hospital, 
Dunfermline, or the University of Edinburgh where we will ask your child to take part in some 
psychological tests to measure different aspects of their development such as memory, 
attention, and general development.  
 
We will also use eye-tracking to assess memory and attention. This involves watching a 
screen with still or moving pictures while a remote device situated on the computer records 
eye movements. This is safe and requires no direct contact with the eyes. Eye-tracking will 
take approximately 30-40 minutes. Eye-tracking is suitable for children with attention 
difficulties such as short attention span. 
 
As part of normal epilepsy clinical procedure your child will undergo an MRI scan. We will ask 
to obtain copies of your child’s scan. During an MRI scan the child is placed under general 
anaesthetic. An MRI uses a magnetic field to build a picture of the brain. It is a painless and 
harmless procedure. 
 
We will ask you as parent/legal guardian to sign a consent form on the day of assessment 
which will allow you and your child to take part. 
Are there any benefits to taking part? 
People take part in research for different reasons. Taking part in the research may be fun 
and/or of interest to you, and some people also feel they are giving back to the community.  
We will provide an individualized report of the neuropsychology assessment which you will 
receive upon completion of the study. Additionally this research may lead to a better 
understanding of childhood epilepsy and toward better treatment for those affected. 
 




The assessments pose no physical risk to you or your child. The questionnaires and tasks are 
tried and tested standard clinical assessment tools. Eye-tracking is non-invasive and requires 
no contact with the eyes. This study has been reviewed by the NHS South East Scotland 
Research Ethics Service. 
 
The assessment may take a few hours. The length of time will depend on factors such as the 
age of your child or attention and interest level. It is best to set aside a half day for 
assessment. There will be plenty of opportunity to take breaks as required. Assessment can 
be split over two or more occasions if you feel this would be better suited to your needs. If 
you or your child feel tired or stressed during assessment or for any other reason then you 
have the right to stop the assessment without giving explanation.  
 
Travel costs and lunch expenses (if required) will be reimbursed to a maximum of £30. Please 
keep any travel and/or expenses receipts. 
 
Should the testing reveal any implications for your child’s development such as learning  or 




    Flow chart of study and outcomes   
 




The results of the research will be published in appropriate peer-reviewed scientific journals 
for distribution to other healthcare professionals.  Talks and presentations may be made. In 
all cases, your name and personal details will not be identified. 
 
Will this information be kept confidential? 
Yes. The study adheres to strict UK legislation, NHS and University confidentiality guidelines. 
All information collected will be anonymised and no personal information will be made 
public. All participants will be given a unique code number in place of personable data. 
Information may be passed to your paediatrician to enhance the care of the child. As per the 
Child Protection Act (1995), all information will be kept in the strictest of confidence except 
where there is risk to the safety of your child. 
 
You have the right to end the study at any time without explanation. You also have the right 
to withdraw your data after the study if you so wish. 
 
Can I get involved in future studies? 
Yes. Tracking the progress of children’s development is vitally important in understanding 
how epilepsy effects the individual throughout their lifetime and how epilepsy itself 
influences the course of natural development.  We would like to follow-up your child to 
obtain a developmental profile over time. 
 
To do this we will ask for your permission to access routinely stored data on the social, 
education, and health care of your child. In Scotland routine information is held on children 
by the Scottish Government and National Health Service. Access to this information is 
carefully controlled and we would seek permission from relevant bodies such as the Privacy 
Advisory Committee before accessing information on your child.   
 
Such data might include statistics on hospital visits, pupil absence rates, or in-school support 
needs. By linking this kind of information with your data from the current NEUROPROFILES 
study, the research is more useful as we can look at the impact of early onset epilepsy on 
children’s longer term health and wider circumstances which will allow us to inform policy 
makers on the additional educational, health, and social needs of children with early onset 
epilepsy.  
 
Only relevant and necessary information would be made available to us.  We would not have 
access to your child’s full medical or other records.  We will take great care to protect the 
confidentiality of the information we are given and it will be used for statistical research 
purposes only. No information will be released from this or future studies that could identify 
individual participants or families. If you do not wish the research team to access this 




reaches the age of 12 years they will have the option to consent for themselves. The research 
team will contact them personally and ask for consent in order to access any stored 
information. 
 
Additionally we may invite you and your child to take part in future studies like this one 
which involve similar kinds of assessments. We do this to accurately track developmental 
paths which can vary greatly over time. However, you are under NO obligation to decide this 
now.  
 
We will simply ask to retain your contact details in order to contact you at a future time. If 
you would not like to be contacted in the future this will not affect your involvement in the 
current study in any way. 
 
Who do I contact if I have any more questions? 
If you have any questions about the study or about research in general you can contact the 
Research Fellow Matthew Hunter on 0131 536 0801 or email M.Hunter-7@sms.ed.ac.uk or 
the Chief Investigator Dr Richard Chin on 0131 536 0841 or email r.chin@ed.ac.uk.  If you 
wish to contact someone not involved in the study but who can provide information about 
the project then please contact Dr Jay Shetty, Consultant Paediatric Neurologist, RHSC on 
0131 536 0727 or email Jay.Shetty@nhslothian.scot.nhs.uk. 
 
What do I do now? 
You will be contacted by telephone by a member of the research team in no less than 24 
hours. You will have the opportunity to discuss anything further and decide if you would like 
to participate in the study.  
 
Let us take this opportunity to thank you for taking the time to read this information leaflet 
and for your interest thus far. 
 
What if I have a complaint? 
If you wish to make a complaint about the study please contact your NHS Health Board; 
 
NHS Lothian Complaints Team 
2nd Floor 
Waverley Gate 
2-4 waterloo Place 
Fife NHS Board  
Hayfield House  





Edinburgh, EH1 3EG 
Tel: 0131 465 5708 
Fife, KY2 5AH  
Tel: 01592 648 153 
 
More Information 
More information on the various organisations can be found here; 
University of Edinburgh http://www.ed.ac.uk  
Child Life and Health http://www.crh.ed.ac.uk/clah/ 
NHS Scotland http://www.show.scot.nhs.uk/  
MMEC http://www.edinburghneuroscience.ed.ac.uk/MuirMaxwellCentre/  












NEURO-PROFILES – Neurodevelopment in Preschool Children Of Fife and 
Lothian Epilepsy Study 
Consent Form 
Please initial box 
1.  I confirm that I have read and understood the information sheet (12/11/13 version 
5) for the above study and have had the opportunity to ask questions. 
 
2.  I understand that my child’s and my own  participation is voluntary and that we are  
free to withdraw at any time without giving any reason. 
 
3.  I understand that the results as well as the participation in the current experiment  
will be confidentially treated. 
 
4. I agree to let my personal details be stored securely to enable contact by the research  
team in the future and I understand that I can request to withdraw this information at  
any time in the future. (In the event of loss of capacity you and your child will be  
withdrawn from the study. Data already collected will be retained and used in the study.) 
 
5. I allow the research team to access routinely stored data on education, health and  
social information for my child, as described in the study information sheet, to follow-up  
my child’s development.  
 
6. I understand that relevant sections of my child’s medical notes and data collected 
during the study may be looked at by individuals from the sponsor(s),  regulatory  
authorities or from the NHS Board, where it is relevant to my taking part in this research. 
I give permission for these individuals to have access to my child’s records. 
 
7. I agree to let my child’s GP and/or Paediatrician be informed of entry onto the study  
and to be informed of assessment results if appropriate. 
 
8.  I consent to my child and I taking part in the above study, and understand that not  




Parent/guardian’s signature: ________________________________________________ Date:____________ 




Appendix D – Anonymously gathered data 
- Age (determined by age at diagnosis) 
- Gender 
- Socioeconomic status (determined using Scottish Index of Multiple Deprivation as described in - 
chapter I, section 2.4.3) 
- Aetiology (ILAE 1989 and 2010 classifications) 
- Mode of seizure onset 
- Date of first seizure 
- Seizure type(s) 
- Ethnic origin 
- Epilepsy syndrome 
 
Appendix E – Medical History Questionnaire 
1. Basic information 
- Gender (male/female) 
- Birth weight (kg) 
- Gestation time (weeks) 
- Birth order (sibling order) 
- Twin (yes/no) 
- Breast fed duration (months) 
- Ethnicity 
- Parent marital status 
 
2. Epilepsy-related information 
- Date or age at first seizure 
- Diagnosis date or age 
- Syndrome  
- Seizure frequency (current) 
- Time since last seizure (days/weeks) 
- History of febrile seizures (yes/no) 
- History of status epilepticus if known or longest seizure duration 
- Status epilepticus frequency 
- Current AED medication (type/dosage) 
- Previous AED medication (type/dosage) 
- Time on current AED (days/weeks) 





3. Other relevant information 
- History of pregnancy complications/medication during pregnancy/history of drug or 
substance abuse during pregnancy 
- Family history of epilepsy or febrile seizures 
- Family history of psychiatric/mental disorder, learning disability, or developmental disorder 
- Other significant medical history of child 
 
Appendix F – Electroencephalograph Characteristics Proforma                           
EEG No:  
Age/ DOB   
Medication  
 
SECTION A: OVERALL FINDINGS: 
 
1. Conscious state recorded:  Wake only 
Sleep only   
-  record deepest sleep stage N1  N2  N3  REM 
Wake and sleep  
-  record deepest sleep stage N1  N2  N3  REM 
 
2. Attacks recorded:  Yes 
    No  
 
3. Overall impression of EEG: Normal  
    Abnormal 
- Abnormal, non-epileptiform 
- Abnormal, epileptiform 
 
IF ABNORMAL, COMPLETE SECTION B  
 
SECTION B 
1.  Non-epileptic abnormalities:  










- Interictal epileptiform discharges recorded?   YES /   NO 
-  Focal – single focus 
- Focal – multifocal, unilateral 
- Focal – multifocal, bilateral 
- Generalised 
 
- Ictal changes recorded?   YES /  NO  
- Focal – single focus                     [   temporal  /    extratemporal   ]   
- Focal – multifocal, unilateral 
- Focal – multifocal, bilateral 
- Generalised 
 
3.  Any syndrome-specific pattern?     YES / NO 
  - Idiopathic generalised epilepsy 
   -CAE                          other 
  - Symptomatic generalised epilepsy 
   -West Syndrome         Lennox Gastaut Syndrome        Other 
  -  BECTS 
  - Benign occipital epilepsy 
  - Other (describe) 
 
Appendix G – Search strategy for systematic review (chapter II, section 3.2) 
Database Selection: (i) Medline (Ovid) from 1946, (ii) Embase classic and EMBASE (Ovid) from 
1946, and (iii) Web of Science Core Collection (Thomson Reuters). 
Main target search terms: Children, epilepsy, incidence, and epidemiology. 
Database specific searches; 
(i) Medline, and (ii) EMBASE classic and EMBASE 
MESH search terms with relevant subheadings, and supplementary free-text searches were 
used;  
1. MESH terms; 
- Epilepsy (includes seizures and seizure disorders) 








2. Title and abstract free-text searches; 
- epilepsy 




(iii) Web Of Science 
Terms searched using ‘topic’ searches; 
1. epilep* OR “pediatric epilepsy” OR “paediatric epilepsy” OR “childhood epilepsy” OR “epilep* 
encephalopathy*” 
2. preschool* OR Infant* OR Children OR Childhood OR Todller* 





Appendix H – Risk of Bias assessment 
Methodological quality checklist from Kotsopoulos et al (2002) 






Yes – not clear 
Yes - clear 






Review of medical records and re-examination of positive cases 
Review of medical records 
Survey and re-examination of positive cases 
Survey 
3. Study population   










Yes – not clear 
Yes – clear 







epileptic seizures (provoked and unprovoked) 














Maximum possible score 30 
 
Risk bias assessment NEUROPROFILES 
1. Definition of epilepsy or 





Yes – not clear 
Yes – clear 
2. Population  type 2 
3 
Cohort (e.g. GP or birth)  
Geographic only 
3. Identification    




Surveillance of medical departments 
Mixed surveillance and medical registries 
b. Medical registry only 1 
2 
None or partial validation of positive cases 
Full validation of cases 




5. Population denominators or 









Two to five years 
≥Six years 
Maximum score 18*   




Points for each subsection were determined on a scale of 0 to 3. 0 points reflected an absence 
of a factor that may have improved accuracy of the true estimate, to a maximum of 3 points 
for the inclusion of methods that maximally increase the accuracy of the estimate or reduce 
bias.   
Subsection rationale; 
1. Definition - A clear definition of epilepsy is required in order to determine the accuracy of 
the underlying population. 
2. Population type – A cohort design (e.g. birth cohort or General Practitioner surgery) may 
potentially underestimate cases by excluding cases who have migrated into the area, or not 
registered with a General Practitioner. 
3. Identification – prospective design was given more weight than retrospective studies as per 
Kotsopoulos (2002). Mixed sourcing given more weight as this increases potential 
identification. 
4. Identification sources – multiple sources of case identification are preferred, as they are more 
likely to maximise case ascertainment. 
5. Population denominators or confidence intervals stated – All incidence estimates are likely 
to differ, even within the same population. As such, a confidence interval allows an appraisal 
of the uncertainty around the estimate. 
6. Incidence period – Incidence figures within a region may vary by year, and cases identified 
by underlying population size. Thus, longer identification phases increase total person-years 





Appendix I – ESSENCE Questionnaire  
 
___________________   _________  Girl Boy 
Name of child  Age 
 
___________________ _________ 
Completed by  Date 
 
Please take a few minutes to read and check the following items. 
 
Have you (or anybody else, who?___________________) been concerned for more than a few 
months regarding child´s 
          Y M/AL N* 
 
1.  General development     
2.  Motor development/Milestones 
3.          Reaction to sensory environment (sounds, light, smell,  
             taste, heat, cold) 
4. Communication/language/babble 
5.  Activity level (overactivity/passivity) or impulsivity 
6.  Attention/concentration/”listening” 
7.  Social interaction/Interest in other children 
8.  Behaviour 
9.  Mood (”depressed”, ”elated”, ”crying spells”) 
10.  Sleep 
11.  Feeding  
 




Appendix J – Abbreviations 
ABAS II – Adaptive Behaviour Assessment System, second edition 
AC – General adaptive composite of ABAS II 
ADHD – Attention Deficit Hyperactivity Disorder 
AED - Antiepileptic drugs 
ANCOVA – Analysis of covariance 
ANOVA – Analysis of variance 
AOI – Area of interest 
ASD - Autism spectrum disorder 
 
BRIEF-P - The Behavioural Rating Inventory of Executive Function – Preschool 
BMEI - Benign Myoclonic Epilepsy of Infancy 
 
CAE - Childhood Absence Epilepsy 
CEC - Conners Early Childhood-Behaviour Scales 
CI – Confidence interval 
CWEOE – Children with early-onset epilepsy 
 
DSM - Diagnostic and Statistical Manual of Mental Disorders 
DQ – Developmental quotient 
 
EEG – Electroencephalogram 
EMM – Estimated marginal mean 
ESSENCE-Q - Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical 
Examinations – Questionnaire 
 
FET – Fisher’s exact test 
FSIQ – Full scale intelligence quotient 
 
GCA - General cognitive ability 
GEC – General executive composite 
GQ - General quotient  
GP – General Practitioner 
 
ILAE - The International League Against Epilepsy 
IQ - Intelligence quotient 
IQR – Interquartile range 
ISI – Interstimulus interval 





M – Mean 
M-CHAT - The Modified Checklist for Autism in Toddlers 
MD – Mean difference 
MRI - Magnetic resonance imaging 
 
NEPSY – The Developmental Neuropsychological Assessment 
 
OR – Odds ratio 
 
PRISMA - Preferred Items for Systematic Reviews and Meta-Analyses 
 
rANCOVA – Rank analysis of covariance 
 
SD – Standard deviation 
SDQ – Strength and Difficulties Questionnaire 
SEGC – Social Emotional Growth Chart 
SES - Socioeconomic status 
SIMD – Scottish Index of Multiple Deprivation 
SNP – Spatial negative priming 
SRS-2 - The Social Responsiveness Scale - Second Edition 
 
TFD – Total fixation duration 
TSC - Tuberous sclerosis complex 
TTFF – Time to first fixation 
 
VABS - Vineland Adaptive Behaviour Scales 
VPC – Visual paired comparisons 
 
WPPSI III – Wechsler Preschool and Primary Scales of Intelligence 
